[
  {
    "bcr_patient_uuid": "6E7D5EC6-A469-467C-B748-237353C23416",
    "patient_ID": "TCGA.3C.AAAU",
    "bcr_drug_barcode": "TCGA-3C-AAAU-D60350",
    "bcr_drug_uuid": "B8C5D175-54E9-4659-A630-DC1EA2BBD315",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1828,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "55262FCB-1B01-4480-B322-36570430C917",
    "patient_ID": "TCGA.3C.AALI",
    "bcr_drug_barcode": "TCGA-3C-AALI-D62900",
    "bcr_drug_uuid": "C09E3F7D-0FC8-4316-AF95-1D9CE3497071",
    "form_completion_date": "2014-7-28",
    "pharmaceutical_therapy_drug_name": "POLY E",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "427D0648-3F77-4FFC-B52C-89855426D647",
    "patient_ID": "TCGA.3C.AALJ",
    "bcr_drug_barcode": "TCGA-3C-AALJ-D62904",
    "bcr_drug_uuid": "D9762142-667A-4123-846B-B3B965CE9A90",
    "form_completion_date": "2014-7-28",
    "pharmaceutical_therapy_drug_name": "METFORMIN",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "427D0648-3F77-4FFC-B52C-89855426D647",
    "patient_ID": "TCGA.3C.AALJ",
    "bcr_drug_barcode": "TCGA-3C-AALJ-D65377",
    "bcr_drug_uuid": "EA7483F7-D53B-4A10-9E28-68A29E1F04A9",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 490,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "427D0648-3F77-4FFC-B52C-89855426D647",
    "patient_ID": "TCGA.3C.AALJ",
    "bcr_drug_barcode": "TCGA-3C-AALJ-D65375",
    "bcr_drug_uuid": "F0F4D7C5-9237-480F-876C-60663BBBE325",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "427D0648-3F77-4FFC-B52C-89855426D647",
    "patient_ID": "TCGA.3C.AALJ",
    "bcr_drug_barcode": "TCGA-3C-AALJ-D65527",
    "bcr_drug_uuid": "4EFE0CA1-39BA-4A36-9BDD-55F322DA8C11",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "427D0648-3F77-4FFC-B52C-89855426D647",
    "patient_ID": "TCGA.3C.AALJ",
    "bcr_drug_barcode": "TCGA-3C-AALJ-D65378",
    "bcr_drug_uuid": "B5D318C4-A505-475B-8ABC-DFEAA6B55593",
    "form_completion_date": "2014-12-18",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C31900A4-5DCD-4022-97AC-638E86E889E4",
    "patient_ID": "TCGA.3C.AALK",
    "bcr_drug_barcode": "TCGA-3C-AALK-D62908",
    "bcr_drug_uuid": "571B5F2E-D8FE-48A4-8649-10F230CC8BB9",
    "form_completion_date": "2014-7-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 371,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 528,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C31900A4-5DCD-4022-97AC-638E86E889E4",
    "patient_ID": "TCGA.3C.AALK",
    "bcr_drug_barcode": "TCGA-3C-AALK-D65510",
    "bcr_drug_uuid": "6E4745D5-0034-4021-9CF7-C578C4793766",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 829,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C31900A4-5DCD-4022-97AC-638E86E889E4",
    "patient_ID": "TCGA.3C.AALK",
    "bcr_drug_barcode": "TCGA-3C-AALK-D65525",
    "bcr_drug_uuid": "0E79A684-C8F1-4AEB-9831-77AA9B72957E",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 371,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 528,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C31900A4-5DCD-4022-97AC-638E86E889E4",
    "patient_ID": "TCGA.3C.AALK",
    "bcr_drug_barcode": "TCGA-3C-AALK-D65526",
    "bcr_drug_uuid": "404CEE87-D8B8-4CEE-92A7-3A7FAD80183C",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 371,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 528,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6623FC5E-00BE-4476-967A-CBD55F676EA6",
    "patient_ID": "TCGA.4H.AAAK",
    "bcr_drug_barcode": "TCGA-4H-AAAK-D68065",
    "bcr_drug_uuid": "08F129B2-D118-4CA1-B51F-A648445EC84E",
    "form_completion_date": "2014-11-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6623FC5E-00BE-4476-967A-CBD55F676EA6",
    "patient_ID": "TCGA.4H.AAAK",
    "bcr_drug_barcode": "TCGA-4H-AAAK-D68067",
    "bcr_drug_uuid": "D675535D-A6A0-4634-8E6C-A5B7C8E61289",
    "form_completion_date": "2014-11-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6623FC5E-00BE-4476-967A-CBD55F676EA6",
    "patient_ID": "TCGA.4H.AAAK",
    "bcr_drug_barcode": "TCGA-4H-AAAK-D68072",
    "bcr_drug_uuid": "A6A3B982-CF4E-4E87-9F53-A31FE7AD6C2E",
    "form_completion_date": "2014-11-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86C6F993-327F-4525-9983-29C55625593A",
    "patient_ID": "TCGA.5L.AAT0",
    "bcr_drug_barcode": "TCGA-5L-AAT0-D63723",
    "bcr_drug_uuid": "BCA5B47A-BE3A-4258-8A17-692D7DFDDF87",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 322,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16FC3677-0393-4ED1-AD3F-C8355F056369",
    "patient_ID": "TCGA.5L.AAT1",
    "bcr_drug_barcode": "TCGA-5L-AAT1-D63716",
    "bcr_drug_uuid": "747059AE-DC7B-409F-9178-2DD683C19A6F",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "LETROZOL",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2FD36838-5A83-433E-AC80-B1F77448E5AA",
    "patient_ID": "TCGA.5T.A9QA",
    "bcr_drug_barcode": "TCGA-5T-A9QA-D66890",
    "bcr_drug_uuid": "41E877E4-A74A-4E15-A061-03DAFF7922A1",
    "form_completion_date": "2014-10-25",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2FD36838-5A83-433E-AC80-B1F77448E5AA",
    "patient_ID": "TCGA.5T.A9QA",
    "bcr_drug_barcode": "TCGA-5T-A9QA-D66891",
    "bcr_drug_uuid": "906BC4D2-3C18-42A8-ABE2-BF47933ABA1F",
    "form_completion_date": "2014-10-25",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 304,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2FD36838-5A83-433E-AC80-B1F77448E5AA",
    "patient_ID": "TCGA.5T.A9QA",
    "bcr_drug_barcode": "TCGA-5T-A9QA-D66892",
    "bcr_drug_uuid": "70C5FF1B-00BC-47E3-BD00-A0923F47645F",
    "form_completion_date": "2014-10-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2FD36838-5A83-433E-AC80-B1F77448E5AA",
    "patient_ID": "TCGA.5T.A9QA",
    "bcr_drug_barcode": "TCGA-5T-A9QA-D66893",
    "bcr_drug_uuid": "DCD07D88-6185-4E6B-B95A-FCBE7B9ECDDB",
    "form_completion_date": "2014-10-25",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b620966-b4c7-4615-bf58-ca9d3226b9bd",
    "patient_ID": "TCGA.A1.A0SF",
    "bcr_drug_barcode": "TCGA-A1-A0SF-D12152",
    "bcr_drug_uuid": "911C7AF6-25C0-4A50-BE12-4E139C861AC0",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "TC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4b620966-b4c7-4615-bf58-ca9d3226b9bd",
    "patient_ID": "TCGA.A1.A0SF",
    "bcr_drug_barcode": "TCGA-A1-A0SF-D12154",
    "bcr_drug_uuid": "8B91D294-5433-4D18-A271-253430DDD871",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 918,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4b620966-b4c7-4615-bf58-ca9d3226b9bd",
    "patient_ID": "TCGA.A1.A0SF",
    "bcr_drug_barcode": "TCGA-A1-A0SF-D12156",
    "bcr_drug_uuid": "7D85A866-4109-48A5-A927-6B9F5C64BD59",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1010,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "AROMATASE INHIBITOR",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0ed9ad26-7fdc-4d75-93f9-d029eee94993",
    "patient_ID": "TCGA.A1.A0SG",
    "bcr_drug_barcode": "TCGA-A1-A0SG-D12390",
    "bcr_drug_uuid": "8D77AB37-9AB4-43CE-86A0-AFB9DF77E6FA",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6a863d9-b39d-4965-b47f-79a1bcf3c976",
    "patient_ID": "TCGA.A1.A0SH",
    "bcr_drug_barcode": "TCGA-A1-A0SH-D4488",
    "bcr_drug_uuid": "13E24868-A281-4960-AF6C-21F950AF311B",
    "form_completion_date": "2010-12-7",
    "pharmaceutical_therapy_drug_name": "TC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0dc337fa-da8b-42c4-b9a7-fb76d81c161f",
    "patient_ID": "TCGA.A1.A0SN",
    "bcr_drug_barcode": "TCGA-A1-A0SN-D12066",
    "bcr_drug_uuid": "46FC4D8A-2EEC-454B-BC8F-447030B0D761",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "AC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0dc337fa-da8b-42c4-b9a7-fb76d81c161f",
    "patient_ID": "TCGA.A1.A0SN",
    "bcr_drug_barcode": "TCGA-A1-A0SN-D12067",
    "bcr_drug_uuid": "6BE7B34C-4BFD-4AFD-B4FA-EF6DFA0CA6D0",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0dc337fa-da8b-42c4-b9a7-fb76d81c161f",
    "patient_ID": "TCGA.A1.A0SN",
    "bcr_drug_barcode": "TCGA-A1-A0SN-D12157",
    "bcr_drug_uuid": "4E133864-9EDE-40C9-91C3-E5E05D9D8545",
    "form_completion_date": "2011-5-24",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 879,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6644fd4e-d2fe-4785-a73c-0f36fcc740e2",
    "patient_ID": "TCGA.A1.A0SO",
    "bcr_drug_barcode": "TCGA-A1-A0SO-D4449",
    "bcr_drug_uuid": "26D19DA7-541E-4272-8678-F08424C58A63",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a9bb8159-32f0-454c-a946-b3286a52b9d5",
    "patient_ID": "TCGA.A1.A0SP",
    "bcr_drug_barcode": "TCGA-A1-A0SP-D4489",
    "bcr_drug_uuid": "D44AD8B4-4B21-4F10-A99A-EEB2C92222FD",
    "form_completion_date": "2010-12-7",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "08de63a2-7b76-43c3-80dc-df748b1d81bc",
    "patient_ID": "TCGA.A1.A0SQ",
    "bcr_drug_barcode": "TCGA-A1-A0SQ-D15541",
    "bcr_drug_uuid": "6EF5104B-825D-4C69-94C9-85CB727D5457",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "AC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "08de63a2-7b76-43c3-80dc-df748b1d81bc",
    "patient_ID": "TCGA.A1.A0SQ",
    "bcr_drug_barcode": "TCGA-A1-A0SQ-D15542",
    "bcr_drug_uuid": "DE1DD233-6EE9-4C5D-8CAB-CF9336114C4A",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "08de63a2-7b76-43c3-80dc-df748b1d81bc",
    "patient_ID": "TCGA.A1.A0SQ",
    "bcr_drug_barcode": "TCGA-A1-A0SQ-D15544",
    "bcr_drug_uuid": "CC54C460-ED66-4313-9C2B-BA4816081388",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 299,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "197428f7-bd77-4c5f-8119-87157b5c35b9",
    "patient_ID": "TCGA.A2.A04N",
    "bcr_drug_barcode": "TCGA-A2-A04N-D7482",
    "bcr_drug_uuid": "87e62dc0-ef4f-4a7c-9870-8919bc877226",
    "form_completion_date": "2011-1-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 308,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2121,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "197428f7-bd77-4c5f-8119-87157b5c35b9",
    "patient_ID": "TCGA.A2.A04N",
    "bcr_drug_barcode": "TCGA-A2-A04N-D7480",
    "bcr_drug_uuid": "9eaef08e-aeb6-4f55-b9dd-61803a467369",
    "form_completion_date": "2011-1-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 113,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 452
  },
  {
    "bcr_patient_uuid": "197428f7-bd77-4c5f-8119-87157b5c35b9",
    "patient_ID": "TCGA.A2.A04N",
    "bcr_drug_barcode": "TCGA-A2-A04N-D7481",
    "bcr_drug_uuid": "6e45013f-a69c-43a0-8972-435c99dafbd9",
    "form_completion_date": "2011-1-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1130,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4520
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2662",
    "bcr_drug_uuid": "021fbfcb-44dd-4dcd-952e-486a8aa9ecd0",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 424,
    "drug_cycles": 1,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2661",
    "bcr_drug_uuid": "17d09ea1-32bc-4cc2-998e-e9368e472335",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 424,
    "drug_cycles": 1,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2656",
    "bcr_drug_uuid": "355b6e7c-0b78-4127-8a9b-218b7e9c260b",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2660",
    "bcr_drug_uuid": "365f5d4a-5bca-494e-82fa-3648ee6acfaa",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 303,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 424,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2663",
    "bcr_drug_uuid": "3a1d9f6f-f1ca-46c5-b2a8-de1975c543bc",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2657",
    "bcr_drug_uuid": "8779d88c-d7d4-492c-b46f-bebb3650f0e8",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2658",
    "bcr_drug_uuid": "82ad8e80-6818-481d-83da-17868130a545",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 242,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21",
    "patient_ID": "TCGA.A2.A04P",
    "bcr_drug_barcode": "TCGA-A2-A04P-D2659",
    "bcr_drug_uuid": "2af268e5-309a-4cc6-8239-5fad8fe2c4e1",
    "form_completion_date": "2010-8-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 242,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b5fba77b-1f50-4e71-95b2-566afba4bdd7",
    "patient_ID": "TCGA.A2.A04Q",
    "bcr_drug_barcode": "TCGA-A2-A04Q-D2766",
    "bcr_drug_uuid": "df8339c3-f6d8-4121-a22d-949df819ce16",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 204
  },
  {
    "bcr_patient_uuid": "b5fba77b-1f50-4e71-95b2-566afba4bdd7",
    "patient_ID": "TCGA.A2.A04Q",
    "bcr_drug_barcode": "TCGA-A2-A04Q-D2764",
    "bcr_drug_uuid": "9f6d826b-b6b9-4f14-8640-7e859b8c7f95",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4048
  },
  {
    "bcr_patient_uuid": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5",
    "patient_ID": "TCGA.A2.A04R",
    "bcr_drug_barcode": "TCGA-A2-A04R-D2555",
    "bcr_drug_uuid": "59cf62c8-9052-43df-aefa-ea940996727a",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 909,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5",
    "patient_ID": "TCGA.A2.A04R",
    "bcr_drug_barcode": "TCGA-A2-A04R-D2553",
    "bcr_drug_uuid": "80d22cd5-ee42-4e09-b192-f6b2183cf0b3",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5",
    "patient_ID": "TCGA.A2.A04R",
    "bcr_drug_barcode": "TCGA-A2-A04R-D2556",
    "bcr_drug_uuid": "258814a0-8e67-4ac2-84ec-1353588f2f9d",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 910,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5",
    "patient_ID": "TCGA.A2.A04R",
    "bcr_drug_barcode": "TCGA-A2-A04R-D2554",
    "bcr_drug_uuid": "575ace17-a333-4457-837f-9f4210296cb5",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5",
    "patient_ID": "TCGA.A2.A04R",
    "bcr_drug_barcode": "TCGA-A2-A04R-D2552",
    "bcr_drug_uuid": "7430b157-f641-4b64-86b4-38f47b845980",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 354,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 354
  },
  {
    "bcr_patient_uuid": "b58ad350-5140-4fa8-bc2c-24bca8395f3a",
    "patient_ID": "TCGA.A2.A04T",
    "bcr_drug_barcode": "TCGA-A2-A04T-D2760",
    "bcr_drug_uuid": "dc41b9d2-298f-4934-b566-dfdda2dea217",
    "form_completion_date": "2010-8-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 58,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 232
  },
  {
    "bcr_patient_uuid": "b58ad350-5140-4fa8-bc2c-24bca8395f3a",
    "patient_ID": "TCGA.A2.A04T",
    "bcr_drug_barcode": "TCGA-A2-A04T-D2761",
    "bcr_drug_uuid": "6ad79761-aee6-43f7-83c2-d7f5f8ac6189",
    "form_completion_date": "2010-8-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 838
  },
  {
    "bcr_patient_uuid": "b58ad350-5140-4fa8-bc2c-24bca8395f3a",
    "patient_ID": "TCGA.A2.A04T",
    "bcr_drug_barcode": "TCGA-A2-A04T-D2759",
    "bcr_drug_uuid": "cd18d339-0df7-42da-a74d-266504627111",
    "form_completion_date": "2010-8-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4600
  },
  {
    "bcr_patient_uuid": "1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9",
    "patient_ID": "TCGA.A2.A04U",
    "bcr_drug_barcode": "TCGA-A2-A04U-D6673",
    "bcr_drug_uuid": "7c4f7833-834c-4045-b558-4a53c47aec04",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 116,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 464
  },
  {
    "bcr_patient_uuid": "1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9",
    "patient_ID": "TCGA.A2.A04U",
    "bcr_drug_barcode": "TCGA-A2-A04U-D6680",
    "bcr_drug_uuid": "14adba24-28a7-4eac-bcdf-6542a26395b8",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 481,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 671,
    "drug_cycles": 3,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9",
    "patient_ID": "TCGA.A2.A04U",
    "bcr_drug_barcode": "TCGA-A2-A04U-D6679",
    "bcr_drug_uuid": "0a1f5288-fb98-4a32-ab56-4dca69f8d629",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 612
  },
  {
    "bcr_patient_uuid": "1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9",
    "patient_ID": "TCGA.A2.A04U",
    "bcr_drug_barcode": "TCGA-A2-A04U-D6675",
    "bcr_drug_uuid": "15e8f3ac-8410-402b-85c4-76caeb242226",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1160,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4640
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2667",
    "bcr_drug_uuid": "e691b7e7-6b22-430c-9b18-b7f08912f85a",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1146,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4584
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2668",
    "bcr_drug_uuid": "8e869f6b-ed8a-4174-ad9e-fff54d6496cc",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2672",
    "bcr_drug_uuid": "c1e949b8-77cf-4bbb-b6f2-a74ede20457a",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1258,
    "drug_units": "MG",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2674",
    "bcr_drug_uuid": "a2308b51-8301-425e-b065-0be458fe1672",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2768",
    "bcr_drug_uuid": "4de0e435-5d29-44a0-a877-986681b96a3b",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1269,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1439,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "64f67506-f2df-4f0a-b7be-29b4949e986a",
    "patient_ID": "TCGA.A2.A04V",
    "bcr_drug_barcode": "TCGA-A2-A04V-D2673",
    "bcr_drug_uuid": "41160c56-81c5-42b7-83b8-cc0018073cac",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1452,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb",
    "patient_ID": "TCGA.A2.A04W",
    "bcr_drug_barcode": "TCGA-A2-A04W-D6689",
    "bcr_drug_uuid": "65ec14e5-944c-4f65-bd7f-af3f9f1de109",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb",
    "patient_ID": "TCGA.A2.A04W",
    "bcr_drug_barcode": "TCGA-A2-A04W-D6687",
    "bcr_drug_uuid": "236eedf5-1416-4267-9403-20ce7d6acbf7",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb",
    "patient_ID": "TCGA.A2.A04W",
    "bcr_drug_barcode": "TCGA-A2-A04W-D6690",
    "bcr_drug_uuid": "ce20855f-bc0d-4156-97a3-58368e52b5fa",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1768
  },
  {
    "bcr_patient_uuid": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb",
    "patient_ID": "TCGA.A2.A04W",
    "bcr_drug_barcode": "TCGA-A2-A04W-D6692",
    "bcr_drug_uuid": "a9c9c08e-0668-48ba-a67a-68928076d805",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1023,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_dose": 4,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb",
    "patient_ID": "TCGA.A2.A04W",
    "bcr_drug_barcode": "TCGA-A2-A04W-D6691",
    "bcr_drug_uuid": "ed0088f6-01ce-4f8a-99e1-998641ad9eac",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 352,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4187
  },
  {
    "bcr_patient_uuid": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37",
    "patient_ID": "TCGA.A2.A04X",
    "bcr_drug_barcode": "TCGA-A2-A04X-D2681",
    "bcr_drug_uuid": "9e16caf0-b8c7-4aed-a2d9-5a2494cafed1",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4560
  },
  {
    "bcr_patient_uuid": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37",
    "patient_ID": "TCGA.A2.A04X",
    "bcr_drug_barcode": "TCGA-A2-A04X-D2682",
    "bcr_drug_uuid": "b94cdbfc-4069-4d6a-8d85-c6b17dbc5d93",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 114,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 456
  },
  {
    "bcr_patient_uuid": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37",
    "patient_ID": "TCGA.A2.A04X",
    "bcr_drug_barcode": "TCGA-A2-A04X-D2684",
    "bcr_drug_uuid": "b8724add-8494-4d41-af82-b8a8e396c6df",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "drug_cycles": 20,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6471.5
  },
  {
    "bcr_patient_uuid": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37",
    "patient_ID": "TCGA.A2.A04X",
    "bcr_drug_barcode": "TCGA-A2-A04X-D2683",
    "bcr_drug_uuid": "ca766a09-75f1-4329-9994-9dd95f79c497",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1858
  },
  {
    "bcr_patient_uuid": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37",
    "patient_ID": "TCGA.A2.A04X",
    "bcr_drug_barcode": "TCGA-A2-A04X-D2685",
    "bcr_drug_uuid": "a4d66c51-5221-4ab9-aa36-900913040d4b",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 490,
    "drug_units": "MG",
    "drug_dose": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2733",
    "bcr_drug_uuid": "ea8b13ac-f088-4440-a155-06c71299a37e",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 659,
    "drug_cycles": 22,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10037
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2741",
    "bcr_drug_uuid": "d6d00a85-5494-4f08-8711-63169285c197",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 371,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2754",
    "bcr_drug_uuid": "e34536c3-f6b1-4a30-8208-da6658e0d4bd",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 503,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "BISPHOSPHONATE THERAPY",
    "drug_units": "MG",
    "drug_dose": 4,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PATIENT HAS OESTEOPOROSIS (PREVENTION OF FURTHER BONE LOSS"
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2729",
    "bcr_drug_uuid": "bb88b686-73af-4f28-b19b-97bdb837eddb",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2732",
    "bcr_drug_uuid": "e7199f09-af18-4584-8015-6eebc968cd8c",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2731",
    "bcr_drug_uuid": "351c5069-eb0c-468e-ba16-bf6ab636303f",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "9ce7ce09-4409-4fa3-9f78-b2b24716f860",
    "patient_ID": "TCGA.A2.A04Y",
    "bcr_drug_barcode": "TCGA-A2-A04Y-D2746",
    "bcr_drug_uuid": "227dd2b0-0b22-46bd-95d4-20775978c5dd",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 372,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D32654",
    "bcr_drug_uuid": "9B39167B-12F1-4113-A4B9-6D87C0D579F0",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D32655",
    "bcr_drug_uuid": "66EDDC61-9F6C-4BBA-A99E-BCD484A1A162",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D32656",
    "bcr_drug_uuid": "9C6B9B44-4C5B-42CD-8AA6-38038395E117",
    "form_completion_date": "2012-6-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D42397",
    "bcr_drug_uuid": "F5986AFE-856D-4225-B5CE-EA9C5922B674",
    "form_completion_date": "2013-4-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1451,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1518,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D42398",
    "bcr_drug_uuid": "DACB6594-4AB8-425A-8BF3-E16A2296F99E",
    "form_completion_date": "2013-4-18",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1569,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5ACA16CA-4516-4E27-8249-6914029A7EBF",
    "patient_ID": "TCGA.A2.A0CK",
    "bcr_drug_barcode": "TCGA-A2-A0CK-D42399",
    "bcr_drug_uuid": "DB784ADC-6137-423C-8F1C-5832E32592E5",
    "form_completion_date": "2013-4-18",
    "pharmaceutical_therapy_drug_name": "E-75",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7411",
    "bcr_drug_uuid": "68e80464-73a4-4094-9487-d45dc4d516d7",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 102,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 408
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7408",
    "bcr_drug_uuid": "6e17a5be-5bf0-4bf3-8e88-caab1ca38aed",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1006
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7415",
    "bcr_drug_uuid": "9ded5455-e05f-4b38-b10a-0accda9fdabb",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7409",
    "bcr_drug_uuid": "7f7f933f-bab0-42a9-b14f-e3b8eaee2866",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1020,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4080
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7412",
    "bcr_drug_uuid": "c002a4ce-ae2a-4c04-9941-a4fa99d93666",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 504,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D7417",
    "bcr_drug_uuid": "8844d562-a5b6-4ebb-9006-a8eba7177d29",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 752,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_dose": 4,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTENANCE (FOR OSTEOPENIA)"
  },
  {
    "bcr_patient_uuid": "5c8983f2-9788-4dfa-971c-3ec457b6166e",
    "patient_ID": "TCGA.A2.A0CL",
    "bcr_drug_barcode": "TCGA-A2-A0CL-D39784",
    "bcr_drug_uuid": "3CD728D5-9818-47B3-AED9-099463BAC77E",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "clinical_trial_drug_classification": "ANTIMETABOLITE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2018",
    "bcr_drug_uuid": "51cca21e-fd29-4d59-9de1-916fc77056e0",
    "form_completion_date": "2010-8-23",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 106,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2026",
    "bcr_drug_uuid": "80df2add-560a-429f-9f42-6469a5e88bba",
    "form_completion_date": "2010-8-23",
    "pharmaceutical_therapy_drug_name": "CAPECETABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 391,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 24400
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2022",
    "bcr_drug_uuid": "afae9c46-2307-4844-b80b-cb436fc1e8bb",
    "form_completion_date": "2010-8-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 234,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2020",
    "bcr_drug_uuid": "88adeb77-bcc1-48cb-a270-92cdc1fe8f24",
    "form_completion_date": "2010-8-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1062,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4248
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2027",
    "bcr_drug_uuid": "e8027663-89df-4c62-9c8c-b7709606de60",
    "form_completion_date": "2010-8-24",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 391,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_cycles": 2,
    "pharma_type_other": "BISPHOSPHONATE THERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "eb2dbb4f-66b6-4525-8323-431970f7a64e",
    "patient_ID": "TCGA.A2.A0CM",
    "bcr_drug_barcode": "TCGA-A2-A0CM-D2024",
    "bcr_drug_uuid": "2a0f9e7d-47a8-4977-9845-f9255d292e92",
    "form_completion_date": "2010-8-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 391,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 890
  },
  {
    "bcr_patient_uuid": "8E54232D-D8BB-4612-8B0E-4FEB076A60F9",
    "patient_ID": "TCGA.A2.A0CO",
    "bcr_drug_barcode": "TCGA-A2-A0CO-D33663",
    "bcr_drug_uuid": "80B1C97B-8D60-43C3-BDCE-AC0B58A11419",
    "form_completion_date": "2012-7-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 512,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8E54232D-D8BB-4612-8B0E-4FEB076A60F9",
    "patient_ID": "TCGA.A2.A0CO",
    "bcr_drug_barcode": "TCGA-A2-A0CO-D33664",
    "bcr_drug_uuid": "68699598-6953-48BB-BD8B-76AC54625819",
    "form_completion_date": "2012-7-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 513,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fe15c48b-116d-461e-9b40-68514730fd18",
    "patient_ID": "TCGA.A2.A0CP",
    "bcr_drug_barcode": "TCGA-A2-A0CP-D2003",
    "bcr_drug_uuid": "e1068c5e-35cf-4b45-9e78-0d8b415602e8",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 106,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "fe15c48b-116d-461e-9b40-68514730fd18",
    "patient_ID": "TCGA.A2.A0CP",
    "bcr_drug_barcode": "TCGA-A2-A0CP-D2002",
    "bcr_drug_uuid": "f2a18707-8081-432a-ba13-4789e14d46c9",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4236
  },
  {
    "bcr_patient_uuid": "fe15c48b-116d-461e-9b40-68514730fd18",
    "patient_ID": "TCGA.A2.A0CP",
    "bcr_drug_barcode": "TCGA-A2-A0CP-D2004",
    "bcr_drug_uuid": "6a6c88d1-1963-4a43-b81a-b46a280df51f",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 206,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2043,
    "drug_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ab34a9a2-d72d-4106-94fb-118844b1b60b",
    "patient_ID": "TCGA.A2.A0CQ",
    "bcr_drug_barcode": "TCGA-A2-A0CQ-D1988",
    "bcr_drug_uuid": "865e1c55-d241-4076-bd9a-0bffed3475aa",
    "form_completion_date": "2010-8-30",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 201,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ab34a9a2-d72d-4106-94fb-118844b1b60b",
    "patient_ID": "TCGA.A2.A0CQ",
    "bcr_drug_barcode": "TCGA-A2-A0CQ-D1987",
    "bcr_drug_uuid": "3bae8101-5295-4dd1-b21f-31ed7bf92ec2",
    "form_completion_date": "2010-8-30",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 104,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 416
  },
  {
    "bcr_patient_uuid": "ab34a9a2-d72d-4106-94fb-118844b1b60b",
    "patient_ID": "TCGA.A2.A0CQ",
    "bcr_drug_barcode": "TCGA-A2-A0CQ-D1986",
    "bcr_drug_uuid": "664f836e-85b0-4c5f-8869-42321a27e983",
    "form_completion_date": "2010-8-30",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1044,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4176
  },
  {
    "bcr_patient_uuid": "ab34a9a2-d72d-4106-94fb-118844b1b60b",
    "patient_ID": "TCGA.A2.A0CQ",
    "bcr_drug_barcode": "TCGA-A2-A0CQ-D1990",
    "bcr_drug_uuid": "71de8349-bb98-4691-8138-1cdcc08f849c",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "AE-37",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 492,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 628,
    "drug_cycles": 6,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_dose": 100,
    "regimen_number": 4,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CANCER VACCINE TRIAL",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "4CF0F639-7940-48B6-8EA1-2A3494097CDB",
    "patient_ID": "TCGA.A2.A0CR",
    "bcr_drug_barcode": "TCGA-A2-A0CR-D32690",
    "bcr_drug_uuid": "D0B85F79-B3D8-4E9F-A1AA-E2C032E70AB5",
    "form_completion_date": "2012-6-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4CF0F639-7940-48B6-8EA1-2A3494097CDB",
    "patient_ID": "TCGA.A2.A0CR",
    "bcr_drug_barcode": "TCGA-A2-A0CR-D32691",
    "bcr_drug_uuid": "A7033B5A-843E-4899-98F4-FAA742F71CB5",
    "form_completion_date": "2012-6-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4CF0F639-7940-48B6-8EA1-2A3494097CDB",
    "patient_ID": "TCGA.A2.A0CR",
    "bcr_drug_barcode": "TCGA-A2-A0CR-D32692",
    "bcr_drug_uuid": "B04147AD-6DB7-426E-AA27-E42D79761AE0",
    "form_completion_date": "2012-6-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4CF0F639-7940-48B6-8EA1-2A3494097CDB",
    "patient_ID": "TCGA.A2.A0CR",
    "bcr_drug_barcode": "TCGA-A2-A0CR-D32693",
    "bcr_drug_uuid": "15734CC3-5FE8-44C0-8E0B-651B026DFC80",
    "form_completion_date": "2012-6-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 224,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4CF0F639-7940-48B6-8EA1-2A3494097CDB",
    "patient_ID": "TCGA.A2.A0CR",
    "bcr_drug_barcode": "TCGA-A2-A0CR-D32695",
    "bcr_drug_uuid": "4B109ECE-53BB-4544-A269-3DBBEFFDF432",
    "form_completion_date": "2012-6-7",
    "pharmaceutical_therapy_drug_name": "ANASTRAZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 315,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d071c16b-7cee-45ed-8ec9-612418143815",
    "patient_ID": "TCGA.A2.A0CS",
    "bcr_drug_barcode": "TCGA-A2-A0CS-D7280",
    "bcr_drug_uuid": "0b827c0b-3829-40ed-8e56-86f2a957472b",
    "form_completion_date": "2011-1-28",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 597,
    "drug_cycles": 3,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTENANCE THERAPY",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "d071c16b-7cee-45ed-8ec9-612418143815",
    "patient_ID": "TCGA.A2.A0CS",
    "bcr_drug_barcode": "TCGA-A2-A0CS-D7277",
    "bcr_drug_uuid": "c1d5ddf5-8870-4ff6-a547-018f3e5d0bc4",
    "form_completion_date": "2011-1-28",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "378778d2-b331-4867-a93b-c64028c8b4c7",
    "patient_ID": "TCGA.A2.A0CT",
    "bcr_drug_barcode": "TCGA-A2-A0CT-D1975",
    "bcr_drug_uuid": "b6f4f507-e6ee-45bc-b50b-d9a2bb53bcaa",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "378778d2-b331-4867-a93b-c64028c8b4c7",
    "patient_ID": "TCGA.A2.A0CT",
    "bcr_drug_barcode": "TCGA-A2-A0CT-D1973",
    "bcr_drug_uuid": "46d7f184-146c-4978-a041-32b27f642b48",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "378778d2-b331-4867-a93b-c64028c8b4c7",
    "patient_ID": "TCGA.A2.A0CT",
    "bcr_drug_barcode": "TCGA-A2-A0CT-D1976",
    "bcr_drug_uuid": "fe69a660-e936-4a3f-8e5d-8cbfbb6dfeb4",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1537,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "378778d2-b331-4867-a93b-c64028c8b4c7",
    "patient_ID": "TCGA.A2.A0CT",
    "bcr_drug_barcode": "TCGA-A2-A0CT-D1974",
    "bcr_drug_uuid": "76a54d5e-e978-4768-b8d6-d25277ef9803",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "332423a7-8866-4ee3-b08f-3c8d7c16af80",
    "patient_ID": "TCGA.A2.A0CU",
    "bcr_drug_barcode": "TCGA-A2-A0CU-D1971",
    "bcr_drug_uuid": "a4307c98-baf1-4f65-b40b-87bb611d8a4a",
    "form_completion_date": "2010-10-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad7fcc89-82a3-48aa-8461-581c1a857677",
    "patient_ID": "TCGA.A2.A0CV",
    "bcr_drug_barcode": "TCGA-A2-A0CV-D7431",
    "bcr_drug_uuid": "c7ce28fd-8d85-4a62-949f-f36325333465",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 276,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1104
  },
  {
    "bcr_patient_uuid": "ad7fcc89-82a3-48aa-8461-581c1a857677",
    "patient_ID": "TCGA.A2.A0CV",
    "bcr_drug_barcode": "TCGA-A2-A0CV-D7432",
    "bcr_drug_uuid": "546eb18e-fefa-41d3-a86b-bef28743095c",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad7fcc89-82a3-48aa-8461-581c1a857677",
    "patient_ID": "TCGA.A2.A0CV",
    "bcr_drug_barcode": "TCGA-A2-A0CV-D7430",
    "bcr_drug_uuid": "f6b8fbb1-9792-48f4-ad8f-0f6490d403ae",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 950,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "ad7fcc89-82a3-48aa-8461-581c1a857677",
    "patient_ID": "TCGA.A2.A0CV",
    "bcr_drug_barcode": "TCGA-A2-A0CV-D7428",
    "bcr_drug_uuid": "0fecbde9-3113-43c9-9873-5c3dc1c9158c",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 95,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "32efa6e8-6b19-480a-9d04-ace02e93318a",
    "patient_ID": "TCGA.A2.A0CW",
    "bcr_drug_barcode": "TCGA-A2-A0CW-D7229",
    "bcr_drug_uuid": "c36b63ba-4a02-4afd-881a-952408223aa4",
    "form_completion_date": "2011-2-1",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1968",
    "bcr_drug_uuid": "aa0d58a3-07f6-4683-b664-53d0eec5ffcf",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1273,
    "drug_units": "MG",
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1963",
    "bcr_drug_uuid": "dcb6e770-4623-4b7b-81dc-ed8d4d0a0f44",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 126,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 504
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1964",
    "bcr_drug_uuid": "b6f6197b-da60-4a3c-8ad3-684df50b6dfa",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 165,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1966",
    "bcr_drug_uuid": "f97daa85-db58-457f-9c18-66c61a97cfcf",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": false,
    "pharma_type_other": "GIVEN TO INDUCE MENOPAUSE",
    "drug_units": "MG",
    "drug_dose": 3.6,
    "regimen_number": 5,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "GIVEN TO INDUCE MENOPAUSE"
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1967",
    "bcr_drug_uuid": "7eae7122-ba45-4ed8-86c7-0b0b15f5a9e8",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 686,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1962",
    "bcr_drug_uuid": "76481ee3-1221-4453-8712-e377d62dadcc",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1250,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "bcr_patient_uuid": "c744fc13-3aca-4245-9e24-abd368cc8bef",
    "patient_ID": "TCGA.A2.A0CX",
    "bcr_drug_barcode": "TCGA-A2-A0CX-D1965",
    "bcr_drug_uuid": "f31ba050-8c08-4914-b20d-75d85501bb13",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 367,
    "drug_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2037",
    "bcr_drug_uuid": "18ee660a-937e-4b2e-8965-26eac0c8eeca",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4320,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8640
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2038",
    "bcr_drug_uuid": "3dd69ff8-546a-4ac3-bc5b-256b74c682b9",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 357,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2036",
    "bcr_drug_uuid": "f14a412b-1425-4f47-ae9a-36a4915d9a26",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1121
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2039",
    "bcr_drug_uuid": "447a07c8-be8d-45d3-8404-b6d76b16b0bc",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 455,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 507,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2042",
    "bcr_drug_uuid": "f939ece6-83f5-47de-903f-49a909ca253c",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1261,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2035",
    "bcr_drug_uuid": "9b6cfae2-3c2c-4c37-9713-fe0ab090e606",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5216
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2041",
    "bcr_drug_uuid": "d5d250f1-15c3-4766-94ed-40ac4f8f7cc0",
    "form_completion_date": "2010-9-13",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1071,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1162,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2034",
    "bcr_drug_uuid": "bb794a4d-53f8-4917-bb80-d7fc4646766c",
    "form_completion_date": "2010-9-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "757df7b0-4774-4493-98bf-999ded9ac86e",
    "patient_ID": "TCGA.A2.A0CY",
    "bcr_drug_barcode": "TCGA-A2-A0CY-D2040",
    "bcr_drug_uuid": "bad877aa-b726-4dc3-ab46-c4c508f5b58c",
    "form_completion_date": "2010-9-14",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 634,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 665,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9f93ea0a-1687-44e0-9e8a-eeb4097d471c",
    "patient_ID": "TCGA.A2.A0CZ",
    "bcr_drug_barcode": "TCGA-A2-A0CZ-D2008",
    "bcr_drug_uuid": "df7c95fe-5410-4be7-b482-c0d6c6973671",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 236,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9f93ea0a-1687-44e0-9e8a-eeb4097d471c",
    "patient_ID": "TCGA.A2.A0CZ",
    "bcr_drug_barcode": "TCGA-A2-A0CZ-D2007",
    "bcr_drug_uuid": "8d024ed9-cab0-4645-9ef7-d2443495432a",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1045,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4180
  },
  {
    "bcr_patient_uuid": "9f93ea0a-1687-44e0-9e8a-eeb4097d471c",
    "patient_ID": "TCGA.A2.A0CZ",
    "bcr_drug_barcode": "TCGA-A2-A0CZ-D2006",
    "bcr_drug_uuid": "b80c8dcd-95cb-43e8-baaf-50704eb883f9",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 418
  },
  {
    "bcr_patient_uuid": "324bcba2-f6a4-45a6-807c-215bdffcca21",
    "patient_ID": "TCGA.A2.A0D0",
    "bcr_drug_barcode": "TCGA-A2-A0D0-D1851",
    "bcr_drug_uuid": "f423013c-d03a-46bf-9df8-4261396bdc99",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1230,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4920
  },
  {
    "bcr_patient_uuid": "324bcba2-f6a4-45a6-807c-215bdffcca21",
    "patient_ID": "TCGA.A2.A0D0",
    "bcr_drug_barcode": "TCGA-A2-A0D0-D1852",
    "bcr_drug_uuid": "e74bfde2-3653-4de9-bff3-80e8d53d150d",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 153,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 612
  },
  {
    "bcr_patient_uuid": "084c6aec-94f7-4090-8f3f-59fa9e89721a",
    "patient_ID": "TCGA.A2.A0D1",
    "bcr_drug_barcode": "TCGA-A2-A0D1-D1837",
    "bcr_drug_uuid": "883b03cb-e338-4344-822c-fd144c3d5280",
    "form_completion_date": "2010-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 366,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 366
  },
  {
    "bcr_patient_uuid": "084c6aec-94f7-4090-8f3f-59fa9e89721a",
    "patient_ID": "TCGA.A2.A0D1",
    "bcr_drug_barcode": "TCGA-A2-A0D1-D1840",
    "bcr_drug_uuid": "cb590dde-3e1f-4b38-a4fb-a6a1fc7eb4cc",
    "form_completion_date": "2010-9-21",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "084c6aec-94f7-4090-8f3f-59fa9e89721a",
    "patient_ID": "TCGA.A2.A0D1",
    "bcr_drug_barcode": "TCGA-A2-A0D1-D1838",
    "bcr_drug_uuid": "6ef785f5-54a6-46b8-a1bd-09fe99c2ed9a",
    "form_completion_date": "2010-9-21",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 428,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6575
  },
  {
    "bcr_patient_uuid": "084c6aec-94f7-4090-8f3f-59fa9e89721a",
    "patient_ID": "TCGA.A2.A0D1",
    "bcr_drug_barcode": "TCGA-A2-A0D1-D1836",
    "bcr_drug_uuid": "051e5eee-d34e-496f-bd8f-bdb8f99368a0",
    "form_completion_date": "2010-9-21",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "99e32c59-aa73-43fa-88c9-399ddadb2c72",
    "patient_ID": "TCGA.A2.A0D2",
    "bcr_drug_barcode": "TCGA-A2-A0D2-D1824",
    "bcr_drug_uuid": "ef46d977-60f0-4915-9438-4c3e9c7e66d8",
    "form_completion_date": "2010-9-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1308
  },
  {
    "bcr_patient_uuid": "99e32c59-aa73-43fa-88c9-399ddadb2c72",
    "patient_ID": "TCGA.A2.A0D2",
    "bcr_drug_barcode": "TCGA-A2-A0D2-D1822",
    "bcr_drug_uuid": "0b7ae681-1762-4598-b9c5-79d77a5f208a",
    "form_completion_date": "2010-9-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 435
  },
  {
    "bcr_patient_uuid": "99e32c59-aa73-43fa-88c9-399ddadb2c72",
    "patient_ID": "TCGA.A2.A0D2",
    "bcr_drug_barcode": "TCGA-A2-A0D2-D1823",
    "bcr_drug_uuid": "956680fa-6dc8-437e-8529-32d884b2e572",
    "form_completion_date": "2010-9-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1086,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4344
  },
  {
    "bcr_patient_uuid": "4a16429b-884f-4c95-8683-feeedf0d6a55",
    "patient_ID": "TCGA.A2.A0D3",
    "bcr_drug_barcode": "TCGA-A2-A0D3-D7246",
    "bcr_drug_uuid": "8f0c0628-9dff-4a13-bd14-246b3416cee2",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 142,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 852
  },
  {
    "bcr_patient_uuid": "4a16429b-884f-4c95-8683-feeedf0d6a55",
    "patient_ID": "TCGA.A2.A0D3",
    "bcr_drug_barcode": "TCGA-A2-A0D3-D7252",
    "bcr_drug_uuid": "490b634f-290f-4617-ab36-d0b91a1def75",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4a16429b-884f-4c95-8683-feeedf0d6a55",
    "patient_ID": "TCGA.A2.A0D3",
    "bcr_drug_barcode": "TCGA-A2-A0D3-D7248",
    "bcr_drug_uuid": "4676c63b-5c36-433a-a19d-b77bd02a9747",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 768,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4608
  },
  {
    "bcr_patient_uuid": "4a16429b-884f-4c95-8683-feeedf0d6a55",
    "patient_ID": "TCGA.A2.A0D3",
    "bcr_drug_barcode": "TCGA-A2-A0D3-D7254",
    "bcr_drug_uuid": "b8248a0e-7dbf-47a8-a4d5-83d530250db9",
    "form_completion_date": "2011-1-31",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 19,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2917
  },
  {
    "bcr_patient_uuid": "75113445-d2d6-44a0-866c-c9175e6d214b",
    "patient_ID": "TCGA.A2.A0D4",
    "bcr_drug_barcode": "TCGA-A2-A0D4-D1849",
    "bcr_drug_uuid": "04ba8237-4afb-4363-8a82-459dabc3dae3",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 279,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "75113445-d2d6-44a0-866c-c9175e6d214b",
    "patient_ID": "TCGA.A2.A0D4",
    "bcr_drug_barcode": "TCGA-A2-A0D4-D1846",
    "bcr_drug_uuid": "dfa2e5c7-323c-4d7a-bd29-45874eb4249b",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "75113445-d2d6-44a0-866c-c9175e6d214b",
    "patient_ID": "TCGA.A2.A0D4",
    "bcr_drug_barcode": "TCGA-A2-A0D4-D1848",
    "bcr_drug_uuid": "8883ac5c-2a78-4739-b762-eb643646c226",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 380,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1520
  },
  {
    "bcr_patient_uuid": "75113445-d2d6-44a0-866c-c9175e6d214b",
    "patient_ID": "TCGA.A2.A0D4",
    "bcr_drug_barcode": "TCGA-A2-A0D4-D1845",
    "bcr_drug_uuid": "ccf14e19-fbff-4548-b109-e64aeb37f5b7",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1304,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5216
  },
  {
    "bcr_patient_uuid": "2fdfd287-d13c-4910-9788-73987d45908a",
    "patient_ID": "TCGA.A2.A0EM",
    "bcr_drug_barcode": "TCGA-A2-A0EM-D1856",
    "bcr_drug_uuid": "74da4aa7-764e-4340-8062-1e2f5b8e5479",
    "form_completion_date": "2010-8-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5e670fec-8992-44bf-8657-f7f9a272306b",
    "patient_ID": "TCGA.A2.A0EN",
    "bcr_drug_barcode": "TCGA-A2-A0EN-D2544",
    "bcr_drug_uuid": "b71d60f7-798d-44c2-8d89-f63514233b1e",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1985,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5e670fec-8992-44bf-8657-f7f9a272306b",
    "patient_ID": "TCGA.A2.A0EN",
    "bcr_drug_barcode": "TCGA-A2-A0EN-D2543",
    "bcr_drug_uuid": "4d55dd20-b5b7-40c3-8015-41a32a417673",
    "form_completion_date": "2010-10-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1926,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf88ddf5-a6d4-498c-bf7f-db9bfabff72d",
    "patient_ID": "TCGA.A2.A0EO",
    "bcr_drug_barcode": "TCGA-A2-A0EO-D1993",
    "bcr_drug_uuid": "2292be73-49ad-45dd-a4af-0073e6cdf61e",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 876,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf88ddf5-a6d4-498c-bf7f-db9bfabff72d",
    "patient_ID": "TCGA.A2.A0EO",
    "bcr_drug_barcode": "TCGA-A2-A0EO-D1994",
    "bcr_drug_uuid": "5d5957c7-956b-45b3-981b-3030c7aac47c",
    "form_completion_date": "2010-8-11",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 876,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf88ddf5-a6d4-498c-bf7f-db9bfabff72d",
    "patient_ID": "TCGA.A2.A0EO",
    "bcr_drug_barcode": "TCGA-A2-A0EO-D1995",
    "bcr_drug_uuid": "27d60124-9f25-4998-9bd1-d10689365a73",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "E-75",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 361,
    "drug_cycles": 4,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_dose": 500,
    "regimen_number": 3,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CANCER VACCINE TRIAL",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "670F5022-5066-48F1-8472-5670129A1E0F",
    "patient_ID": "TCGA.A2.A0EP",
    "bcr_drug_barcode": "TCGA-A2-A0EP-D34476",
    "bcr_drug_uuid": "2B8CBF67-155E-4E57-A98D-DE14635EFF9B",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "670F5022-5066-48F1-8472-5670129A1E0F",
    "patient_ID": "TCGA.A2.A0EP",
    "bcr_drug_barcode": "TCGA-A2-A0EP-D34477",
    "bcr_drug_uuid": "173BF0C9-24F6-4410-AFF4-7061C0A143DB",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "670F5022-5066-48F1-8472-5670129A1E0F",
    "patient_ID": "TCGA.A2.A0EP",
    "bcr_drug_barcode": "TCGA-A2-A0EP-D34479",
    "bcr_drug_uuid": "C6483A02-70E1-4780-BC05-4AE04CAF32CB",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "670F5022-5066-48F1-8472-5670129A1E0F",
    "patient_ID": "TCGA.A2.A0EP",
    "bcr_drug_barcode": "TCGA-A2-A0EP-D34480",
    "bcr_drug_uuid": "FFB9FA64-1267-4A11-8416-9F07A311CF55",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1781,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "670F5022-5066-48F1-8472-5670129A1E0F",
    "patient_ID": "TCGA.A2.A0EP",
    "bcr_drug_barcode": "TCGA-A2-A0EP-D34482",
    "bcr_drug_uuid": "0E2A204E-622E-437C-ADF2-E2DEA2F32B38",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1959,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2461,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2192c1db-4718-4254-ba42-3ae7f30ad5a8",
    "patient_ID": "TCGA.A2.A0EQ",
    "bcr_drug_barcode": "TCGA-A2-A0EQ-D1954",
    "bcr_drug_uuid": "51e8ec2a-d6cf-441c-9bbb-e3cc24771544",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 488
  },
  {
    "bcr_patient_uuid": "2192c1db-4718-4254-ba42-3ae7f30ad5a8",
    "patient_ID": "TCGA.A2.A0EQ",
    "bcr_drug_barcode": "TCGA-A2-A0EQ-D1957",
    "bcr_drug_uuid": "68372627-8263-45a3-8639-655764fcb576",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 586,
    "drug_cycles": 22,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10543
  },
  {
    "bcr_patient_uuid": "2192c1db-4718-4254-ba42-3ae7f30ad5a8",
    "patient_ID": "TCGA.A2.A0EQ",
    "bcr_drug_barcode": "TCGA-A2-A0EQ-D1955",
    "bcr_drug_uuid": "56d1ca0d-0923-4f84-9ede-e315f87f1648",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1218,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4872
  },
  {
    "bcr_patient_uuid": "2192c1db-4718-4254-ba42-3ae7f30ad5a8",
    "patient_ID": "TCGA.A2.A0EQ",
    "bcr_drug_barcode": "TCGA-A2-A0EQ-D1956",
    "bcr_drug_uuid": "f5f84132-0ffb-472d-bf1d-c1d076a7708b",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 355,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 355
  },
  {
    "bcr_patient_uuid": "2192c1db-4718-4254-ba42-3ae7f30ad5a8",
    "patient_ID": "TCGA.A2.A0EQ",
    "bcr_drug_barcode": "TCGA-A2-A0EQ-D1958",
    "bcr_drug_uuid": "5dc02798-980f-40ea-b086-988e10bfba6d",
    "form_completion_date": "2010-9-9",
    "pharmaceutical_therapy_drug_name": "AE-37",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 679,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 796,
    "drug_cycles": 6,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_dose": 500,
    "regimen_number": 5,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CANCER VACCINE TRIAL",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "7455d832-ad66-40df-85d7-3a7051c4498d",
    "patient_ID": "TCGA.A2.A0ER",
    "bcr_drug_barcode": "TCGA-A2-A0ER-D1978",
    "bcr_drug_uuid": "81147c8f-47a7-4712-8495-8af0047c51d9",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1038,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4152
  },
  {
    "bcr_patient_uuid": "7455d832-ad66-40df-85d7-3a7051c4498d",
    "patient_ID": "TCGA.A2.A0ER",
    "bcr_drug_barcode": "TCGA-A2-A0ER-D1980",
    "bcr_drug_uuid": "72972060-56c4-4ffe-971d-d5772839072a",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7455d832-ad66-40df-85d7-3a7051c4498d",
    "patient_ID": "TCGA.A2.A0ER",
    "bcr_drug_barcode": "TCGA-A2-A0ER-D1981",
    "bcr_drug_uuid": "51090311-5909-4760-bf5a-1cefb8292222",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 173,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 173
  },
  {
    "bcr_patient_uuid": "7455d832-ad66-40df-85d7-3a7051c4498d",
    "patient_ID": "TCGA.A2.A0ER",
    "bcr_drug_barcode": "TCGA-A2-A0ER-D1979",
    "bcr_drug_uuid": "e44399f3-f0fc-40bf-8966-a2644119679e",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 104,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 416
  },
  {
    "bcr_patient_uuid": "7455d832-ad66-40df-85d7-3a7051c4498d",
    "patient_ID": "TCGA.A2.A0ER",
    "bcr_drug_barcode": "TCGA-A2-A0ER-D1982",
    "bcr_drug_uuid": "72844d5d-8e7f-4b64-80a5-ee6e676e0b32",
    "form_completion_date": "2010-9-10",
    "pharmaceutical_therapy_drug_name": "E-75",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_cycles": 7,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_dose": 1000,
    "regimen_number": 5,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CANCER VACCINE TRIAL",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "a2934508-3daf-49e2-b14f-ed9b7693f96f",
    "patient_ID": "TCGA.A2.A0ES",
    "bcr_drug_barcode": "TCGA-A2-A0ES-D6683",
    "bcr_drug_uuid": "6ea08fed-b015-4b7a-9ab3-d4beda0a721e",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "a2934508-3daf-49e2-b14f-ed9b7693f96f",
    "patient_ID": "TCGA.A2.A0ES",
    "bcr_drug_barcode": "TCGA-A2-A0ES-D6684",
    "bcr_drug_uuid": "08fef96e-bb08-4bf3-ad02-6018935a8f47",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 458,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a2934508-3daf-49e2-b14f-ed9b7693f96f",
    "patient_ID": "TCGA.A2.A0ES",
    "bcr_drug_barcode": "TCGA-A2-A0ES-D6682",
    "bcr_drug_uuid": "6c50633b-c480-4794-b943-a834c0c12463",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5018
  },
  {
    "bcr_patient_uuid": "a2934508-3daf-49e2-b14f-ed9b7693f96f",
    "patient_ID": "TCGA.A2.A0ES",
    "bcr_drug_barcode": "TCGA-A2-A0ES-D6685",
    "bcr_drug_uuid": "410e1f53-15e7-4ae7-9d01-2fee31ecd2f6",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "96f23d8a-be0f-4925-ba00-805dc293414c",
    "patient_ID": "TCGA.A2.A0ET",
    "bcr_drug_barcode": "TCGA-A2-A0ET-D1869",
    "bcr_drug_uuid": "27062a5c-294b-42b5-83d5-4823fa303cf6",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4650
  },
  {
    "bcr_patient_uuid": "96f23d8a-be0f-4925-ba00-805dc293414c",
    "patient_ID": "TCGA.A2.A0ET",
    "bcr_drug_barcode": "TCGA-A2-A0ET-D1872",
    "bcr_drug_uuid": "2b5d05ab-12db-4d8a-b19d-bfadbd0be27f",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 464
  },
  {
    "bcr_patient_uuid": "96f23d8a-be0f-4925-ba00-805dc293414c",
    "patient_ID": "TCGA.A2.A0ET",
    "bcr_drug_barcode": "TCGA-A2-A0ET-D1871",
    "bcr_drug_uuid": "595833d0-af3e-4038-80c4-3f798f222a6d",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 225,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1367
  },
  {
    "bcr_patient_uuid": "96f23d8a-be0f-4925-ba00-805dc293414c",
    "patient_ID": "TCGA.A2.A0ET",
    "bcr_drug_barcode": "TCGA-A2-A0ET-D1873",
    "bcr_drug_uuid": "f4c9aca2-477b-48f3-8c8c-8bff0959670c",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 282,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D6797",
    "bcr_drug_uuid": "29e822b5-c5e4-453f-9c1b-a7e30508d9e2",
    "form_completion_date": "2009-1-6",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 812,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D6754",
    "bcr_drug_uuid": "e9277ae6-b3a0-4b3b-a966-f019eda5e035",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1158,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4632
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D6794",
    "bcr_drug_uuid": "fd289cfd-fcaf-4acb-8fc0-5ca6b1ab340b",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 463
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D6795",
    "bcr_drug_uuid": "d456b88f-f515-4180-8cd6-ff63d245e198",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1344
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59516",
    "bcr_drug_uuid": "435F5BFB-5046-4569-B0B6-57857326B73A",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 813,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 903,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59517",
    "bcr_drug_uuid": "9978CD5C-428A-4871-B65B-A055D9325955",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 904,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1001,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59518",
    "bcr_drug_uuid": "086CE23B-765A-4665-BD7E-9CD16396B4B9",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1002,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1365,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59519",
    "bcr_drug_uuid": "69429F28-2A38-4B0B-9306-59A9133230D7",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 1158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1422,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59520",
    "bcr_drug_uuid": "1071A37F-0128-473D-8BA3-2DBF3AD5953E",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1366,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1562,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59521",
    "bcr_drug_uuid": "01259757-DD3D-4DF9-9686-9CB07AE8A150",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "DENOSUMAB",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1718,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59522",
    "bcr_drug_uuid": "C89E1F88-A478-4697-9540-2AC63A295747",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1618,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde",
    "patient_ID": "TCGA.A2.A0EW",
    "bcr_drug_barcode": "TCGA-A2-A0EW-D59523",
    "bcr_drug_uuid": "9FAAE45E-9014-4CD8-BBBA-F327C60E65D7",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN LIPOSOME",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1696,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1787,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9d8702e1-1a36-4bca-85ab-5f11d58d7953",
    "patient_ID": "TCGA.A2.A0EX",
    "bcr_drug_barcode": "TCGA-A2-A0EX-D2011",
    "bcr_drug_uuid": "a18f54ee-33e5-4dc3-a61a-ba662d4e192d",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "LUPRON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3.75,
    "regimen_number": 2,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11.25
  },
  {
    "bcr_patient_uuid": "9d8702e1-1a36-4bca-85ab-5f11d58d7953",
    "patient_ID": "TCGA.A2.A0EX",
    "bcr_drug_barcode": "TCGA-A2-A0EX-D2012",
    "bcr_drug_uuid": "2a817b25-0580-4742-b337-8cd0a8bfb143",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 3,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9d8702e1-1a36-4bca-85ab-5f11d58d7953",
    "patient_ID": "TCGA.A2.A0EX",
    "bcr_drug_barcode": "TCGA-A2-A0EX-D2010",
    "bcr_drug_uuid": "e8a75fe6-b841-46ea-9bd8-51b5fe21c01e",
    "form_completion_date": "2010-8-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1893",
    "bcr_drug_uuid": "8da373c9-e16f-4a58-b3ff-6c294e12787c",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1887",
    "bcr_drug_uuid": "1c31f4fe-aaf3-45bb-85cc-ddc5a1ed81e9",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 418
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1888",
    "bcr_drug_uuid": "5da60b2a-4a81-450f-8a9a-f577b0f3dc83",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4176
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1890",
    "bcr_drug_uuid": "4ffd1583-1089-4c1a-9c65-3b1413b8983c",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 129,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 516
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1891",
    "bcr_drug_uuid": "e621dfac-f2ac-4604-a5fa-520f61070b6c",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "LAPATINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d67cd793-2931-429a-9084-2f3c4c8be7ad",
    "patient_ID": "TCGA.A2.A0EY",
    "bcr_drug_barcode": "TCGA-A2-A0EY-D1892",
    "bcr_drug_uuid": "c5f2e97a-c397-4193-a55d-c10d91996a6b",
    "form_completion_date": "2010-9-22",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3718",
    "bcr_drug_uuid": "0ad8fde3-e018-471c-a012-d97a9ad7a75e",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 287,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1148
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3719",
    "bcr_drug_uuid": "8c26b6ae-71a7-47c8-86ce-4f99b68272d0",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 286,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3721",
    "bcr_drug_uuid": "f6b4a321-022e-475b-8d7d-a813f500b336",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 495,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3716",
    "bcr_drug_uuid": "4c03e578-c8ca-49dd-abbd-aa6f1f676b33",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 98,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 392
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3720",
    "bcr_drug_uuid": "b18f2d63-850a-44b6-b52d-f59f6187d11a",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 287,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12d31787-e54d-4729-ace8-9141043c92b8",
    "patient_ID": "TCGA.A2.A0ST",
    "bcr_drug_barcode": "TCGA-A2-A0ST-D3717",
    "bcr_drug_uuid": "47ecba15-fb35-479e-beaa-92b787d0d2c6",
    "form_completion_date": "2010-11-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 984,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3936
  },
  {
    "bcr_patient_uuid": "c632675e-e8af-43cd-8744-5be3754c1c14",
    "patient_ID": "TCGA.A2.A0SU",
    "bcr_drug_barcode": "TCGA-A2-A0SU-D3989",
    "bcr_drug_uuid": "94ab7027-4e66-4e27-be4f-266bfe28933f",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad01259b-d858-40bc-a6ba-0bb06e996afb",
    "patient_ID": "TCGA.A2.A0SV",
    "bcr_drug_barcode": "TCGA-A2-A0SV-D3723",
    "bcr_drug_uuid": "dffb0d8f-27a1-4dc6-855e-0fb99d5c4584",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 7,
    "pharma_type_other": "BISPHOSPHONATE THERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16
  },
  {
    "bcr_patient_uuid": "ad01259b-d858-40bc-a6ba-0bb06e996afb",
    "patient_ID": "TCGA.A2.A0SV",
    "bcr_drug_barcode": "TCGA-A2-A0SV-D3724",
    "bcr_drug_uuid": "5207293a-a541-4268-9200-ec61f261433f",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad01259b-d858-40bc-a6ba-0bb06e996afb",
    "patient_ID": "TCGA.A2.A0SV",
    "bcr_drug_barcode": "TCGA-A2-A0SV-D3725",
    "bcr_drug_uuid": "ff55eeb9-fb43-4b8c-915b-c74dc4195ffe",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "ad01259b-d858-40bc-a6ba-0bb06e996afb",
    "patient_ID": "TCGA.A2.A0SV",
    "bcr_drug_barcode": "TCGA-A2-A0SV-D3726",
    "bcr_drug_uuid": "93f9d2f6-5376-40a2-b368-fc89e4e8650c",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 304,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3000,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "991e1427-3c01-423d-abfd-4584302ca72c",
    "patient_ID": "TCGA.A2.A0SW",
    "bcr_drug_barcode": "TCGA-A2-A0SW-D3702",
    "bcr_drug_uuid": "5751c947-6519-4f54-b423-fda73bc2b43a",
    "form_completion_date": "2010-11-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 479,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "991e1427-3c01-423d-abfd-4584302ca72c",
    "patient_ID": "TCGA.A2.A0SW",
    "bcr_drug_barcode": "TCGA-A2-A0SW-D3703",
    "bcr_drug_uuid": "1e0659e4-5a29-4057-a83b-90e3e8f398ee",
    "form_completion_date": "2010-11-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 479,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1365,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "18d35983-ea6a-4b70-a209-9bef37595956",
    "patient_ID": "TCGA.A2.A0SX",
    "bcr_drug_barcode": "TCGA-A2-A0SX-D4024",
    "bcr_drug_uuid": "8f6e3477-88fd-4f1b-b06f-0e3510b0ac5d",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "18d35983-ea6a-4b70-a209-9bef37595956",
    "patient_ID": "TCGA.A2.A0SX",
    "bcr_drug_barcode": "TCGA-A2-A0SX-D4019",
    "bcr_drug_uuid": "76901188-6afa-4900-ae30-7d296985c5de",
    "form_completion_date": "2010-11-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "18d35983-ea6a-4b70-a209-9bef37595956",
    "patient_ID": "TCGA.A2.A0SX",
    "bcr_drug_barcode": "TCGA-A2-A0SX-D4025",
    "bcr_drug_uuid": "16e4fd14-6c2b-4c7e-964a-c240c2b36ceb",
    "form_completion_date": "2010-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1359,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1800,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7200
  },
  {
    "bcr_patient_uuid": "18d35983-ea6a-4b70-a209-9bef37595956",
    "patient_ID": "TCGA.A2.A0SX",
    "bcr_drug_barcode": "TCGA-A2-A0SX-D4023",
    "bcr_drug_uuid": "a0280f47-3ba8-42cf-ab14-ff4fd7db88b0",
    "form_completion_date": "2010-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1359,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 610,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2203
  },
  {
    "bcr_patient_uuid": "18d35983-ea6a-4b70-a209-9bef37595956",
    "patient_ID": "TCGA.A2.A0SX",
    "bcr_drug_barcode": "TCGA-A2-A0SX-D14036",
    "bcr_drug_uuid": "634383B8-9F0E-4A8B-84FE-B308540A6F38",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1429,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "dc696e3c-f448-468f-a576-f4429be0338a",
    "patient_ID": "TCGA.A2.A0SY",
    "bcr_drug_barcode": "TCGA-A2-A0SY-D3399",
    "bcr_drug_uuid": "ee88474f-8a2d-4902-9de7-f016aac05379",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc696e3c-f448-468f-a576-f4429be0338a",
    "patient_ID": "TCGA.A2.A0SY",
    "bcr_drug_barcode": "TCGA-A2-A0SY-D3394",
    "bcr_drug_uuid": "25d2f8f4-0b06-4677-b483-998d03b900e1",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc696e3c-f448-468f-a576-f4429be0338a",
    "patient_ID": "TCGA.A2.A0SY",
    "bcr_drug_barcode": "TCGA-A2-A0SY-D3401",
    "bcr_drug_uuid": "03bf9c75-4ae4-4747-a8b1-e1823ce91368",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc696e3c-f448-468f-a576-f4429be0338a",
    "patient_ID": "TCGA.A2.A0SY",
    "bcr_drug_barcode": "TCGA-A2-A0SY-D3408",
    "bcr_drug_uuid": "75561abb-f715-4b09-b607-0ebecf96ca9f",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc696e3c-f448-468f-a576-f4429be0338a",
    "patient_ID": "TCGA.A2.A0SY",
    "bcr_drug_barcode": "TCGA-A2-A0SY-D3397",
    "bcr_drug_uuid": "c8d31da4-4cdc-4236-9aff-f8004227981c",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "95c53f69-0f05-4348-822a-571f3d757001",
    "patient_ID": "TCGA.A2.A0T0",
    "bcr_drug_barcode": "TCGA-A2-A0T0-D3430",
    "bcr_drug_uuid": "7b30d8b7-1a91-4f14-93d1-1d690c083a3a",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "95c53f69-0f05-4348-822a-571f3d757001",
    "patient_ID": "TCGA.A2.A0T0",
    "bcr_drug_barcode": "TCGA-A2-A0T0-D3432",
    "bcr_drug_uuid": "e011bb8b-77b8-4daa-9bea-75f9c039e676",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "95c53f69-0f05-4348-822a-571f3d757001",
    "patient_ID": "TCGA.A2.A0T0",
    "bcr_drug_barcode": "TCGA-A2-A0T0-D3434",
    "bcr_drug_uuid": "d86d4e6c-4305-493c-b8bf-968971f358c9",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "02bed00f-bef7-4fb7-b243-540354990e45",
    "patient_ID": "TCGA.A2.A0T1",
    "bcr_drug_barcode": "TCGA-A2-A0T1-D3712",
    "bcr_drug_uuid": "3674b5d0-54ba-4c56-b4d1-096bcdddbe9d",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "02bed00f-bef7-4fb7-b243-540354990e45",
    "patient_ID": "TCGA.A2.A0T1",
    "bcr_drug_barcode": "TCGA-A2-A0T1-D3711",
    "bcr_drug_uuid": "f7aadf3f-5dcd-4cf4-b04d-5b9f6907fc68",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "02bed00f-bef7-4fb7-b243-540354990e45",
    "patient_ID": "TCGA.A2.A0T1",
    "bcr_drug_barcode": "TCGA-A2-A0T1-D3710",
    "bcr_drug_uuid": "8ecf4ba5-9b63-4f13-90be-e4249f4d024b",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "128d198e-9b22-427c-90db-3714455f3a17",
    "patient_ID": "TCGA.A2.A0T2",
    "bcr_drug_barcode": "TCGA-A2-A0T2-D3707",
    "bcr_drug_uuid": "374f0db8-26b8-4cd4-828d-1250a5a81df3",
    "form_completion_date": "2010-11-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 225,
    "drug_cycles": 4,
    "drug_units": "G/DAY",
    "drug_tota_dose_units": "G/DAY",
    "drug_dose": 3,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "058dcb78-bed1-40c3-a6c2-a0cc40065531",
    "patient_ID": "TCGA.A2.A0T3",
    "bcr_drug_barcode": "TCGA-A2-A0T3-D9214",
    "bcr_drug_uuid": "4c04520d-d4ae-4202-b00b-a2782b640207",
    "form_completion_date": "2011-2-21",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 930
  },
  {
    "bcr_patient_uuid": "058dcb78-bed1-40c3-a6c2-a0cc40065531",
    "patient_ID": "TCGA.A2.A0T3",
    "bcr_drug_barcode": "TCGA-A2-A0T3-D9218",
    "bcr_drug_uuid": "f9514221-8f9b-403b-99d4-e4843d0b2eb6",
    "form_completion_date": "2011-2-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "058dcb78-bed1-40c3-a6c2-a0cc40065531",
    "patient_ID": "TCGA.A2.A0T3",
    "bcr_drug_barcode": "TCGA-A2-A0T3-D9216",
    "bcr_drug_uuid": "2a946428-c9e3-4910-8589-57d6230d7cd4",
    "form_completion_date": "2011-2-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1030,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6180
  },
  {
    "bcr_patient_uuid": "058dcb78-bed1-40c3-a6c2-a0cc40065531",
    "patient_ID": "TCGA.A2.A0T3",
    "bcr_drug_barcode": "TCGA-A2-A0T3-D9215",
    "bcr_drug_uuid": "b41bdca7-b0bf-4308-b906-1dcc9bf77b23",
    "form_completion_date": "2011-2-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 103,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 618
  },
  {
    "bcr_patient_uuid": "b0f8d698-a30e-4d8d-b0a2-a5a01fac8406",
    "patient_ID": "TCGA.A2.A0T4",
    "bcr_drug_barcode": "TCGA-A2-A0T4-D3991",
    "bcr_drug_uuid": "c3b20047-64e2-4f31-b600-d2eb3c74c467",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "36d77496-99f8-4911-ba7c-89fae32662aa",
    "patient_ID": "TCGA.A2.A0T5",
    "bcr_drug_barcode": "TCGA-A2-A0T5-D4004",
    "bcr_drug_uuid": "da0a191b-d070-4b24-a363-86c0b3ba4582",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "36d77496-99f8-4911-ba7c-89fae32662aa",
    "patient_ID": "TCGA.A2.A0T5",
    "bcr_drug_barcode": "TCGA-A2-A0T5-D4007",
    "bcr_drug_uuid": "ad72c4e8-6494-47a3-b46a-180feb91e7ce",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "36d77496-99f8-4911-ba7c-89fae32662aa",
    "patient_ID": "TCGA.A2.A0T5",
    "bcr_drug_barcode": "TCGA-A2-A0T5-D4005",
    "bcr_drug_uuid": "651802d7-8efb-4de1-acac-0cde103d8b74",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "08306ede-e74b-4be9-b768-7fd98647b6ac",
    "patient_ID": "TCGA.A2.A0T6",
    "bcr_drug_barcode": "TCGA-A2-A0T6-D3997",
    "bcr_drug_uuid": "9a7b6e0f-5e16-4bcf-a58f-a0ee35e617af",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "08306ede-e74b-4be9-b768-7fd98647b6ac",
    "patient_ID": "TCGA.A2.A0T6",
    "bcr_drug_barcode": "TCGA-A2-A0T6-D3994",
    "bcr_drug_uuid": "3ea8097f-3255-4d00-85b9-5d1f6e426c5f",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 810
  },
  {
    "bcr_patient_uuid": "08306ede-e74b-4be9-b768-7fd98647b6ac",
    "patient_ID": "TCGA.A2.A0T6",
    "bcr_drug_barcode": "TCGA-A2-A0T6-D3996",
    "bcr_drug_uuid": "bd93c307-9d87-4a15-bb03-b8d02cc44b57",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "08306ede-e74b-4be9-b768-7fd98647b6ac",
    "patient_ID": "TCGA.A2.A0T6",
    "bcr_drug_barcode": "TCGA-A2-A0T6-D3995",
    "bcr_drug_uuid": "23fa8497-3a06-42ab-900c-69deab1936ed",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "43d5632e-7272-4aad-9496-7f5a99671223",
    "patient_ID": "TCGA.A2.A0T7",
    "bcr_drug_barcode": "TCGA-A2-A0T7-D4001",
    "bcr_drug_uuid": "3a7507c1-490c-40f0-b3fb-dc14638ea9b7",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43d5632e-7272-4aad-9496-7f5a99671223",
    "patient_ID": "TCGA.A2.A0T7",
    "bcr_drug_barcode": "TCGA-A2-A0T7-D4000",
    "bcr_drug_uuid": "045f1736-1059-4fa3-bfeb-d36fc7a6c693",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43d5632e-7272-4aad-9496-7f5a99671223",
    "patient_ID": "TCGA.A2.A0T7",
    "bcr_drug_barcode": "TCGA-A2-A0T7-D4002",
    "bcr_drug_uuid": "c5d05f28-9eff-492b-9d3d-086b3d55ffdd",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 365,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43d5632e-7272-4aad-9496-7f5a99671223",
    "patient_ID": "TCGA.A2.A0T7",
    "bcr_drug_barcode": "TCGA-A2-A0T7-D3999",
    "bcr_drug_uuid": "55597860-77c6-472c-8515-75406e8ee3b4",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a1872011-b928-4189-ac02-e87506c20bca",
    "patient_ID": "TCGA.A2.A0YC",
    "bcr_drug_barcode": "TCGA-A2-A0YC-D5677",
    "bcr_drug_uuid": "0c6ae6c0-6396-40ca-8f21-e1d33a8e9ad0",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2c6adb12-380d-4710-a7e6-93d5a0e53289",
    "patient_ID": "TCGA.A2.A0YD",
    "bcr_drug_barcode": "TCGA-A2-A0YD-D5674",
    "bcr_drug_uuid": "678cae6d-29ae-4c7c-b9f8-72d3270dc402",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "2c6adb12-380d-4710-a7e6-93d5a0e53289",
    "patient_ID": "TCGA.A2.A0YD",
    "bcr_drug_barcode": "TCGA-A2-A0YD-D5673",
    "bcr_drug_uuid": "39d13e05-d042-4915-a89b-eb9460b38f36",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "2c6adb12-380d-4710-a7e6-93d5a0e53289",
    "patient_ID": "TCGA.A2.A0YD",
    "bcr_drug_barcode": "TCGA-A2-A0YD-D5675",
    "bcr_drug_uuid": "94197033-7886-421d-a619-88769cecaade",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33",
    "patient_ID": "TCGA.A2.A0YE",
    "bcr_drug_barcode": "TCGA-A2-A0YE-D5669",
    "bcr_drug_uuid": "635760ed-24dd-4491-bd61-c6793eb02a35",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33",
    "patient_ID": "TCGA.A2.A0YE",
    "bcr_drug_barcode": "TCGA-A2-A0YE-D5670",
    "bcr_drug_uuid": "a2d7f767-e939-4557-b767-387f1623d5ba",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33",
    "patient_ID": "TCGA.A2.A0YE",
    "bcr_drug_barcode": "TCGA-A2-A0YE-D5668",
    "bcr_drug_uuid": "8aff8385-be06-4dc8-900a-bd3755cdd8e5",
    "form_completion_date": "2010-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ae8c77fe-e6c8-44d5-8265-4a38c637bbef",
    "patient_ID": "TCGA.A2.A0YF",
    "bcr_drug_barcode": "TCGA-A2-A0YF-D5507",
    "bcr_drug_uuid": "481c8460-6527-43a9-a403-f39ee68057e2",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5628",
    "bcr_drug_uuid": "310907f8-03bc-46fe-abfd-562722f26798",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1224,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4896
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5636",
    "bcr_drug_uuid": "7a5fb8b1-74dd-4cdf-a42e-10aa9ae382ad",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 173,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 229,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 229
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5637",
    "bcr_drug_uuid": "ea67ac32-9c00-4232-aa39-39d493f18b95",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 12,
    "drug_units": "MG",
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5627",
    "bcr_drug_uuid": "854cdbfa-8797-4255-ae54-9a7b1278579e",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 488
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5639",
    "bcr_drug_uuid": "a99a6cef-a2db-4dcb-aba7-24b62d65de98",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0892598-1f7b-4f23-9cd8-731f797753d5",
    "patient_ID": "TCGA.A2.A0YG",
    "bcr_drug_barcode": "TCGA-A2-A0YG-D5638",
    "bcr_drug_uuid": "b3943b3d-4e9a-4ccc-bd23-65d88a9afc7e",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "298d33da-15af-48cb-b30f-eaf54e7baa43",
    "patient_ID": "TCGA.A2.A0YH",
    "bcr_drug_barcode": "TCGA-A2-A0YH-D5440",
    "bcr_drug_uuid": "599117f8-1d3d-4e44-bf96-83aaba1b8ca7",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6600
  },
  {
    "bcr_patient_uuid": "298d33da-15af-48cb-b30f-eaf54e7baa43",
    "patient_ID": "TCGA.A2.A0YH",
    "bcr_drug_barcode": "TCGA-A2-A0YH-D5437",
    "bcr_drug_uuid": "80f9e542-473a-4608-9e1c-491b215c50d7",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 138,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 828
  },
  {
    "bcr_patient_uuid": "298d33da-15af-48cb-b30f-eaf54e7baa43",
    "patient_ID": "TCGA.A2.A0YH",
    "bcr_drug_barcode": "TCGA-A2-A0YH-D5441",
    "bcr_drug_uuid": "cbf163a4-c78e-463e-8de3-c0981fefd6f9",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "298d33da-15af-48cb-b30f-eaf54e7baa43",
    "patient_ID": "TCGA.A2.A0YH",
    "bcr_drug_barcode": "TCGA-A2-A0YH-D5435",
    "bcr_drug_uuid": "e60cd9fa-5849-49a5-8bb1-69491f0379a1",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "72cd1b17-d349-4551-83f7-3062ce9db865",
    "patient_ID": "TCGA.A2.A0YI",
    "bcr_drug_barcode": "TCGA-A2-A0YI-D5446",
    "bcr_drug_uuid": "9b1f4d69-c1f1-49a2-b010-51bdc29628fa",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "796b593f-5886-4a27-bf94-7ea8df325e1a",
    "patient_ID": "TCGA.A2.A0YJ",
    "bcr_drug_barcode": "TCGA-A2-A0YJ-D5821",
    "bcr_drug_uuid": "54cf26b3-3b56-440e-9d2e-6c4df631992b",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "796b593f-5886-4a27-bf94-7ea8df325e1a",
    "patient_ID": "TCGA.A2.A0YJ",
    "bcr_drug_barcode": "TCGA-A2-A0YJ-D5820",
    "bcr_drug_uuid": "3d201259-de17-489f-89f8-f605fa43fe37",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8f34cb4c-5798-47a0-89a1-f0ee26a8ae93",
    "patient_ID": "TCGA.A2.A0YK",
    "bcr_drug_barcode": "TCGA-A2-A0YK-D5847",
    "bcr_drug_uuid": "2805802e-eb3a-4f17-90b5-9fa824b24022",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8f34cb4c-5798-47a0-89a1-f0ee26a8ae93",
    "patient_ID": "TCGA.A2.A0YK",
    "bcr_drug_barcode": "TCGA-A2-A0YK-D5846",
    "bcr_drug_uuid": "c494a6d6-0fcb-4709-b505-fef203efcd1b",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "8f34cb4c-5798-47a0-89a1-f0ee26a8ae93",
    "patient_ID": "TCGA.A2.A0YK",
    "bcr_drug_barcode": "TCGA-A2-A0YK-D5845",
    "bcr_drug_uuid": "c5a7f0c7-a217-4ad7-a621-78da30961ddc",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1115,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4460
  },
  {
    "bcr_patient_uuid": "b205c89f-af62-4186-acad-ed23d243fa98",
    "patient_ID": "TCGA.A2.A0YL",
    "bcr_drug_barcode": "TCGA-A2-A0YL-D5816",
    "bcr_drug_uuid": "e0eb6325-2068-4cbc-83a8-228079ff9e5f",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 840
  },
  {
    "bcr_patient_uuid": "b205c89f-af62-4186-acad-ed23d243fa98",
    "patient_ID": "TCGA.A2.A0YL",
    "bcr_drug_barcode": "TCGA-A2-A0YL-D5814",
    "bcr_drug_uuid": "15d20bc4-14c3-4ec8-8005-389f518e1ac0",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 940,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5640
  },
  {
    "bcr_patient_uuid": "b205c89f-af62-4186-acad-ed23d243fa98",
    "patient_ID": "TCGA.A2.A0YL",
    "bcr_drug_barcode": "TCGA-A2-A0YL-D5815",
    "bcr_drug_uuid": "9f659c06-6017-43f8-b229-7164566871f4",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 94,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 564
  },
  {
    "bcr_patient_uuid": "b205c89f-af62-4186-acad-ed23d243fa98",
    "patient_ID": "TCGA.A2.A0YL",
    "bcr_drug_barcode": "TCGA-A2-A0YL-D5817",
    "bcr_drug_uuid": "57d63ce1-4d7f-430f-930c-e6605a768c00",
    "form_completion_date": "2010-12-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 177,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "14b95463-2108-4921-afc2-e29eef52b18f",
    "patient_ID": "TCGA.A2.A0YT",
    "bcr_drug_barcode": "TCGA-A2-A0YT-D5687",
    "bcr_drug_uuid": "5b1e9a0c-a2c4-41f0-a952-c9b39c961f76",
    "form_completion_date": "2010-12-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 286,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 723,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cd0c96a4-6414-4efb-879b-7408b62ed5b6",
    "patient_ID": "TCGA.A2.A1FV",
    "bcr_drug_barcode": "TCGA-A2-A1FV-D12265",
    "bcr_drug_uuid": "bad34945-e422-45a6-9c03-6f05d34514c8",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 129,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 516
  },
  {
    "bcr_patient_uuid": "cd0c96a4-6414-4efb-879b-7408b62ed5b6",
    "patient_ID": "TCGA.A2.A1FV",
    "bcr_drug_barcode": "TCGA-A2-A1FV-D12266",
    "bcr_drug_uuid": "09c584e4-9d41-455c-9e08-87c9f0f931b7",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cd0c96a4-6414-4efb-879b-7408b62ed5b6",
    "patient_ID": "TCGA.A2.A1FV",
    "bcr_drug_barcode": "TCGA-A2-A1FV-D12263",
    "bcr_drug_uuid": "4a36ce19-e3bb-4484-a0c0-8c815afa84a7",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1032,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4128
  },
  {
    "bcr_patient_uuid": "54883111-d475-4515-ba3f-fece8a71e79e",
    "patient_ID": "TCGA.A2.A1FW",
    "bcr_drug_barcode": "TCGA-A2-A1FW-D11823",
    "bcr_drug_uuid": "4ea58c35-fcc2-4136-9aa0-752ace9b87e0",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "54883111-d475-4515-ba3f-fece8a71e79e",
    "patient_ID": "TCGA.A2.A1FW",
    "bcr_drug_barcode": "TCGA-A2-A1FW-D11830",
    "bcr_drug_uuid": "86b10331-62e5-40e8-bdc7-80184a5896d4",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "54883111-d475-4515-ba3f-fece8a71e79e",
    "patient_ID": "TCGA.A2.A1FW",
    "bcr_drug_barcode": "TCGA-A2-A1FW-D11831",
    "bcr_drug_uuid": "1c60eee0-e3cd-4edb-8287-bf56a9f4efa9",
    "form_completion_date": "2011-5-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "54883111-d475-4515-ba3f-fece8a71e79e",
    "patient_ID": "TCGA.A2.A1FW",
    "bcr_drug_barcode": "TCGA-A2-A1FW-D20812",
    "bcr_drug_uuid": "4F2494FD-3934-42BA-8414-FE4FEFF62B75",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 364,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ac6d3ba9-f84f-4657-aa85-4d66fb7c09da",
    "patient_ID": "TCGA.A2.A1FX",
    "bcr_drug_barcode": "TCGA-A2-A1FX-D11811",
    "bcr_drug_uuid": "d761afbc-f8fb-4593-8461-0b7bafa935e9",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ac6d3ba9-f84f-4657-aa85-4d66fb7c09da",
    "patient_ID": "TCGA.A2.A1FX",
    "bcr_drug_barcode": "TCGA-A2-A1FX-D11806",
    "bcr_drug_uuid": "a39f5502-14a7-4c8d-8d51-34ef34e9bb26",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ac6d3ba9-f84f-4657-aa85-4d66fb7c09da",
    "patient_ID": "TCGA.A2.A1FX",
    "bcr_drug_barcode": "TCGA-A2-A1FX-D11802",
    "bcr_drug_uuid": "b78310b5-e2f5-4a69-a170-d5d8b9f9ff96",
    "form_completion_date": "2011-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "805bfe39-3695-43c2-93e4-d66d0559b89f",
    "patient_ID": "TCGA.A2.A1FZ",
    "bcr_drug_barcode": "TCGA-A2-A1FZ-D12285",
    "bcr_drug_uuid": "453a2e9f-7e83-478a-a0f5-0aa01232d4fb",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e538802-2a31-4774-89a8-c6e4381a887d",
    "patient_ID": "TCGA.A2.A1G0",
    "bcr_drug_barcode": "TCGA-A2-A1G0-D12277",
    "bcr_drug_uuid": "3f7e4bbf-f665-40a2-b4ac-ec01e86be371",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 574
  },
  {
    "bcr_patient_uuid": "2e538802-2a31-4774-89a8-c6e4381a887d",
    "patient_ID": "TCGA.A2.A1G0",
    "bcr_drug_barcode": "TCGA-A2-A1G0-D12279",
    "bcr_drug_uuid": "684a3831-0dbd-4c77-bcad-abc00bca6fcf",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5720
  },
  {
    "bcr_patient_uuid": "2e538802-2a31-4774-89a8-c6e4381a887d",
    "patient_ID": "TCGA.A2.A1G0",
    "bcr_drug_barcode": "TCGA-A2-A1G0-D12281",
    "bcr_drug_uuid": "ef4fe873-a6fc-46bb-a3f7-225d1f22dbc3",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e538802-2a31-4774-89a8-c6e4381a887d",
    "patient_ID": "TCGA.A2.A1G0",
    "bcr_drug_barcode": "TCGA-A2-A1G0-D12278",
    "bcr_drug_uuid": "98afbca9-9725-421f-98a6-9f7f299a0e0b",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 872
  },
  {
    "bcr_patient_uuid": "e3b555aa-7f0a-49c6-9b13-182c61a144c1",
    "patient_ID": "TCGA.A2.A1G4",
    "bcr_drug_barcode": "TCGA-A2-A1G4-D12345",
    "bcr_drug_uuid": "6491326b-97e4-4bc3-bc1b-3420c081b2bf",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "e3b555aa-7f0a-49c6-9b13-182c61a144c1",
    "patient_ID": "TCGA.A2.A1G4",
    "bcr_drug_barcode": "TCGA-A2-A1G4-D12347",
    "bcr_drug_uuid": "f7d16c97-46c7-4712-83cb-f31c52b38ea4",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3b555aa-7f0a-49c6-9b13-182c61a144c1",
    "patient_ID": "TCGA.A2.A1G4",
    "bcr_drug_barcode": "TCGA-A2-A1G4-D12346",
    "bcr_drug_uuid": "59b0a147-3154-47c9-907a-765fdba4002d",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "e3b555aa-7f0a-49c6-9b13-182c61a144c1",
    "patient_ID": "TCGA.A2.A1G4",
    "bcr_drug_barcode": "TCGA-A2-A1G4-D12344",
    "bcr_drug_uuid": "5971ea22-14b8-49be-8ee4-c621e8529ea7",
    "form_completion_date": "2011-4-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 795,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4770
  },
  {
    "bcr_patient_uuid": "295cf595-4a29-46a3-a0c5-e5f08f947031",
    "patient_ID": "TCGA.A2.A1G6",
    "bcr_drug_barcode": "TCGA-A2-A1G6-D12537",
    "bcr_drug_uuid": "03170c14-0cc8-47b8-8211-e7feae86ed65",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 3,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "295cf595-4a29-46a3-a0c5-e5f08f947031",
    "patient_ID": "TCGA.A2.A1G6",
    "bcr_drug_barcode": "TCGA-A2-A1G6-D12535",
    "bcr_drug_uuid": "57fef464-1259-484f-8b66-7473fa062401",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "295cf595-4a29-46a3-a0c5-e5f08f947031",
    "patient_ID": "TCGA.A2.A1G6",
    "bcr_drug_barcode": "TCGA-A2-A1G6-D12532",
    "bcr_drug_uuid": "b86d0b45-cd36-46d7-9964-b170549420ac",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3fc3755d-a3f8-4e2c-813f-ff124f2a75c1",
    "patient_ID": "TCGA.A2.A259",
    "bcr_drug_barcode": "TCGA-A2-A259-D14577",
    "bcr_drug_uuid": "F4C128EF-E7C2-407A-833B-C1EC52088D3D",
    "form_completion_date": "2011-7-20",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aaea5f9c-b35b-47f8-93cb-bdc7b81844ff",
    "patient_ID": "TCGA.A2.A25A",
    "bcr_drug_barcode": "TCGA-A2-A25A-D14583",
    "bcr_drug_uuid": "37B653A5-16F9-4CFA-91C8-7AAE12B3D81D",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aaea5f9c-b35b-47f8-93cb-bdc7b81844ff",
    "patient_ID": "TCGA.A2.A25A",
    "bcr_drug_barcode": "TCGA-A2-A25A-D14581",
    "bcr_drug_uuid": "DAE723E3-48C2-47C6-932F-B670C43AAEF1",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aaea5f9c-b35b-47f8-93cb-bdc7b81844ff",
    "patient_ID": "TCGA.A2.A25A",
    "bcr_drug_barcode": "TCGA-A2-A25A-D14585",
    "bcr_drug_uuid": "CD0F0B87-4BE9-4070-BC27-F4217BB6F250",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aaea5f9c-b35b-47f8-93cb-bdc7b81844ff",
    "patient_ID": "TCGA.A2.A25A",
    "bcr_drug_barcode": "TCGA-A2-A25A-D14584",
    "bcr_drug_uuid": "CDAB626B-3EFA-48B1-A671-C525E974334C",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eadf8482-e60e-4307-adb7-d5c3b9fa6cae",
    "patient_ID": "TCGA.A2.A25B",
    "bcr_drug_barcode": "TCGA-A2-A25B-D14505",
    "bcr_drug_uuid": "4DB7724B-1C49-4082-A477-83CAA3AD9A6D",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4965
  },
  {
    "bcr_patient_uuid": "eadf8482-e60e-4307-adb7-d5c3b9fa6cae",
    "patient_ID": "TCGA.A2.A25B",
    "bcr_drug_barcode": "TCGA-A2-A25B-D14502",
    "bcr_drug_uuid": "5CA1AA16-D037-4F6E-8F7B-46F0BFB54F17",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 745
  },
  {
    "bcr_patient_uuid": "eadf8482-e60e-4307-adb7-d5c3b9fa6cae",
    "patient_ID": "TCGA.A2.A25B",
    "bcr_drug_barcode": "TCGA-A2-A25B-D14504",
    "bcr_drug_uuid": "E1774708-5D16-4022-9B47-09313FA0BF3F",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 498
  },
  {
    "bcr_patient_uuid": "eadf8482-e60e-4307-adb7-d5c3b9fa6cae",
    "patient_ID": "TCGA.A2.A25B",
    "bcr_drug_barcode": "TCGA-A2-A25B-D31264",
    "bcr_drug_uuid": "05A1B7D2-5DCF-454F-9FE4-33CA8289D1B2",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D14511",
    "bcr_drug_uuid": "9A192F59-CCEE-4DCF-97FD-152DA7203A62",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 870,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4350
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D14512",
    "bcr_drug_uuid": "B0EDF6A8-BC7C-44F3-B9A2-4306EC1EDE95",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 87,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 435
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D14513",
    "bcr_drug_uuid": "789E3F3F-057D-41A2-BC01-3C6103E3A603",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 650
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D14514",
    "bcr_drug_uuid": "164E441C-E2D3-4CDA-B591-397424B65942",
    "form_completion_date": "2011-7-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D31284",
    "bcr_drug_uuid": "ED492381-E4FE-41BA-8ECB-CEC9010547CB",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 476,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1",
    "patient_ID": "TCGA.A2.A25C",
    "bcr_drug_barcode": "TCGA-A2-A25C-D31283",
    "bcr_drug_uuid": "77D6AC50-7A0B-4BB5-9FA8-BFECB11CDC34",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 325,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 475,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b963d72-ba5c-467b-83c9-fbdb462510a3",
    "patient_ID": "TCGA.A2.A25D",
    "bcr_drug_barcode": "TCGA-A2-A25D-D14498",
    "bcr_drug_uuid": "4E0D9B7A-4FB4-4A35-92D4-B0CF3C369CEE",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "drug_units": "MG",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b963d72-ba5c-467b-83c9-fbdb462510a3",
    "patient_ID": "TCGA.A2.A25D",
    "bcr_drug_barcode": "TCGA-A2-A25D-D14499",
    "bcr_drug_uuid": "A604328B-BACF-486C-9E11-4CEC7C695BC6",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b963d72-ba5c-467b-83c9-fbdb462510a3",
    "patient_ID": "TCGA.A2.A25D",
    "bcr_drug_barcode": "TCGA-A2-A25D-D14497",
    "bcr_drug_uuid": "13453903-A47B-4D8A-9288-9EE9FE596226",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14567",
    "bcr_drug_uuid": "0D2DEFB3-3E8B-4761-8BD1-897AB03EFA98",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14569",
    "bcr_drug_uuid": "335FCDB6-340C-4A4F-B08B-F509B2B0DEF5",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14564",
    "bcr_drug_uuid": "019B2AA1-9E61-4BE6-BDE1-B885EEE5589B",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_cycles": 47,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5142
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14568",
    "bcr_drug_uuid": "189903E4-A8AF-4AE4-A953-0928F10646D2",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14570",
    "bcr_drug_uuid": "029F44F2-9A34-45CF-8E9F-2AFEB11BE5CD",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "GOSERELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2380,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 3.6,
    "regimen_number": 6,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PREVENTATIVE"
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D14565",
    "bcr_drug_uuid": "63600442-2336-493D-BC5F-CECB9800FD53",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2155,
    "drug_units": "MG/M2/DAY",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e",
    "patient_ID": "TCGA.A2.A25E",
    "bcr_drug_barcode": "TCGA-A2-A25E-D44981",
    "bcr_drug_uuid": "99D343A1-BE9A-407D-80DC-45B049932EE1",
    "form_completion_date": "2013-7-2",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 3055,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c836951b-3ffb-4e20-8504-0eccb7d50dd4",
    "patient_ID": "TCGA.A2.A25F",
    "bcr_drug_barcode": "TCGA-A2-A25F-D31195",
    "bcr_drug_uuid": "891B2981-580C-4A0A-9C41-BED150D2AEB8",
    "form_completion_date": "2012-4-19",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c836951b-3ffb-4e20-8504-0eccb7d50dd4",
    "patient_ID": "TCGA.A2.A25F",
    "bcr_drug_barcode": "TCGA-A2-A25F-D31196",
    "bcr_drug_uuid": "D5EBB6A6-DE10-4033-AB1F-6ADA8072684A",
    "form_completion_date": "2012-4-19",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E",
    "patient_ID": "TCGA.A2.A3KC",
    "bcr_drug_barcode": "TCGA-A2-A3KC-D30125",
    "bcr_drug_uuid": "ABA4D3E6-1A06-465B-83A0-EF2E9F3BAA4A",
    "form_completion_date": "2012-3-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1060,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6360
  },
  {
    "bcr_patient_uuid": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E",
    "patient_ID": "TCGA.A2.A3KC",
    "bcr_drug_barcode": "TCGA-A2-A3KC-D30127",
    "bcr_drug_uuid": "332AAD9D-0369-443A-B563-28B1E2B02E65",
    "form_completion_date": "2012-3-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 159,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 954
  },
  {
    "bcr_patient_uuid": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E",
    "patient_ID": "TCGA.A2.A3KC",
    "bcr_drug_barcode": "TCGA-A2-A3KC-D30126",
    "bcr_drug_uuid": "89F4A022-4646-4C62-92B2-D98CBA444FB0",
    "form_completion_date": "2012-3-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 106,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 636
  },
  {
    "bcr_patient_uuid": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E",
    "patient_ID": "TCGA.A2.A3KC",
    "bcr_drug_barcode": "TCGA-A2-A3KC-D30128",
    "bcr_drug_uuid": "16218EC6-7B12-489E-8AB0-BD5C8278E00F",
    "form_completion_date": "2012-3-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1101,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E",
    "patient_ID": "TCGA.A2.A3KC",
    "bcr_drug_barcode": "TCGA-A2-A3KC-D59209",
    "bcr_drug_uuid": "7D787BBB-1268-4E08-9C9E-BFA413D22B04",
    "form_completion_date": "2014-5-5",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1102,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB026999-0AAB-4232-96D7-2C93B6C9691D",
    "patient_ID": "TCGA.A2.A3KD",
    "bcr_drug_barcode": "TCGA-A2-A3KD-D30119",
    "bcr_drug_uuid": "02CCA825-E874-4DCB-A863-18EF85224977",
    "form_completion_date": "2012-2-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 962,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3848
  },
  {
    "bcr_patient_uuid": "BB026999-0AAB-4232-96D7-2C93B6C9691D",
    "patient_ID": "TCGA.A2.A3KD",
    "bcr_drug_barcode": "TCGA-A2-A3KD-D30121",
    "bcr_drug_uuid": "042F7696-E248-4F7D-AC91-A50E35E2E99F",
    "form_completion_date": "2012-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 282,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "BB026999-0AAB-4232-96D7-2C93B6C9691D",
    "patient_ID": "TCGA.A2.A3KD",
    "bcr_drug_barcode": "TCGA-A2-A3KD-D30120",
    "bcr_drug_uuid": "AB03C3FC-D1ED-4F17-8BFB-C5123D0EC3B1",
    "form_completion_date": "2012-2-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34447",
    "bcr_drug_uuid": "B3410728-5DD2-4C46-8F60-384AE7FD0DE0",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34449",
    "bcr_drug_uuid": "57BE30DA-D982-441F-9385-4A8F49FD6C7F",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34450",
    "bcr_drug_uuid": "C4D6719C-2751-4CCD-A188-EC01BB23E1B0",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34451",
    "bcr_drug_uuid": "8FC4D02E-D7CA-465A-A5DF-A4C2323A2ACC",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 682,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34452",
    "bcr_drug_uuid": "0E43D65F-FF3E-49BB-9DEA-8C8B0BF3AD17",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 695,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 806,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34453",
    "bcr_drug_uuid": "F4FCCE3E-BB62-4A80-909D-A1DC2198705D",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 895,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 958,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34454",
    "bcr_drug_uuid": "055A4779-B7FE-4F15-894F-81785BED5BE4",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 874,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 980,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A78B04B4-2380-4803-963E-E4E633CD69AB",
    "patient_ID": "TCGA.A2.A3XS",
    "bcr_drug_barcode": "TCGA-A2-A3XS-D34455",
    "bcr_drug_uuid": "0221663A-3CAA-42B8-B315-073962FBD6FF",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1022,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C72CB184-462D-4009-9CDB-848782FF8A76",
    "patient_ID": "TCGA.A2.A3XT",
    "bcr_drug_barcode": "TCGA-A2-A3XT-D34495",
    "bcr_drug_uuid": "C93B9D6C-DE38-4B66-AA69-C788731E6DA2",
    "form_completion_date": "2012-8-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C72CB184-462D-4009-9CDB-848782FF8A76",
    "patient_ID": "TCGA.A2.A3XT",
    "bcr_drug_barcode": "TCGA-A2-A3XT-D34496",
    "bcr_drug_uuid": "314F8E23-81C1-41B5-BB1D-78A78525EE50",
    "form_completion_date": "2012-8-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C72CB184-462D-4009-9CDB-848782FF8A76",
    "patient_ID": "TCGA.A2.A3XT",
    "bcr_drug_barcode": "TCGA-A2-A3XT-D34497",
    "bcr_drug_uuid": "3E9B81CF-BFAD-4C78-AC24-32461C485692",
    "form_completion_date": "2012-8-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6",
    "patient_ID": "TCGA.A2.A3XU",
    "bcr_drug_barcode": "TCGA-A2-A3XU-D34706",
    "bcr_drug_uuid": "F99B1711-2441-4D81-BE35-E77D8DB5DD5C",
    "form_completion_date": "2012-8-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6",
    "patient_ID": "TCGA.A2.A3XU",
    "bcr_drug_barcode": "TCGA-A2-A3XU-D34707",
    "bcr_drug_uuid": "22884654-200E-40BD-8E0D-C5BB2915AC39",
    "form_completion_date": "2012-8-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6",
    "patient_ID": "TCGA.A2.A3XU",
    "bcr_drug_barcode": "TCGA-A2-A3XU-D34708",
    "bcr_drug_uuid": "BF14305C-8340-470C-B0C2-57AD71B8C1DE",
    "form_completion_date": "2012-8-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6",
    "patient_ID": "TCGA.A2.A3XU",
    "bcr_drug_barcode": "TCGA-A2-A3XU-D34709",
    "bcr_drug_uuid": "D7667385-C63A-4D90-AE37-D95D1BC45AD5",
    "form_completion_date": "2012-8-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 596,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 718,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6",
    "patient_ID": "TCGA.A2.A3XU",
    "bcr_drug_barcode": "TCGA-A2-A3XU-D34710",
    "bcr_drug_uuid": "45C67643-FF02-4C5B-874F-3D7D85A8FE9D",
    "form_completion_date": "2012-8-28",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 657,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 902,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "189E1F27-7738-413A-A4D4-97D41D592A13",
    "patient_ID": "TCGA.A2.A3XV",
    "bcr_drug_barcode": "TCGA-A2-A3XV-D34630",
    "bcr_drug_uuid": "71D050BF-7E93-4BA7-B969-F1887FC94B89",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "189E1F27-7738-413A-A4D4-97D41D592A13",
    "patient_ID": "TCGA.A2.A3XV",
    "bcr_drug_barcode": "TCGA-A2-A3XV-D34631",
    "bcr_drug_uuid": "7CF49A37-54D6-47C1-B0FA-F3732990E8A2",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "189E1F27-7738-413A-A4D4-97D41D592A13",
    "patient_ID": "TCGA.A2.A3XV",
    "bcr_drug_barcode": "TCGA-A2-A3XV-D34632",
    "bcr_drug_uuid": "212FE1BA-E2B8-435A-91E6-5BC6F1B03C9B",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 428,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "189E1F27-7738-413A-A4D4-97D41D592A13",
    "patient_ID": "TCGA.A2.A3XV",
    "bcr_drug_barcode": "TCGA-A2-A3XV-D34633",
    "bcr_drug_uuid": "660D3D61-D8EE-44B2-8CE3-F93CB2202075",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C02699B5-580A-4D55-971E-F4692B2CCE57",
    "patient_ID": "TCGA.A2.A3XW",
    "bcr_drug_barcode": "TCGA-A2-A3XW-D34431",
    "bcr_drug_uuid": "5DE33005-8993-4B5B-8D3A-F74A18EAE600",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C02699B5-580A-4D55-971E-F4692B2CCE57",
    "patient_ID": "TCGA.A2.A3XW",
    "bcr_drug_barcode": "TCGA-A2-A3XW-D34432",
    "bcr_drug_uuid": "FBBE5DDA-17FD-4605-B38C-1F391379A514",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C02699B5-580A-4D55-971E-F4692B2CCE57",
    "patient_ID": "TCGA.A2.A3XW",
    "bcr_drug_barcode": "TCGA-A2-A3XW-D34433",
    "bcr_drug_uuid": "17ED55A4-16C3-4F43-8986-3714A71F0F78",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C02699B5-580A-4D55-971E-F4692B2CCE57",
    "patient_ID": "TCGA.A2.A3XW",
    "bcr_drug_barcode": "TCGA-A2-A3XW-D34434",
    "bcr_drug_uuid": "5E8166C0-1206-4A0B-9FC3-806B511A494D",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "53886143-C1C6-40E9-88E6-E4E5E0271FC8",
    "patient_ID": "TCGA.A2.A3XX",
    "bcr_drug_barcode": "TCGA-A2-A3XX-D34438",
    "bcr_drug_uuid": "9F081506-F377-47BB-8EE6-EDE38541E7B9",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53886143-C1C6-40E9-88E6-E4E5E0271FC8",
    "patient_ID": "TCGA.A2.A3XX",
    "bcr_drug_barcode": "TCGA-A2-A3XX-D34439",
    "bcr_drug_uuid": "588DB182-2F95-48D2-A365-0BDF34B3C1FB",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53886143-C1C6-40E9-88E6-E4E5E0271FC8",
    "patient_ID": "TCGA.A2.A3XX",
    "bcr_drug_barcode": "TCGA-A2-A3XX-D34441",
    "bcr_drug_uuid": "B6FD1396-6FE8-44FF-A6AC-72B380261AD5",
    "form_completion_date": "2012-8-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D34406",
    "bcr_drug_uuid": "CBE5F428-42AB-4719-A28B-3D8E9903B596",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D34407",
    "bcr_drug_uuid": "E7F46F97-06FB-49A1-B9B2-DC0F211325DC",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D34408",
    "bcr_drug_uuid": "2BB3150F-2130-4FA5-9E80-A2F76E236D3C",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D34409",
    "bcr_drug_uuid": "385416B0-05A4-45C0-A807-DDFFE65C59EE",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D34411",
    "bcr_drug_uuid": "6B22D335-A270-451A-93F4-A11F8A4875A6",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 254,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D43312",
    "bcr_drug_uuid": "4620C49F-B2FE-4FBD-8CD3-C2CAFBD9EEA4",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 913,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D43313",
    "bcr_drug_uuid": "89205666-328A-4D84-8355-E8627C761EC5",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1019,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D43314",
    "bcr_drug_uuid": "D2AD9346-11EA-432E-94D0-DC4429648DC1",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1040,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1061,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DEBA32E4-0E68-4711-941B-3B63BD965AFB",
    "patient_ID": "TCGA.A2.A3XY",
    "bcr_drug_barcode": "TCGA-A2-A3XY-D43315",
    "bcr_drug_uuid": "D420260B-7367-4532-AC11-A5A0966EBCBC",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "DENOSUMAB",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1058,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0",
    "patient_ID": "TCGA.A2.A3XZ",
    "bcr_drug_barcode": "TCGA-A2-A3XZ-D34516",
    "bcr_drug_uuid": "EC157BD8-01E2-4587-87D0-ED9A7863A136",
    "form_completion_date": "2012-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0",
    "patient_ID": "TCGA.A2.A3XZ",
    "bcr_drug_barcode": "TCGA-A2-A3XZ-D34517",
    "bcr_drug_uuid": "9E6E1263-16AB-4E0E-8C59-14347BB6F50C",
    "form_completion_date": "2012-8-21",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0",
    "patient_ID": "TCGA.A2.A3XZ",
    "bcr_drug_barcode": "TCGA-A2-A3XZ-D34518",
    "bcr_drug_uuid": "3F688A9E-5E71-4676-BA57-190015FED400",
    "form_completion_date": "2012-8-21",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 423,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34570",
    "bcr_drug_uuid": "9F7B7F8B-718E-4740-93BC-324EE04D01E8",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34571",
    "bcr_drug_uuid": "FBC64FA5-C743-40B6-9565-79BFB168FF4E",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34587",
    "bcr_drug_uuid": "27FAEC54-F24D-438B-8005-1AA132B3092A",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34588",
    "bcr_drug_uuid": "8E48C12C-49AB-4BAE-A24E-F9DA45AAA81F",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34589",
    "bcr_drug_uuid": "8A141947-57F7-47C1-9301-538DC497884B",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "174850B4-5EC2-462B-A890-89BD1716B3C2",
    "patient_ID": "TCGA.A2.A3Y0",
    "bcr_drug_barcode": "TCGA-A2-A3Y0-D34590",
    "bcr_drug_uuid": "7CD22268-A875-4227-AB7F-E16930C56DDC",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5A53EC47-E63F-44A2-8078-87659544FB04",
    "patient_ID": "TCGA.A2.A4RY",
    "bcr_drug_barcode": "TCGA-A2-A4RY-D40659",
    "bcr_drug_uuid": "1BCAA28C-A1D9-45B4-993D-DC411B983F6C",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5A53EC47-E63F-44A2-8078-87659544FB04",
    "patient_ID": "TCGA.A2.A4RY",
    "bcr_drug_barcode": "TCGA-A2-A4RY-D40660",
    "bcr_drug_uuid": "49B3D51C-F502-4AB9-9548-345C27375EA6",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5A53EC47-E63F-44A2-8078-87659544FB04",
    "patient_ID": "TCGA.A2.A4RY",
    "bcr_drug_barcode": "TCGA-A2-A4RY-D40661",
    "bcr_drug_uuid": "026BFA4A-9212-4110-83E8-783895513760",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5A53EC47-E63F-44A2-8078-87659544FB04",
    "patient_ID": "TCGA.A2.A4RY",
    "bcr_drug_barcode": "TCGA-A2-A4RY-D40662",
    "bcr_drug_uuid": "E5560868-E57D-4A2B-83C8-C2B50D5B8224",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DDC014D-9A8B-407B-845F-452A73F08E5E",
    "patient_ID": "TCGA.A2.A4S2",
    "bcr_drug_barcode": "TCGA-A2-A4S2-D40762",
    "bcr_drug_uuid": "72B353D4-7256-4161-B9C8-EA9FDC872D78",
    "form_completion_date": "2013-2-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DDC014D-9A8B-407B-845F-452A73F08E5E",
    "patient_ID": "TCGA.A2.A4S2",
    "bcr_drug_barcode": "TCGA-A2-A4S2-D40763",
    "bcr_drug_uuid": "30184077-58DE-45BD-94A3-1F57F5419536",
    "form_completion_date": "2013-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DDC014D-9A8B-407B-845F-452A73F08E5E",
    "patient_ID": "TCGA.A2.A4S2",
    "bcr_drug_barcode": "TCGA-A2-A4S2-D40764",
    "bcr_drug_uuid": "B81A498A-A3FC-4E99-A912-6B5CBC9E288D",
    "form_completion_date": "2013-2-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DDC014D-9A8B-407B-845F-452A73F08E5E",
    "patient_ID": "TCGA.A2.A4S2",
    "bcr_drug_barcode": "TCGA-A2-A4S2-D59084",
    "bcr_drug_uuid": "8B0F87F5-E925-40EB-9A72-E44475BF4CB3",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09765b0a-94f6-47d2-af56-93368084ac3a",
    "patient_ID": "TCGA.A7.A0CD",
    "bcr_drug_barcode": "TCGA-A7-A0CD-D4373",
    "bcr_drug_uuid": "94451533-8be6-41aa-a175-9eaa6aae7381",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9d95a65b-e41d-4f93-92d4-99dce29ff40d",
    "patient_ID": "TCGA.A7.A0CE",
    "bcr_drug_barcode": "TCGA-A7-A0CE-D3142",
    "bcr_drug_uuid": "30d2d91e-18e4-4adb-87e1-e9154ad7cf0e",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5250
  },
  {
    "bcr_patient_uuid": "9d95a65b-e41d-4f93-92d4-99dce29ff40d",
    "patient_ID": "TCGA.A7.A0CE",
    "bcr_drug_barcode": "TCGA-A7-A0CE-D3140",
    "bcr_drug_uuid": "89072b52-11c9-4fe9-86c0-fff7dbaf8e8e",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "9d95a65b-e41d-4f93-92d4-99dce29ff40d",
    "patient_ID": "TCGA.A7.A0CE",
    "bcr_drug_barcode": "TCGA-A7-A0CE-D3143",
    "bcr_drug_uuid": "9464606d-3ece-43bd-aad1-7126b43626c9",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 380,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1520
  },
  {
    "bcr_patient_uuid": "9de678e5-67ed-4453-a98b-7ac351d5d0f1",
    "patient_ID": "TCGA.A7.A0CH",
    "bcr_drug_barcode": "TCGA-A7-A0CH-D2934",
    "bcr_drug_uuid": "2daa89c3-a79e-4a11-9bd4-c2472930362c",
    "form_completion_date": "2010-11-5",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 247
  },
  {
    "bcr_patient_uuid": "d69e59a8-b10b-46f5-b859-b6c178d90506",
    "patient_ID": "TCGA.A7.A0CJ",
    "bcr_drug_barcode": "TCGA-A7-A0CJ-D2941",
    "bcr_drug_uuid": "cde6bb96-e9e1-4308-9aed-0d9eadef467f",
    "form_completion_date": "2010-11-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "d69e59a8-b10b-46f5-b859-b6c178d90506",
    "patient_ID": "TCGA.A7.A0CJ",
    "bcr_drug_barcode": "TCGA-A7-A0CJ-D2940",
    "bcr_drug_uuid": "12be856f-cc3d-4090-844e-bddee5eda9d4",
    "form_completion_date": "2010-11-5",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1080,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4320
  },
  {
    "bcr_patient_uuid": "d69e59a8-b10b-46f5-b859-b6c178d90506",
    "patient_ID": "TCGA.A7.A0CJ",
    "bcr_drug_barcode": "TCGA-A7-A0CJ-D13150",
    "bcr_drug_uuid": "03D86C19-07DE-41C5-8A27-A742EA3E7D3D",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 208,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17baef7c-d97d-4b98-ab53-503ef856523d",
    "patient_ID": "TCGA.A7.A0D9",
    "bcr_drug_barcode": "TCGA-A7-A0D9-D2907",
    "bcr_drug_uuid": "80d0a61f-a26b-46d4-91b4-5028df32c9cb",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1080,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4320
  },
  {
    "bcr_patient_uuid": "17baef7c-d97d-4b98-ab53-503ef856523d",
    "patient_ID": "TCGA.A7.A0D9",
    "bcr_drug_barcode": "TCGA-A7-A0D9-D2912",
    "bcr_drug_uuid": "2a6eeaea-d6cf-4c0b-a97f-8dd3dd922972",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "17baef7c-d97d-4b98-ab53-503ef856523d",
    "patient_ID": "TCGA.A7.A0D9",
    "bcr_drug_barcode": "TCGA-A7-A0D9-D2916",
    "bcr_drug_uuid": "57f1f05f-cb78-4305-9469-fe76399db912",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4140
  },
  {
    "bcr_patient_uuid": "3afa1e93-1df8-4e4c-aaa4-557463f4bb77",
    "patient_ID": "TCGA.A7.A0DA",
    "bcr_drug_barcode": "TCGA-A7-A0DA-D6126",
    "bcr_drug_uuid": "1b1e115e-9a35-4b44-a883-94573341a893",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1435
  },
  {
    "bcr_patient_uuid": "3afa1e93-1df8-4e4c-aaa4-557463f4bb77",
    "patient_ID": "TCGA.A7.A0DA",
    "bcr_drug_barcode": "TCGA-A7-A0DA-D6123",
    "bcr_drug_uuid": "848337bd-29ff-4b6c-8710-4bb3ac828398",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "3afa1e93-1df8-4e4c-aaa4-557463f4bb77",
    "patient_ID": "TCGA.A7.A0DA",
    "bcr_drug_barcode": "TCGA-A7-A0DA-D6125",
    "bcr_drug_uuid": "84e6d642-6da6-4216-a376-2077ac969442",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3990
  },
  {
    "bcr_patient_uuid": "f130f376-5801-40f9-975d-a7e2f7b5670d",
    "patient_ID": "TCGA.A7.A0DB",
    "bcr_drug_barcode": "TCGA-A7-A0DB-D2932",
    "bcr_drug_uuid": "bcfb5d3f-efe5-4ea8-be83-bee5a5a802a4",
    "form_completion_date": "2010-11-5",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 216
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D3191",
    "bcr_drug_uuid": "cd2fd85e-9fad-473c-b1f1-47ec2596186b",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8346
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D3192",
    "bcr_drug_uuid": "cbcf5f6d-0308-484f-bc64-044efa3d5e86",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 170
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D3189",
    "bcr_drug_uuid": "ca0fef41-cd39-4497-b295-38a48b89774c",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 558
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D3187",
    "bcr_drug_uuid": "9d5ba4cc-c114-4c1d-a59b-c3a11120136a",
    "form_completion_date": "2010-11-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8346
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D19973",
    "bcr_drug_uuid": "8404643D-1E6E-44D8-A955-3B398A0A05AF",
    "form_completion_date": "2012-1-5",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 509,
    "drug_cycles": 245,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 245
  },
  {
    "bcr_patient_uuid": "cb9f5e50-f49d-4899-8895-9367afcc1015",
    "patient_ID": "TCGA.A7.A0DC",
    "bcr_drug_barcode": "TCGA-A7-A0DC-D34625",
    "bcr_drug_uuid": "0E08C9C8-C699-416C-AE02-F59B9358B98C",
    "form_completion_date": "2012-8-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 510,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8785012f-f73e-4d68-87cf-1d804af32782",
    "patient_ID": "TCGA.A7.A13D",
    "bcr_drug_barcode": "TCGA-A7-A13D-D8215",
    "bcr_drug_uuid": "559c6d67-c4d2-4b4d-bf0b-b13454988426",
    "form_completion_date": "2011-2-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 889
  },
  {
    "bcr_patient_uuid": "8785012f-f73e-4d68-87cf-1d804af32782",
    "patient_ID": "TCGA.A7.A13D",
    "bcr_drug_barcode": "TCGA-A7-A13D-D8216",
    "bcr_drug_uuid": "c345ebac-a9ee-49bc-b310-9629cee33830",
    "form_completion_date": "2011-2-23",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7104
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D8481",
    "bcr_drug_uuid": "6b9ba4ba-7f9d-4756-b32b-d5bc244ed7e7",
    "form_completion_date": "2011-2-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D8386",
    "bcr_drug_uuid": "d8fde920-62a6-411b-8bb4-b2d156e504c4",
    "form_completion_date": "2011-3-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1908
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D8387",
    "bcr_drug_uuid": "2a1cd4f5-b57f-4701-a524-65a4c933838e",
    "form_completion_date": "2011-3-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9136
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D8385",
    "bcr_drug_uuid": "dacbe1fe-726e-49ea-807c-c058a56849ab",
    "form_completion_date": "2011-3-21",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4848
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D8384",
    "bcr_drug_uuid": "ab9b71e4-bef4-4ef9-aee1-f529cd48d75e",
    "form_completion_date": "2011-3-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 486
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D30411",
    "bcr_drug_uuid": "17FFDC6B-E84C-4E5B-999D-D68ED4BF7881",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 574,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 574,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 157,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 157
  },
  {
    "bcr_patient_uuid": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9",
    "patient_ID": "TCGA.A7.A13E",
    "bcr_drug_barcode": "TCGA-A7-A13E-D30410",
    "bcr_drug_uuid": "983433D3-76A3-4F8C-9397-6496805CDAB0",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 589,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 379
  },
  {
    "bcr_patient_uuid": "2cf68894-168b-458b-af4f-53cad72989a8",
    "patient_ID": "TCGA.A7.A13F",
    "bcr_drug_barcode": "TCGA-A7-A13F-D8659",
    "bcr_drug_uuid": "16003a88-4c4e-4f56-ad98-b6e02346fe51",
    "form_completion_date": "2011-3-1",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 798
  },
  {
    "bcr_patient_uuid": "2cf68894-168b-458b-af4f-53cad72989a8",
    "patient_ID": "TCGA.A7.A13F",
    "bcr_drug_barcode": "TCGA-A7-A13F-D8657",
    "bcr_drug_uuid": "ff50db3d-c7d9-4aca-8616-bd68d8d81157",
    "form_completion_date": "2011-3-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 487
  },
  {
    "bcr_patient_uuid": "2cf68894-168b-458b-af4f-53cad72989a8",
    "patient_ID": "TCGA.A7.A13F",
    "bcr_drug_barcode": "TCGA-A7-A13F-D8658",
    "bcr_drug_uuid": "a3494e0e-47ac-4bf1-8911-42330fdda6fe",
    "form_completion_date": "2011-3-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4854
  },
  {
    "bcr_patient_uuid": "2cf68894-168b-458b-af4f-53cad72989a8",
    "patient_ID": "TCGA.A7.A13F",
    "bcr_drug_barcode": "TCGA-A7-A13F-D17813",
    "bcr_drug_uuid": "22203C82-11A9-45F7-A172-B99BE2FC855D",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2cf68894-168b-458b-af4f-53cad72989a8",
    "patient_ID": "TCGA.A7.A13F",
    "bcr_drug_barcode": "TCGA-A7-A13F-D17801",
    "bcr_drug_uuid": "D0D604CB-1045-4D02-AC97-F5AE8513DA0F",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 106
  },
  {
    "bcr_patient_uuid": "6cd9baf5-bbe0-4c1e-a87f-c53b3af22890",
    "patient_ID": "TCGA.A7.A13G",
    "bcr_drug_barcode": "TCGA-A7-A13G-D17698",
    "bcr_drug_uuid": "123A3E9A-D014-419E-93FC-E001C3B336B2",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 376
  },
  {
    "bcr_patient_uuid": "6cd9baf5-bbe0-4c1e-a87f-c53b3af22890",
    "patient_ID": "TCGA.A7.A13G",
    "bcr_drug_barcode": "TCGA-A7-A13G-D35038",
    "bcr_drug_uuid": "BEEDA94D-D6C3-4811-A18E-AA495A0EF9C3",
    "form_completion_date": "2012-9-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2E243F0E-9D7D-4CB0-9678-70607F90430A",
    "patient_ID": "TCGA.A7.A13H",
    "bcr_drug_barcode": "TCGA-A7-A13H-D36144",
    "bcr_drug_uuid": "5204919F-EBC8-4F13-A5D7-E1135D397732",
    "form_completion_date": "2012-10-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "011b9b2d-ebe5-42bf-9662-d922faccc7a1",
    "patient_ID": "TCGA.A7.A26E",
    "bcr_drug_barcode": "TCGA-A7-A26E-D14334",
    "bcr_drug_uuid": "0C2B9A8F-545C-48C7-A411-6086687670A8",
    "form_completion_date": "2011-7-28",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 174,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "011b9b2d-ebe5-42bf-9662-d922faccc7a1",
    "patient_ID": "TCGA.A7.A26E",
    "bcr_drug_barcode": "TCGA-A7-A26E-D14323",
    "bcr_drug_uuid": "BFCADEC4-0E84-4052-BA0C-C5F91DCDE496",
    "form_completion_date": "2011-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "011b9b2d-ebe5-42bf-9662-d922faccc7a1",
    "patient_ID": "TCGA.A7.A26E",
    "bcr_drug_barcode": "TCGA-A7-A26E-D14322",
    "bcr_drug_uuid": "C7645868-53FA-4051-9EEE-5F7F6FD7DEB5",
    "form_completion_date": "2011-7-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "3b7b9c1e-a84c-47ed-983c-9e4b00cbf01a",
    "patient_ID": "TCGA.A7.A26F",
    "bcr_drug_barcode": "TCGA-A7-A26F-D15010",
    "bcr_drug_uuid": "C3FD872C-2A13-45EF-9151-361979053F67",
    "form_completion_date": "2011-8-11",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "3b7b9c1e-a84c-47ed-983c-9e4b00cbf01a",
    "patient_ID": "TCGA.A7.A26F",
    "bcr_drug_barcode": "TCGA-A7-A26F-D15011",
    "bcr_drug_uuid": "52516E85-91DF-4339-92FC-15606CA08875",
    "form_completion_date": "2011-8-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "5ed024e8-d05e-4c65-9441-eda9930ccc82",
    "patient_ID": "TCGA.A7.A26G",
    "bcr_drug_barcode": "TCGA-A7-A26G-D14906",
    "bcr_drug_uuid": "90ABBBFF-599A-4245-A3A3-FAFC37EEC924",
    "form_completion_date": "2011-8-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 648
  },
  {
    "bcr_patient_uuid": "5ed024e8-d05e-4c65-9441-eda9930ccc82",
    "patient_ID": "TCGA.A7.A26G",
    "bcr_drug_barcode": "TCGA-A7-A26G-D14908",
    "bcr_drug_uuid": "7D7AE68F-EC3A-4BA6-A19A-4A4D2590CA7E",
    "form_completion_date": "2011-8-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5292
  },
  {
    "bcr_patient_uuid": "dddd8e2f-e540-418a-b02e-698d18a12c14",
    "patient_ID": "TCGA.A7.A26H",
    "bcr_drug_barcode": "TCGA-A7-A26H-D29623",
    "bcr_drug_uuid": "B0A12ECD-CF75-4AE7-BE0D-05D694119222",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 311,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 486,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1535
  },
  {
    "bcr_patient_uuid": "dddd8e2f-e540-418a-b02e-698d18a12c14",
    "patient_ID": "TCGA.A7.A26H",
    "bcr_drug_barcode": "TCGA-A7-A26H-D29622",
    "bcr_drug_uuid": "5ABD5AE2-14DC-45D0-8CD9-C1CE4EE9A336",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 296,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 253
  },
  {
    "bcr_patient_uuid": "b2ecbc0f-2c30-4200-8d5e-7b95424bcadb",
    "patient_ID": "TCGA.A7.A26I",
    "bcr_drug_barcode": "TCGA-A7-A26I-D31057",
    "bcr_drug_uuid": "B0D2110C-8FC3-414F-ABF8-61FEC6144D1D",
    "form_completion_date": "2012-4-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 840
  },
  {
    "bcr_patient_uuid": "b2ecbc0f-2c30-4200-8d5e-7b95424bcadb",
    "patient_ID": "TCGA.A7.A26I",
    "bcr_drug_barcode": "TCGA-A7-A26I-D31070",
    "bcr_drug_uuid": "8D9064E7-67A8-4172-A033-3A6E46CA915D",
    "form_completion_date": "2012-4-23",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6780
  },
  {
    "bcr_patient_uuid": "6cb6f179-defd-4661-af0a-c353b74c0c49",
    "patient_ID": "TCGA.A7.A26J",
    "bcr_drug_barcode": "TCGA-A7-A26J-D30819",
    "bcr_drug_uuid": "486CE20D-4F3C-40CA-B3BB-95A9F2BC54F7",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5540
  },
  {
    "bcr_patient_uuid": "92654F8D-5137-4FFD-AAA3-5AE38EB88226",
    "patient_ID": "TCGA.A7.A2KD",
    "bcr_drug_barcode": "TCGA-A7-A2KD-D31129",
    "bcr_drug_uuid": "D27EB374-1499-4A17-9A6F-D6EF17DF32D0",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1370,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4110
  },
  {
    "bcr_patient_uuid": "92654F8D-5137-4FFD-AAA3-5AE38EB88226",
    "patient_ID": "TCGA.A7.A2KD",
    "bcr_drug_barcode": "TCGA-A7-A2KD-D31144",
    "bcr_drug_uuid": "037E9933-2221-4B0E-B8CA-1397B14B6523",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 810,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2430
  },
  {
    "bcr_patient_uuid": "92654F8D-5137-4FFD-AAA3-5AE38EB88226",
    "patient_ID": "TCGA.A7.A2KD",
    "bcr_drug_barcode": "TCGA-A7-A2KD-D31143",
    "bcr_drug_uuid": "A86965D9-33B4-40A5-B803-EBD8F3205AA3",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 170,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "92654F8D-5137-4FFD-AAA3-5AE38EB88226",
    "patient_ID": "TCGA.A7.A2KD",
    "bcr_drug_barcode": "TCGA-A7-A2KD-D32490",
    "bcr_drug_uuid": "A17F619D-81A6-4A7B-BEB1-20FA1C828843",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6B4E0262-F589-4532-B578-9F2D76C19D90",
    "patient_ID": "TCGA.A7.A3IY",
    "bcr_drug_barcode": "TCGA-A7-A3IY-D33857",
    "bcr_drug_uuid": "C48F9151-4B8D-4590-AE3F-C0FD5C568755",
    "form_completion_date": "2012-7-20",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "15FF4B02-BB69-4D24-8A07-B82F428E428D",
    "patient_ID": "TCGA.A7.A3IZ",
    "bcr_drug_barcode": "TCGA-A7-A3IZ-D29225",
    "bcr_drug_uuid": "A1B93297-6E83-4565-943F-92213D0BA738",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 522
  },
  {
    "bcr_patient_uuid": "15FF4B02-BB69-4D24-8A07-B82F428E428D",
    "patient_ID": "TCGA.A7.A3IZ",
    "bcr_drug_barcode": "TCGA-A7-A3IZ-D29226",
    "bcr_drug_uuid": "D6D7C497-BCC6-4864-94CB-FCD2B53EC7B6",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "15FF4B02-BB69-4D24-8A07-B82F428E428D",
    "patient_ID": "TCGA.A7.A3IZ",
    "bcr_drug_barcode": "TCGA-A7-A3IZ-D34493",
    "bcr_drug_uuid": "D4791F16-F661-488F-9546-AE3B6AC25372",
    "form_completion_date": "2012-8-16",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DA70CF7E-0E61-4C72-B4C5-C408569D11B8",
    "patient_ID": "TCGA.A7.A3J0",
    "bcr_drug_barcode": "TCGA-A7-A3J0-D35966",
    "bcr_drug_uuid": "CDDA22AF-C26F-4051-9D80-3C195030DF0E",
    "form_completion_date": "2012-10-12",
    "pharmaceutical_therapy_drug_name": "ANASTRAZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F9AD301-6699-4078-A80D-886E40894AF7",
    "patient_ID": "TCGA.A7.A3J1",
    "bcr_drug_barcode": "TCGA-A7-A3J1-D36742",
    "bcr_drug_uuid": "DD2D3EBE-A0AB-41A9-B7C7-D19BCEF1E844",
    "form_completion_date": "2012-11-12",
    "pharmaceutical_therapy_drug_name": "ANASTRAZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F9AD301-6699-4078-A80D-886E40894AF7",
    "patient_ID": "TCGA.A7.A3J1",
    "bcr_drug_barcode": "TCGA-A7-A3J1-D36752",
    "bcr_drug_uuid": "637756E0-631E-439C-AE4F-8627197B8B18",
    "form_completion_date": "2012-11-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 251,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F9AD301-6699-4078-A80D-886E40894AF7",
    "patient_ID": "TCGA.A7.A3J1",
    "bcr_drug_barcode": "TCGA-A7-A3J1-D36755",
    "bcr_drug_uuid": "14B7B938-1FD8-4DE7-8846-C4F32A49A5DE",
    "form_completion_date": "2012-11-12",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 300,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7451AF3C-ACC0-4D79-8429-6B8BE96911D8",
    "patient_ID": "TCGA.A7.A3RF",
    "bcr_drug_barcode": "TCGA-A7-A3RF-D40414",
    "bcr_drug_uuid": "C60A018E-A8EC-4C00-AB28-40901C23F33E",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8F5C479-8685-4E2D-BB60-63F1CC651083",
    "patient_ID": "TCGA.A7.A425",
    "bcr_drug_barcode": "TCGA-A7-A425-D36587",
    "bcr_drug_uuid": "7AA4AFE0-6678-4A17-96DE-062AB5E85D67",
    "form_completion_date": "2012-11-5",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8F5C479-8685-4E2D-BB60-63F1CC651083",
    "patient_ID": "TCGA.A7.A425",
    "bcr_drug_barcode": "TCGA-A7-A425-D36588",
    "bcr_drug_uuid": "65234BE9-7E88-41BF-9163-37261DF76FED",
    "form_completion_date": "2012-11-5",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8F5C479-8685-4E2D-BB60-63F1CC651083",
    "patient_ID": "TCGA.A7.A425",
    "bcr_drug_barcode": "TCGA-A7-A425-D36589",
    "bcr_drug_uuid": "D8A19C0E-E2E4-410F-B480-D1FC1EAEA6CD",
    "form_completion_date": "2012-11-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8F5C479-8685-4E2D-BB60-63F1CC651083",
    "patient_ID": "TCGA.A7.A425",
    "bcr_drug_barcode": "TCGA-A7-A425-D41690",
    "bcr_drug_uuid": "3E02A5A3-AF45-42DE-BF76-E56FAE2440DA",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D48E9F25-F083-4F88-A92D-C12D9F765BA6",
    "patient_ID": "TCGA.A7.A426",
    "bcr_drug_barcode": "TCGA-A7-A426-D36577",
    "bcr_drug_uuid": "96AB3786-43CC-4EB7-B2CE-1A163FDA1647",
    "form_completion_date": "2012-11-3",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D48E9F25-F083-4F88-A92D-C12D9F765BA6",
    "patient_ID": "TCGA.A7.A426",
    "bcr_drug_barcode": "TCGA-A7-A426-D36578",
    "bcr_drug_uuid": "942628C7-12A1-4EF8-8464-8813B3BE2536",
    "form_completion_date": "2012-11-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D48E9F25-F083-4F88-A92D-C12D9F765BA6",
    "patient_ID": "TCGA.A7.A426",
    "bcr_drug_barcode": "TCGA-A7-A426-D36579",
    "bcr_drug_uuid": "BD940BFE-90EE-4928-8D31-2084078B12E6",
    "form_completion_date": "2012-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D48E9F25-F083-4F88-A92D-C12D9F765BA6",
    "patient_ID": "TCGA.A7.A426",
    "bcr_drug_barcode": "TCGA-A7-A426-D41740",
    "bcr_drug_uuid": "E049A833-72A0-4C05-8F37-8DB9DDE9746D",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A2EFE7E1-ACA3-440F-825F-ED621EDCA69F",
    "patient_ID": "TCGA.A7.A4SA",
    "bcr_drug_barcode": "TCGA-A7-A4SA-D40422",
    "bcr_drug_uuid": "D1394A9B-E263-4C3E-9B21-9C7C7A27F4DD",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A2EFE7E1-ACA3-440F-825F-ED621EDCA69F",
    "patient_ID": "TCGA.A7.A4SA",
    "bcr_drug_barcode": "TCGA-A7-A4SA-D40423",
    "bcr_drug_uuid": "90ABC9E4-87E8-4C1B-A001-A9A02F4B7AAB",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A2EFE7E1-ACA3-440F-825F-ED621EDCA69F",
    "patient_ID": "TCGA.A7.A4SA",
    "bcr_drug_barcode": "TCGA-A7-A4SA-D40424",
    "bcr_drug_uuid": "6BB3CF2B-3286-4031-A91D-48803A014612",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A2EFE7E1-ACA3-440F-825F-ED621EDCA69F",
    "patient_ID": "TCGA.A7.A4SA",
    "bcr_drug_barcode": "TCGA-A7-A4SA-D40425",
    "bcr_drug_uuid": "625C328C-CA7E-445E-A8AB-B77D5CC49C4A",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A947A945-4721-45CC-BC45-13B8EA41C10E",
    "patient_ID": "TCGA.A7.A4SB",
    "bcr_drug_barcode": "TCGA-A7-A4SB-D40444",
    "bcr_drug_uuid": "50FAB4F7-9961-47ED-A399-7EA0F55FF5EC",
    "form_completion_date": "2013-2-20",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A947A945-4721-45CC-BC45-13B8EA41C10E",
    "patient_ID": "TCGA.A7.A4SB",
    "bcr_drug_barcode": "TCGA-A7-A4SB-D40445",
    "bcr_drug_uuid": "9F679293-FBF6-4C18-8842-A0A4A2E10805",
    "form_completion_date": "2013-2-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A947A945-4721-45CC-BC45-13B8EA41C10E",
    "patient_ID": "TCGA.A7.A4SB",
    "bcr_drug_barcode": "TCGA-A7-A4SB-D49626",
    "bcr_drug_uuid": "8051EB4D-DE3F-4F20-B2D4-F5559D2AE0AD",
    "form_completion_date": "2013-10-4",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EC0AB947-9341-4FFF-BDA4-FDFB9434D508",
    "patient_ID": "TCGA.A7.A4SC",
    "bcr_drug_barcode": "TCGA-A7-A4SC-D40466",
    "bcr_drug_uuid": "4CDA31F3-7B21-4B73-9B41-8406C9958051",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EC0AB947-9341-4FFF-BDA4-FDFB9434D508",
    "patient_ID": "TCGA.A7.A4SC",
    "bcr_drug_barcode": "TCGA-A7-A4SC-D40469",
    "bcr_drug_uuid": "D20C10DB-BE58-4536-9BE0-3547209715C7",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8C09F413-E938-4F2E-A414-84F0E7FCFE41",
    "patient_ID": "TCGA.A7.A4SD",
    "bcr_drug_barcode": "TCGA-A7-A4SD-D40418",
    "bcr_drug_uuid": "AC6661B8-5744-4B0F-99D8-1C6C82FF86D4",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8C09F413-E938-4F2E-A414-84F0E7FCFE41",
    "patient_ID": "TCGA.A7.A4SD",
    "bcr_drug_barcode": "TCGA-A7-A4SD-D40420",
    "bcr_drug_uuid": "642ABB42-0832-4A3A-9FB0-AE825D90EEC6",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DBF6F981-15CC-40AD-91AC-A66360405FBD",
    "patient_ID": "TCGA.A7.A4SE",
    "bcr_drug_barcode": "TCGA-A7-A4SE-D41891",
    "bcr_drug_uuid": "8C1D4FAD-B3C5-4009-94B8-51BE6B474423",
    "form_completion_date": "2013-4-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DBF6F981-15CC-40AD-91AC-A66360405FBD",
    "patient_ID": "TCGA.A7.A4SE",
    "bcr_drug_barcode": "TCGA-A7-A4SE-D41892",
    "bcr_drug_uuid": "B8237736-7799-4490-A1CA-2A15E2985B17",
    "form_completion_date": "2013-4-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DBF6F981-15CC-40AD-91AC-A66360405FBD",
    "patient_ID": "TCGA.A7.A4SE",
    "bcr_drug_barcode": "TCGA-A7-A4SE-D41893",
    "bcr_drug_uuid": "5FA600E2-E487-4345-A4BE-E4A7AD3738EB",
    "form_completion_date": "2013-4-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D81594D9-DD6A-45C3-8BAD-61960611D78D",
    "patient_ID": "TCGA.A7.A4SF",
    "bcr_drug_barcode": "TCGA-A7-A4SF-D40583",
    "bcr_drug_uuid": "308EA6ED-2B83-4B5B-95E0-CBDEF48D7909",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D81594D9-DD6A-45C3-8BAD-61960611D78D",
    "patient_ID": "TCGA.A7.A4SF",
    "bcr_drug_barcode": "TCGA-A7-A4SF-D40584",
    "bcr_drug_uuid": "68535884-BA16-4956-99F0-FB17F5DE630D",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D81594D9-DD6A-45C3-8BAD-61960611D78D",
    "patient_ID": "TCGA.A7.A4SF",
    "bcr_drug_barcode": "TCGA-A7-A4SF-D40585",
    "bcr_drug_uuid": "1A67FA24-FD67-47D8-A0B6-75D33DABFB3A",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 453,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D81594D9-DD6A-45C3-8BAD-61960611D78D",
    "patient_ID": "TCGA.A7.A4SF",
    "bcr_drug_barcode": "TCGA-A7-A4SF-D40586",
    "bcr_drug_uuid": "0F0BE62E-9086-4B0B-9D8A-0D6DE8B921E5",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 306,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F062CBD0-2426-40AC-A4BE-E74AC61FA2A7",
    "patient_ID": "TCGA.A7.A56D",
    "bcr_drug_barcode": "TCGA-A7-A56D-D41835",
    "bcr_drug_uuid": "80BF0AFC-29C9-4B5B-A9E4-95F4B5A4EEDC",
    "form_completion_date": "2013-4-1",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0EC70E40-07DF-461D-8FF9-351240A0D454",
    "patient_ID": "TCGA.A7.A5ZV",
    "bcr_drug_barcode": "TCGA-A7-A5ZV-D43178",
    "bcr_drug_uuid": "8F1125F3-DBBB-47BC-BACF-5CE4963DC966",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0EC70E40-07DF-461D-8FF9-351240A0D454",
    "patient_ID": "TCGA.A7.A5ZV",
    "bcr_drug_barcode": "TCGA-A7-A5ZV-D43179",
    "bcr_drug_uuid": "EADD43A7-E14F-4643-A3BE-C251663F4AA0",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0EC70E40-07DF-461D-8FF9-351240A0D454",
    "patient_ID": "TCGA.A7.A5ZV",
    "bcr_drug_barcode": "TCGA-A7-A5ZV-D43180",
    "bcr_drug_uuid": "52DC65F2-30C0-4BDD-89AC-641853A9E429",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "523E24A2-51B9-4658-BE2F-42E5FCCEBB17",
    "patient_ID": "TCGA.A7.A5ZW",
    "bcr_drug_barcode": "TCGA-A7-A5ZW-D50165",
    "bcr_drug_uuid": "4AF33B96-C484-42DE-8F9B-AAB6DC4E168D",
    "form_completion_date": "2013-10-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "523E24A2-51B9-4658-BE2F-42E5FCCEBB17",
    "patient_ID": "TCGA.A7.A5ZW",
    "bcr_drug_barcode": "TCGA-A7-A5ZW-D50166",
    "bcr_drug_uuid": "C795DC4E-1F39-460D-9E49-17CB3709BE9E",
    "form_completion_date": "2013-10-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "523E24A2-51B9-4658-BE2F-42E5FCCEBB17",
    "patient_ID": "TCGA.A7.A5ZW",
    "bcr_drug_barcode": "TCGA-A7-A5ZW-D50168",
    "bcr_drug_uuid": "D46476DA-66D7-47D9-9AAA-19A388D19BAA",
    "form_completion_date": "2013-10-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA80DB4E-D899-4DA4-AE49-5263D98E1530",
    "patient_ID": "TCGA.A7.A5ZX",
    "bcr_drug_barcode": "TCGA-A7-A5ZX-D51332",
    "bcr_drug_uuid": "9C29891D-CFA8-48D4-A646-C3AD561F20DA",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA80DB4E-D899-4DA4-AE49-5263D98E1530",
    "patient_ID": "TCGA.A7.A5ZX",
    "bcr_drug_barcode": "TCGA-A7-A5ZX-D51333",
    "bcr_drug_uuid": "F5C792BC-E5C5-4C56-9434-A746E1B17038",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA80DB4E-D899-4DA4-AE49-5263D98E1530",
    "patient_ID": "TCGA.A7.A5ZX",
    "bcr_drug_barcode": "TCGA-A7-A5ZX-D51334",
    "bcr_drug_uuid": "46461AEB-BAB0-45F1-A893-FCD00A28BBEA",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA80DB4E-D899-4DA4-AE49-5263D98E1530",
    "patient_ID": "TCGA.A7.A5ZX",
    "bcr_drug_barcode": "TCGA-A7-A5ZX-D52815",
    "bcr_drug_uuid": "056878FC-D30B-4BF4-8BD2-972B61510B2D",
    "form_completion_date": "2013-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F",
    "patient_ID": "TCGA.A7.A6VV",
    "bcr_drug_barcode": "TCGA-A7-A6VV-D57247",
    "bcr_drug_uuid": "8A804A22-B193-4C71-8EBB-6FD22D9F605E",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F",
    "patient_ID": "TCGA.A7.A6VV",
    "bcr_drug_barcode": "TCGA-A7-A6VV-D57248",
    "bcr_drug_uuid": "52B5F633-7FB7-42E1-A8EC-60B50825FBCF",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98E709E7-E195-4B37-9537-F6081AFFB609",
    "patient_ID": "TCGA.A7.A6VW",
    "bcr_drug_barcode": "TCGA-A7-A6VW-D57225",
    "bcr_drug_uuid": "037B0D49-1CCC-47FB-9442-F8841E1663C5",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98E709E7-E195-4B37-9537-F6081AFFB609",
    "patient_ID": "TCGA.A7.A6VW",
    "bcr_drug_barcode": "TCGA-A7-A6VW-D57226",
    "bcr_drug_uuid": "DD497F99-3155-4D4E-904E-FD5904316A52",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98E709E7-E195-4B37-9537-F6081AFFB609",
    "patient_ID": "TCGA.A7.A6VW",
    "bcr_drug_barcode": "TCGA-A7-A6VW-D57254",
    "bcr_drug_uuid": "02D81B38-5418-4F7D-B18B-0AE11DBE806B",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EEA2B6E-771F-44C0-9350-38F45C8DBE87",
    "patient_ID": "TCGA.A7.A6VX",
    "bcr_drug_barcode": "TCGA-A7-A6VX-D50834",
    "bcr_drug_uuid": "660703C0-DE54-4AB9-A7E1-9AC73C6D7D75",
    "form_completion_date": "2013-10-31",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EEA2B6E-771F-44C0-9350-38F45C8DBE87",
    "patient_ID": "TCGA.A7.A6VX",
    "bcr_drug_barcode": "TCGA-A7-A6VX-D50836",
    "bcr_drug_uuid": "7F01C477-E69D-4E9E-81AB-2DB85686C1D2",
    "form_completion_date": "2013-10-31",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EEA2B6E-771F-44C0-9350-38F45C8DBE87",
    "patient_ID": "TCGA.A7.A6VX",
    "bcr_drug_barcode": "TCGA-A7-A6VX-D57517",
    "bcr_drug_uuid": "699D81B9-5EC8-4E6A-AE3A-3C9AD9B40B98",
    "form_completion_date": "2014-3-13",
    "pharmaceutical_therapy_drug_name": "ANASTRAZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E8EA576B-EB16-44F7-B241-DAEFC1375388",
    "patient_ID": "TCGA.A7.A6VY",
    "bcr_drug_barcode": "TCGA-A7-A6VY-D57229",
    "bcr_drug_uuid": "5D3D1784-E381-460E-B773-DE56BABA6BCF",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E8EA576B-EB16-44F7-B241-DAEFC1375388",
    "patient_ID": "TCGA.A7.A6VY",
    "bcr_drug_barcode": "TCGA-A7-A6VY-D57230",
    "bcr_drug_uuid": "2DB83098-CA32-424E-ACFA-3207D2899E95",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E8EA576B-EB16-44F7-B241-DAEFC1375388",
    "patient_ID": "TCGA.A7.A6VY",
    "bcr_drug_barcode": "TCGA-A7-A6VY-D57231",
    "bcr_drug_uuid": "5D349A3C-E310-48A5-A0E1-248ABE65246D",
    "form_completion_date": "2014-3-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69054195-9e93-49e5-b820-69b0091cc2d4",
    "patient_ID": "TCGA.A8.A06O",
    "bcr_drug_barcode": "TCGA-A8-A06O-D37896",
    "bcr_drug_uuid": "C45C3AB5-2102-4DC9-AABA-2E722C048077",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb",
    "patient_ID": "TCGA.A8.A06P",
    "bcr_drug_barcode": "TCGA-A8-A06P-D37894",
    "bcr_drug_uuid": "5069E310-A864-427D-819F-D2601933A155",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb",
    "patient_ID": "TCGA.A8.A06P",
    "bcr_drug_barcode": "TCGA-A8-A06P-D37895",
    "bcr_drug_uuid": "31453368-BCF6-42B5-AAC7-78DADCD6A50B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3ba71f9-25f3-4784-bf2d-3aa522a0cba8",
    "patient_ID": "TCGA.A8.A06R",
    "bcr_drug_barcode": "TCGA-A8-A06R-D37825",
    "bcr_drug_uuid": "D8FE6469-6DAB-4BCB-9DF8-8AD53DF522F2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3ba71f9-25f3-4784-bf2d-3aa522a0cba8",
    "patient_ID": "TCGA.A8.A06R",
    "bcr_drug_barcode": "TCGA-A8-A06R-D37826",
    "bcr_drug_uuid": "02116C14-0DE0-40A5-9224-0A2BBC4D0DEB",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3ba71f9-25f3-4784-bf2d-3aa522a0cba8",
    "patient_ID": "TCGA.A8.A06R",
    "bcr_drug_barcode": "TCGA-A8-A06R-D37827",
    "bcr_drug_uuid": "24AF886F-B700-4E8D-91FA-5A62222090E4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f3ba71f9-25f3-4784-bf2d-3aa522a0cba8",
    "patient_ID": "TCGA.A8.A06R",
    "bcr_drug_barcode": "TCGA-A8-A06R-D37828",
    "bcr_drug_uuid": "A8ADA003-4EDE-4F08-BD6D-033E139A8077",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2c04a2f5-321e-4dea-8e00-268325da65cb",
    "patient_ID": "TCGA.A8.A06T",
    "bcr_drug_barcode": "TCGA-A8-A06T-D37762",
    "bcr_drug_uuid": "686C3C70-6D5F-4633-B169-6268CF0EF5A7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "515b1400-e896-4f2a-81bd-70895441a0bd",
    "patient_ID": "TCGA.A8.A06Y",
    "bcr_drug_barcode": "TCGA-A8-A06Y-D37851",
    "bcr_drug_uuid": "E625C1D0-D92D-46AE-8C5E-BD0D9436E191",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21",
    "patient_ID": "TCGA.A8.A075",
    "bcr_drug_barcode": "TCGA-A8-A075-D37846",
    "bcr_drug_uuid": "01EB4E82-BDB4-4A0D-AE50-BE001501E918",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICOIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21",
    "patient_ID": "TCGA.A8.A075",
    "bcr_drug_barcode": "TCGA-A8-A075-D37847",
    "bcr_drug_uuid": "4F50CB8E-0F25-40D0-A2A9-E840A63A5158",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21",
    "patient_ID": "TCGA.A8.A075",
    "bcr_drug_barcode": "TCGA-A8-A075-D37848",
    "bcr_drug_uuid": "3B670A10-80C3-4879-BC47-89AD2311D0CA",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21",
    "patient_ID": "TCGA.A8.A075",
    "bcr_drug_barcode": "TCGA-A8-A075-D37849",
    "bcr_drug_uuid": "BEDE978F-31C6-4E5C-98AE-D4AE802920F2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 275,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21",
    "patient_ID": "TCGA.A8.A075",
    "bcr_drug_barcode": "TCGA-A8-A075-D37850",
    "bcr_drug_uuid": "02D06787-6B7F-42B2-BEB7-F10802F43C59",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23dabeef-8e3c-44bc-9a12-a9522d17be5c",
    "patient_ID": "TCGA.A8.A076",
    "bcr_drug_barcode": "TCGA-A8-A076-D37845",
    "bcr_drug_uuid": "D9725F84-E2BD-4A29-8D96-2689DDF06EB0",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31c31cce-1b4d-4f12-922f-84f389403170",
    "patient_ID": "TCGA.A8.A079",
    "bcr_drug_barcode": "TCGA-A8-A079-D37842",
    "bcr_drug_uuid": "D30A1FC1-2462-464E-B8B4-6EC389A33928",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31c31cce-1b4d-4f12-922f-84f389403170",
    "patient_ID": "TCGA.A8.A079",
    "bcr_drug_barcode": "TCGA-A8-A079-D37843",
    "bcr_drug_uuid": "83CBDD5D-F540-4E22-BFF6-1977215312E5",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31c31cce-1b4d-4f12-922f-84f389403170",
    "patient_ID": "TCGA.A8.A079",
    "bcr_drug_barcode": "TCGA-A8-A079-D37844",
    "bcr_drug_uuid": "D39B1438-ADE8-40F1-A772-470F7B3FE40D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b6633c36-7ce4-4b69-9bf6-30b64d46c66f",
    "patient_ID": "TCGA.A8.A07C",
    "bcr_drug_barcode": "TCGA-A8-A07C-D37838",
    "bcr_drug_uuid": "80A825CD-F344-4738-AB3F-163220CF126F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b6633c36-7ce4-4b69-9bf6-30b64d46c66f",
    "patient_ID": "TCGA.A8.A07C",
    "bcr_drug_barcode": "TCGA-A8-A07C-D37839",
    "bcr_drug_uuid": "44BA63A5-D965-4A75-BB06-9C2DD6F50AD6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b6633c36-7ce4-4b69-9bf6-30b64d46c66f",
    "patient_ID": "TCGA.A8.A07C",
    "bcr_drug_barcode": "TCGA-A8-A07C-D37840",
    "bcr_drug_uuid": "1A826A54-48E2-429B-A130-9112B0552A47",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b6633c36-7ce4-4b69-9bf6-30b64d46c66f",
    "patient_ID": "TCGA.A8.A07C",
    "bcr_drug_barcode": "TCGA-A8-A07C-D37841",
    "bcr_drug_uuid": "4749D00E-48DA-45FB-BDBF-BAD8C06F1036",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "853456d8-2367-404e-abc9-020fe8bbd209",
    "patient_ID": "TCGA.A8.A07E",
    "bcr_drug_barcode": "TCGA-A8-A07E-D37761",
    "bcr_drug_uuid": "4C0CE1A6-BDC8-4C9A-8A4B-C562220040B4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5d688049-f271-40ef-813a-d37240ffe21c",
    "patient_ID": "TCGA.A8.A07F",
    "bcr_drug_barcode": "TCGA-A8-A07F-D37883",
    "bcr_drug_uuid": "9376A2EE-E979-4870-8EE1-39BC963B3B53",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5d688049-f271-40ef-813a-d37240ffe21c",
    "patient_ID": "TCGA.A8.A07F",
    "bcr_drug_barcode": "TCGA-A8-A07F-D37884",
    "bcr_drug_uuid": "1E1543B7-C41E-4E32-B36C-8B255B09B7C0",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5d688049-f271-40ef-813a-d37240ffe21c",
    "patient_ID": "TCGA.A8.A07F",
    "bcr_drug_barcode": "TCGA-A8-A07F-D37885",
    "bcr_drug_uuid": "2EF8C377-0721-408E-BEFA-873ECE792E98",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5d688049-f271-40ef-813a-d37240ffe21c",
    "patient_ID": "TCGA.A8.A07F",
    "bcr_drug_barcode": "TCGA-A8-A07F-D37886",
    "bcr_drug_uuid": "68745060-A6F4-4638-9ADB-D798AA9BF1F7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 365,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa",
    "patient_ID": "TCGA.A8.A07G",
    "bcr_drug_barcode": "TCGA-A8-A07G-D37879",
    "bcr_drug_uuid": "0211068A-96FE-4994-9F2A-BA4918363F47",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa",
    "patient_ID": "TCGA.A8.A07G",
    "bcr_drug_barcode": "TCGA-A8-A07G-D37880",
    "bcr_drug_uuid": "28A905FA-0749-46CF-9381-CFD29F1403E3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa",
    "patient_ID": "TCGA.A8.A07G",
    "bcr_drug_barcode": "TCGA-A8-A07G-D37881",
    "bcr_drug_uuid": "E2B01A91-364F-43EC-ACE7-587DA7947387",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa",
    "patient_ID": "TCGA.A8.A07G",
    "bcr_drug_barcode": "TCGA-A8-A07G-D37882",
    "bcr_drug_uuid": "EF6F7284-A441-4DE8-BD6E-C34BC40D261E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37873",
    "bcr_drug_uuid": "2E3715CB-3802-4392-A7FD-4A36AE0E3D43",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37874",
    "bcr_drug_uuid": "DEE16E8F-6322-49BB-8B56-D708F62283F3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37875",
    "bcr_drug_uuid": "D9C7F7BE-AA3C-45E5-B2B3-272DA8642C88",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37876",
    "bcr_drug_uuid": "AF49DCB1-E14E-4848-9903-7D13E60573C7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37877",
    "bcr_drug_uuid": "4626641D-270B-4338-980A-D4A594F94997",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "566792ae-f853-4a47-856d-f02cdcfcb18a",
    "patient_ID": "TCGA.A8.A07I",
    "bcr_drug_barcode": "TCGA-A8-A07I-D37878",
    "bcr_drug_uuid": "5488CE4C-EA04-476A-AA6B-6FE37646BC75",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "316625b8-a217-4829-90d1-dfd9cb7e4bc3",
    "patient_ID": "TCGA.A8.A07J",
    "bcr_drug_barcode": "TCGA-A8-A07J-D37868",
    "bcr_drug_uuid": "30FC02A5-ACD9-4CE4-A312-69CCBD6291A6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "316625b8-a217-4829-90d1-dfd9cb7e4bc3",
    "patient_ID": "TCGA.A8.A07J",
    "bcr_drug_barcode": "TCGA-A8-A07J-D37869",
    "bcr_drug_uuid": "67EB5A96-AE11-405C-854F-6ABAE77D78A2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "316625b8-a217-4829-90d1-dfd9cb7e4bc3",
    "patient_ID": "TCGA.A8.A07J",
    "bcr_drug_barcode": "TCGA-A8-A07J-D37870",
    "bcr_drug_uuid": "042C8BB6-D133-47F7-86D9-C19D091DC859",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "316625b8-a217-4829-90d1-dfd9cb7e4bc3",
    "patient_ID": "TCGA.A8.A07J",
    "bcr_drug_barcode": "TCGA-A8-A07J-D37871",
    "bcr_drug_uuid": "4D185435-8F11-4933-9616-FE908DBDF03F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "316625b8-a217-4829-90d1-dfd9cb7e4bc3",
    "patient_ID": "TCGA.A8.A07J",
    "bcr_drug_barcode": "TCGA-A8-A07J-D37872",
    "bcr_drug_uuid": "3048378F-307F-4B1C-8A8E-286754868C32",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e89a9deb-6321-4e61-b412-b4993d4277dd",
    "patient_ID": "TCGA.A8.A07L",
    "bcr_drug_barcode": "TCGA-A8-A07L-D37866",
    "bcr_drug_uuid": "F05105AD-1CB2-444A-9701-65ECDF294EC2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "e89a9deb-6321-4e61-b412-b4993d4277dd",
    "patient_ID": "TCGA.A8.A07L",
    "bcr_drug_barcode": "TCGA-A8-A07L-D37867",
    "bcr_drug_uuid": "F35579B1-B246-4D73-899D-43A1DAB766AD",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cf9db1af-17f0-490e-8139-142bd704763a",
    "patient_ID": "TCGA.A8.A07O",
    "bcr_drug_barcode": "TCGA-A8-A07O-D37865",
    "bcr_drug_uuid": "FE74A740-3180-4A13-A733-54DDF7212A91",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "8cccf160-93e9-48a5-9b8b-54aa50153142",
    "patient_ID": "TCGA.A8.A07P",
    "bcr_drug_barcode": "TCGA-A8-A07P-D37860",
    "bcr_drug_uuid": "51A06630-6788-4AF6-B0A3-C4B649D4966B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cccf160-93e9-48a5-9b8b-54aa50153142",
    "patient_ID": "TCGA.A8.A07P",
    "bcr_drug_barcode": "TCGA-A8-A07P-D37861",
    "bcr_drug_uuid": "8927D85C-E657-4253-9085-7F56495EEBCE",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cccf160-93e9-48a5-9b8b-54aa50153142",
    "patient_ID": "TCGA.A8.A07P",
    "bcr_drug_barcode": "TCGA-A8-A07P-D37862",
    "bcr_drug_uuid": "9AA7C3E5-F877-4767-99B4-5D448798AE79",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cccf160-93e9-48a5-9b8b-54aa50153142",
    "patient_ID": "TCGA.A8.A07P",
    "bcr_drug_barcode": "TCGA-A8-A07P-D37863",
    "bcr_drug_uuid": "75AA33AD-D619-4CF8-BA27-5431C367A9B3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8cccf160-93e9-48a5-9b8b-54aa50153142",
    "patient_ID": "TCGA.A8.A07P",
    "bcr_drug_barcode": "TCGA-A8-A07P-D37864",
    "bcr_drug_uuid": "6E70AFEF-B5DD-4CDE-89B1-50C8857BA3CF",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "72e486b8-a866-4916-b2e4-8b4bb5dcd92d",
    "patient_ID": "TCGA.A8.A07R",
    "bcr_drug_barcode": "TCGA-A8-A07R-D37859",
    "bcr_drug_uuid": "405A82A8-7239-4AA4-9C46-4C081D26D8E4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a20fa2c4-a502-47e3-bfaa-2ec4cce3a859",
    "patient_ID": "TCGA.A8.A07S",
    "bcr_drug_barcode": "TCGA-A8-A07S-D37858",
    "bcr_drug_uuid": "D07D6350-F930-4F58-9B82-9257EC76316B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59bf0ce4-715a-4017-bccb-c59916e78324",
    "patient_ID": "TCGA.A8.A07U",
    "bcr_drug_barcode": "TCGA-A8-A07U-D37854",
    "bcr_drug_uuid": "D0CD63EE-CD6F-43C9-9FB5-FB2114055A14",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59bf0ce4-715a-4017-bccb-c59916e78324",
    "patient_ID": "TCGA.A8.A07U",
    "bcr_drug_barcode": "TCGA-A8-A07U-D37855",
    "bcr_drug_uuid": "8D55552F-9B8D-4002-B654-C83EED6FD35E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59bf0ce4-715a-4017-bccb-c59916e78324",
    "patient_ID": "TCGA.A8.A07U",
    "bcr_drug_barcode": "TCGA-A8-A07U-D37856",
    "bcr_drug_uuid": "B2F4C015-EAF0-4448-B665-1B8C5A7B8908",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59bf0ce4-715a-4017-bccb-c59916e78324",
    "patient_ID": "TCGA.A8.A07U",
    "bcr_drug_barcode": "TCGA-A8-A07U-D37857",
    "bcr_drug_uuid": "B33C7BC7-4100-448C-AD46-5A4BE08C2A53",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01263518-5f7c-49dc-8d7e-84b0c03a6a63",
    "patient_ID": "TCGA.A8.A07W",
    "bcr_drug_barcode": "TCGA-A8-A07W-D37852",
    "bcr_drug_uuid": "F73231E4-FFC8-4EE0-8B3C-49503701A0E1",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01263518-5f7c-49dc-8d7e-84b0c03a6a63",
    "patient_ID": "TCGA.A8.A07W",
    "bcr_drug_barcode": "TCGA-A8-A07W-D37853",
    "bcr_drug_uuid": "65DF696C-50FD-4538-824D-29D00F8BAB9A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY"
  },
  {
    "bcr_patient_uuid": "a272171b-44f5-47a5-89be-7520413c01ad",
    "patient_ID": "TCGA.A8.A07Z",
    "bcr_drug_barcode": "TCGA-A8-A07Z-D37893",
    "bcr_drug_uuid": "7451614E-5AF0-44F4-8C54-978B7E546B5D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37887",
    "bcr_drug_uuid": "07C01032-C857-4682-B8E3-C03FA024ECB9",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37888",
    "bcr_drug_uuid": "EFA90125-FED8-4301-A595-3CB4798D1F22",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37889",
    "bcr_drug_uuid": "A155B75A-412B-4A2E-921A-67A737A29E6A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37890",
    "bcr_drug_uuid": "122E4A81-1D23-44AB-8070-1F44572B6AE8",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37891",
    "bcr_drug_uuid": "BCB4083F-8DF9-4847-8F80-00E4A0CD49F5",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a",
    "patient_ID": "TCGA.A8.A082",
    "bcr_drug_barcode": "TCGA-A8-A082-D37892",
    "bcr_drug_uuid": "03AE2E15-1D31-4DAD-8D42-434C2FF4769A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 852,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 914,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3c08aabd-d5b5-4bbe-857c-38a7527b2163",
    "patient_ID": "TCGA.A8.A085",
    "bcr_drug_barcode": "TCGA-A8-A085-D37772",
    "bcr_drug_uuid": "DA0D6313-0886-4A80-817A-6FDF72104A27",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 394,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9eb88f7-9293-46bf-ace4-a746e4ff80dc",
    "patient_ID": "TCGA.A8.A086",
    "bcr_drug_barcode": "TCGA-A8-A086-D37770",
    "bcr_drug_uuid": "69FDE7B7-F6E1-48E5-B4EC-553EBEA6839C",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9eb88f7-9293-46bf-ace4-a746e4ff80dc",
    "patient_ID": "TCGA.A8.A086",
    "bcr_drug_barcode": "TCGA-A8-A086-D37771",
    "bcr_drug_uuid": "0C96C615-A569-425F-A761-07276A751736",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37819",
    "bcr_drug_uuid": "61251669-19D4-4215-A0A6-13B53CB464EC",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37820",
    "bcr_drug_uuid": "DD7BF60D-0661-4F71-8217-FBA9068C17CB",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37821",
    "bcr_drug_uuid": "D7E15D1C-7E0D-4F82-86A7-8411A4207C23",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37822",
    "bcr_drug_uuid": "E1FC34BF-AF83-49E2-9FB0-6CE574F0AAE7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 883,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37823",
    "bcr_drug_uuid": "4E401259-435D-4C0B-AD8D-33361A32FEE6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 579,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d8d7a6c2-6427-4f47-968c-6c3affba4617",
    "patient_ID": "TCGA.A8.A08B",
    "bcr_drug_barcode": "TCGA-A8-A08B-D37824",
    "bcr_drug_uuid": "D84A4E44-43BA-4E63-8B8E-8CA529809BC3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 914,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78e1da41-127c-4e9c-aaaa-77a0d94c31d0",
    "patient_ID": "TCGA.A8.A08C",
    "bcr_drug_barcode": "TCGA-A8-A08C-D37815",
    "bcr_drug_uuid": "316BC7DA-9F45-49F7-92C4-16831B2B6BE7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78e1da41-127c-4e9c-aaaa-77a0d94c31d0",
    "patient_ID": "TCGA.A8.A08C",
    "bcr_drug_barcode": "TCGA-A8-A08C-D37816",
    "bcr_drug_uuid": "DE7131F0-268C-4FA4-B008-01D742EDF242",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78e1da41-127c-4e9c-aaaa-77a0d94c31d0",
    "patient_ID": "TCGA.A8.A08C",
    "bcr_drug_barcode": "TCGA-A8-A08C-D37817",
    "bcr_drug_uuid": "FE9DA209-FD04-42A5-B165-8596370AC78C",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78e1da41-127c-4e9c-aaaa-77a0d94c31d0",
    "patient_ID": "TCGA.A8.A08C",
    "bcr_drug_barcode": "TCGA-A8-A08C-D37818",
    "bcr_drug_uuid": "12320A9F-0C0D-402C-92BD-95A4C989BA15",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a017f15-1c6b-45e7-8d55-e0a71df1b2e8",
    "patient_ID": "TCGA.A8.A08F",
    "bcr_drug_barcode": "TCGA-A8-A08F-D37756",
    "bcr_drug_uuid": "A407F51A-F51F-4CCD-B64B-41D298C30F9C",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a017f15-1c6b-45e7-8d55-e0a71df1b2e8",
    "patient_ID": "TCGA.A8.A08F",
    "bcr_drug_barcode": "TCGA-A8-A08F-D37757",
    "bcr_drug_uuid": "BD575045-6AED-4137-9E4C-2BB9C02A1E89",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a017f15-1c6b-45e7-8d55-e0a71df1b2e8",
    "patient_ID": "TCGA.A8.A08F",
    "bcr_drug_barcode": "TCGA-A8-A08F-D37758",
    "bcr_drug_uuid": "D0945071-31AC-4310-AF0A-4AC89DC8D74D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a017f15-1c6b-45e7-8d55-e0a71df1b2e8",
    "patient_ID": "TCGA.A8.A08F",
    "bcr_drug_barcode": "TCGA-A8-A08F-D37759",
    "bcr_drug_uuid": "4213A223-3502-4936-813C-875A28B2F161",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0a017f15-1c6b-45e7-8d55-e0a71df1b2e8",
    "patient_ID": "TCGA.A8.A08F",
    "bcr_drug_barcode": "TCGA-A8-A08F-D37760",
    "bcr_drug_uuid": "4B4B76FD-2BE6-4E59-9D03-D67BFF3D823F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "719082cc-1ebe-4a51-a659-85a59db1d77d",
    "patient_ID": "TCGA.A8.A08G",
    "bcr_drug_barcode": "TCGA-A8-A08G-D37833",
    "bcr_drug_uuid": "E6829D65-9323-4DFA-86D6-AB3D485C1105",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "719082cc-1ebe-4a51-a659-85a59db1d77d",
    "patient_ID": "TCGA.A8.A08G",
    "bcr_drug_barcode": "TCGA-A8-A08G-D37834",
    "bcr_drug_uuid": "4C83B99B-AD52-428E-B14F-0623E65A872F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "719082cc-1ebe-4a51-a659-85a59db1d77d",
    "patient_ID": "TCGA.A8.A08G",
    "bcr_drug_barcode": "TCGA-A8-A08G-D37835",
    "bcr_drug_uuid": "AD33A302-4E92-4716-B438-F7605A26337D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "719082cc-1ebe-4a51-a659-85a59db1d77d",
    "patient_ID": "TCGA.A8.A08G",
    "bcr_drug_barcode": "TCGA-A8-A08G-D37836",
    "bcr_drug_uuid": "0B6BC52D-FF9B-4B29-9078-94FD2D4A935F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "719082cc-1ebe-4a51-a659-85a59db1d77d",
    "patient_ID": "TCGA.A8.A08G",
    "bcr_drug_barcode": "TCGA-A8-A08G-D37837",
    "bcr_drug_uuid": "A2F25EB4-625A-4E4F-A809-B67F837EB7AE",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7acf33e7-c386-45fd-8c9a-469600378687",
    "patient_ID": "TCGA.A8.A08I",
    "bcr_drug_barcode": "TCGA-A8-A08I-D37829",
    "bcr_drug_uuid": "9BEA877F-F02D-449C-96A0-557D85624425",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7acf33e7-c386-45fd-8c9a-469600378687",
    "patient_ID": "TCGA.A8.A08I",
    "bcr_drug_barcode": "TCGA-A8-A08I-D37830",
    "bcr_drug_uuid": "F5F19298-9376-430D-9F41-C332F2ABAB4F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7acf33e7-c386-45fd-8c9a-469600378687",
    "patient_ID": "TCGA.A8.A08I",
    "bcr_drug_barcode": "TCGA-A8-A08I-D37831",
    "bcr_drug_uuid": "C33E9B1F-F94C-41BC-B949-028D039B668A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7acf33e7-c386-45fd-8c9a-469600378687",
    "patient_ID": "TCGA.A8.A08I",
    "bcr_drug_barcode": "TCGA-A8-A08I-D37832",
    "bcr_drug_uuid": "8817E13F-ED74-42EB-9E2A-B873D79488B6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37779",
    "bcr_drug_uuid": "985B0E53-6F65-4082-B0F8-813791E8AFC3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37780",
    "bcr_drug_uuid": "4301A8E9-4F7C-4D4F-BD1B-6ACEB2E8A058",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 790,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37781",
    "bcr_drug_uuid": "11802BE2-DDBF-48C1-A327-EDE548A2FF37",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 366,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 397,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37782",
    "bcr_drug_uuid": "6AA48F49-4040-4A21-B74C-DACF035A783D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 943,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37783",
    "bcr_drug_uuid": "AF51E7FE-12FB-4680-9277-972D6F241035",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 335,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f5964a8-8e07-4620-98f0-93d162dbc31e",
    "patient_ID": "TCGA.A8.A08O",
    "bcr_drug_barcode": "TCGA-A8-A08O-D37784",
    "bcr_drug_uuid": "A70656EE-B142-4029-AB38-FAC922222B5A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "IBANDRONATE",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37773",
    "bcr_drug_uuid": "BB038A0C-0856-4FB6-B98B-8CC6ACAAB26B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37774",
    "bcr_drug_uuid": "234F1043-A0C4-49F6-A6ED-C6290863D7BF",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37775",
    "bcr_drug_uuid": "1253B515-4F10-40BF-B18B-2AA5B260D821",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37776",
    "bcr_drug_uuid": "12F7BB14-6DC6-4008-9BF1-55DA93552260",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37777",
    "bcr_drug_uuid": "66F6BB3D-C124-464B-ADA7-88793D0C636F",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f947d67f-4aa2-4eb9-977e-21a5ae563613",
    "patient_ID": "TCGA.A8.A08P",
    "bcr_drug_barcode": "TCGA-A8-A08P-D37778",
    "bcr_drug_uuid": "05503837-81F2-4017-88A9-C22758556147",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 578,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2779fa01-ac93-4e80-a997-3385f72172c3",
    "patient_ID": "TCGA.A8.A08S",
    "bcr_drug_barcode": "TCGA-A8-A08S-D37747",
    "bcr_drug_uuid": "F9B9A52B-AF15-41B3-9116-D18A681DCB1B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37787",
    "bcr_drug_uuid": "BE723714-41E5-4FCD-A43A-AF09F02ECE83",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37788",
    "bcr_drug_uuid": "FA20A7B4-6AD1-4A7C-885A-4A7B13295649",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37789",
    "bcr_drug_uuid": "1112F7D7-6984-4F61-85B5-5D60C66A006B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37790",
    "bcr_drug_uuid": "77710F3F-EECC-49E3-AA85-02773DE4D243",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37791",
    "bcr_drug_uuid": "68CC8611-6E89-4582-9597-FCA264BEE43C",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 669,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 884,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f5539207-6534-4edc-a5a5-7666b5d16ba4",
    "patient_ID": "TCGA.A8.A08X",
    "bcr_drug_barcode": "TCGA-A8-A08X-D37792",
    "bcr_drug_uuid": "2DA191F1-8A7A-4538-A7E6-BD7F8ECA8A15",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 366,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37748",
    "bcr_drug_uuid": "BB7A58AA-67C4-4906-8662-C5ADC58A70E7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37749",
    "bcr_drug_uuid": "8FDB6109-FEFD-4D8A-BD04-D88DE1852A87",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37750",
    "bcr_drug_uuid": "CAB281AD-1C82-4832-9982-1EC937E75187",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37751",
    "bcr_drug_uuid": "A318C975-5C70-465F-B50F-29E1A23C842A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 639,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37752",
    "bcr_drug_uuid": "F9769A43-9D9A-4A64-8ACF-0B51D8CDD614",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 639,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37753",
    "bcr_drug_uuid": "B4B5A2CC-1753-4C12-8472-45D92D2CF095",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f39edd06-1016-4e8e-a42e-12f7e699ddc5",
    "patient_ID": "TCGA.A8.A091",
    "bcr_drug_barcode": "TCGA-A8-A091-D37754",
    "bcr_drug_uuid": "72915C6D-EEBE-4670-ABF0-E15D34050969",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PAMIDRONATE",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 669,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38a8b734-9acc-42f9-b5b7-e51b0dfc6504",
    "patient_ID": "TCGA.A8.A092",
    "bcr_drug_barcode": "TCGA-A8-A092-D37793",
    "bcr_drug_uuid": "3BB14198-BDE6-4F06-85E6-41F6C1519A1E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38a8b734-9acc-42f9-b5b7-e51b0dfc6504",
    "patient_ID": "TCGA.A8.A092",
    "bcr_drug_barcode": "TCGA-A8-A092-D37794",
    "bcr_drug_uuid": "7DEE3F98-1E1E-41EF-A92F-77AE88709E27",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38a8b734-9acc-42f9-b5b7-e51b0dfc6504",
    "patient_ID": "TCGA.A8.A092",
    "bcr_drug_barcode": "TCGA-A8-A092-D37795",
    "bcr_drug_uuid": "5EC320E1-3655-436C-B8CC-5E65353FEC34",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38a8b734-9acc-42f9-b5b7-e51b0dfc6504",
    "patient_ID": "TCGA.A8.A092",
    "bcr_drug_barcode": "TCGA-A8-A092-D37796",
    "bcr_drug_uuid": "2E5FD555-117E-45B5-BD9D-9F6653236007",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "02f5ae33-a563-4ecb-9e33-dfa500a44931",
    "patient_ID": "TCGA.A8.A093",
    "bcr_drug_barcode": "TCGA-A8-A093-D37755",
    "bcr_drug_uuid": "53987C58-785E-4E57-B53F-0CBD9C1C3579",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29df128d-ace2-40cf-88ee-3f6f2170f159",
    "patient_ID": "TCGA.A8.A095",
    "bcr_drug_barcode": "TCGA-A8-A095-D37811",
    "bcr_drug_uuid": "57584D49-5DD8-4991-A154-50BB92C2FB5A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29df128d-ace2-40cf-88ee-3f6f2170f159",
    "patient_ID": "TCGA.A8.A095",
    "bcr_drug_barcode": "TCGA-A8-A095-D37812",
    "bcr_drug_uuid": "4968DB45-29C7-41D8-BC0A-204367F2EB4E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29df128d-ace2-40cf-88ee-3f6f2170f159",
    "patient_ID": "TCGA.A8.A095",
    "bcr_drug_barcode": "TCGA-A8-A095-D37813",
    "bcr_drug_uuid": "023B7F41-CB22-43B7-81EE-6DC8B72DD4F3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "29df128d-ace2-40cf-88ee-3f6f2170f159",
    "patient_ID": "TCGA.A8.A095",
    "bcr_drug_barcode": "TCGA-A8-A095-D37814",
    "bcr_drug_uuid": "DD6C452A-B9DD-48FF-B9C3-2D1DCC1F1143",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1",
    "patient_ID": "TCGA.A8.A097",
    "bcr_drug_barcode": "TCGA-A8-A097-D37808",
    "bcr_drug_uuid": "98353B03-FA94-480C-BB09-9F440783BCA7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1",
    "patient_ID": "TCGA.A8.A097",
    "bcr_drug_barcode": "TCGA-A8-A097-D37809",
    "bcr_drug_uuid": "E6EE618F-B8F8-4389-93CE-F97B35570AC1",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1",
    "patient_ID": "TCGA.A8.A097",
    "bcr_drug_barcode": "TCGA-A8-A097-D37810",
    "bcr_drug_uuid": "ED10C356-D8E5-44B6-A777-8AF1E49CDD49",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e98b69bc-766a-485f-b5e8-9166b8d457b3",
    "patient_ID": "TCGA.A8.A099",
    "bcr_drug_barcode": "TCGA-A8-A099-D37807",
    "bcr_drug_uuid": "0287D246-1FC1-4967-B545-E9D3A91C35A9",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b205bba0-1870-4458-9088-8817e20389fe",
    "patient_ID": "TCGA.A8.A09A",
    "bcr_drug_barcode": "TCGA-A8-A09A-D37802",
    "bcr_drug_uuid": "CD73A61D-093A-4D49-B667-77B33D535F5B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b205bba0-1870-4458-9088-8817e20389fe",
    "patient_ID": "TCGA.A8.A09A",
    "bcr_drug_barcode": "TCGA-A8-A09A-D37803",
    "bcr_drug_uuid": "88F900CF-4B32-407F-8868-F0C403EDE587",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b205bba0-1870-4458-9088-8817e20389fe",
    "patient_ID": "TCGA.A8.A09A",
    "bcr_drug_barcode": "TCGA-A8-A09A-D37804",
    "bcr_drug_uuid": "0AF1F61C-EA80-4E11-91D7-55B88B1E1B3D",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b205bba0-1870-4458-9088-8817e20389fe",
    "patient_ID": "TCGA.A8.A09A",
    "bcr_drug_barcode": "TCGA-A8-A09A-D37805",
    "bcr_drug_uuid": "4C782B94-02AD-4D3A-AC10-A300BDDC79D7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b205bba0-1870-4458-9088-8817e20389fe",
    "patient_ID": "TCGA.A8.A09A",
    "bcr_drug_barcode": "TCGA-A8-A09A-D37806",
    "bcr_drug_uuid": "92C7BE24-ECD6-4492-AD23-374F8B00872A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3828b534-908e-4953-a3fb-07d01cf49c7d",
    "patient_ID": "TCGA.A8.A09B",
    "bcr_drug_barcode": "TCGA-A8-A09B-D37797",
    "bcr_drug_uuid": "DB9805C1-DC29-4382-829A-BC707E268861",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3828b534-908e-4953-a3fb-07d01cf49c7d",
    "patient_ID": "TCGA.A8.A09B",
    "bcr_drug_barcode": "TCGA-A8-A09B-D37798",
    "bcr_drug_uuid": "D8720C19-DA4E-4B7C-AD4B-82EFBFDBF3E2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3828b534-908e-4953-a3fb-07d01cf49c7d",
    "patient_ID": "TCGA.A8.A09B",
    "bcr_drug_barcode": "TCGA-A8-A09B-D37799",
    "bcr_drug_uuid": "1BC9A48C-10DD-439C-A959-4DD7B05CDF82",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 30,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3828b534-908e-4953-a3fb-07d01cf49c7d",
    "patient_ID": "TCGA.A8.A09B",
    "bcr_drug_barcode": "TCGA-A8-A09B-D37800",
    "bcr_drug_uuid": "C0BCD5E9-32B6-4BA1-96BB-FB00CB9DA2E4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3828b534-908e-4953-a3fb-07d01cf49c7d",
    "patient_ID": "TCGA.A8.A09B",
    "bcr_drug_barcode": "TCGA-A8-A09B-D37801",
    "bcr_drug_uuid": "A108C623-BC80-4675-931F-301E1BA62157",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36449392-de76-4ee9-bc09-627a07e18727",
    "patient_ID": "TCGA.A8.A09D",
    "bcr_drug_barcode": "TCGA-A8-A09D-D37763",
    "bcr_drug_uuid": "7501154C-AB3E-4BCF-8170-83C79CD130EF",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36449392-de76-4ee9-bc09-627a07e18727",
    "patient_ID": "TCGA.A8.A09D",
    "bcr_drug_barcode": "TCGA-A8-A09D-D37764",
    "bcr_drug_uuid": "2832D3CB-D8F2-4D5E-BCF9-1352FF358AE8",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36449392-de76-4ee9-bc09-627a07e18727",
    "patient_ID": "TCGA.A8.A09D",
    "bcr_drug_barcode": "TCGA-A8-A09D-D37765",
    "bcr_drug_uuid": "58419487-BBD7-4BC3-A34A-1791CFFDFD05",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36449392-de76-4ee9-bc09-627a07e18727",
    "patient_ID": "TCGA.A8.A09D",
    "bcr_drug_barcode": "TCGA-A8-A09D-D37766",
    "bcr_drug_uuid": "B4C8E610-F345-484B-BC53-E1B72842ABE2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1400,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36449392-de76-4ee9-bc09-627a07e18727",
    "patient_ID": "TCGA.A8.A09D",
    "bcr_drug_barcode": "TCGA-A8-A09D-D37767",
    "bcr_drug_uuid": "3CE1FDD7-6CB8-4FEB-9A0A-D9C352B117AF",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1400,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dfefb76a-ec6b-4cd2-9d45-2e1e4befc7ea",
    "patient_ID": "TCGA.A8.A09E",
    "bcr_drug_barcode": "TCGA-A8-A09E-D37745",
    "bcr_drug_uuid": "312D7C87-4134-4840-A47E-CA2E186B1CEA",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1557183c-aedd-4df6-b98a-3654667f7b69",
    "patient_ID": "TCGA.A8.A09I",
    "bcr_drug_barcode": "TCGA-A8-A09I-D37746",
    "bcr_drug_uuid": "331D363E-6139-4987-8F35-4A2453871C03",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "626b4ff0-2188-4a14-aac8-6703c624917f",
    "patient_ID": "TCGA.A8.A09M",
    "bcr_drug_barcode": "TCGA-A8-A09M-D37785",
    "bcr_drug_uuid": "C1C79A95-B5D8-45E8-8FE0-B54E7E435634",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "626b4ff0-2188-4a14-aac8-6703c624917f",
    "patient_ID": "TCGA.A8.A09M",
    "bcr_drug_barcode": "TCGA-A8-A09M-D37786",
    "bcr_drug_uuid": "09FBDD53-0E66-4D9E-AACA-888BC15FA3CF",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 276,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09c2bc35-c21f-4aa4-ac30-0d8db02ad811",
    "patient_ID": "TCGA.A8.A09Q",
    "bcr_drug_barcode": "TCGA-A8-A09Q-D37769",
    "bcr_drug_uuid": "F3220351-3FF6-4231-8B5E-3A27001C00EB",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cb0a2055-2168-4454-8755-47dd613db36f",
    "patient_ID": "TCGA.A8.A09R",
    "bcr_drug_barcode": "TCGA-A8-A09R-D37768",
    "bcr_drug_uuid": "E2A85158-819F-473B-AD84-8F5B443F5CCC",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0adf59c6-581a-475d-a2f4-40aa40060b5b",
    "patient_ID": "TCGA.A8.A09T",
    "bcr_drug_barcode": "TCGA-A8-A09T-D37898",
    "bcr_drug_uuid": "BDD31916-FC21-4D48-B1B5-442465133D4B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cc348a26-ee11-47a4-8b51-de922967e175",
    "patient_ID": "TCGA.A8.A09V",
    "bcr_drug_barcode": "TCGA-A8-A09V-D37903",
    "bcr_drug_uuid": "4BD8862A-EC1F-43A3-8343-7616B73F5DB5",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3efa245d-177d-4ef9-94f7-f554c54e345e",
    "patient_ID": "TCGA.A8.A0A1",
    "bcr_drug_barcode": "TCGA-A8-A0A1-D37902",
    "bcr_drug_uuid": "A7EE46AB-50EC-4F0E-9E46-F0C31EC14204",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34d5a193-85e5-4399-8a9b-e92858eafdfe",
    "patient_ID": "TCGA.A8.A0A2",
    "bcr_drug_barcode": "TCGA-A8-A0A2-D37901",
    "bcr_drug_uuid": "3C849DD1-A3D9-4F0A-A1B2-332514713CC6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2cb8c866-9296-4c70-a3ea-f9a9b707895c",
    "patient_ID": "TCGA.A8.A0A4",
    "bcr_drug_barcode": "TCGA-A8-A0A4-D37899",
    "bcr_drug_uuid": "CE92BF3F-277B-41E8-9B20-867CE5DDAC50",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2cb8c866-9296-4c70-a3ea-f9a9b707895c",
    "patient_ID": "TCGA.A8.A0A4",
    "bcr_drug_barcode": "TCGA-A8-A0A4-D37900",
    "bcr_drug_uuid": "D8E03D97-D2C6-498F-8B32-372ACA5AB2C9",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b0d295c-e185-4b52-9752-178e5bc1d47d",
    "patient_ID": "TCGA.A8.A0A6",
    "bcr_drug_barcode": "TCGA-A8-A0A6-D37740",
    "bcr_drug_uuid": "2FD51391-D472-472E-9309-A80A518724D1",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b0d295c-e185-4b52-9752-178e5bc1d47d",
    "patient_ID": "TCGA.A8.A0A6",
    "bcr_drug_barcode": "TCGA-A8-A0A6-D37741",
    "bcr_drug_uuid": "B93873B4-2604-43FB-8AF4-C7BF99021F9A",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b0d295c-e185-4b52-9752-178e5bc1d47d",
    "patient_ID": "TCGA.A8.A0A6",
    "bcr_drug_barcode": "TCGA-A8-A0A6-D37742",
    "bcr_drug_uuid": "0C70B64D-A56E-43D4-BC98-F0E21C22E396",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b0d295c-e185-4b52-9752-178e5bc1d47d",
    "patient_ID": "TCGA.A8.A0A6",
    "bcr_drug_barcode": "TCGA-A8-A0A6-D37743",
    "bcr_drug_uuid": "524B50B7-2D72-437D-B997-68ACAEE9481B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b0d295c-e185-4b52-9752-178e5bc1d47d",
    "patient_ID": "TCGA.A8.A0A6",
    "bcr_drug_barcode": "TCGA-A8-A0A6-D37744",
    "bcr_drug_uuid": "81F60DB0-ED0A-47FB-8CCE-8848A03AB8F4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 306,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b605fb6-d077-401e-b870-b87ddf505f82",
    "patient_ID": "TCGA.A8.A0A9",
    "bcr_drug_barcode": "TCGA-A8-A0A9-D37904",
    "bcr_drug_uuid": "9728FE30-70C8-4399-84BC-DCE88562667E",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22eaba28-be67-4730-9846-860bc1fca29a",
    "patient_ID": "TCGA.A8.A0AB",
    "bcr_drug_barcode": "TCGA-A8-A0AB-D37905",
    "bcr_drug_uuid": "C764E219-0133-4595-A695-9FC0D32C02E6",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22eaba28-be67-4730-9846-860bc1fca29a",
    "patient_ID": "TCGA.A8.A0AB",
    "bcr_drug_barcode": "TCGA-A8-A0AB-D37906",
    "bcr_drug_uuid": "24D0F28A-D91B-47A2-AE9C-BD963075AFE4",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22eaba28-be67-4730-9846-860bc1fca29a",
    "patient_ID": "TCGA.A8.A0AB",
    "bcr_drug_barcode": "TCGA-A8-A0AB-D37907",
    "bcr_drug_uuid": "CB9E17C3-E42E-4B04-9ADC-59AB74070C25",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22eaba28-be67-4730-9846-860bc1fca29a",
    "patient_ID": "TCGA.A8.A0AB",
    "bcr_drug_barcode": "TCGA-A8-A0AB-D37908",
    "bcr_drug_uuid": "E3113882-092E-4FBB-8664-055788237872",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "af5453a9-cf1f-40de-aec4-0e0710908fb7",
    "patient_ID": "TCGA.A8.A0AD",
    "bcr_drug_barcode": "TCGA-A8-A0AD-D37897",
    "bcr_drug_uuid": "246120A5-AB0B-454B-B52D-6055129097FE",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dfd0b7ba-c7d3-498e-b455-346301865452",
    "patient_ID": "TCGA.AC.A23C",
    "bcr_drug_barcode": "TCGA-AC-A23C-D43236",
    "bcr_drug_uuid": "76E26F66-B516-401D-8620-D4CEF98B70D2",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7bae6e7-f779-449d-92b9-66996041e00d",
    "patient_ID": "TCGA.AC.A23E",
    "bcr_drug_barcode": "TCGA-AC-A23E-D43238",
    "bcr_drug_uuid": "D789C42F-8DB9-4956-B101-E5635D52C40D",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A721DAC6-0126-476C-B2D4-2DBF7406454B",
    "patient_ID": "TCGA.AC.A23G",
    "bcr_drug_barcode": "TCGA-AC-A23G-D43243",
    "bcr_drug_uuid": "10502588-843C-4F06-BCB5-FC3640306A2F",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A721DAC6-0126-476C-B2D4-2DBF7406454B",
    "patient_ID": "TCGA.AC.A23G",
    "bcr_drug_barcode": "TCGA-AC-A23G-D43244",
    "bcr_drug_uuid": "AD503E66-08BD-4F4E-877D-4D9D499AB832",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A721DAC6-0126-476C-B2D4-2DBF7406454B",
    "patient_ID": "TCGA.AC.A23G",
    "bcr_drug_barcode": "TCGA-AC-A23G-D43245",
    "bcr_drug_uuid": "24D15948-49E0-4B96-870D-492C786C0937",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A721DAC6-0126-476C-B2D4-2DBF7406454B",
    "patient_ID": "TCGA.AC.A23G",
    "bcr_drug_barcode": "TCGA-AC-A23G-D43246",
    "bcr_drug_uuid": "8C1BBA20-CDAA-4C57-BAE6-BF46E12CFDE0",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E126B73-D3E8-4641-A128-306F3B313E40",
    "patient_ID": "TCGA.AC.A2B8",
    "bcr_drug_barcode": "TCGA-AC-A2B8-D43212",
    "bcr_drug_uuid": "01CD233B-B68C-458C-932F-5FD7F87DCB3F",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E126B73-D3E8-4641-A128-306F3B313E40",
    "patient_ID": "TCGA.AC.A2B8",
    "bcr_drug_barcode": "TCGA-AC-A2B8-D43213",
    "bcr_drug_uuid": "FE83C33F-CAF2-4C0F-8447-2905F8864C89",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6FA2A667-9C36-4526-8A58-1975E863A806",
    "patient_ID": "TCGA.AC.A2BK",
    "bcr_drug_barcode": "TCGA-AC-A2BK-D43988",
    "bcr_drug_uuid": "9DE66FB7-BCEC-4B84-B97E-1A9F68D8E87A",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6FA2A667-9C36-4526-8A58-1975E863A806",
    "patient_ID": "TCGA.AC.A2BK",
    "bcr_drug_barcode": "TCGA-AC-A2BK-D43990",
    "bcr_drug_uuid": "1502DE28-84D8-4351-BCEE-9661DACD2B21",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6FA2A667-9C36-4526-8A58-1975E863A806",
    "patient_ID": "TCGA.AC.A2BK",
    "bcr_drug_barcode": "TCGA-AC-A2BK-D43991",
    "bcr_drug_uuid": "4869DCB0-723E-46A0-AB90-3D5FF038203A",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6FA2A667-9C36-4526-8A58-1975E863A806",
    "patient_ID": "TCGA.AC.A2BK",
    "bcr_drug_barcode": "TCGA-AC-A2BK-D43992",
    "bcr_drug_uuid": "8283B14A-D235-4D20-B272-9B4A8A095886",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "02BBB632-0F7F-439D-B8F0-C86A06237424",
    "patient_ID": "TCGA.AC.A2FB",
    "bcr_drug_barcode": "TCGA-AC-A2FB-D45600",
    "bcr_drug_uuid": "874799CE-92C6-4A14-9087-50637D5A0BFB",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "02BBB632-0F7F-439D-B8F0-C86A06237424",
    "patient_ID": "TCGA.AC.A2FB",
    "bcr_drug_barcode": "TCGA-AC-A2FB-D45601",
    "bcr_drug_uuid": "83D4DEF8-DDC1-4477-B951-DA1E2EE02B89",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "02BBB632-0F7F-439D-B8F0-C86A06237424",
    "patient_ID": "TCGA.AC.A2FB",
    "bcr_drug_barcode": "TCGA-AC-A2FB-D45602",
    "bcr_drug_uuid": "E9BB9D9C-C752-4FC4-AA16-B531C23C1BEF",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 895,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D37368",
    "bcr_drug_uuid": "B60BCD38-9FFA-43B5-B2C0-C855C05883BB",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D37369",
    "bcr_drug_uuid": "516F7FB6-37E9-4E44-AD00-37D688CD51FA",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D37370",
    "bcr_drug_uuid": "4DF74C32-567B-4238-B008-44BA2231AC3A",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D47779",
    "bcr_drug_uuid": "A99BF733-8B3D-4B21-921E-79FDE40A04AF",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D47781",
    "bcr_drug_uuid": "8AC64C61-1BA6-4891-B438-AFF91FC30F54",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655",
    "patient_ID": "TCGA.AC.A2FE",
    "bcr_drug_barcode": "TCGA-AC-A2FE-D47782",
    "bcr_drug_uuid": "E2A083D8-3A0B-465B-9603-BE32342ACC48",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D",
    "patient_ID": "TCGA.AC.A2FF",
    "bcr_drug_barcode": "TCGA-AC-A2FF-D56170",
    "bcr_drug_uuid": "2F38E250-56D9-415C-8694-16634DED723D",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D",
    "patient_ID": "TCGA.AC.A2FF",
    "bcr_drug_barcode": "TCGA-AC-A2FF-D56171",
    "bcr_drug_uuid": "DF17DE1B-3B13-469B-B9AF-F461F5B9791D",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D",
    "patient_ID": "TCGA.AC.A2FF",
    "bcr_drug_barcode": "TCGA-AC-A2FF-D56172",
    "bcr_drug_uuid": "C4A61CA0-51A5-4811-8017-090A5DE9AA62",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D",
    "patient_ID": "TCGA.AC.A2FF",
    "bcr_drug_barcode": "TCGA-AC-A2FF-D56173",
    "bcr_drug_uuid": "CA6E2206-6437-4F20-B4CE-07925A8A8D79",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "39CDA4C9-E1C8-44C2-BAB7-F5849C12F879",
    "patient_ID": "TCGA.AC.A2FG",
    "bcr_drug_barcode": "TCGA-AC-A2FG-D43222",
    "bcr_drug_uuid": "1263ADA3-9E75-48E3-AC3C-891A3C9AF9AB",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 39,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "79126E88-9CF8-45FF-BF91-A98DA3B304D7",
    "patient_ID": "TCGA.AC.A2FK",
    "bcr_drug_barcode": "TCGA-AC-A2FK-D66198",
    "bcr_drug_uuid": "A85E31F8-6790-4964-AC1A-C6253F9E413D",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "79126E88-9CF8-45FF-BF91-A98DA3B304D7",
    "patient_ID": "TCGA.AC.A2FK",
    "bcr_drug_barcode": "TCGA-AC-A2FK-D66199",
    "bcr_drug_uuid": "118A7D45-089C-4980-B978-FD970C000905",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "79126E88-9CF8-45FF-BF91-A98DA3B304D7",
    "patient_ID": "TCGA.AC.A2FK",
    "bcr_drug_barcode": "TCGA-AC-A2FK-D66200",
    "bcr_drug_uuid": "96CBB13E-8C96-4CE4-B4FE-2FC707EC8044",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 294,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "79126E88-9CF8-45FF-BF91-A98DA3B304D7",
    "patient_ID": "TCGA.AC.A2FK",
    "bcr_drug_barcode": "TCGA-AC-A2FK-D66201",
    "bcr_drug_uuid": "67C16321-C0D6-4EE5-AA5C-25C290914D9E",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F5D4C2D3-CC69-4B38-8551-0917E3622A68",
    "patient_ID": "TCGA.AC.A2FO",
    "bcr_drug_barcode": "TCGA-AC-A2FO-D43224",
    "bcr_drug_uuid": "E2156068-0D07-42BF-877C-C70B71322A3E",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F5D4C2D3-CC69-4B38-8551-0917E3622A68",
    "patient_ID": "TCGA.AC.A2FO",
    "bcr_drug_barcode": "TCGA-AC-A2FO-D43227",
    "bcr_drug_uuid": "74E898D7-9552-4550-9764-4F924FC55872",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "HORMONE, NOS",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C5F371-3FA9-47C5-8B15-C2DD9ACC8519",
    "patient_ID": "TCGA.AC.A2QH",
    "bcr_drug_barcode": "TCGA-AC-A2QH-D64102",
    "bcr_drug_uuid": "35EB8EC6-E1A8-4C43-9FF1-8743A658A8F9",
    "form_completion_date": "2014-8-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C5F371-3FA9-47C5-8B15-C2DD9ACC8519",
    "patient_ID": "TCGA.AC.A2QH",
    "bcr_drug_barcode": "TCGA-AC-A2QH-D64103",
    "bcr_drug_uuid": "5555AA7B-5597-4D92-BC2B-20E6EC3BB630",
    "form_completion_date": "2014-8-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C5F371-3FA9-47C5-8B15-C2DD9ACC8519",
    "patient_ID": "TCGA.AC.A2QH",
    "bcr_drug_barcode": "TCGA-AC-A2QH-D64104",
    "bcr_drug_uuid": "CFAD5F9E-8CC3-430E-A4BC-F6079D09BC84",
    "form_completion_date": "2014-8-26",
    "pharmaceutical_therapy_drug_name": "ALOXI",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C57835BE-77AB-4CF5-9B23-62C11A7B2EAF",
    "patient_ID": "TCGA.AC.A2QI",
    "bcr_drug_barcode": "TCGA-AC-A2QI-D57049",
    "bcr_drug_uuid": "7AE4D249-9E5B-463E-9352-BB540E0FD3AB",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C57835BE-77AB-4CF5-9B23-62C11A7B2EAF",
    "patient_ID": "TCGA.AC.A2QI",
    "bcr_drug_barcode": "TCGA-AC-A2QI-D57050",
    "bcr_drug_uuid": "811FCC91-6880-400D-B7BB-C848DF5A5C23",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "5-FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C57835BE-77AB-4CF5-9B23-62C11A7B2EAF",
    "patient_ID": "TCGA.AC.A2QI",
    "bcr_drug_barcode": "TCGA-AC-A2QI-D57051",
    "bcr_drug_uuid": "ED0E149B-307C-4202-9AD7-09B21CE8FAB9",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44024",
    "bcr_drug_uuid": "C5CB5329-7C61-47A9-A6C2-1BA45837EE19",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44025",
    "bcr_drug_uuid": "ED128C91-BA77-4FBB-B670-962EA86F9365",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44026",
    "bcr_drug_uuid": "900E4830-C0E0-4B02-8648-811C3D9C6780",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44873",
    "bcr_drug_uuid": "D4B923DD-9936-4FD1-B31D-7EC1BD1E03EB",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44874",
    "bcr_drug_uuid": "AE31D0D7-2D48-4096-8A15-44362B8615FB",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 386,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 407,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F",
    "patient_ID": "TCGA.AC.A2QJ",
    "bcr_drug_barcode": "TCGA-AC-A2QJ-D44876",
    "bcr_drug_uuid": "A7788968-8449-4721-9548-BFB6C599C876",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "FASLODEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 418,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "048549CF-D0A5-4743-A0A1-2004F7CC2B08",
    "patient_ID": "TCGA.AC.A3BB",
    "bcr_drug_barcode": "TCGA-AC-A3BB-D58955",
    "bcr_drug_uuid": "29980E13-140D-4302-8067-9256665BC673",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "048549CF-D0A5-4743-A0A1-2004F7CC2B08",
    "patient_ID": "TCGA.AC.A3BB",
    "bcr_drug_barcode": "TCGA-AC-A3BB-D58956",
    "bcr_drug_uuid": "CAB74A66-0CCF-4E51-8F5A-FF613B5A43C7",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "048549CF-D0A5-4743-A0A1-2004F7CC2B08",
    "patient_ID": "TCGA.AC.A3BB",
    "bcr_drug_barcode": "TCGA-AC-A3BB-D58957",
    "bcr_drug_uuid": "260FF621-0F12-4118-8D3F-AA44CC70F345",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F4C8D30-47FB-47DF-9EB7-4E5881E3711E",
    "patient_ID": "TCGA.AC.A3QP",
    "bcr_drug_barcode": "TCGA-AC-A3QP-D56162",
    "bcr_drug_uuid": "112B1EE9-F2CE-42E6-9BAF-6648ACB7226D",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C73260-A242-4BBA-87C5-D2302556DFF7",
    "patient_ID": "TCGA.AC.A3TM",
    "bcr_drug_barcode": "TCGA-AC-A3TM-D60195",
    "bcr_drug_uuid": "B113D625-D78D-45A4-ADD0-80AB8685389D",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C73260-A242-4BBA-87C5-D2302556DFF7",
    "patient_ID": "TCGA.AC.A3TM",
    "bcr_drug_barcode": "TCGA-AC-A3TM-D60196",
    "bcr_drug_uuid": "B550D10F-C488-4B1D-9461-2F40087F552D",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C73260-A242-4BBA-87C5-D2302556DFF7",
    "patient_ID": "TCGA.AC.A3TM",
    "bcr_drug_barcode": "TCGA-AC-A3TM-D60197",
    "bcr_drug_uuid": "EDF4E71D-99B4-4E19-AB96-9999AC773627",
    "form_completion_date": "2014-5-31",
    "clinical_trial_drug_classification": "BIOLOGICAL THERAPY/MONOCLONAL ANTIBODY",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "67C73260-A242-4BBA-87C5-D2302556DFF7",
    "patient_ID": "TCGA.AC.A3TM",
    "bcr_drug_barcode": "TCGA-AC-A3TM-D60198",
    "bcr_drug_uuid": "B38B327E-F854-4338-B383-77104EC6F403",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 272,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "81B70C58-4A12-448C-A594-2ADE44F6A0AE",
    "patient_ID": "TCGA.AC.A3TN",
    "bcr_drug_barcode": "TCGA-AC-A3TN-D60192",
    "bcr_drug_uuid": "66521E70-01FD-49E2-B58C-E2A9B05E4F2C",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4C313E5B-4DC3-408E-8E92-22427F74743E",
    "patient_ID": "TCGA.AC.A3W5",
    "bcr_drug_barcode": "TCGA-AC-A3W5-D56178",
    "bcr_drug_uuid": "3299B6BC-BE87-4C84-91EA-AEF9CE77EACE",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4C313E5B-4DC3-408E-8E92-22427F74743E",
    "patient_ID": "TCGA.AC.A3W5",
    "bcr_drug_barcode": "TCGA-AC-A3W5-D56179",
    "bcr_drug_uuid": "44D7F9EC-9D9E-48D2-A04D-33F37CEC738A",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4C313E5B-4DC3-408E-8E92-22427F74743E",
    "patient_ID": "TCGA.AC.A3W5",
    "bcr_drug_barcode": "TCGA-AC-A3W5-D56180",
    "bcr_drug_uuid": "8ABC79CD-6BDB-44B7-8F89-4E5762E620F8",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 392,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4C313E5B-4DC3-408E-8E92-22427F74743E",
    "patient_ID": "TCGA.AC.A3W5",
    "bcr_drug_barcode": "TCGA-AC-A3W5-D56181",
    "bcr_drug_uuid": "402336C9-639C-49F2-BFA8-F0BA1A3636F2",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2481A671-760B-428C-968D-42E25FD42AC5",
    "patient_ID": "TCGA.AC.A3W7",
    "bcr_drug_barcode": "TCGA-AC-A3W7-D57848",
    "bcr_drug_uuid": "99F4E33A-B847-43FF-98B1-80EBFB1944E9",
    "form_completion_date": "2014-3-27",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A45D296E-EFC0-479E-B2F6-BAD834668CDF",
    "patient_ID": "TCGA.AC.A3YI",
    "bcr_drug_barcode": "TCGA-AC-A3YI-D61514",
    "bcr_drug_uuid": "53B8EF0C-8F23-4867-B4D9-F4A71B62BED0",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A45D296E-EFC0-479E-B2F6-BAD834668CDF",
    "patient_ID": "TCGA.AC.A3YI",
    "bcr_drug_barcode": "TCGA-AC-A3YI-D61515",
    "bcr_drug_uuid": "2509B84B-EC3A-457C-9E7B-7F7095910A28",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A45D296E-EFC0-479E-B2F6-BAD834668CDF",
    "patient_ID": "TCGA.AC.A3YI",
    "bcr_drug_barcode": "TCGA-AC-A3YI-D61516",
    "bcr_drug_uuid": "710B0219-323F-4EF2-A310-54559049BEDB",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "5-FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86CF879E-3B40-44DD-AAA7-6F49F54A15D9",
    "patient_ID": "TCGA.AC.A3YJ",
    "bcr_drug_barcode": "TCGA-AC-A3YJ-D60188",
    "bcr_drug_uuid": "C21296BA-1657-4E74-A813-2141490BA609",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86CF879E-3B40-44DD-AAA7-6F49F54A15D9",
    "patient_ID": "TCGA.AC.A3YJ",
    "bcr_drug_barcode": "TCGA-AC-A3YJ-D60189",
    "bcr_drug_uuid": "DF2F7479-281D-48B4-AB92-DB37A062A978",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9627184-B972-4E00-8C11-B0B946AC357A",
    "patient_ID": "TCGA.AC.A5XS",
    "bcr_drug_barcode": "TCGA-AC-A5XS-D64109",
    "bcr_drug_uuid": "3EECF063-E00F-473F-AC9F-C848E33C6EA6",
    "form_completion_date": "2014-8-26",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97677FD7-8523-48C5-A8CE-614FD4010551",
    "patient_ID": "TCGA.AC.A5XU",
    "bcr_drug_barcode": "TCGA-AC-A5XU-D60183",
    "bcr_drug_uuid": "C044891E-2E52-4DC9-BA16-4CA6D345F0D6",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 235,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5F2B85A-94A9-4168-BBE8-149EC71342B0",
    "patient_ID": "TCGA.AC.A62V",
    "bcr_drug_barcode": "TCGA-AC-A62V-D60179",
    "bcr_drug_uuid": "1206FBA9-884A-4E22-8D01-5CFD61F171AD",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "DENOSUMAB",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5F2B85A-94A9-4168-BBE8-149EC71342B0",
    "patient_ID": "TCGA.AC.A62V",
    "bcr_drug_barcode": "TCGA-AC-A62V-D60180",
    "bcr_drug_uuid": "356FD6D4-61DF-485A-AB87-3A4A43CFC9B7",
    "form_completion_date": "2014-5-31",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1174f6e4-ffbe-4e59-a000-8d861c968369",
    "patient_ID": "TCGA.AO.A03L",
    "bcr_drug_barcode": "TCGA-AO-A03L-D5921",
    "bcr_drug_uuid": "f4461ec4-9a69-4f0c-a38c-2fb57692c388",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1174f6e4-ffbe-4e59-a000-8d861c968369",
    "patient_ID": "TCGA.AO.A03L",
    "bcr_drug_barcode": "TCGA-AO-A03L-D5923",
    "bcr_drug_uuid": "70c52b36-df70-4dd1-b109-5d7c12ef900e",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1174f6e4-ffbe-4e59-a000-8d861c968369",
    "patient_ID": "TCGA.AO.A03L",
    "bcr_drug_barcode": "TCGA-AO-A03L-D5920",
    "bcr_drug_uuid": "bdf77be9-8a97-410e-9290-fe7f90761885",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1174f6e4-ffbe-4e59-a000-8d861c968369",
    "patient_ID": "TCGA.AO.A03L",
    "bcr_drug_barcode": "TCGA-AO-A03L-D5925",
    "bcr_drug_uuid": "57884874-30e3-4850-a42c-bf89ec191ccd",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2057,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1174f6e4-ffbe-4e59-a000-8d861c968369",
    "patient_ID": "TCGA.AO.A03L",
    "bcr_drug_barcode": "TCGA-AO-A03L-D5926",
    "bcr_drug_uuid": "1def3807-a1e2-4d1c-a417-9b8d8302d065",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "LUPRON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2057,
    "regimen_number": 2,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "095c7985-3842-494f-b591-706ad1cd2133",
    "patient_ID": "TCGA.AO.A03M",
    "bcr_drug_barcode": "TCGA-AO-A03M-D5995",
    "bcr_drug_uuid": "20c31de8-d96e-4867-8335-719ccb5806a3",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "095c7985-3842-494f-b591-706ad1cd2133",
    "patient_ID": "TCGA.AO.A03M",
    "bcr_drug_barcode": "TCGA-AO-A03M-D5996",
    "bcr_drug_uuid": "c13d0b89-a948-4f3f-ac88-4e9387d555db",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "095c7985-3842-494f-b591-706ad1cd2133",
    "patient_ID": "TCGA.AO.A03M",
    "bcr_drug_barcode": "TCGA-AO-A03M-D5994",
    "bcr_drug_uuid": "9bdbaaed-6f6d-4d45-a7c0-dd1366b813db",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3768
  },
  {
    "bcr_patient_uuid": "095c7985-3842-494f-b591-706ad1cd2133",
    "patient_ID": "TCGA.AO.A03M",
    "bcr_drug_barcode": "TCGA-AO-A03M-D5992",
    "bcr_drug_uuid": "e5a69005-a19c-4fc9-a8f2-9a2c939cb391",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 376
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6117",
    "bcr_drug_uuid": "6324b024-c954-4a43-b14e-c5c1a4acb314",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 449,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6120",
    "bcr_drug_uuid": "4dc6b6e5-f0c5-4dce-8cbc-a61ccc36b856",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1007,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6114",
    "bcr_drug_uuid": "a849ee00-3092-4cca-a302-6ecb620fb617",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6119",
    "bcr_drug_uuid": "00512901-db10-4833-8adf-5b3734b5d64f",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 821,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1007,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6118",
    "bcr_drug_uuid": "bb405d51-df85-4189-a4ab-9692bcadc16d",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 450,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 820,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6116",
    "bcr_drug_uuid": "e9d527b8-949b-464a-82d8-3c5b5812ce32",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D6113",
    "bcr_drug_uuid": "bb14e284-9eb3-47cd-b0fa-660a24ff2c7b",
    "form_completion_date": "2011-1-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20932",
    "bcr_drug_uuid": "5CB72B1A-283E-4161-A53A-824BC9641E61",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "XGEVA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1989,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "pharma_type_other": "BONE METASTASES",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 13,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20923",
    "bcr_drug_uuid": "105C9E04-6F4F-4BC9-98D4-C5E70D9BC254",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1667,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG",
    "regimen_number": 8,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20929",
    "bcr_drug_uuid": "182B47E5-FF2D-4BD1-A5D1-EBD1C0CDD4C0",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1814,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1828,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20927",
    "bcr_drug_uuid": "DC919671-3B3F-4A46-B89C-1B4BB7F356D1",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "TESETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1699,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1762,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 27,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 230
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20930",
    "bcr_drug_uuid": "C4226DFD-8E7A-4898-ACD6-2E907F30DD99",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1835,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1842,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 11,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2800
  },
  {
    "bcr_patient_uuid": "9435447e-d65f-408b-863b-6576b1d652dd",
    "patient_ID": "TCGA.AO.A03N",
    "bcr_drug_barcode": "TCGA-AO-A03N-D20931",
    "bcr_drug_uuid": "1B00197C-7F84-4429-80E9-471F087D8753",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1857,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 16,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 704
  },
  {
    "bcr_patient_uuid": "1111fb30-46ce-4722-98da-ec9ba2323d90",
    "patient_ID": "TCGA.AO.A03O",
    "bcr_drug_barcode": "TCGA-AO-A03O-D3145",
    "bcr_drug_uuid": "dc3d1205-5393-48bd-bdeb-9f9a8ac66e73",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4380
  },
  {
    "bcr_patient_uuid": "1111fb30-46ce-4722-98da-ec9ba2323d90",
    "patient_ID": "TCGA.AO.A03O",
    "bcr_drug_barcode": "TCGA-AO-A03O-D3149",
    "bcr_drug_uuid": "61963f8b-da23-40f1-9f6b-787d38f7651a",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 993,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1111fb30-46ce-4722-98da-ec9ba2323d90",
    "patient_ID": "TCGA.AO.A03O",
    "bcr_drug_barcode": "TCGA-AO-A03O-D3147",
    "bcr_drug_uuid": "46526dc6-105c-4615-981d-3ce9f318d5ab",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1276
  },
  {
    "bcr_patient_uuid": "1111fb30-46ce-4722-98da-ec9ba2323d90",
    "patient_ID": "TCGA.AO.A03O",
    "bcr_drug_barcode": "TCGA-AO-A03O-D3144",
    "bcr_drug_uuid": "fe3f418d-b735-4bd3-8ed0-0b7ad64da47d",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 436
  },
  {
    "bcr_patient_uuid": "2d4c778c-7f77-4f0a-8261-2086accf15fd",
    "patient_ID": "TCGA.AO.A03P",
    "bcr_drug_barcode": "TCGA-AO-A03P-D3084",
    "bcr_drug_uuid": "a2e0b197-c210-47bf-94ae-a6c24311cc17",
    "form_completion_date": "2010-9-6",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 2451,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2822,
    "drug_cycles": 27,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20050
  },
  {
    "bcr_patient_uuid": "2d4c778c-7f77-4f0a-8261-2086accf15fd",
    "patient_ID": "TCGA.AO.A03P",
    "bcr_drug_barcode": "TCGA-AO-A03P-D3083",
    "bcr_drug_uuid": "9d61ae92-631d-4965-be2d-59cb2d7b83eb",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CAPECITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2422,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2839,
    "drug_units": "MG/DAY",
    "drug_dose": 1500,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2d4c778c-7f77-4f0a-8261-2086accf15fd",
    "patient_ID": "TCGA.AO.A03P",
    "bcr_drug_barcode": "TCGA-AO-A03P-D3079",
    "bcr_drug_uuid": "fd50d042-4a2a-43d3-9cd4-d7f90dd15f4e",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1918,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2331,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2d4c778c-7f77-4f0a-8261-2086accf15fd",
    "patient_ID": "TCGA.AO.A03P",
    "bcr_drug_barcode": "TCGA-AO-A03P-D3082",
    "bcr_drug_uuid": "726efafa-90dd-4a5e-b0fd-4e283d1caebb",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE (AROMASIN)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2332,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2422,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2d4c778c-7f77-4f0a-8261-2086accf15fd",
    "patient_ID": "TCGA.AO.A03P",
    "bcr_drug_barcode": "TCGA-AO-A03P-D15460",
    "bcr_drug_uuid": "0431F2EF-29FF-4AD2-A3CC-BF47622615EA",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2853,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2881,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 5,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ESTROGEN RECEPTOR ANTAGONIST IN METASTATIC BREAST CANCER",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "2e82e576-3095-4aee-9853-65f676647c34",
    "patient_ID": "TCGA.AO.A03R",
    "bcr_drug_barcode": "TCGA-AO-A03R-D2956",
    "bcr_drug_uuid": "5ae7957b-39b0-45da-96ed-2c27dda3e59a",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e82e576-3095-4aee-9853-65f676647c34",
    "patient_ID": "TCGA.AO.A03R",
    "bcr_drug_barcode": "TCGA-AO-A03R-D2952",
    "bcr_drug_uuid": "0484daf8-16e0-46d1-8655-ec65e9573fe0",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4248
  },
  {
    "bcr_patient_uuid": "2e82e576-3095-4aee-9853-65f676647c34",
    "patient_ID": "TCGA.AO.A03R",
    "bcr_drug_barcode": "TCGA-AO-A03R-D2955",
    "bcr_drug_uuid": "880fcfd1-ad27-4247-8df0-2518b514a93e",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1240
  },
  {
    "bcr_patient_uuid": "2e82e576-3095-4aee-9853-65f676647c34",
    "patient_ID": "TCGA.AO.A03R",
    "bcr_drug_barcode": "TCGA-AO-A03R-D2953",
    "bcr_drug_uuid": "ef4485c7-bf90-4b7a-a8db-28bc351ea4be",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3059",
    "bcr_drug_uuid": "b907f99e-3495-43b4-b00a-67573ac72ce9",
    "form_completion_date": "2010-9-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4032
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3061",
    "bcr_drug_uuid": "febd5704-d4cd-477f-8be2-22d0c03c0826",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 404
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3065",
    "bcr_drug_uuid": "ab1ed21c-89e2-4211-8db0-501a91fcb91d",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN (NOVADEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1095,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3062",
    "bcr_drug_uuid": "faee37a8-911b-420f-a9a3-de6d58ef9583",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1176
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3068",
    "bcr_drug_uuid": "02ff28ad-6659-4062-8dd8-45461526756a",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1130,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae",
    "patient_ID": "TCGA.AO.A03T",
    "bcr_drug_barcode": "TCGA-AO-A03T-D3070",
    "bcr_drug_uuid": "89f9ff00-958d-462b-9439-712c34271b9b",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "LUPRON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1095,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 7.5,
    "regimen_number": 3,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0685edd2-ce1c-4e0e-8dda-393139af4223",
    "patient_ID": "TCGA.AO.A03U",
    "bcr_drug_barcode": "TCGA-AO-A03U-D5987",
    "bcr_drug_uuid": "12f8a04a-2cf9-4e12-9417-eb6e8ca1ef3d",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8640
  },
  {
    "bcr_patient_uuid": "0685edd2-ce1c-4e0e-8dda-393139af4223",
    "patient_ID": "TCGA.AO.A03U",
    "bcr_drug_barcode": "TCGA-AO-A03U-D5990",
    "bcr_drug_uuid": "cd54a4e8-2031-4653-a3af-4a21b63888d7",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8640
  },
  {
    "bcr_patient_uuid": "0685edd2-ce1c-4e0e-8dda-393139af4223",
    "patient_ID": "TCGA.AO.A03U",
    "bcr_drug_barcode": "TCGA-AO-A03U-D5989",
    "bcr_drug_uuid": "c1bd6420-c945-476c-afdc-c107a55824c4",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 576
  },
  {
    "bcr_patient_uuid": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee",
    "patient_ID": "TCGA.AO.A03V",
    "bcr_drug_barcode": "TCGA-AO-A03V-D5998",
    "bcr_drug_uuid": "6b741be6-03f1-4acd-b9c2-4b38fa485a52",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8800
  },
  {
    "bcr_patient_uuid": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee",
    "patient_ID": "TCGA.AO.A03V",
    "bcr_drug_barcode": "TCGA-AO-A03V-D5999",
    "bcr_drug_uuid": "54c7a76e-7409-4470-9021-6b209c2c9b7b",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee",
    "patient_ID": "TCGA.AO.A03V",
    "bcr_drug_barcode": "TCGA-AO-A03V-D6004",
    "bcr_drug_uuid": "3d49c566-fdcb-4849-9312-d27620f772f4",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 753,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee",
    "patient_ID": "TCGA.AO.A03V",
    "bcr_drug_barcode": "TCGA-AO-A03V-D6001",
    "bcr_drug_uuid": "7a86ed9d-040d-497b-b401-e175e0ad5024",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8800
  },
  {
    "bcr_patient_uuid": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee",
    "patient_ID": "TCGA.AO.A03V",
    "bcr_drug_barcode": "TCGA-AO-A03V-D6002",
    "bcr_drug_uuid": "a7b71a1a-29a2-4ced-9a77-1b29bf37f48a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 735,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d2f2560c-ec80-4fea-9474-c47a2e85ea95",
    "patient_ID": "TCGA.AO.A0J2",
    "bcr_drug_barcode": "TCGA-AO-A0J2-D3124",
    "bcr_drug_uuid": "ed9afd15-7930-40b7-808e-705182137410",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "d2f2560c-ec80-4fea-9474-c47a2e85ea95",
    "patient_ID": "TCGA.AO.A0J2",
    "bcr_drug_barcode": "TCGA-AO-A0J2-D3122",
    "bcr_drug_uuid": "e2ba693c-5978-4227-b81a-4a4823d3ee84",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "d2f2560c-ec80-4fea-9474-c47a2e85ea95",
    "patient_ID": "TCGA.AO.A0J2",
    "bcr_drug_barcode": "TCGA-AO-A0J2-D3125",
    "bcr_drug_uuid": "56624a3a-1602-438a-b089-4782c8fcbed6",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1040
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3054",
    "bcr_drug_uuid": "4d690b3c-0e7e-4e46-91c4-a1405ba74fa1",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3044",
    "bcr_drug_uuid": "b66cb509-ac95-4cae-8fde-5fecc8d6d9a6",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4700
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3050",
    "bcr_drug_uuid": "d78ab251-4543-49f7-b7a5-3dd2cbe6ff27",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3055",
    "bcr_drug_uuid": "514f9a1d-4c93-4657-9f68-4a5a83d64589",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3042",
    "bcr_drug_uuid": "04eb8d7b-e0fe-48f0-903f-0b0a03343d79",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 470
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3047",
    "bcr_drug_uuid": "d0506624-2dd1-4f05-995e-fe7527c6ccaa",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "39cde586-df95-435f-b9a6-73b0c0ee5e92",
    "patient_ID": "TCGA.AO.A0J3",
    "bcr_drug_barcode": "TCGA-AO-A0J3-D3051",
    "bcr_drug_uuid": "2cba97f0-e44a-41cf-a5e6-96b637c1e453",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "a9b7d7fe-be31-4f71-afee-c1bfdf511888",
    "patient_ID": "TCGA.AO.A0J4",
    "bcr_drug_barcode": "TCGA-AO-A0J4-D2750",
    "bcr_drug_uuid": "1a7870eb-a79b-421d-af13-fcf0d3654788",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 580
  },
  {
    "bcr_patient_uuid": "a9b7d7fe-be31-4f71-afee-c1bfdf511888",
    "patient_ID": "TCGA.AO.A0J4",
    "bcr_drug_barcode": "TCGA-AO-A0J4-D2748",
    "bcr_drug_uuid": "e8d55b3d-7228-4fe0-b888-86ebfb98dc59",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHASPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "a9b7d7fe-be31-4f71-afee-c1bfdf511888",
    "patient_ID": "TCGA.AO.A0J4",
    "bcr_drug_barcode": "TCGA-AO-A0J4-D2749",
    "bcr_drug_uuid": "60d39515-fbed-4588-80f8-0a3c0172f94e",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "c1442467-d618-435f-8792-b1a18f696f1a",
    "patient_ID": "TCGA.AO.A0J5",
    "bcr_drug_barcode": "TCGA-AO-A0J5-D6008",
    "bcr_drug_uuid": "272824b5-160a-4d48-8b48-bcaa074214bb",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FULVESTRANT (FASLODEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 618,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 250,
    "regimen_number": 3,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c1442467-d618-435f-8792-b1a18f696f1a",
    "patient_ID": "TCGA.AO.A0J5",
    "bcr_drug_barcode": "TCGA-AO-A0J5-D6007",
    "bcr_drug_uuid": "effd840a-7e52-4422-a5e1-ad5c2f84aa8a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "XELODA (CAPECITABINE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 422,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1500,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c1442467-d618-435f-8792-b1a18f696f1a",
    "patient_ID": "TCGA.AO.A0J5",
    "bcr_drug_barcode": "TCGA-AO-A0J5-D6005",
    "bcr_drug_uuid": "3daac793-eb29-42ea-8866-27b14eca5820",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c1442467-d618-435f-8792-b1a18f696f1a",
    "patient_ID": "TCGA.AO.A0J5",
    "bcr_drug_barcode": "TCGA-AO-A0J5-D6006",
    "bcr_drug_uuid": "2819fde9-35d0-4e7e-a9eb-da8263789223",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FEMARA (LETROZOLE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 422,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e9f4f373-37a5-48ad-a1a0-b0d47820111a",
    "patient_ID": "TCGA.AO.A0J6",
    "bcr_drug_barcode": "TCGA-AO-A0J6-D3103",
    "bcr_drug_uuid": "56b00f1d-94c6-47aa-bfe8-3475b64b8754",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "e9f4f373-37a5-48ad-a1a0-b0d47820111a",
    "patient_ID": "TCGA.AO.A0J6",
    "bcr_drug_barcode": "TCGA-AO-A0J6-D3107",
    "bcr_drug_uuid": "73049389-f0b2-42ee-8cb0-3220e24c2132",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1320
  },
  {
    "bcr_patient_uuid": "e9f4f373-37a5-48ad-a1a0-b0d47820111a",
    "patient_ID": "TCGA.AO.A0J6",
    "bcr_drug_barcode": "TCGA-AO-A0J6-D3105",
    "bcr_drug_uuid": "a007109f-8d09-47c0-8962-c3fdccc14bd9",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MEQ",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "9536bec0-dae0-4d63-a1b3-956741835243",
    "patient_ID": "TCGA.AO.A0J7",
    "bcr_drug_barcode": "TCGA-AO-A0J7-D3114",
    "bcr_drug_uuid": "304050e5-dfd9-48ce-aab0-49d8d7f731a0",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "9536bec0-dae0-4d63-a1b3-956741835243",
    "patient_ID": "TCGA.AO.A0J7",
    "bcr_drug_barcode": "TCGA-AO-A0J7-D3113",
    "bcr_drug_uuid": "c6d2fa6c-c6bb-4696-9ffd-3cada015a624",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "9536bec0-dae0-4d63-a1b3-956741835243",
    "patient_ID": "TCGA.AO.A0J7",
    "bcr_drug_barcode": "TCGA-AO-A0J7-D3118",
    "bcr_drug_uuid": "926f18ae-e779-45e5-b100-5edfc2e97133",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9536bec0-dae0-4d63-a1b3-956741835243",
    "patient_ID": "TCGA.AO.A0J7",
    "bcr_drug_barcode": "TCGA-AO-A0J7-D3116",
    "bcr_drug_uuid": "99f7ae0d-d072-40fc-be36-42be73a600e5",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1280
  },
  {
    "bcr_patient_uuid": "02bf5203-f9cd-4c5a-97b4-e5584dc22325",
    "patient_ID": "TCGA.AO.A0J8",
    "bcr_drug_barcode": "TCGA-AO-A0J8-D3137",
    "bcr_drug_uuid": "7b8d5881-41d9-4c7b-ad68-60ae52734e66",
    "form_completion_date": "2010-9-6",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8800
  },
  {
    "bcr_patient_uuid": "02bf5203-f9cd-4c5a-97b4-e5584dc22325",
    "patient_ID": "TCGA.AO.A0J8",
    "bcr_drug_barcode": "TCGA-AO-A0J8-D3138",
    "bcr_drug_uuid": "9b5ca20e-c9f2-4b98-be3a-d7ddacbf8329",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "02bf5203-f9cd-4c5a-97b4-e5584dc22325",
    "patient_ID": "TCGA.AO.A0J8",
    "bcr_drug_barcode": "TCGA-AO-A0J8-D3131",
    "bcr_drug_uuid": "101e4937-20c7-461a-a4ce-a2e0b03c5f2d",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8800
  },
  {
    "bcr_patient_uuid": "02bf5203-f9cd-4c5a-97b4-e5584dc22325",
    "patient_ID": "TCGA.AO.A0J8",
    "bcr_drug_barcode": "TCGA-AO-A0J8-D3136",
    "bcr_drug_uuid": "082d6734-1bb5-4efc-90a5-d63188cb7651",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3158",
    "bcr_drug_uuid": "e90c4e19-b755-47c9-9d5e-41881194b7ed",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3165",
    "bcr_drug_uuid": "a55ae465-7d58-4b39-9163-396c9a4dbf15",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1207,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3160",
    "bcr_drug_uuid": "45f1bb9c-2863-49b6-a2ab-f5bc422f0bd4",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 370
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3155",
    "bcr_drug_uuid": "01d99b67-790d-4c94-82b8-faedb014d4e7",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5040
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3161",
    "bcr_drug_uuid": "52a37453-0a2a-41e6-a1e6-b5d5bc0d512c",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 630
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3164",
    "bcr_drug_uuid": "d1156805-edbe-42f7-9472-b3e1a3039370",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1072,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 16
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3162",
    "bcr_drug_uuid": "9943c67b-c3e6-4829-8c90-a843eae50524",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX (ANASTROZOLE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1023,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a4903de8-6cf5-4541-8ec7-065beace8b44",
    "patient_ID": "TCGA.AO.A0J9",
    "bcr_drug_barcode": "TCGA-AO-A0J9-D3163",
    "bcr_drug_uuid": "faf150fa-8213-4fec-96fb-069b05d3cb0d",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "AROMASIN (EXEMESTANE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1072,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1207,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "86b7b206-8e69-432d-acc9-bccce710955e",
    "patient_ID": "TCGA.AO.A0JA",
    "bcr_drug_barcode": "TCGA-AO-A0JA-D3169",
    "bcr_drug_uuid": "bdf4593a-cafd-4db8-b132-eb1d37a76eee",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "pharma_type_other": "BISPHOSPHONATE",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 24
  },
  {
    "bcr_patient_uuid": "86b7b206-8e69-432d-acc9-bccce710955e",
    "patient_ID": "TCGA.AO.A0JA",
    "bcr_drug_barcode": "TCGA-AO-A0JA-D3168",
    "bcr_drug_uuid": "3e3ada60-dd5a-4b4e-8cf2-53587263d938",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "LEUPROLIDE ACETATE (LUPRON)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 7.5,
    "regimen_number": 1,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "86b7b206-8e69-432d-acc9-bccce710955e",
    "patient_ID": "TCGA.AO.A0JA",
    "bcr_drug_barcode": "TCGA-AO-A0JA-D3167",
    "bcr_drug_uuid": "3c735330-523e-41f1-9fad-ef714a373d23",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "86b7b206-8e69-432d-acc9-bccce710955e",
    "patient_ID": "TCGA.AO.A0JA",
    "bcr_drug_barcode": "TCGA-AO-A0JA-D3170",
    "bcr_drug_uuid": "357e7201-60df-425e-9cab-dd4722ff6b34",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 980
  },
  {
    "bcr_patient_uuid": "3ea9412b-429e-4dcf-90cd-c53be06885a1",
    "patient_ID": "TCGA.AO.A0JB",
    "bcr_drug_barcode": "TCGA-AO-A0JB-D3178",
    "bcr_drug_uuid": "f228c0ee-6d98-4cde-b962-c60cf3e59085",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "3ea9412b-429e-4dcf-90cd-c53be06885a1",
    "patient_ID": "TCGA.AO.A0JB",
    "bcr_drug_barcode": "TCGA-AO-A0JB-D3177",
    "bcr_drug_uuid": "6ffc6760-7989-43cc-a868-cacb2893c699",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3680
  },
  {
    "bcr_patient_uuid": "3ea9412b-429e-4dcf-90cd-c53be06885a1",
    "patient_ID": "TCGA.AO.A0JB",
    "bcr_drug_barcode": "TCGA-AO-A0JB-D3176",
    "bcr_drug_uuid": "c5d0586b-c47f-494b-94ac-41f12deeb702",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 368
  },
  {
    "bcr_patient_uuid": "3ea9412b-429e-4dcf-90cd-c53be06885a1",
    "patient_ID": "TCGA.AO.A0JB",
    "bcr_drug_barcode": "TCGA-AO-A0JB-D3174",
    "bcr_drug_uuid": "f1f16a87-8aa3-4ab9-8872-f3dba71b6d93",
    "form_completion_date": "2010-9-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "03565036-b6d3-432f-8d9a-7099818e0788",
    "patient_ID": "TCGA.AO.A0JC",
    "bcr_drug_barcode": "TCGA-AO-A0JC-D3182",
    "bcr_drug_uuid": "ae622289-bf49-4818-8ada-6629cddbb999",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8700
  },
  {
    "bcr_patient_uuid": "03565036-b6d3-432f-8d9a-7099818e0788",
    "patient_ID": "TCGA.AO.A0JC",
    "bcr_drug_barcode": "TCGA-AO-A0JC-D3184",
    "bcr_drug_uuid": "7ca89abd-c5d1-4bb2-a0d8-80b329119bdd",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "03565036-b6d3-432f-8d9a-7099818e0788",
    "patient_ID": "TCGA.AO.A0JC",
    "bcr_drug_barcode": "TCGA-AO-A0JC-D3183",
    "bcr_drug_uuid": "8599b409-0662-4eea-a61a-c27500d39b91",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8700
  },
  {
    "bcr_patient_uuid": "03565036-b6d3-432f-8d9a-7099818e0788",
    "patient_ID": "TCGA.AO.A0JC",
    "bcr_drug_barcode": "TCGA-AO-A0JC-D3181",
    "bcr_drug_uuid": "04fadaa5-10b7-4b05-be8a-2f5ad9ea89b6",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "0a229f95-0ea1-4d63-953e-74f5ec2f3028",
    "patient_ID": "TCGA.AO.A0JD",
    "bcr_drug_barcode": "TCGA-AO-A0JD-D3196",
    "bcr_drug_uuid": "2d8f1a8d-5cbd-4852-b7e3-145eec155402",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a229f95-0ea1-4d63-953e-74f5ec2f3028",
    "patient_ID": "TCGA.AO.A0JD",
    "bcr_drug_barcode": "TCGA-AO-A0JD-D3190",
    "bcr_drug_uuid": "447d92b5-bace-4477-9abc-3687a1fab237",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4536
  },
  {
    "bcr_patient_uuid": "0a229f95-0ea1-4d63-953e-74f5ec2f3028",
    "patient_ID": "TCGA.AO.A0JD",
    "bcr_drug_barcode": "TCGA-AO-A0JD-D3195",
    "bcr_drug_uuid": "4c003fb7-7ce0-45bf-bec5-8af6fb62d6b3",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1296
  },
  {
    "bcr_patient_uuid": "0a229f95-0ea1-4d63-953e-74f5ec2f3028",
    "patient_ID": "TCGA.AO.A0JD",
    "bcr_drug_barcode": "TCGA-AO-A0JD-D3188",
    "bcr_drug_uuid": "bf1780f4-0ad9-4861-ab51-bf0698571363",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 452
  },
  {
    "bcr_patient_uuid": "36fe6152-f61e-4948-9ccc-23ac01a9d77d",
    "patient_ID": "TCGA.AO.A0JE",
    "bcr_drug_barcode": "TCGA-AO-A0JE-D3203",
    "bcr_drug_uuid": "2806bb73-968f-4ce0-a287-e75f00b76f6d",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 22,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7869
  },
  {
    "bcr_patient_uuid": "36fe6152-f61e-4948-9ccc-23ac01a9d77d",
    "patient_ID": "TCGA.AO.A0JE",
    "bcr_drug_barcode": "TCGA-AO-A0JE-D3202",
    "bcr_drug_uuid": "33e32dbf-9c8e-4dff-b75b-c6342c56420a",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1220
  },
  {
    "bcr_patient_uuid": "36fe6152-f61e-4948-9ccc-23ac01a9d77d",
    "patient_ID": "TCGA.AO.A0JE",
    "bcr_drug_barcode": "TCGA-AO-A0JE-D3199",
    "bcr_drug_uuid": "d2701b3c-2642-422e-afff-33ea4ef76359",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4272
  },
  {
    "bcr_patient_uuid": "36fe6152-f61e-4948-9ccc-23ac01a9d77d",
    "patient_ID": "TCGA.AO.A0JE",
    "bcr_drug_barcode": "TCGA-AO-A0JE-D3200",
    "bcr_drug_uuid": "50d69645-1eb9-4fa7-83c0-f6614085a07f",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 428
  },
  {
    "bcr_patient_uuid": "f357fe19-5359-4662-8ce9-aa996132283b",
    "patient_ID": "TCGA.AO.A0JF",
    "bcr_drug_barcode": "TCGA-AO-A0JF-D3207",
    "bcr_drug_uuid": "c6fe7b1e-7d43-4f33-add3-cb45112a5a0b",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "f357fe19-5359-4662-8ce9-aa996132283b",
    "patient_ID": "TCGA.AO.A0JF",
    "bcr_drug_barcode": "TCGA-AO-A0JF-D3209",
    "bcr_drug_uuid": "3f8e0a6f-72a8-4d35-84bf-ed2c931be832",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE (ARIMIDEX)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 336,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 353,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f357fe19-5359-4662-8ce9-aa996132283b",
    "patient_ID": "TCGA.AO.A0JF",
    "bcr_drug_barcode": "TCGA-AO-A0JF-D3211",
    "bcr_drug_uuid": "0e86b873-98ca-4bc2-83b4-9acfddbb62a4",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f357fe19-5359-4662-8ce9-aa996132283b",
    "patient_ID": "TCGA.AO.A0JF",
    "bcr_drug_barcode": "TCGA-AO-A0JF-D3208",
    "bcr_drug_uuid": "957365be-dbc2-4492-98f7-f7125cb4700c",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "f357fe19-5359-4662-8ce9-aa996132283b",
    "patient_ID": "TCGA.AO.A0JF",
    "bcr_drug_barcode": "TCGA-AO-A0JF-D3206",
    "bcr_drug_uuid": "69646598-6e7b-4f0c-a0e9-601b648159df",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "58959e88-54e2-4558-9664-2effda7403dc",
    "patient_ID": "TCGA.AO.A0JG",
    "bcr_drug_barcode": "TCGA-AO-A0JG-D3218",
    "bcr_drug_uuid": "6c1bae55-7974-4d4d-b031-2e8c522b0a5d",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "58959e88-54e2-4558-9664-2effda7403dc",
    "patient_ID": "TCGA.AO.A0JG",
    "bcr_drug_barcode": "TCGA-AO-A0JG-D3215",
    "bcr_drug_uuid": "b263b426-435b-4224-a98e-8fb254f0a03a",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "58959e88-54e2-4558-9664-2effda7403dc",
    "patient_ID": "TCGA.AO.A0JG",
    "bcr_drug_barcode": "TCGA-AO-A0JG-D3217",
    "bcr_drug_uuid": "0da9c957-0267-41cc-9517-ac96284494e9",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1280
  },
  {
    "bcr_patient_uuid": "58959e88-54e2-4558-9664-2effda7403dc",
    "patient_ID": "TCGA.AO.A0JG",
    "bcr_drug_barcode": "TCGA-AO-A0JG-D3216",
    "bcr_drug_uuid": "a33b3892-3e6b-4da6-9f8e-d172913aa440",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "e17c565c-9857-4df3-a352-903b53093c85",
    "patient_ID": "TCGA.AO.A0JI",
    "bcr_drug_barcode": "TCGA-AO-A0JI-D5929",
    "bcr_drug_uuid": "2d6ad2f6-0769-4ee4-b690-7c424bd9fc6a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4176
  },
  {
    "bcr_patient_uuid": "e17c565c-9857-4df3-a352-903b53093c85",
    "patient_ID": "TCGA.AO.A0JI",
    "bcr_drug_barcode": "TCGA-AO-A0JI-D5931",
    "bcr_drug_uuid": "927d22e8-916f-43bb-b085-eacbf3eda2ce",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX (ANASTROZOLE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 224,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e17c565c-9857-4df3-a352-903b53093c85",
    "patient_ID": "TCGA.AO.A0JI",
    "bcr_drug_barcode": "TCGA-AO-A0JI-D5928",
    "bcr_drug_uuid": "cc046508-1134-4ceb-8184-57f1637e4e3e",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 416
  },
  {
    "bcr_patient_uuid": "e17c565c-9857-4df3-a352-903b53093c85",
    "patient_ID": "TCGA.AO.A0JI",
    "bcr_drug_barcode": "TCGA-AO-A0JI-D5930",
    "bcr_drug_uuid": "ddd8f77f-5e9f-443d-afba-17082d2bdb03",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1220
  },
  {
    "bcr_patient_uuid": "bef7b135-a727-45e8-850a-cc4cd56c49aa",
    "patient_ID": "TCGA.AO.A0JJ",
    "bcr_drug_barcode": "TCGA-AO-A0JJ-D2968",
    "bcr_drug_uuid": "099545fb-d2c8-42e3-8f4a-7757316b4d86",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "bef7b135-a727-45e8-850a-cc4cd56c49aa",
    "patient_ID": "TCGA.AO.A0JJ",
    "bcr_drug_barcode": "TCGA-AO-A0JJ-D2969",
    "bcr_drug_uuid": "d4c6bfa5-ed26-40c9-b7df-6e754510d790",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "bef7b135-a727-45e8-850a-cc4cd56c49aa",
    "patient_ID": "TCGA.AO.A0JJ",
    "bcr_drug_barcode": "TCGA-AO-A0JJ-D2971",
    "bcr_drug_uuid": "c14cd41b-9bac-4238-b267-0ccf43eae566",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "bef7b135-a727-45e8-850a-cc4cd56c49aa",
    "patient_ID": "TCGA.AO.A0JJ",
    "bcr_drug_barcode": "TCGA-AO-A0JJ-D2972",
    "bcr_drug_uuid": "d0f2f580-2076-4fcd-9849-8a81d7f2032c",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1280
  },
  {
    "bcr_patient_uuid": "bef7b135-a727-45e8-850a-cc4cd56c49aa",
    "patient_ID": "TCGA.AO.A0JJ",
    "bcr_drug_barcode": "TCGA-AO-A0JJ-D2974",
    "bcr_drug_uuid": "9b8965e1-1b43-431d-9e0a-34e799297fae",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "LETROZOLE (FEMARA)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d5d8e76e-2f2a-49bc-ba0a-d51283611b16",
    "patient_ID": "TCGA.AO.A0JL",
    "bcr_drug_barcode": "TCGA-AO-A0JL-D3224",
    "bcr_drug_uuid": "8dcbe4a5-051a-4efa-8075-bd9b1286cb99",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 488
  },
  {
    "bcr_patient_uuid": "d5d8e76e-2f2a-49bc-ba0a-d51283611b16",
    "patient_ID": "TCGA.AO.A0JL",
    "bcr_drug_barcode": "TCGA-AO-A0JL-D3226",
    "bcr_drug_uuid": "159bd986-fd08-4ac4-bca0-67dfa5bdf56f",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 493,
    "drug_cycles": 22,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9476
  },
  {
    "bcr_patient_uuid": "d5d8e76e-2f2a-49bc-ba0a-d51283611b16",
    "patient_ID": "TCGA.AO.A0JL",
    "bcr_drug_barcode": "TCGA-AO-A0JL-D3225",
    "bcr_drug_uuid": "e91e3c59-4d69-4fa4-8fdb-3221b74de9a2",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1372
  },
  {
    "bcr_patient_uuid": "d5d8e76e-2f2a-49bc-ba0a-d51283611b16",
    "patient_ID": "TCGA.AO.A0JL",
    "bcr_drug_barcode": "TCGA-AO-A0JL-D3223",
    "bcr_drug_uuid": "b9f318a5-5322-4ead-a810-926101586b5e",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4872
  },
  {
    "bcr_patient_uuid": "44bec761-b603-49c0-8634-f6bfe0319bb1",
    "patient_ID": "TCGA.AO.A0JM",
    "bcr_drug_barcode": "TCGA-AO-A0JM-D3233",
    "bcr_drug_uuid": "6106b296-02f3-4373-8d46-4d6c3906a6b4",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 23,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9095
  },
  {
    "bcr_patient_uuid": "44bec761-b603-49c0-8634-f6bfe0319bb1",
    "patient_ID": "TCGA.AO.A0JM",
    "bcr_drug_barcode": "TCGA-AO-A0JM-D3235",
    "bcr_drug_uuid": "140fbd02-a0c1-4e38-99e8-eaaac337f3b2",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 330,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "44bec761-b603-49c0-8634-f6bfe0319bb1",
    "patient_ID": "TCGA.AO.A0JM",
    "bcr_drug_barcode": "TCGA-AO-A0JM-D3230",
    "bcr_drug_uuid": "b2c38850-e368-40ba-afe1-d8faf3c2647d",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4520
  },
  {
    "bcr_patient_uuid": "44bec761-b603-49c0-8634-f6bfe0319bb1",
    "patient_ID": "TCGA.AO.A0JM",
    "bcr_drug_barcode": "TCGA-AO-A0JM-D3231",
    "bcr_drug_uuid": "ad12218d-1986-4f13-bab1-12b1315ad67f",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 452
  },
  {
    "bcr_patient_uuid": "44bec761-b603-49c0-8634-f6bfe0319bb1",
    "patient_ID": "TCGA.AO.A0JM",
    "bcr_drug_barcode": "TCGA-AO-A0JM-D3232",
    "bcr_drug_uuid": "425ca3d3-c246-49e1-9039-fa57865be48a",
    "form_completion_date": "2010-9-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1360
  },
  {
    "bcr_patient_uuid": "b094e8b2-8ece-4b36-8025-18073a8b873c",
    "patient_ID": "TCGA.AO.A124",
    "bcr_drug_barcode": "TCGA-AO-A124-D5932",
    "bcr_drug_uuid": "7bd8d7d3-3c72-4d00-9efb-7b5cc816aae9",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "b094e8b2-8ece-4b36-8025-18073a8b873c",
    "patient_ID": "TCGA.AO.A124",
    "bcr_drug_barcode": "TCGA-AO-A124-D5933",
    "bcr_drug_uuid": "c107f6da-b6fa-47ff-b3a3-d6edac66e0f4",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4240
  },
  {
    "bcr_patient_uuid": "b094e8b2-8ece-4b36-8025-18073a8b873c",
    "patient_ID": "TCGA.AO.A124",
    "bcr_drug_barcode": "TCGA-AO-A124-D5934",
    "bcr_drug_uuid": "02906cd5-712c-423b-8684-6830cf1a7c7e",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "8577ffcb-242e-40e2-98d4-2831d952be34",
    "patient_ID": "TCGA.AO.A125",
    "bcr_drug_barcode": "TCGA-AO-A125-D5936",
    "bcr_drug_uuid": "aa4b5228-8d3d-41fc-8036-e1dd449ea175",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "AROMASIN (EXEMESTANE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 799,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2535,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8577ffcb-242e-40e2-98d4-2831d952be34",
    "patient_ID": "TCGA.AO.A125",
    "bcr_drug_barcode": "TCGA-AO-A125-D5935",
    "bcr_drug_uuid": "3c07a95a-8689-4e1c-8302-8af9978b4c0d",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 799,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cc0902fd-a2fc-4327-929e-d4219e32e1d7",
    "patient_ID": "TCGA.AO.A126",
    "bcr_drug_barcode": "TCGA-AO-A126-D5937",
    "bcr_drug_uuid": "ee9c3d89-3e97-48d7-8e7c-269fe8ad0fd0",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7776
  },
  {
    "bcr_patient_uuid": "cc0902fd-a2fc-4327-929e-d4219e32e1d7",
    "patient_ID": "TCGA.AO.A126",
    "bcr_drug_barcode": "TCGA-AO-A126-D5940",
    "bcr_drug_uuid": "3d58aed6-c8a0-4506-834b-a58fa3a24e6e",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 320,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1795,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cc0902fd-a2fc-4327-929e-d4219e32e1d7",
    "patient_ID": "TCGA.AO.A126",
    "bcr_drug_barcode": "TCGA-AO-A126-D5939",
    "bcr_drug_uuid": "8994c71e-c50a-46fe-bd93-196c3b435d65",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7776
  },
  {
    "bcr_patient_uuid": "cc0902fd-a2fc-4327-929e-d4219e32e1d7",
    "patient_ID": "TCGA.AO.A126",
    "bcr_drug_barcode": "TCGA-AO-A126-D5938",
    "bcr_drug_uuid": "e3937ee2-ef17-48fd-b613-38d265529590",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "cc0902fd-a2fc-4327-929e-d4219e32e1d7",
    "patient_ID": "TCGA.AO.A126",
    "bcr_drug_barcode": "TCGA-AO-A126-D5941",
    "bcr_drug_uuid": "9948fc14-eaff-4311-a8e0-5c0941e2316c",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "016caf42-4e19-4444-ab5d-6cf1e76c4afa",
    "patient_ID": "TCGA.AO.A128",
    "bcr_drug_barcode": "TCGA-AO-A128-D5945",
    "bcr_drug_uuid": "39C00F42-C756-42EC-98DC-BB6F6434718B",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1360
  },
  {
    "bcr_patient_uuid": "016caf42-4e19-4444-ab5d-6cf1e76c4afa",
    "patient_ID": "TCGA.AO.A128",
    "bcr_drug_barcode": "TCGA-AO-A128-D5942",
    "bcr_drug_uuid": "554dcbf2-b7a5-4237-9b68-7484e41a52ab",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 619,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "016caf42-4e19-4444-ab5d-6cf1e76c4afa",
    "patient_ID": "TCGA.AO.A128",
    "bcr_drug_barcode": "TCGA-AO-A128-D5943",
    "bcr_drug_uuid": "e2154fbe-e02b-44f3-a61a-e08146c61db2",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 62,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "c70ee5e1-4703-4996-bb5c-f4cca0fb53ba",
    "patient_ID": "TCGA.AO.A129",
    "bcr_drug_barcode": "TCGA-AO-A129-D5950",
    "bcr_drug_uuid": "2c562434-088f-444b-82ca-9ad77b8fdaa2",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c70ee5e1-4703-4996-bb5c-f4cca0fb53ba",
    "patient_ID": "TCGA.AO.A129",
    "bcr_drug_barcode": "TCGA-AO-A129-D5947",
    "bcr_drug_uuid": "592cacd9-a024-4b2d-a780-d45766869b1a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c70ee5e1-4703-4996-bb5c-f4cca0fb53ba",
    "patient_ID": "TCGA.AO.A129",
    "bcr_drug_barcode": "TCGA-AO-A129-D5949",
    "bcr_drug_uuid": "7a4726f6-1df6-4d6c-af20-b21164882894",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "99927651-34be-4795-893a-128d8a1fdb30",
    "patient_ID": "TCGA.AO.A12A",
    "bcr_drug_barcode": "TCGA-AO-A12A-D5955",
    "bcr_drug_uuid": "f0990117-c231-40b2-9fdd-2e0c99c53259",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 830,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "99927651-34be-4795-893a-128d8a1fdb30",
    "patient_ID": "TCGA.AO.A12A",
    "bcr_drug_barcode": "TCGA-AO-A12A-D5954",
    "bcr_drug_uuid": "b5aa7d03-a502-4ee1-97df-86d2ea4a1a5d",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "99927651-34be-4795-893a-128d8a1fdb30",
    "patient_ID": "TCGA.AO.A12A",
    "bcr_drug_barcode": "TCGA-AO-A12A-D5956",
    "bcr_drug_uuid": "12495058-61d2-4d20-850f-ddfc97c9b7e8",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 831,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1918,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "99927651-34be-4795-893a-128d8a1fdb30",
    "patient_ID": "TCGA.AO.A12A",
    "bcr_drug_barcode": "TCGA-AO-A12A-D5952",
    "bcr_drug_uuid": "da66efbf-8091-4e5b-b1ce-b9427f0eb0e3",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "99927651-34be-4795-893a-128d8a1fdb30",
    "patient_ID": "TCGA.AO.A12A",
    "bcr_drug_barcode": "TCGA-AO-A12A-D5951",
    "bcr_drug_uuid": "6e16923a-f894-4deb-96a0-7b875f5dd9c3",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6ed684f-ee7a-496c-80d5-6eacd494d16a",
    "patient_ID": "TCGA.AO.A12B",
    "bcr_drug_barcode": "TCGA-AO-A12B-D5959",
    "bcr_drug_uuid": "2470c06b-34d1-4a59-9d6c-ee4578b7caac",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 261.6
  },
  {
    "bcr_patient_uuid": "f6ed684f-ee7a-496c-80d5-6eacd494d16a",
    "patient_ID": "TCGA.AO.A12B",
    "bcr_drug_barcode": "TCGA-AO-A12B-D5961",
    "bcr_drug_uuid": "4455833b-0272-453e-8f0b-2ad2e971c751",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1980,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6ed684f-ee7a-496c-80d5-6eacd494d16a",
    "patient_ID": "TCGA.AO.A12B",
    "bcr_drug_barcode": "TCGA-AO-A12B-D5958",
    "bcr_drug_uuid": "adc6778f-388f-403a-af06-ced81e3e0d53",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3924
  },
  {
    "bcr_patient_uuid": "f6ed684f-ee7a-496c-80d5-6eacd494d16a",
    "patient_ID": "TCGA.AO.A12B",
    "bcr_drug_barcode": "TCGA-AO-A12B-D5960",
    "bcr_drug_uuid": "36ded530-1c08-428f-a97e-7c11db1a953c",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3924
  },
  {
    "bcr_patient_uuid": "71626753-cc34-4731-abc0-ae188b0964e7",
    "patient_ID": "TCGA.AO.A12C",
    "bcr_drug_barcode": "TCGA-AO-A12C-D5967",
    "bcr_drug_uuid": "ab88616c-baf7-417e-b9d8-511b3458b868",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1296
  },
  {
    "bcr_patient_uuid": "71626753-cc34-4731-abc0-ae188b0964e7",
    "patient_ID": "TCGA.AO.A12C",
    "bcr_drug_barcode": "TCGA-AO-A12C-D5969",
    "bcr_drug_uuid": "8310a990-257e-49ec-96a6-4addbb579f36",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2149,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "71626753-cc34-4731-abc0-ae188b0964e7",
    "patient_ID": "TCGA.AO.A12C",
    "bcr_drug_barcode": "TCGA-AO-A12C-D5968",
    "bcr_drug_uuid": "acf716d9-c5e8-4e07-b741-6844bb0c2df9",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 524,
    "drug_cycles": 22,
    "drug_units": "MG/KG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "71626753-cc34-4731-abc0-ae188b0964e7",
    "patient_ID": "TCGA.AO.A12C",
    "bcr_drug_barcode": "TCGA-AO-A12C-D5965",
    "bcr_drug_uuid": "9558d4f9-c6cd-495d-acea-01d22843ae19",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4440
  },
  {
    "bcr_patient_uuid": "71626753-cc34-4731-abc0-ae188b0964e7",
    "patient_ID": "TCGA.AO.A12C",
    "bcr_drug_barcode": "TCGA-AO-A12C-D5966",
    "bcr_drug_uuid": "6147d681-b15d-4868-86c9-8f70bb709894",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 444
  },
  {
    "bcr_patient_uuid": "2fe854b4-bac9-4801-9a1c-ee99388e8082",
    "patient_ID": "TCGA.AO.A12D",
    "bcr_drug_barcode": "TCGA-AO-A12D-D5974",
    "bcr_drug_uuid": "9e959e52-721e-4948-8ebb-0b025e5cf4a5",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "drug_cycles": 17,
    "drug_units": "MG/KG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2fe854b4-bac9-4801-9a1c-ee99388e8082",
    "patient_ID": "TCGA.AO.A12D",
    "bcr_drug_barcode": "TCGA-AO-A12D-D5972",
    "bcr_drug_uuid": "6c48065e-2a03-4fe6-a4d7-d5ceaba2cc5f",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "2fe854b4-bac9-4801-9a1c-ee99388e8082",
    "patient_ID": "TCGA.AO.A12D",
    "bcr_drug_barcode": "TCGA-AO-A12D-D5971",
    "bcr_drug_uuid": "cc8a523b-e65b-4413-95b9-ee3bb5e88e41",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3984
  },
  {
    "bcr_patient_uuid": "2fe854b4-bac9-4801-9a1c-ee99388e8082",
    "patient_ID": "TCGA.AO.A12D",
    "bcr_drug_barcode": "TCGA-AO-A12D-D5973",
    "bcr_drug_uuid": "67744251-ab75-4c28-8782-6df6f473f4ed",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ALBUMIN-BOUND PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1728
  },
  {
    "bcr_patient_uuid": "2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9",
    "patient_ID": "TCGA.AO.A12E",
    "bcr_drug_barcode": "TCGA-AO-A12E-D5975",
    "bcr_drug_uuid": "d57c2221-a1f2-48a8-9c17-4f74b834b465",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4080
  },
  {
    "bcr_patient_uuid": "2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9",
    "patient_ID": "TCGA.AO.A12E",
    "bcr_drug_barcode": "TCGA-AO-A12E-D5977",
    "bcr_drug_uuid": "e02b1a51-def1-423d-ae62-08bfedaa5d90",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1192
  },
  {
    "bcr_patient_uuid": "2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9",
    "patient_ID": "TCGA.AO.A12E",
    "bcr_drug_barcode": "TCGA-AO-A12E-D5978",
    "bcr_drug_uuid": "8a8189d2-30da-4c99-b5d7-462cd2a6794e",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9",
    "patient_ID": "TCGA.AO.A12E",
    "bcr_drug_barcode": "TCGA-AO-A12E-D5976",
    "bcr_drug_uuid": "6aaca2a6-421f-4cc8-a564-961b2eeef1e4",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 408
  },
  {
    "bcr_patient_uuid": "495f9eda-b9be-4eef-bae1-766a4bfbd68e",
    "patient_ID": "TCGA.AO.A12F",
    "bcr_drug_barcode": "TCGA-AO-A12F-D5981",
    "bcr_drug_uuid": "272961f9-9281-4a6c-81c0-f2052b56f0e1",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "495f9eda-b9be-4eef-bae1-766a4bfbd68e",
    "patient_ID": "TCGA.AO.A12F",
    "bcr_drug_barcode": "TCGA-AO-A12F-D5979",
    "bcr_drug_uuid": "c34652a1-fcbd-42e8-9bfb-991088feb8bd",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "495f9eda-b9be-4eef-bae1-766a4bfbd68e",
    "patient_ID": "TCGA.AO.A12F",
    "bcr_drug_barcode": "TCGA-AO-A12F-D5980",
    "bcr_drug_uuid": "694d184f-3285-46a6-904c-6c2136c0e92d",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "58c56d4b-3f85-4aad-a779-5f9e1791677d",
    "patient_ID": "TCGA.AO.A12G",
    "bcr_drug_barcode": "TCGA-AO-A12G-D5982",
    "bcr_drug_uuid": "b5ce13aa-ba6c-49c3-aa75-d881b89317cb",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX (ANASTROZOLE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 177,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b5b99291-507e-4b68-a039-9a0f571f55df",
    "patient_ID": "TCGA.AO.A12H",
    "bcr_drug_barcode": "TCGA-AO-A12H-D5983",
    "bcr_drug_uuid": "6712f22e-0667-4a78-baed-2051f7f4f05a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX (ANASTROZOLE)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c25898b4-eb33-42f4-bf3f-bf532a929e7d",
    "patient_ID": "TCGA.AO.A1KO",
    "bcr_drug_barcode": "TCGA-AO-A1KO-D9902",
    "bcr_drug_uuid": "6524d129-d2a8-47ca-8d86-a659d0f1289b",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c25898b4-eb33-42f4-bf3f-bf532a929e7d",
    "patient_ID": "TCGA.AO.A1KO",
    "bcr_drug_barcode": "TCGA-AO-A1KO-D9903",
    "bcr_drug_uuid": "994fc070-2c81-4aec-ad37-86de8d038e4a",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c25898b4-eb33-42f4-bf3f-bf532a929e7d",
    "patient_ID": "TCGA.AO.A1KO",
    "bcr_drug_barcode": "TCGA-AO-A1KO-D9900",
    "bcr_drug_uuid": "20a6f8cb-e82a-4275-99dd-c1dec8bbf00b",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c25898b4-eb33-42f4-bf3f-bf532a929e7d",
    "patient_ID": "TCGA.AO.A1KO",
    "bcr_drug_barcode": "TCGA-AO-A1KO-D9901",
    "bcr_drug_uuid": "fdaf8481-4ae7-4917-a33f-7f4624338ea8",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3aaabc62-f5a4-4025-9b29-5adf82c86c84",
    "patient_ID": "TCGA.AO.A1KP",
    "bcr_drug_barcode": "TCGA-AO-A1KP-D9891",
    "bcr_drug_uuid": "c40a1ef3-ee24-431c-bc24-3d0560dcebef",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8064
  },
  {
    "bcr_patient_uuid": "3aaabc62-f5a4-4025-9b29-5adf82c86c84",
    "patient_ID": "TCGA.AO.A1KP",
    "bcr_drug_barcode": "TCGA-AO-A1KP-D9888",
    "bcr_drug_uuid": "6dbc8d44-d5cc-47ee-884f-abfb08b15c5c",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8064
  },
  {
    "bcr_patient_uuid": "3aaabc62-f5a4-4025-9b29-5adf82c86c84",
    "patient_ID": "TCGA.AO.A1KP",
    "bcr_drug_barcode": "TCGA-AO-A1KP-D9893",
    "bcr_drug_uuid": "263a6dfb-0cbe-43e4-84ce-66714eb4fe98",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2161,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3aaabc62-f5a4-4025-9b29-5adf82c86c84",
    "patient_ID": "TCGA.AO.A1KP",
    "bcr_drug_barcode": "TCGA-AO-A1KP-D9889",
    "bcr_drug_uuid": "756b07bd-7b7d-499b-a092-be8e6c7eab77",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "d2219a3f-4c55-4dee-9b08-c6f330dd1acf",
    "patient_ID": "TCGA.AO.A1KQ",
    "bcr_drug_barcode": "TCGA-AO-A1KQ-D9884",
    "bcr_drug_uuid": "0dd32c09-be32-467e-9a5b-83a6e7f6f713",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b7f74ae1-6f58-447c-be50-a7666eb19d9a",
    "patient_ID": "TCGA.AO.A1KR",
    "bcr_drug_barcode": "TCGA-AO-A1KR-D21772",
    "bcr_drug_uuid": "3870F7E2-7A57-4F72-B49B-6234D97C5792",
    "form_completion_date": "2012-2-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 658
  },
  {
    "bcr_patient_uuid": "b7f74ae1-6f58-447c-be50-a7666eb19d9a",
    "patient_ID": "TCGA.AO.A1KR",
    "bcr_drug_barcode": "TCGA-AO-A1KR-D21770",
    "bcr_drug_uuid": "9814E3A1-23C9-4193-94E2-B1E096A02EA1",
    "form_completion_date": "2012-2-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 452
  },
  {
    "bcr_patient_uuid": "b7f74ae1-6f58-447c-be50-a7666eb19d9a",
    "patient_ID": "TCGA.AO.A1KR",
    "bcr_drug_barcode": "TCGA-AO-A1KR-D21771",
    "bcr_drug_uuid": "BC8E60BC-1325-4D58-8CFC-5647A26B6628",
    "form_completion_date": "2012-2-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4512
  },
  {
    "bcr_patient_uuid": "bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d",
    "patient_ID": "TCGA.AO.A1KS",
    "bcr_drug_barcode": "TCGA-AO-A1KS-D9873",
    "bcr_drug_uuid": "5cf6039b-6a9e-45da-a518-f9ed69ee620f",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f8f87cb-8a0b-474c-97fb-c71b4fd88d97",
    "patient_ID": "TCGA.AO.A1KT",
    "bcr_drug_barcode": "TCGA-AO-A1KT-D9907",
    "bcr_drug_uuid": "4daf246a-634a-4387-94f0-f90e6ef5ed43",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8448
  },
  {
    "bcr_patient_uuid": "1f8f87cb-8a0b-474c-97fb-c71b4fd88d97",
    "patient_ID": "TCGA.AO.A1KT",
    "bcr_drug_barcode": "TCGA-AO-A1KT-D9909",
    "bcr_drug_uuid": "6667d908-2ed7-4435-b5ed-adee0dae9f78",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "1f8f87cb-8a0b-474c-97fb-c71b4fd88d97",
    "patient_ID": "TCGA.AO.A1KT",
    "bcr_drug_barcode": "TCGA-AO-A1KT-D9910",
    "bcr_drug_uuid": "9e5254ab-c0ac-4253-bf73-2858ca59bc89",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f8f87cb-8a0b-474c-97fb-c71b4fd88d97",
    "patient_ID": "TCGA.AO.A1KT",
    "bcr_drug_barcode": "TCGA-AO-A1KT-D9908",
    "bcr_drug_uuid": "8515c4c8-a540-40dd-a831-e564158b5a23",
    "form_completion_date": "2011-4-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8448
  },
  {
    "bcr_patient_uuid": "83f943c7-3975-4b4f-985d-9c057741793b",
    "patient_ID": "TCGA.AQ.A04H",
    "bcr_drug_barcode": "TCGA-AQ-A04H-D4976",
    "bcr_drug_uuid": "984f482a-0e8b-423e-a98f-af30f5c8a883",
    "form_completion_date": "2010-12-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "83f943c7-3975-4b4f-985d-9c057741793b",
    "patient_ID": "TCGA.AQ.A04H",
    "bcr_drug_barcode": "TCGA-AQ-A04H-D4977",
    "bcr_drug_uuid": "178f263e-df57-4fc7-befd-4ea1a346680d",
    "form_completion_date": "2010-12-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "83f943c7-3975-4b4f-985d-9c057741793b",
    "patient_ID": "TCGA.AQ.A04H",
    "bcr_drug_barcode": "TCGA-AQ-A04H-D40872",
    "bcr_drug_uuid": "57AFEA30-9D59-45E4-A309-6717F0FBB64A",
    "form_completion_date": "2013-3-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "83f943c7-3975-4b4f-985d-9c057741793b",
    "patient_ID": "TCGA.AQ.A04H",
    "bcr_drug_barcode": "TCGA-AQ-A04H-D40873",
    "bcr_drug_uuid": "A6C7F4F8-93C6-435A-A59A-88ED37540B88",
    "form_completion_date": "2013-3-4",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9938ce5c-e74e-446e-a932-f096f85cc3b1",
    "patient_ID": "TCGA.AQ.A04J",
    "bcr_drug_barcode": "TCGA-AQ-A04J-D10098",
    "bcr_drug_uuid": "C6A8B218-BCD7-4F96-B5AB-9B20A7A0B735",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "9938ce5c-e74e-446e-a932-f096f85cc3b1",
    "patient_ID": "TCGA.AQ.A04J",
    "bcr_drug_barcode": "TCGA-AQ-A04J-D10110",
    "bcr_drug_uuid": "D8796E39-CFDE-459F-9BCD-D002AFF025CF",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "9938ce5c-e74e-446e-a932-f096f85cc3b1",
    "patient_ID": "TCGA.AQ.A04J",
    "bcr_drug_barcode": "TCGA-AQ-A04J-D10111",
    "bcr_drug_uuid": "9826B415-20EE-4140-A2D8-EA39857695D9",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "78582fbc-dcc7-48ae-9f95-5271c9bc5b72",
    "patient_ID": "TCGA.AQ.A04L",
    "bcr_drug_barcode": "TCGA-AQ-A04L-D5777",
    "bcr_drug_uuid": "8cfa2f3b-c536-46a5-ae5e-d9045e765e11",
    "form_completion_date": "2011-1-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 101,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 404
  },
  {
    "bcr_patient_uuid": "78582fbc-dcc7-48ae-9f95-5271c9bc5b72",
    "patient_ID": "TCGA.AQ.A04L",
    "bcr_drug_barcode": "TCGA-AQ-A04L-D5900",
    "bcr_drug_uuid": "f935f513-a1e9-4ada-87c4-07d532acd756",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1014,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4056
  },
  {
    "bcr_patient_uuid": "78582fbc-dcc7-48ae-9f95-5271c9bc5b72",
    "patient_ID": "TCGA.AQ.A04L",
    "bcr_drug_barcode": "TCGA-AQ-A04L-D5902",
    "bcr_drug_uuid": "d5c327db-f7d5-4cd6-b90d-ea1ac1999f6a",
    "form_completion_date": "2011-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1957,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d0b78f3f-a198-437a-ab8c-204345d3b75d",
    "patient_ID": "TCGA.AQ.A0Y5",
    "bcr_drug_barcode": "TCGA-AQ-A0Y5-D10116",
    "bcr_drug_uuid": "1aef9741-6d96-4b9c-abcf-994ed14f4ce4",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "d0b78f3f-a198-437a-ab8c-204345d3b75d",
    "patient_ID": "TCGA.AQ.A0Y5",
    "bcr_drug_barcode": "TCGA-AQ-A0Y5-D10117",
    "bcr_drug_uuid": "5fbb7fe9-4b27-43af-8832-ae64ee3e4acc",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "d0b78f3f-a198-437a-ab8c-204345d3b75d",
    "patient_ID": "TCGA.AQ.A0Y5",
    "bcr_drug_barcode": "TCGA-AQ-A0Y5-D10118",
    "bcr_drug_uuid": "5c09333c-d15e-4c62-ad09-c1984b22cbda",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 8,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 32
  },
  {
    "bcr_patient_uuid": "4d120899-9a80-4736-b097-285e9e261bcb",
    "patient_ID": "TCGA.AQ.A1H2",
    "bcr_drug_barcode": "TCGA-AQ-A1H2-D19897",
    "bcr_drug_uuid": "94375318-4D27-4A4B-A198-FD922F5A1BA1",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4d120899-9a80-4736-b097-285e9e261bcb",
    "patient_ID": "TCGA.AQ.A1H2",
    "bcr_drug_barcode": "TCGA-AQ-A1H2-D19898",
    "bcr_drug_uuid": "BB2A1345-F78E-4367-87E6-5C17B4221F19",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_units": "MG/KG",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4d120899-9a80-4736-b097-285e9e261bcb",
    "patient_ID": "TCGA.AQ.A1H2",
    "bcr_drug_barcode": "TCGA-AQ-A1H2-D19899",
    "bcr_drug_uuid": "C7DE7726-8978-4819-B64A-71AE48B4A1FF",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82ec33dd-e783-4c74-9a87-797a699e11df",
    "patient_ID": "TCGA.AQ.A1H3",
    "bcr_drug_barcode": "TCGA-AQ-A1H3-D19910",
    "bcr_drug_uuid": "A00FC9E3-5B49-4A54-A683-C81D3B869DAD",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82ec33dd-e783-4c74-9a87-797a699e11df",
    "patient_ID": "TCGA.AQ.A1H3",
    "bcr_drug_barcode": "TCGA-AQ-A1H3-D19918",
    "bcr_drug_uuid": "80735D66-0D8E-43E8-A65D-695327350EBC",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82ec33dd-e783-4c74-9a87-797a699e11df",
    "patient_ID": "TCGA.AQ.A1H3",
    "bcr_drug_barcode": "TCGA-AQ-A1H3-D19909",
    "bcr_drug_uuid": "49FE2EE4-C3CA-449E-9041-AADDB7B2789D",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82ec33dd-e783-4c74-9a87-797a699e11df",
    "patient_ID": "TCGA.AQ.A1H3",
    "bcr_drug_barcode": "TCGA-AQ-A1H3-D19919",
    "bcr_drug_uuid": "98F948E1-A62A-41F8-8B73-54326F302C9F",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "35CA5E2A-861A-4DD2-A4CE-D294CF080DA3",
    "patient_ID": "TCGA.AQ.A54O",
    "bcr_drug_barcode": "TCGA-AQ-A54O-D40684",
    "bcr_drug_uuid": "D051B585-6A82-4408-B25B-3CB75C56A0C8",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35CA5E2A-861A-4DD2-A4CE-D294CF080DA3",
    "patient_ID": "TCGA.AQ.A54O",
    "bcr_drug_barcode": "TCGA-AQ-A54O-D40686",
    "bcr_drug_uuid": "69C618BF-24A2-46C0-BA45-AAD9D605E8E6",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35CA5E2A-861A-4DD2-A4CE-D294CF080DA3",
    "patient_ID": "TCGA.AQ.A54O",
    "bcr_drug_barcode": "TCGA-AQ-A54O-D40687",
    "bcr_drug_uuid": "D56A18AB-9A5D-4B8F-B5FE-4CFDE2C87A45",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35CA5E2A-861A-4DD2-A4CE-D294CF080DA3",
    "patient_ID": "TCGA.AQ.A54O",
    "bcr_drug_barcode": "TCGA-AQ-A54O-D40688",
    "bcr_drug_uuid": "02A79C21-928D-4FE9-BD1D-934CD3ABE809",
    "form_completion_date": "2013-2-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54378",
    "bcr_drug_uuid": "F857DE6F-EDB7-4A82-8BE1-58094AF4D53A",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "RITUXIMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54381",
    "bcr_drug_uuid": "EBE759A2-2DF0-4B0B-B155-47E54A053E90",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54382",
    "bcr_drug_uuid": "5AC8BA1D-DEBC-48E8-83C5-2866BCF86F9B",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54385",
    "bcr_drug_uuid": "894571F0-1421-4634-8EF3-350800E2C13A",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54386",
    "bcr_drug_uuid": "F2C99A5C-0BC4-4921-952F-76BF03F2B539",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "19015644-9C17-4AE7-A656-0FE8623C04AE",
    "patient_ID": "TCGA.AQ.A7U7",
    "bcr_drug_barcode": "TCGA-AQ-A7U7-D54387",
    "bcr_drug_uuid": "CCBE1A5B-B0E1-430F-9221-C2B446502EEC",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 296,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ab89bb2e-da84-4116-a8cd-49aad7bbfd4d",
    "patient_ID": "TCGA.AR.A0TP",
    "bcr_drug_barcode": "TCGA-AR-A0TP-D19030",
    "bcr_drug_uuid": "D1474BAA-9E44-4519-AAA2-B81A0B0F2E2D",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5510
  },
  {
    "bcr_patient_uuid": "ab89bb2e-da84-4116-a8cd-49aad7bbfd4d",
    "patient_ID": "TCGA.AR.A0TP",
    "bcr_drug_barcode": "TCGA-AR-A0TP-D19026",
    "bcr_drug_uuid": "04948347-26AC-49B0-9E46-0812A85833EB",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 555
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19198",
    "bcr_drug_uuid": "8FD0D2B4-23DC-43ED-BAAE-74845D09E5B9",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 550
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19239",
    "bcr_drug_uuid": "73DDD614-1A82-4A11-936A-F1450119F352",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 435
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19247",
    "bcr_drug_uuid": "8BBEC5A9-8FCF-4170-ADB1-F088C1DD8B05",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 495
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19278",
    "bcr_drug_uuid": "306F161F-8B4E-4960-AAA3-774774B68664",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "TRIPTORELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1864,
    "drug_tota_dose_units": "MG",
    "drug_dose": 3.75,
    "regimen_number": 2,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19249",
    "bcr_drug_uuid": "C7A9FEB7-335D-4E12-8111-4308158A36CF",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19240",
    "bcr_drug_uuid": "C1517334-59DE-4F7C-BFC3-DBF7226574CC",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1785
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19238",
    "bcr_drug_uuid": "60A907F7-7E0E-47D5-B9C2-382D8D60B445",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5560
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19250",
    "bcr_drug_uuid": "5C21AE2A-6F50-48B8-B88B-E34B086D11D3",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "drug_cycles": 13,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9720
  },
  {
    "bcr_patient_uuid": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880",
    "patient_ID": "TCGA.AR.A0TQ",
    "bcr_drug_barcode": "TCGA-AR-A0TQ-D19277",
    "bcr_drug_uuid": "57DEE87D-F4D7-4369-B46B-617DB56ABCD0",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1867,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d1703dbd-5c93-4cf2-a4d1-0d90640882bd",
    "patient_ID": "TCGA.AR.A0TR",
    "bcr_drug_barcode": "TCGA-AR-A0TR-D19370",
    "bcr_drug_uuid": "1D3E42DF-081F-4DA4-927E-03701EF9B270",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_units": "MG/DL",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "972447aa-4332-47e7-bddd-2eb699dbb664",
    "patient_ID": "TCGA.AR.A0TS",
    "bcr_drug_barcode": "TCGA-AR-A0TS-D19193",
    "bcr_drug_uuid": "674B9434-AFDB-4831-BF85-31EAEBAB94D1",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4600
  },
  {
    "bcr_patient_uuid": "972447aa-4332-47e7-bddd-2eb699dbb664",
    "patient_ID": "TCGA.AR.A0TS",
    "bcr_drug_barcode": "TCGA-AR-A0TS-D19189",
    "bcr_drug_uuid": "6DDD0B18-B972-42FE-81B7-F4D84C27F23E",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "972447aa-4332-47e7-bddd-2eb699dbb664",
    "patient_ID": "TCGA.AR.A0TS",
    "bcr_drug_barcode": "TCGA-AR-A0TS-D19194",
    "bcr_drug_uuid": "3B977891-44ED-474F-973E-0BB631AA37E4",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1320
  },
  {
    "bcr_patient_uuid": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86",
    "patient_ID": "TCGA.AR.A0TT",
    "bcr_drug_barcode": "TCGA-AR-A0TT-D19117",
    "bcr_drug_uuid": "29A541D6-25FE-4E6E-9273-3A8AC33916A9",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1360
  },
  {
    "bcr_patient_uuid": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86",
    "patient_ID": "TCGA.AR.A0TT",
    "bcr_drug_barcode": "TCGA-AR-A0TT-D19121",
    "bcr_drug_uuid": "70A14733-C2D0-4715-8FA2-FA9E1030DC2E",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 376,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86",
    "patient_ID": "TCGA.AR.A0TT",
    "bcr_drug_barcode": "TCGA-AR-A0TT-D19124",
    "bcr_drug_uuid": "59EF98F0-0F7E-49BE-A00D-AE33AE3F59D1",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86",
    "patient_ID": "TCGA.AR.A0TT",
    "bcr_drug_barcode": "TCGA-AR-A0TT-D19112",
    "bcr_drug_uuid": "AC332E3C-15EC-4568-B022-BC18DD15AC5F",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 465
  },
  {
    "bcr_patient_uuid": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86",
    "patient_ID": "TCGA.AR.A0TT",
    "bcr_drug_barcode": "TCGA-AR-A0TT-D19113",
    "bcr_drug_uuid": "3F6361BB-149D-4D35-A1E0-7968FB1EC94A",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4680
  },
  {
    "bcr_patient_uuid": "dfe6db17-cf45-488e-bd3c-b8433d7343ca",
    "patient_ID": "TCGA.AR.A0TU",
    "bcr_drug_barcode": "TCGA-AR-A0TU-D19571",
    "bcr_drug_uuid": "8B38DA0D-2D5D-4484-BC07-F2BF3584123C",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dfe6db17-cf45-488e-bd3c-b8433d7343ca",
    "patient_ID": "TCGA.AR.A0TU",
    "bcr_drug_barcode": "TCGA-AR-A0TU-D19570",
    "bcr_drug_uuid": "EFEB5E4B-A824-4B78-B373-603E8A1C7BBA",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dfe6db17-cf45-488e-bd3c-b8433d7343ca",
    "patient_ID": "TCGA.AR.A0TU",
    "bcr_drug_barcode": "TCGA-AR-A0TU-D19572",
    "bcr_drug_uuid": "EE4C23A8-EDAC-4DE6-9B48-CD0BCB2D9978",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66",
    "patient_ID": "TCGA.AR.A0TW",
    "bcr_drug_barcode": "TCGA-AR-A0TW-D19101",
    "bcr_drug_uuid": "0AA047EB-A95E-4620-BA52-2589D3AE3F8E",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4050
  },
  {
    "bcr_patient_uuid": "8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66",
    "patient_ID": "TCGA.AR.A0TW",
    "bcr_drug_barcode": "TCGA-AR-A0TW-D19103",
    "bcr_drug_uuid": "AA7EC35A-9A0F-46CC-B59E-CFC2A343EF76",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66",
    "patient_ID": "TCGA.AR.A0TW",
    "bcr_drug_barcode": "TCGA-AR-A0TW-D19094",
    "bcr_drug_uuid": "E7E1F747-7022-4E16-A1E8-F80ECF30503E",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4",
    "patient_ID": "TCGA.AR.A0TY",
    "bcr_drug_barcode": "TCGA-AR-A0TY-D19589",
    "bcr_drug_uuid": "8AF1AE1C-AC88-42CF-85CB-59C890EFBCA7",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4",
    "patient_ID": "TCGA.AR.A0TY",
    "bcr_drug_barcode": "TCGA-AR-A0TY-D19587",
    "bcr_drug_uuid": "035DEB95-23A9-4215-B3F4-9D2A08D941C9",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4",
    "patient_ID": "TCGA.AR.A0TY",
    "bcr_drug_barcode": "TCGA-AR-A0TY-D19588",
    "bcr_drug_uuid": "B06C690B-5D84-4092-8606-77F7AC010E76",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4",
    "patient_ID": "TCGA.AR.A0TY",
    "bcr_drug_barcode": "TCGA-AR-A0TY-D19590",
    "bcr_drug_uuid": "67BBC709-F34C-473D-AFB4-E8E35852ED65",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 557,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c34fd9-3021-45b7-b6ff-30b4196585a8",
    "patient_ID": "TCGA.AR.A0TZ",
    "bcr_drug_barcode": "TCGA-AR-A0TZ-D19584",
    "bcr_drug_uuid": "12E885E0-147E-493C-80A3-3FC7FA47B11A",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c34fd9-3021-45b7-b6ff-30b4196585a8",
    "patient_ID": "TCGA.AR.A0TZ",
    "bcr_drug_barcode": "TCGA-AR-A0TZ-D19580",
    "bcr_drug_uuid": "6D665117-F247-42AF-BCEE-58D9E5A8C4AA",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c34fd9-3021-45b7-b6ff-30b4196585a8",
    "patient_ID": "TCGA.AR.A0TZ",
    "bcr_drug_barcode": "TCGA-AR-A0TZ-D19585",
    "bcr_drug_uuid": "DDAECFBE-9A39-40E2-9949-5BA7F0E59972",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c34fd9-3021-45b7-b6ff-30b4196585a8",
    "patient_ID": "TCGA.AR.A0TZ",
    "bcr_drug_barcode": "TCGA-AR-A0TZ-D19582",
    "bcr_drug_uuid": "0D4D40A8-8486-46B8-9F85-FD8B559B4437",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c34fd9-3021-45b7-b6ff-30b4196585a8",
    "patient_ID": "TCGA.AR.A0TZ",
    "bcr_drug_barcode": "TCGA-AR-A0TZ-D19586",
    "bcr_drug_uuid": "7476015B-5A4D-4FC4-8716-34E766F01ACC",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17d9e646-6ab3-40b3-a0bc-2c834d3c3213",
    "patient_ID": "TCGA.AR.A0U1",
    "bcr_drug_barcode": "TCGA-AR-A0U1-D19568",
    "bcr_drug_uuid": "449863BE-C8F7-4FFC-BF24-F45FC0017C16",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17d9e646-6ab3-40b3-a0bc-2c834d3c3213",
    "patient_ID": "TCGA.AR.A0U1",
    "bcr_drug_barcode": "TCGA-AR-A0U1-D19567",
    "bcr_drug_uuid": "128732AA-7BD1-4411-94E4-8EE57ED82476",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17d9e646-6ab3-40b3-a0bc-2c834d3c3213",
    "patient_ID": "TCGA.AR.A0U1",
    "bcr_drug_barcode": "TCGA-AR-A0U1-D19569",
    "bcr_drug_uuid": "257BEE3C-93D1-422F-8D83-C9A0D7BF86AD",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d",
    "patient_ID": "TCGA.AR.A0U2",
    "bcr_drug_barcode": "TCGA-AR-A0U2-D19593",
    "bcr_drug_uuid": "2E56AF80-2C77-4EA0-AD75-B645BC14CD63",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d",
    "patient_ID": "TCGA.AR.A0U2",
    "bcr_drug_barcode": "TCGA-AR-A0U2-D19594",
    "bcr_drug_uuid": "DC973377-2597-4375-8377-9AB28D884777",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d",
    "patient_ID": "TCGA.AR.A0U2",
    "bcr_drug_barcode": "TCGA-AR-A0U2-D19592",
    "bcr_drug_uuid": "CB681BE2-02B4-4823-BBE4-E34A66E10E57",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d",
    "patient_ID": "TCGA.AR.A0U2",
    "bcr_drug_barcode": "TCGA-AR-A0U2-D19595",
    "bcr_drug_uuid": "59FD28B5-689E-4E96-AC37-80921DB220F9",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d",
    "patient_ID": "TCGA.AR.A0U2",
    "bcr_drug_barcode": "TCGA-AR-A0U2-D19596",
    "bcr_drug_uuid": "320E795E-E0E7-4F90-9D11-014ABF0FF2BD",
    "form_completion_date": "2011-12-15",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1603,
    "regimen_number": 3,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5f00132-1c6b-4337-af6f-596c652665cc",
    "patient_ID": "TCGA.AR.A0U3",
    "bcr_drug_barcode": "TCGA-AR-A0U3-D19033",
    "bcr_drug_uuid": "0E604F50-B14A-4467-953D-6DDF69361452",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1590
  },
  {
    "bcr_patient_uuid": "c5f00132-1c6b-4337-af6f-596c652665cc",
    "patient_ID": "TCGA.AR.A0U3",
    "bcr_drug_barcode": "TCGA-AR-A0U3-D19028",
    "bcr_drug_uuid": "8B7D25A5-DF6C-4F1F-9018-189E343500BB",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "c5f00132-1c6b-4337-af6f-596c652665cc",
    "patient_ID": "TCGA.AR.A0U3",
    "bcr_drug_barcode": "TCGA-AR-A0U3-D19034",
    "bcr_drug_uuid": "3AB2189D-3925-4831-B00A-1E7791363CF8",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2015,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5f00132-1c6b-4337-af6f-596c652665cc",
    "patient_ID": "TCGA.AR.A0U3",
    "bcr_drug_barcode": "TCGA-AR-A0U3-D19031",
    "bcr_drug_uuid": "13CF7E01-51DD-4494-8E95-4C20C42A3E50",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4160
  },
  {
    "bcr_patient_uuid": "71f97b63-c970-44ee-98c2-e02e663d5a40",
    "patient_ID": "TCGA.AR.A0U4",
    "bcr_drug_barcode": "TCGA-AR-A0U4-D19341",
    "bcr_drug_uuid": "324CC111-37BE-4840-A581-F1CED82AA6C5",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "71f97b63-c970-44ee-98c2-e02e663d5a40",
    "patient_ID": "TCGA.AR.A0U4",
    "bcr_drug_barcode": "TCGA-AR-A0U4-D19343",
    "bcr_drug_uuid": "34F346D8-CBF0-4AA7-8B08-1A238EAED715",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "71f97b63-c970-44ee-98c2-e02e663d5a40",
    "patient_ID": "TCGA.AR.A0U4",
    "bcr_drug_barcode": "TCGA-AR-A0U4-D19342",
    "bcr_drug_uuid": "E0C6F2ED-E72F-409A-BB26-85708A763D79",
    "form_completion_date": "2011-12-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5380
  },
  {
    "bcr_patient_uuid": "a6e11b30-3ae8-4dd1-b04c-a730c6a79746",
    "patient_ID": "TCGA.AR.A1AH",
    "bcr_drug_barcode": "TCGA-AR-A1AH-D21706",
    "bcr_drug_uuid": "E17CEAC2-757D-453F-824F-D3835792B356",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6e11b30-3ae8-4dd1-b04c-a730c6a79746",
    "patient_ID": "TCGA.AR.A1AH",
    "bcr_drug_barcode": "TCGA-AR-A1AH-D21712",
    "bcr_drug_uuid": "37BF063D-A8DE-410C-991D-B2FD6B00EA10",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2241,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9848307d-1bd5-40c1-b655-a33297aaf74f",
    "patient_ID": "TCGA.AR.A1AI",
    "bcr_drug_barcode": "TCGA-AR-A1AI-D22166",
    "bcr_drug_uuid": "90D5DC13-564D-48CD-8C71-641D9D851628",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5500
  },
  {
    "bcr_patient_uuid": "9848307d-1bd5-40c1-b655-a33297aaf74f",
    "patient_ID": "TCGA.AR.A1AI",
    "bcr_drug_barcode": "TCGA-AR-A1AI-D22165",
    "bcr_drug_uuid": "7DC45115-BA8C-4FCF-870E-DE0B34A8BB4A",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 550
  },
  {
    "bcr_patient_uuid": "9848307d-1bd5-40c1-b655-a33297aaf74f",
    "patient_ID": "TCGA.AR.A1AI",
    "bcr_drug_barcode": "TCGA-AR-A1AI-D22167",
    "bcr_drug_uuid": "2B5F671F-53D9-4796-B9B5-CF32551C4232",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1520
  },
  {
    "bcr_patient_uuid": "94b03e1d-50ec-4680-bffd-7086d1536ff2",
    "patient_ID": "TCGA.AR.A1AK",
    "bcr_drug_barcode": "TCGA-AR-A1AK-D22155",
    "bcr_drug_uuid": "37D99581-850D-476B-8328-D3E0BD6DC049",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1843,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22159",
    "bcr_drug_uuid": "2856DA7C-FB15-45B1-97F6-4D562D8F705F",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22162",
    "bcr_drug_uuid": "49AE2F00-CB5D-4C4E-8134-0E856F245217",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 366,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22160",
    "bcr_drug_uuid": "434BD03D-F052-4518-BA27-5FFA55676AB0",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22161",
    "bcr_drug_uuid": "CD0DAAB8-2A50-4F39-ABB3-A57C7DB0E95A",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22158",
    "bcr_drug_uuid": "377B613B-C56A-444F-9267-A2E5EDFEA3AF",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e",
    "patient_ID": "TCGA.AR.A1AL",
    "bcr_drug_barcode": "TCGA-AR-A1AL-D22163",
    "bcr_drug_uuid": "D49EE915-818B-484E-BE1B-15C7D3685DF8",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 387,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "EBD1512A-4865-4193-97B3-F599D555759A",
    "patient_ID": "TCGA.AR.A1AM",
    "bcr_drug_barcode": "TCGA-AR-A1AM-D36899",
    "bcr_drug_uuid": "66305035-0C04-4F78-9827-C6945903CB21",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EBD1512A-4865-4193-97B3-F599D555759A",
    "patient_ID": "TCGA.AR.A1AM",
    "bcr_drug_barcode": "TCGA-AR-A1AM-D36913",
    "bcr_drug_uuid": "A6043E89-02FF-41DB-B796-E31AA6778A1F",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EBD1512A-4865-4193-97B3-F599D555759A",
    "patient_ID": "TCGA.AR.A1AM",
    "bcr_drug_barcode": "TCGA-AR-A1AM-D36914",
    "bcr_drug_uuid": "A2E5EB14-9F26-47D5-86B5-95B3B1E65039",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 314,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EBD1512A-4865-4193-97B3-F599D555759A",
    "patient_ID": "TCGA.AR.A1AM",
    "bcr_drug_barcode": "TCGA-AR-A1AM-D63948",
    "bcr_drug_uuid": "1F367D89-FCE1-484D-B3CA-93FF5FE8F4E0",
    "form_completion_date": "2014-8-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21999",
    "bcr_drug_uuid": "C9B603C0-0213-4B45-8199-72032C517BEA",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 442,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21996",
    "bcr_drug_uuid": "B97F58C1-DC5F-486E-BBF6-7A8E364CB1A5",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21998",
    "bcr_drug_uuid": "99CC0213-C42E-4C37-B846-D21F96608C60",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 441,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21994",
    "bcr_drug_uuid": "41723CA9-81FB-486E-8E7E-5ECB2997418E",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4310
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21995",
    "bcr_drug_uuid": "7FCC74A9-CFDF-4804-877F-E82ED18041AB",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "43029932-feb0-4658-97fa-645c1e775009",
    "patient_ID": "TCGA.AR.A1AN",
    "bcr_drug_barcode": "TCGA-AR-A1AN-D21991",
    "bcr_drug_uuid": "0B897029-9392-428C-B8B8-6DA05D449134",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 435
  },
  {
    "bcr_patient_uuid": "623befd6-0ca4-4a6c-9cf5-d9385c3b718f",
    "patient_ID": "TCGA.AR.A1AO",
    "bcr_drug_barcode": "TCGA-AR-A1AO-D21783",
    "bcr_drug_uuid": "FC942EEA-FF1B-4138-9AF0-ACAEB4587C88",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "623befd6-0ca4-4a6c-9cf5-d9385c3b718f",
    "patient_ID": "TCGA.AR.A1AO",
    "bcr_drug_barcode": "TCGA-AR-A1AO-D21782",
    "bcr_drug_uuid": "486A390E-63A5-40C5-871A-82F3EB768849",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 139,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "623befd6-0ca4-4a6c-9cf5-d9385c3b718f",
    "patient_ID": "TCGA.AR.A1AO",
    "bcr_drug_barcode": "TCGA-AR-A1AO-D21776",
    "bcr_drug_uuid": "3FAD143B-6FA0-4A68-BD62-F68CF5C5E212",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 425
  },
  {
    "bcr_patient_uuid": "623befd6-0ca4-4a6c-9cf5-d9385c3b718f",
    "patient_ID": "TCGA.AR.A1AO",
    "bcr_drug_barcode": "TCGA-AR-A1AO-D21781",
    "bcr_drug_uuid": "6AEEDC5D-E064-4E5B-A0BD-E4026DE10F96",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4250
  },
  {
    "bcr_patient_uuid": "9495f029-9882-4c9b-a557-b3aec9e91698",
    "patient_ID": "TCGA.AR.A1AP",
    "bcr_drug_barcode": "TCGA-AR-A1AP-D21795",
    "bcr_drug_uuid": "89F5BA7B-C2F4-41AC-84D2-4EC2FC5D6F02",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "98e0b4de-52fc-4945-9bf5-11e29368f939",
    "patient_ID": "TCGA.AR.A1AQ",
    "bcr_drug_barcode": "TCGA-AR-A1AQ-D21806",
    "bcr_drug_uuid": "E3335007-9F30-4A8C-8027-2E69648DCB76",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "98e0b4de-52fc-4945-9bf5-11e29368f939",
    "patient_ID": "TCGA.AR.A1AQ",
    "bcr_drug_barcode": "TCGA-AR-A1AQ-D21808",
    "bcr_drug_uuid": "26C8ACC1-6306-4A4B-AE2E-178288FA6A52",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4780
  },
  {
    "bcr_patient_uuid": "98e0b4de-52fc-4945-9bf5-11e29368f939",
    "patient_ID": "TCGA.AR.A1AQ",
    "bcr_drug_barcode": "TCGA-AR-A1AQ-D21811",
    "bcr_drug_uuid": "FB4C564B-3B93-4B6F-98A5-FDCE6A415267",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "eda6d2d5-4199-4f76-a45b-1d0401b4e54c",
    "patient_ID": "TCGA.AR.A1AR",
    "bcr_drug_barcode": "TCGA-AR-A1AR-D21853",
    "bcr_drug_uuid": "8E6652BF-209E-4F74-87AE-371F6CB1244D",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eda6d2d5-4199-4f76-a45b-1d0401b4e54c",
    "patient_ID": "TCGA.AR.A1AR",
    "bcr_drug_barcode": "TCGA-AR-A1AR-D21852",
    "bcr_drug_uuid": "A68EA7A7-0E11-4956-8188-70EA2C45DECF",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eda6d2d5-4199-4f76-a45b-1d0401b4e54c",
    "patient_ID": "TCGA.AR.A1AR",
    "bcr_drug_barcode": "TCGA-AR-A1AR-D21854",
    "bcr_drug_uuid": "7B4BBD98-19AC-4156-B24A-AE9E584860AB",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d681cc6-689d-41c8-9e84-e13733089ec9",
    "patient_ID": "TCGA.AR.A1AS",
    "bcr_drug_barcode": "TCGA-AR-A1AS-D22098",
    "bcr_drug_uuid": "A43B3752-2843-4BA5-A3BA-DB1229CD3C62",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d681cc6-689d-41c8-9e84-e13733089ec9",
    "patient_ID": "TCGA.AR.A1AS",
    "bcr_drug_barcode": "TCGA-AR-A1AS-D22094",
    "bcr_drug_uuid": "FE2D8B3C-0216-4CAE-B606-2C2BF40EBB87",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1970
  },
  {
    "bcr_patient_uuid": "7d681cc6-689d-41c8-9e84-e13733089ec9",
    "patient_ID": "TCGA.AR.A1AS",
    "bcr_drug_barcode": "TCGA-AR-A1AS-D22092",
    "bcr_drug_uuid": "31EE0BA4-5B45-4A29-BE1E-D544D6290707",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "4d26dada-5eb7-4d4e-8eb8-f5465c5c3428",
    "patient_ID": "TCGA.AR.A1AT",
    "bcr_drug_barcode": "TCGA-AR-A1AT-D22150",
    "bcr_drug_uuid": "63B8C39E-9EA4-4B8E-9431-A97DAA709EB4",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "NOT OTHERWISE SPECIFIED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4d26dada-5eb7-4d4e-8eb8-f5465c5c3428",
    "patient_ID": "TCGA.AR.A1AT",
    "bcr_drug_barcode": "TCGA-AR-A1AT-D22153",
    "bcr_drug_uuid": "46749B9C-613A-40A5-B0CB-44978EEF1A91",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1272,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4d26dada-5eb7-4d4e-8eb8-f5465c5c3428",
    "patient_ID": "TCGA.AR.A1AT",
    "bcr_drug_barcode": "TCGA-AR-A1AT-D22152",
    "bcr_drug_uuid": "022F99BE-9A3B-44EF-94DE-B304CF259B65",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "36220587-1c1c-4f92-b177-3b2155e7e273",
    "patient_ID": "TCGA.AR.A1AU",
    "bcr_drug_barcode": "TCGA-AR-A1AU-D21864",
    "bcr_drug_uuid": "AA98F6B4-F95F-42BE-8DC4-9453156E46D9",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "36220587-1c1c-4f92-b177-3b2155e7e273",
    "patient_ID": "TCGA.AR.A1AU",
    "bcr_drug_barcode": "TCGA-AR-A1AU-D21869",
    "bcr_drug_uuid": "04058D52-264A-4E9D-80C7-5F003B9F48C6",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1320
  },
  {
    "bcr_patient_uuid": "36220587-1c1c-4f92-b177-3b2155e7e273",
    "patient_ID": "TCGA.AR.A1AU",
    "bcr_drug_barcode": "TCGA-AR-A1AU-D21866",
    "bcr_drug_uuid": "E590785D-CACD-47BA-B643-8C232EC60A72",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4540
  },
  {
    "bcr_patient_uuid": "36220587-1c1c-4f92-b177-3b2155e7e273",
    "patient_ID": "TCGA.AR.A1AU",
    "bcr_drug_barcode": "TCGA-AR-A1AU-D21871",
    "bcr_drug_uuid": "42C369BB-5B2B-41E6-AFEB-DD07F763415A",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "daf62b56-6dd2-4ab7-adaa-f296bb86a0a5",
    "patient_ID": "TCGA.AR.A1AV",
    "bcr_drug_barcode": "TCGA-AR-A1AV-D22108",
    "bcr_drug_uuid": "828B60C5-30E1-454A-BF7D-B31D23ED13CB",
    "form_completion_date": "2012-2-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "daf62b56-6dd2-4ab7-adaa-f296bb86a0a5",
    "patient_ID": "TCGA.AR.A1AV",
    "bcr_drug_barcode": "TCGA-AR-A1AV-D22107",
    "bcr_drug_uuid": "0635BAEF-1285-40DC-820E-8805EC2E3F11",
    "form_completion_date": "2012-2-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1450
  },
  {
    "bcr_patient_uuid": "daf62b56-6dd2-4ab7-adaa-f296bb86a0a5",
    "patient_ID": "TCGA.AR.A1AV",
    "bcr_drug_barcode": "TCGA-AR-A1AV-D22105",
    "bcr_drug_uuid": "2A341311-F186-4BB2-9C3B-77EA76B9B7AE",
    "form_completion_date": "2012-2-29",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5080
  },
  {
    "bcr_patient_uuid": "daf62b56-6dd2-4ab7-adaa-f296bb86a0a5",
    "patient_ID": "TCGA.AR.A1AV",
    "bcr_drug_barcode": "TCGA-AR-A1AV-D22104",
    "bcr_drug_uuid": "E8AA4773-70EB-4FBD-AE3E-8881E5D8E348",
    "form_completion_date": "2012-2-29",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 505
  },
  {
    "bcr_patient_uuid": "a12fd22a-7f84-4b6e-b6d8-012e38eb73d7",
    "patient_ID": "TCGA.AR.A1AW",
    "bcr_drug_barcode": "TCGA-AR-A1AW-D21882",
    "bcr_drug_uuid": "CFE3594C-AFCE-4DC0-9A24-2F3F93988BBE",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1210
  },
  {
    "bcr_patient_uuid": "a12fd22a-7f84-4b6e-b6d8-012e38eb73d7",
    "patient_ID": "TCGA.AR.A1AW",
    "bcr_drug_barcode": "TCGA-AR-A1AW-D21880",
    "bcr_drug_uuid": "B118CFF2-8566-464E-BC22-044DA44E6715",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "a12fd22a-7f84-4b6e-b6d8-012e38eb73d7",
    "patient_ID": "TCGA.AR.A1AW",
    "bcr_drug_barcode": "TCGA-AR-A1AW-D21884",
    "bcr_drug_uuid": "E157CFB4-4E3C-419E-B051-B1574E3EFECB",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22147",
    "bcr_drug_uuid": "B73644E2-BE84-462A-8A8A-7DD3B1096370",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22144",
    "bcr_drug_uuid": "34AD7E93-C4C1-4D25-AB5B-2DB9F3864B85",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22142",
    "bcr_drug_uuid": "EBFA7185-C765-4E3A-95B6-F841E01AD17C",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22145",
    "bcr_drug_uuid": "8B22C59E-5DAE-4372-A2A9-CD57D6D84D53",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "drug_units": "MG/KG",
    "drug_dose": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22146",
    "bcr_drug_uuid": "D3CAF54C-B16D-4B4C-BB7E-85033DB79E0E",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f72c1d69-da35-459f-8542-59bfd6c09c23",
    "patient_ID": "TCGA.AR.A1AX",
    "bcr_drug_barcode": "TCGA-AR-A1AX-D22143",
    "bcr_drug_uuid": "9E6B462C-33CD-4914-B565-BF5F728AA385",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5fd9552a-c742-4388-940d-295d1107ae00",
    "patient_ID": "TCGA.AR.A1AY",
    "bcr_drug_barcode": "TCGA-AR-A1AY-D21981",
    "bcr_drug_uuid": "4898241A-D0FD-474A-AB71-1B9BC5FBE3F1",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5fd9552a-c742-4388-940d-295d1107ae00",
    "patient_ID": "TCGA.AR.A1AY",
    "bcr_drug_barcode": "TCGA-AR-A1AY-D21982",
    "bcr_drug_uuid": "4BBF53A3-33EC-452E-ABEB-55BC506B0EBD",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6f89509c-f802-482e-b4da-94553aa76fe9",
    "patient_ID": "TCGA.AR.A24H",
    "bcr_drug_barcode": "TCGA-AR-A24H-D31253",
    "bcr_drug_uuid": "FB37D0A3-9242-440E-A64A-2859934FB1A9",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1042,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3094,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6f89509c-f802-482e-b4da-94553aa76fe9",
    "patient_ID": "TCGA.AR.A24H",
    "bcr_drug_barcode": "TCGA-AR-A24H-D31252",
    "bcr_drug_uuid": "D5707F24-629C-4F1F-9D73-89CD2F7CA8A3",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1042,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "599c3701-df7a-4a75-a347-fa9b510dd242",
    "patient_ID": "TCGA.AR.A24K",
    "bcr_drug_barcode": "TCGA-AR-A24K-D31262",
    "bcr_drug_uuid": "CDC672D1-9D6E-4784-B377-5AE2546F2EDB",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "599c3701-df7a-4a75-a347-fa9b510dd242",
    "patient_ID": "TCGA.AR.A24K",
    "bcr_drug_barcode": "TCGA-AR-A24K-D31261",
    "bcr_drug_uuid": "CF20F7DD-121A-44A7-B932-B417039C45D5",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "599c3701-df7a-4a75-a347-fa9b510dd242",
    "patient_ID": "TCGA.AR.A24K",
    "bcr_drug_barcode": "TCGA-AR-A24K-D31260",
    "bcr_drug_uuid": "3AFC8797-628E-464D-A40B-5D0B624E3B20",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "de646f6a-6d50-4be2-b3cd-f17554b234df",
    "patient_ID": "TCGA.AR.A24L",
    "bcr_drug_barcode": "TCGA-AR-A24L-D31270",
    "bcr_drug_uuid": "F6EC056E-4FA3-4E3B-890D-E3B8307E19B1",
    "form_completion_date": "2012-4-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "de646f6a-6d50-4be2-b3cd-f17554b234df",
    "patient_ID": "TCGA.AR.A24L",
    "bcr_drug_barcode": "TCGA-AR-A24L-D31271",
    "bcr_drug_uuid": "5B4FA9C9-DE69-4615-BE89-619E2F835DEA",
    "form_completion_date": "2012-4-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "de646f6a-6d50-4be2-b3cd-f17554b234df",
    "patient_ID": "TCGA.AR.A24L",
    "bcr_drug_barcode": "TCGA-AR-A24L-D31272",
    "bcr_drug_uuid": "D11B2960-E58A-4BCC-B247-CD1E491660A2",
    "form_completion_date": "2012-4-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 145,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1414,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "de646f6a-6d50-4be2-b3cd-f17554b234df",
    "patient_ID": "TCGA.AR.A24L",
    "bcr_drug_barcode": "TCGA-AR-A24L-D31269",
    "bcr_drug_uuid": "F4B58638-1544-44FA-9E05-9CA0F74B8232",
    "form_completion_date": "2012-4-26",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa30ac3d-4216-45dd-a314-1ae192fafcb2",
    "patient_ID": "TCGA.AR.A24M",
    "bcr_drug_barcode": "TCGA-AR-A24M-D31349",
    "bcr_drug_uuid": "0CE63344-9846-491C-BB79-071A252824D6",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa30ac3d-4216-45dd-a314-1ae192fafcb2",
    "patient_ID": "TCGA.AR.A24M",
    "bcr_drug_barcode": "TCGA-AR-A24M-D31351",
    "bcr_drug_uuid": "A56BF7ED-38FA-4172-BA59-B2E1B0FED601",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 597,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa30ac3d-4216-45dd-a314-1ae192fafcb2",
    "patient_ID": "TCGA.AR.A24M",
    "bcr_drug_barcode": "TCGA-AR-A24M-D31353",
    "bcr_drug_uuid": "7600BF7D-7046-47BB-B302-45F9C1AD0002",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa30ac3d-4216-45dd-a314-1ae192fafcb2",
    "patient_ID": "TCGA.AR.A24M",
    "bcr_drug_barcode": "TCGA-AR-A24M-D31347",
    "bcr_drug_uuid": "6CF36578-40F0-4B65-B7A9-2E017552BF04",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa30ac3d-4216-45dd-a314-1ae192fafcb2",
    "patient_ID": "TCGA.AR.A24M",
    "bcr_drug_barcode": "TCGA-AR-A24M-D31350",
    "bcr_drug_uuid": "3AAE3639-A0AE-48F7-81A2-C05BA2ED7782",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "125b0a9a-6cbe-4207-9178-e7ff03487e87",
    "patient_ID": "TCGA.AR.A24O",
    "bcr_drug_barcode": "TCGA-AR-A24O-D31363",
    "bcr_drug_uuid": "8B674BE2-3DB0-4A12-942B-F5E9B424F4A1",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3820
  },
  {
    "bcr_patient_uuid": "125b0a9a-6cbe-4207-9178-e7ff03487e87",
    "patient_ID": "TCGA.AR.A24O",
    "bcr_drug_barcode": "TCGA-AR-A24O-D31368",
    "bcr_drug_uuid": "70462AEF-4D61-423E-9388-4DAA2DFDDAE5",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1998,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2283,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "125b0a9a-6cbe-4207-9178-e7ff03487e87",
    "patient_ID": "TCGA.AR.A24O",
    "bcr_drug_barcode": "TCGA-AR-A24O-D31360",
    "bcr_drug_uuid": "38BF2C09-8748-454C-A56E-36FDD41E6268",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "125b0a9a-6cbe-4207-9178-e7ff03487e87",
    "patient_ID": "TCGA.AR.A24O",
    "bcr_drug_barcode": "TCGA-AR-A24O-D31366",
    "bcr_drug_uuid": "473BCA10-A4E7-4AEE-AA89-5A8A66DABFEF",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "125b0a9a-6cbe-4207-9178-e7ff03487e87",
    "patient_ID": "TCGA.AR.A24O",
    "bcr_drug_barcode": "TCGA-AR-A24O-D31367",
    "bcr_drug_uuid": "342B68A1-E8FE-4380-A4A7-669B934A259E",
    "form_completion_date": "2012-5-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1994,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31408",
    "bcr_drug_uuid": "41C3CA51-2FA0-4FB2-B09E-5A39902B85FC",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31410",
    "bcr_drug_uuid": "ECA92825-C9DC-44DF-A73D-AA6635A1F2B3",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31412",
    "bcr_drug_uuid": "04E1D133-F414-45DA-8B0A-F0508DAE0713",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 970
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31416",
    "bcr_drug_uuid": "4476480D-D2D0-4265-8B55-C8622DC76046",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "drug_cycles": 14,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7387
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31409",
    "bcr_drug_uuid": "AA34E461-7470-4313-A778-7199FB3B12DF",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2210
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31413",
    "bcr_drug_uuid": "BFC7D7CA-0605-47AB-8BD1-36E53660AD7F",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31414",
    "bcr_drug_uuid": "F76C3A55-BA43-4C18-A156-8B352AE00302",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "28e9048a-e540-42de-a1f4-4ef894fccc4c",
    "patient_ID": "TCGA.AR.A24Q",
    "bcr_drug_barcode": "TCGA-AR-A24Q-D31418",
    "bcr_drug_uuid": "C01824C6-29F9-492F-9DA8-E9A25BD34492",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 208,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1988,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "db62d9c7-8343-4771-84fc-146d2e307bb8",
    "patient_ID": "TCGA.AR.A24R",
    "bcr_drug_barcode": "TCGA-AR-A24R-D32053",
    "bcr_drug_uuid": "2D99DA1B-9B2A-4ECA-AE32-B72EA98D544B",
    "form_completion_date": "2012-5-15",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1969,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "db62d9c7-8343-4771-84fc-146d2e307bb8",
    "patient_ID": "TCGA.AR.A24R",
    "bcr_drug_barcode": "TCGA-AR-A24R-D31466",
    "bcr_drug_uuid": "2C100981-948D-403E-AD66-4E1C0D27C498",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10500
  },
  {
    "bcr_patient_uuid": "db62d9c7-8343-4771-84fc-146d2e307bb8",
    "patient_ID": "TCGA.AR.A24R",
    "bcr_drug_barcode": "TCGA-AR-A24R-D31464",
    "bcr_drug_uuid": "CCA3DC0B-E23D-40B1-9E84-27AA4E047FF8",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 24,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "db62d9c7-8343-4771-84fc-146d2e307bb8",
    "patient_ID": "TCGA.AR.A24R",
    "bcr_drug_barcode": "TCGA-AR-A24R-D31468",
    "bcr_drug_uuid": "A5F6149E-F23B-460C-976E-013FB96B1C92",
    "form_completion_date": "2012-5-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "db62d9c7-8343-4771-84fc-146d2e307bb8",
    "patient_ID": "TCGA.AR.A24R",
    "bcr_drug_barcode": "TCGA-AR-A24R-D31495",
    "bcr_drug_uuid": "8ABD8AA5-234C-4EE7-8757-5E4639897AF3",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 228,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1904,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "074e8b06-3929-4896-9263-3b80ad6a355b",
    "patient_ID": "TCGA.AR.A24S",
    "bcr_drug_barcode": "TCGA-AR-A24S-D31500",
    "bcr_drug_uuid": "D4ADA29C-A0D8-40B4-9BC1-5C021EE0D1CA",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1124,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "074e8b06-3929-4896-9263-3b80ad6a355b",
    "patient_ID": "TCGA.AR.A24S",
    "bcr_drug_barcode": "TCGA-AR-A24S-D31499",
    "bcr_drug_uuid": "F328D456-9B78-4357-99E0-40F41C3314CE",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e3de467-fb0d-4021-89f8-b34968a7c7bc",
    "patient_ID": "TCGA.AR.A24T",
    "bcr_drug_barcode": "TCGA-AR-A24T-D31507",
    "bcr_drug_uuid": "00300D73-B562-4EE9-A8D4-27E5B97AE501",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4270
  },
  {
    "bcr_patient_uuid": "9e3de467-fb0d-4021-89f8-b34968a7c7bc",
    "patient_ID": "TCGA.AR.A24T",
    "bcr_drug_barcode": "TCGA-AR-A24T-D31505",
    "bcr_drug_uuid": "E38D1685-E03E-45B3-B2E3-14C26D6034CB",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "9e3de467-fb0d-4021-89f8-b34968a7c7bc",
    "patient_ID": "TCGA.AR.A24T",
    "bcr_drug_barcode": "TCGA-AR-A24T-D31512",
    "bcr_drug_uuid": "1CAF26F7-14B5-441D-B185-4B37F4059B93",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e3de467-fb0d-4021-89f8-b34968a7c7bc",
    "patient_ID": "TCGA.AR.A24T",
    "bcr_drug_barcode": "TCGA-AR-A24T-D31510",
    "bcr_drug_uuid": "4564981E-0469-40CD-A0F1-7EA3750491FF",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1864,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e3de467-fb0d-4021-89f8-b34968a7c7bc",
    "patient_ID": "TCGA.AR.A24T",
    "bcr_drug_barcode": "TCGA-AR-A24T-D31508",
    "bcr_drug_uuid": "6582CFB0-38DB-40AA-B9DB-3E4241EE51EF",
    "form_completion_date": "2012-5-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1260
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D31594",
    "bcr_drug_uuid": "DA32B961-80C8-4D77-A98B-4E9FED2AA1CE",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D31598",
    "bcr_drug_uuid": "1EA74BAA-C62D-454E-9666-8311D3957949",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D31600",
    "bcr_drug_uuid": "0F05B513-E5C7-4EBD-9FD0-00D49E148864",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D31603",
    "bcr_drug_uuid": "551E1D04-2F7A-4065-A2A5-530D95047532",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TRUSTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D32229",
    "bcr_drug_uuid": "3B708795-9361-4DC6-8F7A-E6C5D3BD53E6",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc",
    "patient_ID": "TCGA.AR.A24U",
    "bcr_drug_barcode": "TCGA-AR-A24U-D31605",
    "bcr_drug_uuid": "EC9851E1-A6A6-4E59-AAF1-4F25D1B7EA80",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TRUSTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31619",
    "bcr_drug_uuid": "ECA738C2-9571-4A0C-A17D-D3A9713FC600",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31620",
    "bcr_drug_uuid": "076FC6CD-C7E1-47EF-A4D3-A1C9A5B32DB3",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31622",
    "bcr_drug_uuid": "C613A54C-32DC-42A4-93AF-B9A4921BBF5D",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31623",
    "bcr_drug_uuid": "A9AD5C02-19DC-42F0-B096-8FA618C4F7D3",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31624",
    "bcr_drug_uuid": "22B76231-6512-4D60-8D8E-3E9413F870FA",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1027,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd",
    "patient_ID": "TCGA.AR.A24V",
    "bcr_drug_barcode": "TCGA-AR-A24V-D31625",
    "bcr_drug_uuid": "B34AEFC3-E29F-4CBD-B443-2FEE1DB17665",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1027,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67526f5a-3a30-45b2-aeab-2b21a855063e",
    "patient_ID": "TCGA.AR.A24W",
    "bcr_drug_barcode": "TCGA-AR-A24W-D31635",
    "bcr_drug_uuid": "1CD0389E-EE24-475D-B7C2-4004B7E66425",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67526f5a-3a30-45b2-aeab-2b21a855063e",
    "patient_ID": "TCGA.AR.A24W",
    "bcr_drug_barcode": "TCGA-AR-A24W-D31637",
    "bcr_drug_uuid": "B02CD97F-591A-4C8A-ADBE-EDE8209C6296",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67526f5a-3a30-45b2-aeab-2b21a855063e",
    "patient_ID": "TCGA.AR.A24W",
    "bcr_drug_barcode": "TCGA-AR-A24W-D31640",
    "bcr_drug_uuid": "567A9E78-2614-4140-A312-1D519B05A899",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67526f5a-3a30-45b2-aeab-2b21a855063e",
    "patient_ID": "TCGA.AR.A24W",
    "bcr_drug_barcode": "TCGA-AR-A24W-D31641",
    "bcr_drug_uuid": "B0D36A62-52F5-4332-A90A-58BBBE026CE6",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 345,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67526f5a-3a30-45b2-aeab-2b21a855063e",
    "patient_ID": "TCGA.AR.A24W",
    "bcr_drug_barcode": "TCGA-AR-A24W-D31642",
    "bcr_drug_uuid": "1C382941-469A-4FBC-BBFC-AECC59416F32",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 345,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "491d5ebb-e9ab-4b17-acb8-630ff9fef0f2",
    "patient_ID": "TCGA.AR.A24X",
    "bcr_drug_barcode": "TCGA-AR-A24X-D31644",
    "bcr_drug_uuid": "4A49DB24-6D72-4CF9-A396-F9FEC2E3A3FF",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "491d5ebb-e9ab-4b17-acb8-630ff9fef0f2",
    "patient_ID": "TCGA.AR.A24X",
    "bcr_drug_barcode": "TCGA-AR-A24X-D31645",
    "bcr_drug_uuid": "D805353E-47A2-4282-9237-2CAC88D2665E",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "491d5ebb-e9ab-4b17-acb8-630ff9fef0f2",
    "patient_ID": "TCGA.AR.A24X",
    "bcr_drug_barcode": "TCGA-AR-A24X-D31646",
    "bcr_drug_uuid": "5D4ED2DA-2DBA-474E-911D-6EFAE11A411B",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1926,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9fefbe7c-f66a-4940-843e-285cb7b392c1",
    "patient_ID": "TCGA.AR.A24Z",
    "bcr_drug_barcode": "TCGA-AR-A24Z-D31665",
    "bcr_drug_uuid": "24B6AA72-F2AB-4E43-84F8-C9EBEDE6978B",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9fefbe7c-f66a-4940-843e-285cb7b392c1",
    "patient_ID": "TCGA.AR.A24Z",
    "bcr_drug_barcode": "TCGA-AR-A24Z-D31668",
    "bcr_drug_uuid": "CEF63E08-B78B-4BE0-BD0B-1A62629A45AA",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9fefbe7c-f66a-4940-843e-285cb7b392c1",
    "patient_ID": "TCGA.AR.A24Z",
    "bcr_drug_barcode": "TCGA-AR-A24Z-D31667",
    "bcr_drug_uuid": "00E48087-B371-4EB8-93D4-4F9C4E366C28",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1912,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31673",
    "bcr_drug_uuid": "2BB4B137-AA4E-42D6-876B-C9DE7B910372",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31675",
    "bcr_drug_uuid": "28A6AC67-90F8-4C77-8281-C9887C7E6E72",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31676",
    "bcr_drug_uuid": "677A72C5-4625-4239-A896-2AB4FCD7EB83",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31677",
    "bcr_drug_uuid": "6C28195A-B380-475E-A6D9-97FBEAA7FE7F",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31678",
    "bcr_drug_uuid": "DBBFBEC9-088D-4F94-9353-A06600586DF8",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TRUSTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31681",
    "bcr_drug_uuid": "7E468399-B2D5-45FC-A528-0CC24445CD24",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 466,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0963e93-b63e-4de2-86c1-81302e271d3e",
    "patient_ID": "TCGA.AR.A250",
    "bcr_drug_barcode": "TCGA-AR-A250-D31682",
    "bcr_drug_uuid": "90EABCF1-AA20-4EB3-B2A9-B65F7B1C21F3",
    "form_completion_date": "2012-5-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 194,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c51bbcb-7c8d-47ad-9193-70ca157c6900",
    "patient_ID": "TCGA.AR.A251",
    "bcr_drug_barcode": "TCGA-AR-A251-D31823",
    "bcr_drug_uuid": "B8F1A566-55CF-4FF1-A3EE-9C35DD719C78",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c51bbcb-7c8d-47ad-9193-70ca157c6900",
    "patient_ID": "TCGA.AR.A251",
    "bcr_drug_barcode": "TCGA-AR-A251-D31825",
    "bcr_drug_uuid": "999250A8-21B7-48BC-8677-4FC3B42AA617",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c51bbcb-7c8d-47ad-9193-70ca157c6900",
    "patient_ID": "TCGA.AR.A251",
    "bcr_drug_barcode": "TCGA-AR-A251-D31827",
    "bcr_drug_uuid": "2B479B1F-F3B2-41EF-B929-49E70C892BB5",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8c51bbcb-7c8d-47ad-9193-70ca157c6900",
    "patient_ID": "TCGA.AR.A251",
    "bcr_drug_barcode": "TCGA-AR-A251-D31828",
    "bcr_drug_uuid": "96941235-258D-4BEE-85A3-8CFDAAAA042F",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1969,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4d0fec97-e024-4608-a0cc-426a3decc7b1",
    "patient_ID": "TCGA.AR.A252",
    "bcr_drug_barcode": "TCGA-AR-A252-D31834",
    "bcr_drug_uuid": "2B107267-0243-41AB-A8D4-E3A877850BFF",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4d0fec97-e024-4608-a0cc-426a3decc7b1",
    "patient_ID": "TCGA.AR.A252",
    "bcr_drug_barcode": "TCGA-AR-A252-D31835",
    "bcr_drug_uuid": "15E7A4D2-8203-45A9-B8A1-DAB0C819E8AA",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4d0fec97-e024-4608-a0cc-426a3decc7b1",
    "patient_ID": "TCGA.AR.A252",
    "bcr_drug_barcode": "TCGA-AR-A252-D31836",
    "bcr_drug_uuid": "A51DB83F-929F-44F2-B30E-2A608BEFBB50",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31890",
    "bcr_drug_uuid": "276D5F77-4A5C-4323-9158-72968222455E",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31891",
    "bcr_drug_uuid": "3895A0CD-D7A0-4299-AA1D-0CDB26606542",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31892",
    "bcr_drug_uuid": "33D981C7-C2D3-4B84-B64B-267D0B560FC1",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31893",
    "bcr_drug_uuid": "8811257C-6F1A-45B1-93CF-66DB671186E7",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31895",
    "bcr_drug_uuid": "A0A91D98-9C6D-4F84-8E0F-B7124F907FAB",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31896",
    "bcr_drug_uuid": "ADB0D2AC-132B-4083-91AF-52B43CA173F3",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 22,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31897",
    "bcr_drug_uuid": "0197F934-6D0A-489C-BB0C-B8BB754191DE",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31898",
    "bcr_drug_uuid": "7B1B7CB1-6836-4211-916E-AFF61B5EC621",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 344,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6014a582-d22e-46e1-9000-c8e2fbad7acf",
    "patient_ID": "TCGA.AR.A254",
    "bcr_drug_barcode": "TCGA-AR-A254-D31899",
    "bcr_drug_uuid": "82C6D00C-ABFC-4885-88F3-5A4E67579462",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e8f3cc64-5e15-4f4d-b73e-5c9b250a664c",
    "patient_ID": "TCGA.AR.A255",
    "bcr_drug_barcode": "TCGA-AR-A255-D31920",
    "bcr_drug_uuid": "BB558EF4-41E7-493C-A6D2-FC80FE121679",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e8f3cc64-5e15-4f4d-b73e-5c9b250a664c",
    "patient_ID": "TCGA.AR.A255",
    "bcr_drug_barcode": "TCGA-AR-A255-D31921",
    "bcr_drug_uuid": "ECE7A0A4-959E-4CC4-8857-7193628243DC",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 419,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e8f3cc64-5e15-4f4d-b73e-5c9b250a664c",
    "patient_ID": "TCGA.AR.A255",
    "bcr_drug_barcode": "TCGA-AR-A255-D31922",
    "bcr_drug_uuid": "5283FFF6-C4EA-4F3D-AD5E-CAB099B3DF37",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d3d545b3-457f-4389-821f-704cb24aff7f",
    "patient_ID": "TCGA.AR.A256",
    "bcr_drug_barcode": "TCGA-AR-A256-D31926",
    "bcr_drug_uuid": "B6C966AC-D18C-4B33-BFE1-11776EA2F338",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d3d545b3-457f-4389-821f-704cb24aff7f",
    "patient_ID": "TCGA.AR.A256",
    "bcr_drug_barcode": "TCGA-AR-A256-D31927",
    "bcr_drug_uuid": "B4890692-5CC2-43F9-B3F9-89528DD2F720",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E3FCBF94-D3EF-4A37-AA45-5297F96AF9EB",
    "patient_ID": "TCGA.AR.A2LE",
    "bcr_drug_barcode": "TCGA-AR-A2LE-D37189",
    "bcr_drug_uuid": "D5991C24-5B04-45B5-B05F-7F2C6C1167C2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1869,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "376FFE63-EFD7-42AF-90E1-261255B28BB7",
    "patient_ID": "TCGA.AR.A2LH",
    "bcr_drug_barcode": "TCGA-AR-A2LH-D37175",
    "bcr_drug_uuid": "0674353C-7BE2-4FF0-952E-236E7F1BCB93",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "376FFE63-EFD7-42AF-90E1-261255B28BB7",
    "patient_ID": "TCGA.AR.A2LH",
    "bcr_drug_barcode": "TCGA-AR-A2LH-D37260",
    "bcr_drug_uuid": "02991FAB-6700-40A7-86F6-5C1C3507F336",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "376FFE63-EFD7-42AF-90E1-261255B28BB7",
    "patient_ID": "TCGA.AR.A2LH",
    "bcr_drug_barcode": "TCGA-AR-A2LH-D37261",
    "bcr_drug_uuid": "40102DFF-32EF-4C9C-B97B-78B3CC02F990",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8",
    "patient_ID": "TCGA.AR.A2LJ",
    "bcr_drug_barcode": "TCGA-AR-A2LJ-D37263",
    "bcr_drug_uuid": "40A4371F-CF9D-4587-93C3-21D91D80BB9A",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8",
    "patient_ID": "TCGA.AR.A2LJ",
    "bcr_drug_barcode": "TCGA-AR-A2LJ-D37264",
    "bcr_drug_uuid": "46FEDD0F-87E6-4C31-AB41-4B1DA8FAD929",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8",
    "patient_ID": "TCGA.AR.A2LJ",
    "bcr_drug_barcode": "TCGA-AR-A2LJ-D37265",
    "bcr_drug_uuid": "5D6D171A-7CB5-4A45-B2B7-EAAF05E65A29",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8",
    "patient_ID": "TCGA.AR.A2LJ",
    "bcr_drug_barcode": "TCGA-AR-A2LJ-D37696",
    "bcr_drug_uuid": "74F13BD2-4E94-41A3-885F-6E52D52D7446",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 465,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8",
    "patient_ID": "TCGA.AR.A2LJ",
    "bcr_drug_barcode": "TCGA-AR-A2LJ-D37697",
    "bcr_drug_uuid": "5C63D548-84D8-4253-AC3F-91CB50B0178B",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1B703058-E596-45BC-80FE-8B98D545C2E2",
    "patient_ID": "TCGA.AR.A2LK",
    "bcr_drug_barcode": "TCGA-AR-A2LK-D37268",
    "bcr_drug_uuid": "80FE69D1-54B5-44CA-8D96-AFF0EC366BB2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1B703058-E596-45BC-80FE-8B98D545C2E2",
    "patient_ID": "TCGA.AR.A2LK",
    "bcr_drug_barcode": "TCGA-AR-A2LK-D37269",
    "bcr_drug_uuid": "C8B24AF7-897D-4A58-9CF0-393DEB02542C",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1B703058-E596-45BC-80FE-8B98D545C2E2",
    "patient_ID": "TCGA.AR.A2LK",
    "bcr_drug_barcode": "TCGA-AR-A2LK-D37270",
    "bcr_drug_uuid": "873DD1AD-E816-474B-AE05-EB495268C779",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1B703058-E596-45BC-80FE-8B98D545C2E2",
    "patient_ID": "TCGA.AR.A2LK",
    "bcr_drug_barcode": "TCGA-AR-A2LK-D37735",
    "bcr_drug_uuid": "F52A9E2B-71AB-4E83-826D-E7307A8EE004",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1310,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70FC011C-0F22-4026-9D72-87351126203A",
    "patient_ID": "TCGA.AR.A2LL",
    "bcr_drug_barcode": "TCGA-AR-A2LL-D37272",
    "bcr_drug_uuid": "8B4531C7-8D35-45BE-B28C-0497928B42F3",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF6E772-1AA1-4F54-9A50-C1414E2F22F3",
    "patient_ID": "TCGA.AR.A2LM",
    "bcr_drug_barcode": "TCGA-AR-A2LM-D37338",
    "bcr_drug_uuid": "AFF8E2B0-7981-4EDB-811C-11EBF3B60ED0",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF6E772-1AA1-4F54-9A50-C1414E2F22F3",
    "patient_ID": "TCGA.AR.A2LM",
    "bcr_drug_barcode": "TCGA-AR-A2LM-D37339",
    "bcr_drug_uuid": "57372622-06C2-481D-8D49-98803E959075",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF6E772-1AA1-4F54-9A50-C1414E2F22F3",
    "patient_ID": "TCGA.AR.A2LM",
    "bcr_drug_barcode": "TCGA-AR-A2LM-D37345",
    "bcr_drug_uuid": "955A2DF7-0D64-49CF-9A73-05F722680C2B",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BF6E772-1AA1-4F54-9A50-C1414E2F22F3",
    "patient_ID": "TCGA.AR.A2LM",
    "bcr_drug_barcode": "TCGA-AR-A2LM-D37346",
    "bcr_drug_uuid": "F4D3BD0B-BC50-4E1A-A781-07B6C2A53B31",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 967,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A076F135-BE82-40FA-8516-285ED355C965",
    "patient_ID": "TCGA.AR.A2LN",
    "bcr_drug_barcode": "TCGA-AR-A2LN-D37541",
    "bcr_drug_uuid": "CECA734C-34EE-4E7A-BE8F-82D7437D58FB",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37194",
    "bcr_drug_uuid": "FAE98AD4-647B-4B8A-877A-9A3E35C85515",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37258",
    "bcr_drug_uuid": "B5922B72-CFFD-4EE0-9F3E-35C6AE2A69D9",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37259",
    "bcr_drug_uuid": "0751053B-FD4A-4022-A9A0-46243CD85D32",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37607",
    "bcr_drug_uuid": "97212CFD-8883-4CC9-BED8-3F45E9AB5E76",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37608",
    "bcr_drug_uuid": "03E05488-13C5-4F00-BB7D-AA459862D124",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 903,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F",
    "patient_ID": "TCGA.AR.A2LO",
    "bcr_drug_barcode": "TCGA-AR-A2LO-D37609",
    "bcr_drug_uuid": "6F0A0541-DE11-49E8-914A-2AE90BA4BB39",
    "form_completion_date": "2012-12-7",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 903,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4229E432-6AC5-49D2-B58A-E8713DDB79BD",
    "patient_ID": "TCGA.AR.A2LQ",
    "bcr_drug_barcode": "TCGA-AR-A2LQ-D37597",
    "bcr_drug_uuid": "D4763C71-C17E-46DB-A137-2B5B9908DEAE",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4229E432-6AC5-49D2-B58A-E8713DDB79BD",
    "patient_ID": "TCGA.AR.A2LQ",
    "bcr_drug_barcode": "TCGA-AR-A2LQ-D37598",
    "bcr_drug_uuid": "28848860-0F93-4CE5-A7CA-7C85A90EBBC7",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4229E432-6AC5-49D2-B58A-E8713DDB79BD",
    "patient_ID": "TCGA.AR.A2LQ",
    "bcr_drug_barcode": "TCGA-AR-A2LQ-D37599",
    "bcr_drug_uuid": "409752F6-5669-4168-8F31-54550EB34917",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D093173F-08AB-4138-BF3C-399C45A6E163",
    "patient_ID": "TCGA.AR.A2LR",
    "bcr_drug_barcode": "TCGA-AR-A2LR-D37602",
    "bcr_drug_uuid": "03400FAC-D55D-4626-A257-9C1AE7178017",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -1428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -1386,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D093173F-08AB-4138-BF3C-399C45A6E163",
    "patient_ID": "TCGA.AR.A2LR",
    "bcr_drug_barcode": "TCGA-AR-A2LR-D37603",
    "bcr_drug_uuid": "CDD3764F-94E6-493E-8E99-6A9A7370E1B2",
    "form_completion_date": "2012-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -1428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -1386,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9C895825-D6F6-4D14-A662-23212200F6E5",
    "patient_ID": "TCGA.AR.A5QM",
    "bcr_drug_barcode": "TCGA-AR-A5QM-D43857",
    "bcr_drug_uuid": "D7CB0EED-DFD0-48DF-AE12-84DB425177EF",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "077506EA-8F11-405D-BB8E-3C9924FE54D0",
    "patient_ID": "TCGA.AR.A5QN",
    "bcr_drug_barcode": "TCGA-AR-A5QN-D43902",
    "bcr_drug_uuid": "1656A4E7-6208-4559-9005-FBD70C8A7375",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "077506EA-8F11-405D-BB8E-3C9924FE54D0",
    "patient_ID": "TCGA.AR.A5QN",
    "bcr_drug_barcode": "TCGA-AR-A5QN-D43903",
    "bcr_drug_uuid": "DC1B5976-040D-4E03-A09E-78DA087AAD55",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "077506EA-8F11-405D-BB8E-3C9924FE54D0",
    "patient_ID": "TCGA.AR.A5QN",
    "bcr_drug_barcode": "TCGA-AR-A5QN-D43911",
    "bcr_drug_uuid": "5153CC9B-8AD7-4DAA-8A6A-47C5B422CBBE",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 388,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "077506EA-8F11-405D-BB8E-3C9924FE54D0",
    "patient_ID": "TCGA.AR.A5QN",
    "bcr_drug_barcode": "TCGA-AR-A5QN-D43912",
    "bcr_drug_uuid": "9033B921-AB35-4CBF-9362-256C58629822",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 388,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3C275152-D04B-440C-9621-2FC05EA977B6",
    "patient_ID": "TCGA.AR.A5QP",
    "bcr_drug_barcode": "TCGA-AR-A5QP-D43914",
    "bcr_drug_uuid": "8150DA11-23B1-4826-AD05-FFB7FBE8410D",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43954",
    "bcr_drug_uuid": "1E5134F3-A59A-400F-B7B0-64A9497A1897",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43955",
    "bcr_drug_uuid": "BE51B815-9DB6-447D-8819-873D08EDAB68",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43958",
    "bcr_drug_uuid": "A25A87ED-0EBE-4D81-AE56-A8F243B5743B",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43960",
    "bcr_drug_uuid": "7E77E139-F8F0-4B5C-8487-8CAAF7C8D746",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "MESNA-1",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43962",
    "bcr_drug_uuid": "DD9E6CBF-F1BB-4B39-AEBA-AA7A777C9EEC",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "MESNA-2",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D",
    "patient_ID": "TCGA.AR.A5QQ",
    "bcr_drug_barcode": "TCGA-AR-A5QQ-D43964",
    "bcr_drug_uuid": "64A6D9AB-D9A7-47AE-BB5D-FC484F6E56ED",
    "form_completion_date": "2013-6-10",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9434687A-197C-4959-B6B8-9C05F1DD7F53",
    "patient_ID": "TCGA.B6.A3ZX",
    "bcr_drug_barcode": "TCGA-B6-A3ZX-D40951",
    "bcr_drug_uuid": "1F002506-250B-498B-99E6-54FF46B5FB23",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9434687A-197C-4959-B6B8-9C05F1DD7F53",
    "patient_ID": "TCGA.B6.A3ZX",
    "bcr_drug_barcode": "TCGA-B6-A3ZX-D40952",
    "bcr_drug_uuid": "BB2609B3-27AB-446D-85F7-5351CD9EC3A2",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9434687A-197C-4959-B6B8-9C05F1DD7F53",
    "patient_ID": "TCGA.B6.A3ZX",
    "bcr_drug_barcode": "TCGA-B6-A3ZX-D40954",
    "bcr_drug_uuid": "F6C3B0B8-B9E0-4962-BCCD-705214844D6F",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 225,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48FF0420-0F19-4E9D-A75D-6C54949A461A",
    "patient_ID": "TCGA.B6.A401",
    "bcr_drug_barcode": "TCGA-B6-A401-D41100",
    "bcr_drug_uuid": "9AC61F74-CB87-4FC6-B069-6DA7425DABAB",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48FF0420-0F19-4E9D-A75D-6C54949A461A",
    "patient_ID": "TCGA.B6.A401",
    "bcr_drug_barcode": "TCGA-B6-A401-D41102",
    "bcr_drug_uuid": "AA65ED83-981C-42BA-9EDE-AA4991F5374C",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "DOXETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48FF0420-0F19-4E9D-A75D-6C54949A461A",
    "patient_ID": "TCGA.B6.A401",
    "bcr_drug_barcode": "TCGA-B6-A401-D41103",
    "bcr_drug_uuid": "583BFE0F-4663-46A0-81BE-C7282F6EBDE8",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48FF0420-0F19-4E9D-A75D-6C54949A461A",
    "patient_ID": "TCGA.B6.A401",
    "bcr_drug_barcode": "TCGA-B6-A401-D41105",
    "bcr_drug_uuid": "218EF3A9-4E64-430C-8C51-B6EE6EA27054",
    "form_completion_date": "2013-3-12",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 375,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75B3FE55-1A63-426E-867E-2EF52F54778D",
    "patient_ID": "TCGA.B6.A402",
    "bcr_drug_barcode": "TCGA-B6-A402-D40948",
    "bcr_drug_uuid": "35A74783-A336-48EF-8D16-8CE8F0E6FF7D",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75B3FE55-1A63-426E-867E-2EF52F54778D",
    "patient_ID": "TCGA.B6.A402",
    "bcr_drug_barcode": "TCGA-B6-A402-D40949",
    "bcr_drug_uuid": "A9104E79-C312-4005-9AF6-7BC7CCEF7C19",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75B3FE55-1A63-426E-867E-2EF52F54778D",
    "patient_ID": "TCGA.B6.A402",
    "bcr_drug_barcode": "TCGA-B6-A402-D40950",
    "bcr_drug_uuid": "DE8DFC8E-AD88-486E-85C9-DEDAC34CD8AA",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75B3FE55-1A63-426E-867E-2EF52F54778D",
    "patient_ID": "TCGA.B6.A402",
    "bcr_drug_barcode": "TCGA-B6-A402-D59670",
    "bcr_drug_uuid": "AA69A790-B2B4-49B2-B8C3-907251C7338C",
    "form_completion_date": "2014-6-3",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2232,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9964F447-92AD-4D1E-AF20-11CF84FAB7B0",
    "patient_ID": "TCGA.B6.A408",
    "bcr_drug_barcode": "TCGA-B6-A408-D41046",
    "bcr_drug_uuid": "921E7A16-C072-47C3-8810-22048A5B72E7",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9964F447-92AD-4D1E-AF20-11CF84FAB7B0",
    "patient_ID": "TCGA.B6.A408",
    "bcr_drug_barcode": "TCGA-B6-A408-D41049",
    "bcr_drug_uuid": "0ED2B906-7178-435B-9882-692FBAA62DC0",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9964F447-92AD-4D1E-AF20-11CF84FAB7B0",
    "patient_ID": "TCGA.B6.A408",
    "bcr_drug_barcode": "TCGA-B6-A408-D41050",
    "bcr_drug_uuid": "2ABDCF82-F819-4FBE-9C37-623C5AC08467",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2",
    "patient_ID": "TCGA.B6.A409",
    "bcr_drug_barcode": "TCGA-B6-A409-D41060",
    "bcr_drug_uuid": "FF0971AD-14FB-4A85-8FBB-FC306D52E376",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2",
    "patient_ID": "TCGA.B6.A409",
    "bcr_drug_barcode": "TCGA-B6-A409-D41061",
    "bcr_drug_uuid": "E376E464-0759-47CF-A9BD-2B247D16DA20",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2",
    "patient_ID": "TCGA.B6.A409",
    "bcr_drug_barcode": "TCGA-B6-A409-D41062",
    "bcr_drug_uuid": "2FE8275D-A6CE-4337-A4BE-E37271CD0124",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FD0B1B8B-1A76-480A-B61C-D176E4E02C6B",
    "patient_ID": "TCGA.B6.A40C",
    "bcr_drug_barcode": "TCGA-B6-A40C-D41040",
    "bcr_drug_uuid": "0EE50169-85A2-4749-923E-DC70257C063A",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FD0B1B8B-1A76-480A-B61C-D176E4E02C6B",
    "patient_ID": "TCGA.B6.A40C",
    "bcr_drug_barcode": "TCGA-B6-A40C-D41041",
    "bcr_drug_uuid": "AF65E574-4989-44B0-B73C-85E950DF1BC6",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FD0B1B8B-1A76-480A-B61C-D176E4E02C6B",
    "patient_ID": "TCGA.B6.A40C",
    "bcr_drug_barcode": "TCGA-B6-A40C-D41043",
    "bcr_drug_uuid": "93C4C94A-4713-49E3-85A0-2D02AF47B8E8",
    "form_completion_date": "2013-3-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "790ff5db-b7f3-4946-aaed-305f66b1dd6a",
    "patient_ID": "TCGA.BH.A0AV",
    "bcr_drug_barcode": "TCGA-BH-A0AV-D59175",
    "bcr_drug_uuid": "3FC0BA35-5F5A-4C4B-B4F7-34A5A6C872EF",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "790ff5db-b7f3-4946-aaed-305f66b1dd6a",
    "patient_ID": "TCGA.BH.A0AV",
    "bcr_drug_barcode": "TCGA-BH-A0AV-D59176",
    "bcr_drug_uuid": "BA9B227E-1B4A-469B-BCC4-E008C2CA2DAA",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c5891c7a-fd24-4891-8f51-373967e4a6dd",
    "patient_ID": "TCGA.BH.A0AW",
    "bcr_drug_barcode": "TCGA-BH-A0AW-D15447",
    "bcr_drug_uuid": "B2148FF1-940F-45EC-8B2C-74F5951B58D1",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5891c7a-fd24-4891-8f51-373967e4a6dd",
    "patient_ID": "TCGA.BH.A0AW",
    "bcr_drug_barcode": "TCGA-BH-A0AW-D15449",
    "bcr_drug_uuid": "1D5E80DC-168A-47F1-BF39-F8031C065626",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5891c7a-fd24-4891-8f51-373967e4a6dd",
    "patient_ID": "TCGA.BH.A0AW",
    "bcr_drug_barcode": "TCGA-BH-A0AW-D15446",
    "bcr_drug_uuid": "D6D6F047-A44A-41C1-A02C-277B2B508E08",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 410,
    "drug_units": "MG/KG",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5891c7a-fd24-4891-8f51-373967e4a6dd",
    "patient_ID": "TCGA.BH.A0AW",
    "bcr_drug_barcode": "TCGA-BH-A0AW-D15448",
    "bcr_drug_uuid": "6D34C697-F428-4E3B-BD07-BB9E156CC9AB",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 515,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5891c7a-fd24-4891-8f51-373967e4a6dd",
    "patient_ID": "TCGA.BH.A0AW",
    "bcr_drug_barcode": "TCGA-BH-A0AW-D15450",
    "bcr_drug_uuid": "2D1B4C2D-D268-45BF-9ABD-22F9D99DAB07",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 543,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93ed6066-b567-4e1c-ab81-23370f9d3452",
    "patient_ID": "TCGA.BH.A0AY",
    "bcr_drug_barcode": "TCGA-BH-A0AY-D15457",
    "bcr_drug_uuid": "3FA11B70-C4E4-4DA1-954E-E885461FFC9D",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93ed6066-b567-4e1c-ab81-23370f9d3452",
    "patient_ID": "TCGA.BH.A0AY",
    "bcr_drug_barcode": "TCGA-BH-A0AY-D15459",
    "bcr_drug_uuid": "CEBF2E3D-12FA-496F-96BE-C677BBC8A801",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 209,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "518f231c-f5f9-4a39-a97b-7fd5666d3e50",
    "patient_ID": "TCGA.BH.A0AZ",
    "bcr_drug_barcode": "TCGA-BH-A0AZ-D58604",
    "bcr_drug_uuid": "A79EE713-028A-4292-8C92-BDC9735D026F",
    "form_completion_date": "2014-4-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "518f231c-f5f9-4a39-a97b-7fd5666d3e50",
    "patient_ID": "TCGA.BH.A0AZ",
    "bcr_drug_barcode": "TCGA-BH-A0AZ-D58605",
    "bcr_drug_uuid": "862279A3-EF42-4533-8CE4-301C7CD7D3D8",
    "form_completion_date": "2014-4-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "518f231c-f5f9-4a39-a97b-7fd5666d3e50",
    "patient_ID": "TCGA.BH.A0AZ",
    "bcr_drug_barcode": "TCGA-BH-A0AZ-D58606",
    "bcr_drug_uuid": "99401709-0B70-4391-88F9-E458D2839E9E",
    "form_completion_date": "2014-4-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 209,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "518f231c-f5f9-4a39-a97b-7fd5666d3e50",
    "patient_ID": "TCGA.BH.A0AZ",
    "bcr_drug_barcode": "TCGA-BH-A0AZ-D58608",
    "bcr_drug_uuid": "BA304867-79FD-4DED-96AF-D5D57DA4D09C",
    "form_completion_date": "2014-4-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "66af34ea-f471-4092-aff6-9ac9a5b75b11",
    "patient_ID": "TCGA.BH.A0B0",
    "bcr_drug_barcode": "TCGA-BH-A0B0-D59205",
    "bcr_drug_uuid": "7588271F-B241-4AE6-AE91-0065CCD2FE37",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "66af34ea-f471-4092-aff6-9ac9a5b75b11",
    "patient_ID": "TCGA.BH.A0B0",
    "bcr_drug_barcode": "TCGA-BH-A0B0-D59206",
    "bcr_drug_uuid": "9A3AEC18-4AD6-47E3-B8CA-EA762943F950",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "b4e4fea2-b802-4a86-923e-3fcbd3c708fe",
    "patient_ID": "TCGA.BH.A0B1",
    "bcr_drug_barcode": "TCGA-BH-A0B1-D15433",
    "bcr_drug_uuid": "79FCFCBC-5F07-4265-95FB-659E6537BF46",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4e4fea2-b802-4a86-923e-3fcbd3c708fe",
    "patient_ID": "TCGA.BH.A0B1",
    "bcr_drug_barcode": "TCGA-BH-A0B1-D15432",
    "bcr_drug_uuid": "03678C40-36FA-410E-8D6E-C971338392FB",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 311,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4e4fea2-b802-4a86-923e-3fcbd3c708fe",
    "patient_ID": "TCGA.BH.A0B1",
    "bcr_drug_barcode": "TCGA-BH-A0B1-D15430",
    "bcr_drug_uuid": "1B65710D-8E59-4084-9524-988DEC29A8B3",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4e4fea2-b802-4a86-923e-3fcbd3c708fe",
    "patient_ID": "TCGA.BH.A0B1",
    "bcr_drug_barcode": "TCGA-BH-A0B1-D15431",
    "bcr_drug_uuid": "7DBDAF3F-FD88-4F6B-8AD8-B6E6830A8D92",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "18eb4dfc-556f-4bf3-a411-4780209ed1e0",
    "patient_ID": "TCGA.BH.A0B3",
    "bcr_drug_barcode": "TCGA-BH-A0B3-D15420",
    "bcr_drug_uuid": "13E5B5DC-2CA1-474B-A21D-B7AD5884839B",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1128,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4540
  },
  {
    "bcr_patient_uuid": "18eb4dfc-556f-4bf3-a411-4780209ed1e0",
    "patient_ID": "TCGA.BH.A0B3",
    "bcr_drug_barcode": "TCGA-BH-A0B3-D15421",
    "bcr_drug_uuid": "E89062E2-7543-4BBA-9DA0-D4F6C81279C6",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 154,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1873
  },
  {
    "bcr_patient_uuid": "18eb4dfc-556f-4bf3-a411-4780209ed1e0",
    "patient_ID": "TCGA.BH.A0B3",
    "bcr_drug_barcode": "TCGA-BH-A0B3-D15419",
    "bcr_drug_uuid": "49AB6F59-1B1E-4B04-914E-82339768A10C",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 113,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 454
  },
  {
    "bcr_patient_uuid": "c710f4ab-fbd9-42ed-95d4-4e6d51207f38",
    "patient_ID": "TCGA.BH.A0B4",
    "bcr_drug_barcode": "TCGA-BH-A0B4-D15436",
    "bcr_drug_uuid": "E5C444DF-3662-4062-B553-FB8DE188EE81",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 692,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 797,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 785
  },
  {
    "bcr_patient_uuid": "c710f4ab-fbd9-42ed-95d4-4e6d51207f38",
    "patient_ID": "TCGA.BH.A0B4",
    "bcr_drug_barcode": "TCGA-BH-A0B4-D15437",
    "bcr_drug_uuid": "E2E65D25-78D3-4CEC-B111-4B60F152B128",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9da462b0-93c2-4305-89f6-7199a30399a7",
    "patient_ID": "TCGA.BH.A0B5",
    "bcr_drug_barcode": "TCGA-BH-A0B5-D59183",
    "bcr_drug_uuid": "17D3063F-CC13-421E-A738-803D7C558475",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9da462b0-93c2-4305-89f6-7199a30399a7",
    "patient_ID": "TCGA.BH.A0B5",
    "bcr_drug_barcode": "TCGA-BH-A0B5-D59184",
    "bcr_drug_uuid": "05D47456-5206-4EA3-A5A3-8CF061849DEF",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9da462b0-93c2-4305-89f6-7199a30399a7",
    "patient_ID": "TCGA.BH.A0B5",
    "bcr_drug_barcode": "TCGA-BH-A0B5-D59185",
    "bcr_drug_uuid": "C9BF525E-EE34-4064-99CD-996F6EB4C09E",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "214a4507-d974-4b3e-8525-7408fccc6a0f",
    "patient_ID": "TCGA.BH.A0B7",
    "bcr_drug_barcode": "TCGA-BH-A0B7-D58721",
    "bcr_drug_uuid": "341C74D1-788A-4312-A88D-96B3FAAB73CE",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "214a4507-d974-4b3e-8525-7408fccc6a0f",
    "patient_ID": "TCGA.BH.A0B7",
    "bcr_drug_barcode": "TCGA-BH-A0B7-D58722",
    "bcr_drug_uuid": "4F4B553E-E1BA-43B5-AA88-811D9E6FE6A1",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 378,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d3a75976-67d3-40fa-9f6f-cf2a3d7b773c",
    "patient_ID": "TCGA.BH.A0B8",
    "bcr_drug_barcode": "TCGA-BH-A0B8-D15443",
    "bcr_drug_uuid": "00C007B0-1048-4B35-B0C6-48FD9B881A51",
    "form_completion_date": "2010-11-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5a57dc25-d252-4b22-b192-4de630d7002f",
    "patient_ID": "TCGA.BH.A0B9",
    "bcr_drug_barcode": "TCGA-BH-A0B9-D15439",
    "bcr_drug_uuid": "D648DF65-E9A7-46B4-8758-F6D2241D7892",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 95,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "5a57dc25-d252-4b22-b192-4de630d7002f",
    "patient_ID": "TCGA.BH.A0B9",
    "bcr_drug_barcode": "TCGA-BH-A0B9-D15440",
    "bcr_drug_uuid": "13B25C27-6D31-4812-9A44-FC50A5A1DFA8",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 950,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "49dc3e68-6206-4f16-969f-a758cc7be8ed",
    "patient_ID": "TCGA.BH.A0BA",
    "bcr_drug_barcode": "TCGA-BH-A0BA-D15464",
    "bcr_drug_uuid": "DF60161D-106E-4FB8-8D03-71A048D7C3AA",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "49dc3e68-6206-4f16-969f-a758cc7be8ed",
    "patient_ID": "TCGA.BH.A0BA",
    "bcr_drug_barcode": "TCGA-BH-A0BA-D15465",
    "bcr_drug_uuid": "DACDCDBB-0BA5-4572-A515-6E4831F17245",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "49dc3e68-6206-4f16-969f-a758cc7be8ed",
    "patient_ID": "TCGA.BH.A0BA",
    "bcr_drug_barcode": "TCGA-BH-A0BA-D15462",
    "bcr_drug_uuid": "22BBDDCD-4D31-43CF-BA69-28A677A615E4",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "327a2395-85c8-42e1-9638-8e037a1723ed",
    "patient_ID": "TCGA.BH.A0BC",
    "bcr_drug_barcode": "TCGA-BH-A0BC-D15411",
    "bcr_drug_uuid": "4D2FEA19-8DBD-4372-B1A8-4A983BB9D901",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1236,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4944
  },
  {
    "bcr_patient_uuid": "327a2395-85c8-42e1-9638-8e037a1723ed",
    "patient_ID": "TCGA.BH.A0BC",
    "bcr_drug_barcode": "TCGA-BH-A0BC-D15412",
    "bcr_drug_uuid": "599CEF77-9455-48E3-9C50-7119D3A37F58",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 164,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1264
  },
  {
    "bcr_patient_uuid": "327a2395-85c8-42e1-9638-8e037a1723ed",
    "patient_ID": "TCGA.BH.A0BC",
    "bcr_drug_barcode": "TCGA-BH-A0BC-D15408",
    "bcr_drug_uuid": "748DA09C-F045-4030-9629-73419051E23E",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "327a2395-85c8-42e1-9638-8e037a1723ed",
    "patient_ID": "TCGA.BH.A0BC",
    "bcr_drug_barcode": "TCGA-BH-A0BC-D15409",
    "bcr_drug_uuid": "25DE46D5-5A3F-4DAC-A98E-5BFE3430C05F",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 124,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 495
  },
  {
    "bcr_patient_uuid": "327a2395-85c8-42e1-9638-8e037a1723ed",
    "patient_ID": "TCGA.BH.A0BC",
    "bcr_drug_barcode": "TCGA-BH-A0BC-D15413",
    "bcr_drug_uuid": "EA6A86CD-D2D8-4A14-BF9C-4D1918CABE51",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 795,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 900,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 785
  },
  {
    "bcr_patient_uuid": "b379bfb8-284e-4300-8325-85cfd6809cb8",
    "patient_ID": "TCGA.BH.A0BD",
    "bcr_drug_barcode": "TCGA-BH-A0BD-D15424",
    "bcr_drug_uuid": "C55EEF50-995F-4293-B338-42772744791A",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b379bfb8-284e-4300-8325-85cfd6809cb8",
    "patient_ID": "TCGA.BH.A0BD",
    "bcr_drug_barcode": "TCGA-BH-A0BD-D15426",
    "bcr_drug_uuid": "40280B62-391E-46AB-BDFE-BCF96BA2B2A7",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 865,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5230
  },
  {
    "bcr_patient_uuid": "b379bfb8-284e-4300-8325-85cfd6809cb8",
    "patient_ID": "TCGA.BH.A0BD",
    "bcr_drug_barcode": "TCGA-BH-A0BD-D15425",
    "bcr_drug_uuid": "A100360C-297C-429F-B00F-42AC189E7E5B",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 86,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 522
  },
  {
    "bcr_patient_uuid": "d6f911b5-e895-43f8-8f86-0ac2f1bc6fae",
    "patient_ID": "TCGA.BH.A0BJ",
    "bcr_drug_barcode": "TCGA-BH-A0BJ-D4475",
    "bcr_drug_uuid": "77930396-9746-4296-9C9F-1829EDBF76DB",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d6f911b5-e895-43f8-8f86-0ac2f1bc6fae",
    "patient_ID": "TCGA.BH.A0BJ",
    "bcr_drug_barcode": "TCGA-BH-A0BJ-D4478",
    "bcr_drug_uuid": "EE8AE120-A73B-4822-ADBB-CF076779A064",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 219,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 296,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 164,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1640
  },
  {
    "bcr_patient_uuid": "d6f911b5-e895-43f8-8f86-0ac2f1bc6fae",
    "patient_ID": "TCGA.BH.A0BJ",
    "bcr_drug_barcode": "TCGA-BH-A0BJ-D4477",
    "bcr_drug_uuid": "F1AE1E33-905A-4F33-AE9B-5EF9CDF0169A",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 123,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 492
  },
  {
    "bcr_patient_uuid": "d6f911b5-e895-43f8-8f86-0ac2f1bc6fae",
    "patient_ID": "TCGA.BH.A0BJ",
    "bcr_drug_barcode": "TCGA-BH-A0BJ-D4476",
    "bcr_drug_uuid": "50C21FE3-942E-4B85-BB19-70A6C75B85BE",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1230,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4920
  },
  {
    "bcr_patient_uuid": "92b5de82-0221-4df1-8094-80f40c0bb4fa",
    "patient_ID": "TCGA.BH.A0BL",
    "bcr_drug_barcode": "TCGA-BH-A0BL-D59190",
    "bcr_drug_uuid": "3DFD3BA5-2A34-4B70-AC12-5D1FAFE94711",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "92b5de82-0221-4df1-8094-80f40c0bb4fa",
    "patient_ID": "TCGA.BH.A0BL",
    "bcr_drug_barcode": "TCGA-BH-A0BL-D59191",
    "bcr_drug_uuid": "9D3B5CF6-D53E-4A6E-9E36-96AEF566A22F",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "92b5de82-0221-4df1-8094-80f40c0bb4fa",
    "patient_ID": "TCGA.BH.A0BL",
    "bcr_drug_barcode": "TCGA-BH-A0BL-D59192",
    "bcr_drug_uuid": "A18467A5-0B9F-4D1C-97E4-44F1D31AE8F3",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 240,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c2aeee6c-ba10-4cf9-b560-c739580f7bf3",
    "patient_ID": "TCGA.BH.A0BM",
    "bcr_drug_barcode": "TCGA-BH-A0BM-D4481",
    "bcr_drug_uuid": "3C72F82E-10E8-4A73-AAA4-B3074877D2B1",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c2aeee6c-ba10-4cf9-b560-c739580f7bf3",
    "patient_ID": "TCGA.BH.A0BM",
    "bcr_drug_barcode": "TCGA-BH-A0BM-D4483",
    "bcr_drug_uuid": "E9AF4E21-72D8-4812-B417-6233FC2911FF",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c2aeee6c-ba10-4cf9-b560-c739580f7bf3",
    "patient_ID": "TCGA.BH.A0BM",
    "bcr_drug_barcode": "TCGA-BH-A0BM-D4484",
    "bcr_drug_uuid": "07017073-10D9-4DD4-878C-E519D915D613",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2b22db1d-54a1-4b9e-a86e-a174cf51d95c",
    "patient_ID": "TCGA.BH.A0BS",
    "bcr_drug_barcode": "TCGA-BH-A0BS-D63392",
    "bcr_drug_uuid": "FCDA8776-2D25-4001-B9CC-956E0043F6A8",
    "form_completion_date": "2014-8-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2b22db1d-54a1-4b9e-a86e-a174cf51d95c",
    "patient_ID": "TCGA.BH.A0BS",
    "bcr_drug_barcode": "TCGA-BH-A0BS-D63400",
    "bcr_drug_uuid": "993049EF-D3F7-4F12-B97F-3D6AE4023498",
    "form_completion_date": "2014-8-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a32cb96a-78bf-456e-a6ab-2d47b2c67ad4",
    "patient_ID": "TCGA.BH.A0BT",
    "bcr_drug_barcode": "TCGA-BH-A0BT-D59146",
    "bcr_drug_uuid": "162F9144-80E7-4C0F-BF74-1D23DDE80EF5",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a32cb96a-78bf-456e-a6ab-2d47b2c67ad4",
    "patient_ID": "TCGA.BH.A0BT",
    "bcr_drug_barcode": "TCGA-BH-A0BT-D59148",
    "bcr_drug_uuid": "857A1D7C-790E-4A2E-9420-9E23B1F2B32F",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "87f03d04-e651-4a6e-aea6-1c946aa46202",
    "patient_ID": "TCGA.BH.A0BV",
    "bcr_drug_barcode": "TCGA-BH-A0BV-D4511",
    "bcr_drug_uuid": "BAB8E980-A3BB-4674-AA19-F13ED3CD6E8B",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87f03d04-e651-4a6e-aea6-1c946aa46202",
    "patient_ID": "TCGA.BH.A0BV",
    "bcr_drug_barcode": "TCGA-BH-A0BV-D4506",
    "bcr_drug_uuid": "3000F32E-2841-466F-83FF-0A0F01E27285",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87f03d04-e651-4a6e-aea6-1c946aa46202",
    "patient_ID": "TCGA.BH.A0BV",
    "bcr_drug_barcode": "TCGA-BH-A0BV-D4510",
    "bcr_drug_uuid": "11E80478-AE62-404C-9A63-6BC3B6785FA8",
    "form_completion_date": "2010-11-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87f03d04-e651-4a6e-aea6-1c946aa46202",
    "patient_ID": "TCGA.BH.A0BV",
    "bcr_drug_barcode": "TCGA-BH-A0BV-D4512",
    "bcr_drug_uuid": "92F20E69-6E22-4D49-9016-E0127DA28068",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d1d00c6-fcae-479e-ae1e-de76efd41d98",
    "patient_ID": "TCGA.BH.A0BW",
    "bcr_drug_barcode": "TCGA-BH-A0BW-D59133",
    "bcr_drug_uuid": "AFDD7926-10D2-458F-9188-C9634F0A81A6",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5d1d00c6-fcae-479e-ae1e-de76efd41d98",
    "patient_ID": "TCGA.BH.A0BW",
    "bcr_drug_barcode": "TCGA-BH-A0BW-D59134",
    "bcr_drug_uuid": "E47D5A3A-3F23-45FE-AFF6-035D2D0D84BA",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4a032bad-e726-48f2-8f39-e3acc109cc91",
    "patient_ID": "TCGA.BH.A0BZ",
    "bcr_drug_barcode": "TCGA-BH-A0BZ-D58689",
    "bcr_drug_uuid": "B11042C3-48A4-4427-AD8F-54AE2DE97D00",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4a032bad-e726-48f2-8f39-e3acc109cc91",
    "patient_ID": "TCGA.BH.A0BZ",
    "bcr_drug_barcode": "TCGA-BH-A0BZ-D58690",
    "bcr_drug_uuid": "025FAF2B-F67F-42A2-86B3-DFC2BBB21487",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4a032bad-e726-48f2-8f39-e3acc109cc91",
    "patient_ID": "TCGA.BH.A0BZ",
    "bcr_drug_barcode": "TCGA-BH-A0BZ-D58691",
    "bcr_drug_uuid": "27F92F87-436A-44BE-A7AE-0AE19498D67C",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7875018b-91dc-4ab1-83b0-ee3883e2816e",
    "patient_ID": "TCGA.BH.A0C0",
    "bcr_drug_barcode": "TCGA-BH-A0C0-D4516",
    "bcr_drug_uuid": "D15BAC27-4BE3-4929-8B32-41DCA93AC97F",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 116,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 710
  },
  {
    "bcr_patient_uuid": "7875018b-91dc-4ab1-83b0-ee3883e2816e",
    "patient_ID": "TCGA.BH.A0C0",
    "bcr_drug_barcode": "TCGA-BH-A0C0-D4515",
    "bcr_drug_uuid": "A22F23D5-AC34-48AE-85C2-6EE1B5E65A0C",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 620,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3740
  },
  {
    "bcr_patient_uuid": "7875018b-91dc-4ab1-83b0-ee3883e2816e",
    "patient_ID": "TCGA.BH.A0C0",
    "bcr_drug_barcode": "TCGA-BH-A0C0-D4514",
    "bcr_drug_uuid": "7E66711C-BC10-4345-92B8-220DF4EE8F19",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d10a4887-373b-4726-a61d-126f950e4a06",
    "patient_ID": "TCGA.BH.A0C1",
    "bcr_drug_barcode": "TCGA-BH-A0C1-D63401",
    "bcr_drug_uuid": "61C5552F-F0F5-40A2-9749-2A2F13D9FFDA",
    "form_completion_date": "2014-8-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1167,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d10a4887-373b-4726-a61d-126f950e4a06",
    "patient_ID": "TCGA.BH.A0C1",
    "bcr_drug_barcode": "TCGA-BH-A0C1-D63402",
    "bcr_drug_uuid": "5104D7EB-AA20-495D-B052-EA95B8DB9658",
    "form_completion_date": "2014-8-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1167,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7bcf6d42-eb8f-4aa2-825b-38671d4f9e3a",
    "patient_ID": "TCGA.BH.A0C3",
    "bcr_drug_barcode": "TCGA-BH-A0C3-D63540",
    "bcr_drug_uuid": "4DF39809-E3F7-4075-A18D-2883605F6B37",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7bcf6d42-eb8f-4aa2-825b-38671d4f9e3a",
    "patient_ID": "TCGA.BH.A0C3",
    "bcr_drug_barcode": "TCGA-BH-A0C3-D63541",
    "bcr_drug_uuid": "0540668E-ECBB-43B1-AEE3-51C9F20C42B1",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e1119732-3e97-4259-bc69-dc4269d9496d",
    "patient_ID": "TCGA.BH.A0C7",
    "bcr_drug_barcode": "TCGA-BH-A0C7-D59179",
    "bcr_drug_uuid": "716C77CF-18B0-4B77-BE11-C5B4B61DFCED",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e1119732-3e97-4259-bc69-dc4269d9496d",
    "patient_ID": "TCGA.BH.A0C7",
    "bcr_drug_barcode": "TCGA-BH-A0C7-D59180",
    "bcr_drug_uuid": "34A1744E-AFE4-4ECB-A86D-0AA9F44D0ABF",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e1119732-3e97-4259-bc69-dc4269d9496d",
    "patient_ID": "TCGA.BH.A0C7",
    "bcr_drug_barcode": "TCGA-BH-A0C7-D59181",
    "bcr_drug_uuid": "04AB53D8-4D37-4845-B139-414A9D08CFC3",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dba9beec-5e51-48c0-9229-0ee286a02a1a",
    "patient_ID": "TCGA.BH.A0DD",
    "bcr_drug_barcode": "TCGA-BH-A0DD-D60387",
    "bcr_drug_uuid": "5889C498-95E3-4F7F-AFCD-CC096717CD6C",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dba9beec-5e51-48c0-9229-0ee286a02a1a",
    "patient_ID": "TCGA.BH.A0DD",
    "bcr_drug_barcode": "TCGA-BH-A0DD-D60388",
    "bcr_drug_uuid": "7421BB29-2783-495B-8C92-73DC7451EEB8",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0bc5744c-5fa3-45bb-87d0-70a02068b392",
    "patient_ID": "TCGA.BH.A0DG",
    "bcr_drug_barcode": "TCGA-BH-A0DG-D63659",
    "bcr_drug_uuid": "9B494472-AB4F-4900-8EA9-FBFB49E1C6A9",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0bc5744c-5fa3-45bb-87d0-70a02068b392",
    "patient_ID": "TCGA.BH.A0DG",
    "bcr_drug_barcode": "TCGA-BH-A0DG-D63660",
    "bcr_drug_uuid": "3BDFD427-B336-4AB3-A362-7E6587C297E7",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0bc5744c-5fa3-45bb-87d0-70a02068b392",
    "patient_ID": "TCGA.BH.A0DG",
    "bcr_drug_barcode": "TCGA-BH-A0DG-D63661",
    "bcr_drug_uuid": "B7B05AD1-68C3-489B-A7EB-F57176297F1B",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "491b6364-1223-474f-816f-e248c8c841e2",
    "patient_ID": "TCGA.BH.A0DH",
    "bcr_drug_barcode": "TCGA-BH-A0DH-D4521",
    "bcr_drug_uuid": "739195B2-FD02-405E-9A84-3013536F114F",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "491b6364-1223-474f-816f-e248c8c841e2",
    "patient_ID": "TCGA.BH.A0DH",
    "bcr_drug_barcode": "TCGA-BH-A0DH-D4519",
    "bcr_drug_uuid": "3CED1251-3C25-4394-9ACA-4BE463307C37",
    "form_completion_date": "2010-11-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "491b6364-1223-474f-816f-e248c8c841e2",
    "patient_ID": "TCGA.BH.A0DH",
    "bcr_drug_barcode": "TCGA-BH-A0DH-D4524",
    "bcr_drug_uuid": "D3845BE6-7A25-470F-A220-34434866432E",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "491b6364-1223-474f-816f-e248c8c841e2",
    "patient_ID": "TCGA.BH.A0DH",
    "bcr_drug_barcode": "TCGA-BH-A0DH-D4522",
    "bcr_drug_uuid": "60D7BF55-6327-457F-973E-6A5BF4E8FDC3",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "27ba717a-5cd8-440a-9345-4ae086f6efca",
    "patient_ID": "TCGA.BH.A0DI",
    "bcr_drug_barcode": "TCGA-BH-A0DI-D58707",
    "bcr_drug_uuid": "062DAD22-5616-49FF-9EE5-1C0763405FEE",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "27ba717a-5cd8-440a-9345-4ae086f6efca",
    "patient_ID": "TCGA.BH.A0DI",
    "bcr_drug_barcode": "TCGA-BH-A0DI-D58708",
    "bcr_drug_uuid": "CD0C2F47-0F49-4143-8B90-4DD1AEF83C03",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "27ba717a-5cd8-440a-9345-4ae086f6efca",
    "patient_ID": "TCGA.BH.A0DI",
    "bcr_drug_barcode": "TCGA-BH-A0DI-D58709",
    "bcr_drug_uuid": "443925EA-94E1-4E24-96E1-9D9EAC2A280A",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 319,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad",
    "patient_ID": "TCGA.BH.A0DK",
    "bcr_drug_barcode": "TCGA-BH-A0DK-D4531",
    "bcr_drug_uuid": "F66FFF44-E13B-490E-B862-8317DB185752",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ba39bfbc-5cac-4f6c-b55c-4eee3466ee93",
    "patient_ID": "TCGA.BH.A0DL",
    "bcr_drug_barcode": "TCGA-BH-A0DL-D60392",
    "bcr_drug_uuid": "ED098E0D-9D8B-45CE-BCD7-8583BBCAAE58",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ba39bfbc-5cac-4f6c-b55c-4eee3466ee93",
    "patient_ID": "TCGA.BH.A0DL",
    "bcr_drug_barcode": "TCGA-BH-A0DL-D60393",
    "bcr_drug_uuid": "31BEEEBA-90EE-411E-AD7B-89ABD5BE59B9",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "14267783-5624-4fe5-ba81-9d67f1017474",
    "patient_ID": "TCGA.BH.A0DP",
    "bcr_drug_barcode": "TCGA-BH-A0DP-D4536",
    "bcr_drug_uuid": "09705E2D-CC53-4DA2-A6E5-73E70334B727",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a851ca14-7bbf-455b-a054-ec03979a4247",
    "patient_ID": "TCGA.BH.A0DQ",
    "bcr_drug_barcode": "TCGA-BH-A0DQ-D4541",
    "bcr_drug_uuid": "A7564051-9FF3-4CF9-8103-E8F1EA030475",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a851ca14-7bbf-455b-a054-ec03979a4247",
    "patient_ID": "TCGA.BH.A0DQ",
    "bcr_drug_barcode": "TCGA-BH-A0DQ-D4554",
    "bcr_drug_uuid": "B62A0DC1-F5F2-4A14-B4F0-D5F688D2387C",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a851ca14-7bbf-455b-a054-ec03979a4247",
    "patient_ID": "TCGA.BH.A0DQ",
    "bcr_drug_barcode": "TCGA-BH-A0DQ-D4556",
    "bcr_drug_uuid": "9B9ED158-839A-41DD-A7B0-844FA3D347A2",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 309,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fb57c598-b45b-478a-9d34-ca1f050d5b7c",
    "patient_ID": "TCGA.BH.A0DS",
    "bcr_drug_barcode": "TCGA-BH-A0DS-D4565",
    "bcr_drug_uuid": "BD1D875E-B540-4026-831D-F6E299CD76BE",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fb57c598-b45b-478a-9d34-ca1f050d5b7c",
    "patient_ID": "TCGA.BH.A0DS",
    "bcr_drug_barcode": "TCGA-BH-A0DS-D4567",
    "bcr_drug_uuid": "65485195-3F60-4437-BB26-7445C4269376",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "74f31744-0aed-4633-beec-4e203315f0b7",
    "patient_ID": "TCGA.BH.A0DT",
    "bcr_drug_barcode": "TCGA-BH-A0DT-D59150",
    "bcr_drug_uuid": "3624978D-3FC4-4B29-A10C-B30306A0483B",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "74f31744-0aed-4633-beec-4e203315f0b7",
    "patient_ID": "TCGA.BH.A0DT",
    "bcr_drug_barcode": "TCGA-BH-A0DT-D59151",
    "bcr_drug_uuid": "C4190558-6F95-4A8A-9E8D-218E6E89D189",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "74f31744-0aed-4633-beec-4e203315f0b7",
    "patient_ID": "TCGA.BH.A0DT",
    "bcr_drug_barcode": "TCGA-BH-A0DT-D59152",
    "bcr_drug_uuid": "0F068054-E971-4558-AD6A-D6CD1FB72167",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96b9c7db-1be1-4b60-b47c-26b654c3d64c",
    "patient_ID": "TCGA.BH.A0DV",
    "bcr_drug_barcode": "TCGA-BH-A0DV-D63673",
    "bcr_drug_uuid": "C3346CC5-8B94-4A86-A119-C6A580D232C8",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96b9c7db-1be1-4b60-b47c-26b654c3d64c",
    "patient_ID": "TCGA.BH.A0DV",
    "bcr_drug_barcode": "TCGA-BH-A0DV-D63674",
    "bcr_drug_uuid": "6D3D306F-FA11-4AED-93F7-6388AEE8F089",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96b9c7db-1be1-4b60-b47c-26b654c3d64c",
    "patient_ID": "TCGA.BH.A0DV",
    "bcr_drug_barcode": "TCGA-BH-A0DV-D63675",
    "bcr_drug_uuid": "BB94428A-1E62-47AC-BB42-8CA90FF6F1BD",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "035cb359-eac3-484a-9e88-3ddc739440a3",
    "patient_ID": "TCGA.BH.A0DX",
    "bcr_drug_barcode": "TCGA-BH-A0DX-D59137",
    "bcr_drug_uuid": "174495DC-4D02-47CB-8306-FF4E876B9A7E",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "035cb359-eac3-484a-9e88-3ddc739440a3",
    "patient_ID": "TCGA.BH.A0DX",
    "bcr_drug_barcode": "TCGA-BH-A0DX-D59138",
    "bcr_drug_uuid": "1FA0D545-9D52-4FDC-B43B-62C04A51EC4E",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "035cb359-eac3-484a-9e88-3ddc739440a3",
    "patient_ID": "TCGA.BH.A0DX",
    "bcr_drug_barcode": "TCGA-BH-A0DX-D59140",
    "bcr_drug_uuid": "9D0C1A3D-2B12-41EB-AF5F-8A97855518FE",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "035cb359-eac3-484a-9e88-3ddc739440a3",
    "patient_ID": "TCGA.BH.A0DX",
    "bcr_drug_barcode": "TCGA-BH-A0DX-D59141",
    "bcr_drug_uuid": "E8FE1855-0A33-4663-A2E3-605059890515",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "478eb8aa-50b8-4ce5-98e4-d518ede4b174",
    "patient_ID": "TCGA.BH.A0DZ",
    "bcr_drug_barcode": "TCGA-BH-A0DZ-D4577",
    "bcr_drug_uuid": "AC6C5D22-298B-4E01-A4BB-024810BF148A",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 234,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "478eb8aa-50b8-4ce5-98e4-d518ede4b174",
    "patient_ID": "TCGA.BH.A0DZ",
    "bcr_drug_barcode": "TCGA-BH-A0DZ-D4580",
    "bcr_drug_uuid": "DD38FE68-F847-493F-A1B3-73A5A98F41C1",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "478eb8aa-50b8-4ce5-98e4-d518ede4b174",
    "patient_ID": "TCGA.BH.A0DZ",
    "bcr_drug_barcode": "TCGA-BH-A0DZ-D4582",
    "bcr_drug_uuid": "C1100150-9A45-4A80-86C7-05997DFF9557",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "478eb8aa-50b8-4ce5-98e4-d518ede4b174",
    "patient_ID": "TCGA.BH.A0DZ",
    "bcr_drug_barcode": "TCGA-BH-A0DZ-D4585",
    "bcr_drug_uuid": "5C77B282-C471-4C6B-83CC-468EB487B8F5",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20e8106b-1290-4735-abe4-7621e08e3dc8",
    "patient_ID": "TCGA.BH.A0E0",
    "bcr_drug_barcode": "TCGA-BH-A0E0-D4593",
    "bcr_drug_uuid": "B2E22558-CF61-46B8-90DA-D2B204CF8D7A",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 820,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5034
  },
  {
    "bcr_patient_uuid": "20e8106b-1290-4735-abe4-7621e08e3dc8",
    "patient_ID": "TCGA.BH.A0E0",
    "bcr_drug_barcode": "TCGA-BH-A0E0-D4596",
    "bcr_drug_uuid": "DF2372AA-F01A-4FB6-9656-6FE9E01FE4E1",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 87,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 503
  },
  {
    "bcr_patient_uuid": "20e8106b-1290-4735-abe4-7621e08e3dc8",
    "patient_ID": "TCGA.BH.A0E0",
    "bcr_drug_barcode": "TCGA-BH-A0E0-D4599",
    "bcr_drug_uuid": "8EB7D1DE-E03C-401A-A845-0B5329E85271",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 763
  },
  {
    "bcr_patient_uuid": "606fbc6a-b41b-441d-9401-51e54912bf5e",
    "patient_ID": "TCGA.BH.A0E1",
    "bcr_drug_barcode": "TCGA-BH-A0E1-D4606",
    "bcr_drug_uuid": "F8C26458-97F0-4CF8-A153-FBA11A222937",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "606fbc6a-b41b-441d-9401-51e54912bf5e",
    "patient_ID": "TCGA.BH.A0E1",
    "bcr_drug_barcode": "TCGA-BH-A0E1-D4605",
    "bcr_drug_uuid": "80A0A78F-619A-4E22-AFF1-7C0E3E08A26B",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "606fbc6a-b41b-441d-9401-51e54912bf5e",
    "patient_ID": "TCGA.BH.A0E1",
    "bcr_drug_barcode": "TCGA-BH-A0E1-D4630",
    "bcr_drug_uuid": "040CDDFF-2EDD-437D-AB7D-3C4C995301A3",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 308,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 12,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "606fbc6a-b41b-441d-9401-51e54912bf5e",
    "patient_ID": "TCGA.BH.A0E1",
    "bcr_drug_barcode": "TCGA-BH-A0E1-D4604",
    "bcr_drug_uuid": "87AC4755-E995-47CF-90E0-FDD408456387",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8ace3b8c-f23e-48a9-a137-9e046bd9549b",
    "patient_ID": "TCGA.BH.A0E2",
    "bcr_drug_barcode": "TCGA-BH-A0E2-D4633",
    "bcr_drug_uuid": "86CFCEA0-9EEF-48CD-BA6A-C91C80629601",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8ace3b8c-f23e-48a9-a137-9e046bd9549b",
    "patient_ID": "TCGA.BH.A0E2",
    "bcr_drug_barcode": "TCGA-BH-A0E2-D4635",
    "bcr_drug_uuid": "3DA5FC61-EF46-4724-959A-D97A1AC066DE",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1104,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4392
  },
  {
    "bcr_patient_uuid": "8ace3b8c-f23e-48a9-a137-9e046bd9549b",
    "patient_ID": "TCGA.BH.A0E2",
    "bcr_drug_barcode": "TCGA-BH-A0E2-D4636",
    "bcr_drug_uuid": "2DA42AF6-78FA-4A56-B03C-9732F565896A",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 438
  },
  {
    "bcr_patient_uuid": "8ace3b8c-f23e-48a9-a137-9e046bd9549b",
    "patient_ID": "TCGA.BH.A0E2",
    "bcr_drug_barcode": "TCGA-BH-A0E2-D4637",
    "bcr_drug_uuid": "DBDA746D-4CC8-48BC-B2DA-84801984F92A",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 146,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1589
  },
  {
    "bcr_patient_uuid": "6c0066e3-96df-4870-bcd3-98cda64082e9",
    "patient_ID": "TCGA.BH.A0E6",
    "bcr_drug_barcode": "TCGA-BH-A0E6-D4646",
    "bcr_drug_uuid": "85D6AB5B-4057-4C31-B9B0-CF2D73E1CE93",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6c0066e3-96df-4870-bcd3-98cda64082e9",
    "patient_ID": "TCGA.BH.A0E6",
    "bcr_drug_barcode": "TCGA-BH-A0E6-D4647",
    "bcr_drug_uuid": "066B8D3A-D2FB-4BC0-B6C5-9D06F6529B73",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d3b9d925-ae04-4721-8bfc-50b41225bc74",
    "patient_ID": "TCGA.BH.A0E7",
    "bcr_drug_barcode": "TCGA-BH-A0E7-D4653",
    "bcr_drug_uuid": "7F0147D6-EB47-47CD-A3B8-E8B645FAB517",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "76ace6aa-0505-442c-978a-f889cf2d44bb",
    "patient_ID": "TCGA.BH.A0E9",
    "bcr_drug_barcode": "TCGA-BH-A0E9-D59110",
    "bcr_drug_uuid": "ED0808E6-A224-44C7-8353-2A9DF81486C5",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76ace6aa-0505-442c-978a-f889cf2d44bb",
    "patient_ID": "TCGA.BH.A0E9",
    "bcr_drug_barcode": "TCGA-BH-A0E9-D59111",
    "bcr_drug_uuid": "303A080F-9FE8-4C7A-B424-44DF8F97B57C",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76ace6aa-0505-442c-978a-f889cf2d44bb",
    "patient_ID": "TCGA.BH.A0E9",
    "bcr_drug_barcode": "TCGA-BH-A0E9-D59113",
    "bcr_drug_uuid": "D3529E84-7664-4493-AF4D-F8B121B6983B",
    "form_completion_date": "2014-5-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 503,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f601832-eee3-48fb-acf5-80c4a454f26e",
    "patient_ID": "TCGA.BH.A0EA",
    "bcr_drug_barcode": "TCGA-BH-A0EA-D58578",
    "bcr_drug_uuid": "90419813-A572-48FF-972A-949B5811D2F8",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 363,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f601832-eee3-48fb-acf5-80c4a454f26e",
    "patient_ID": "TCGA.BH.A0EA",
    "bcr_drug_barcode": "TCGA-BH-A0EA-D58581",
    "bcr_drug_uuid": "FECD8A5A-10AD-4DB7-91F2-08A6B16C19B9",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 522,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ec6930e5-2d83-435a-9a57-a2c5c22caf02",
    "patient_ID": "TCGA.BH.A0EB",
    "bcr_drug_barcode": "TCGA-BH-A0EB-D4659",
    "bcr_drug_uuid": "187080D3-F3AD-4B6D-BEE2-FB2DCA27EA0C",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ca76c6fc-ff30-4833-884d-3a94fe53ff17",
    "patient_ID": "TCGA.BH.A0EE",
    "bcr_drug_barcode": "TCGA-BH-A0EE-D4672",
    "bcr_drug_uuid": "5C2E885D-E1C2-409E-BBF0-05B55F3AF8B7",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2632
  },
  {
    "bcr_patient_uuid": "ca76c6fc-ff30-4833-884d-3a94fe53ff17",
    "patient_ID": "TCGA.BH.A0EE",
    "bcr_drug_barcode": "TCGA-BH-A0EE-D4671",
    "bcr_drug_uuid": "578D5C85-931D-4D7F-A308-7699D8870212",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 839
  },
  {
    "bcr_patient_uuid": "ca76c6fc-ff30-4833-884d-3a94fe53ff17",
    "patient_ID": "TCGA.BH.A0EE",
    "bcr_drug_barcode": "TCGA-BH-A0EE-D4670",
    "bcr_drug_uuid": "8B266B9C-45E7-4072-A13E-0146D0834946",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 839
  },
  {
    "bcr_patient_uuid": "ca76c6fc-ff30-4833-884d-3a94fe53ff17",
    "patient_ID": "TCGA.BH.A0EE",
    "bcr_drug_barcode": "TCGA-BH-A0EE-D4673",
    "bcr_drug_uuid": "03244A97-6A7C-44C9-86DC-65110C599437",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 411,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 549,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6800
  },
  {
    "bcr_patient_uuid": "7d9d3522-ec3b-4efe-8c8e-c0e675276ef5",
    "patient_ID": "TCGA.BH.A0GY",
    "bcr_drug_barcode": "TCGA-BH-A0GY-D4688",
    "bcr_drug_uuid": "4D4A179C-D0BD-42DC-AD93-EAC585385ACD",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d9d3522-ec3b-4efe-8c8e-c0e675276ef5",
    "patient_ID": "TCGA.BH.A0GY",
    "bcr_drug_barcode": "TCGA-BH-A0GY-D4690",
    "bcr_drug_uuid": "F37A755D-57BF-47B5-BB9B-4656199BC057",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d9d3522-ec3b-4efe-8c8e-c0e675276ef5",
    "patient_ID": "TCGA.BH.A0GY",
    "bcr_drug_barcode": "TCGA-BH-A0GY-D4692",
    "bcr_drug_uuid": "6C08A79A-E8ED-4073-B385-8D190A48E158",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYOTXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "27dfb9d4-3a2c-44bc-9acf-8f638d3f3004",
    "patient_ID": "TCGA.BH.A0GZ",
    "bcr_drug_barcode": "TCGA-BH-A0GZ-D4691",
    "bcr_drug_uuid": "DF515EB3-0AC1-4BBE-B0F5-D74BBA8B245C",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "96457ebf-ae88-41f4-97e5-cdc3163418aa",
    "patient_ID": "TCGA.BH.A0H0",
    "bcr_drug_barcode": "TCGA-BH-A0H0-D4700",
    "bcr_drug_uuid": "A14326DB-605D-438E-8A8A-4F5740293909",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cab38ea8-4555-413c-b81e-4621aac4ef85",
    "patient_ID": "TCGA.BH.A0H5",
    "bcr_drug_barcode": "TCGA-BH-A0H5-D58731",
    "bcr_drug_uuid": "AE71C06F-4D9D-4EE7-B6D1-14FF06F8C6E8",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cab38ea8-4555-413c-b81e-4621aac4ef85",
    "patient_ID": "TCGA.BH.A0H5",
    "bcr_drug_barcode": "TCGA-BH-A0H5-D58732",
    "bcr_drug_uuid": "C099D047-9A31-4CB6-8F0B-FEAF89B6F351",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2021ed1f-dc75-4701-b8b8-1386466e4802",
    "patient_ID": "TCGA.BH.A0H7",
    "bcr_drug_barcode": "TCGA-BH-A0H7-D4715",
    "bcr_drug_uuid": "3A96F8DB-2BB6-4F01-A332-0CC10127499B",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2021ed1f-dc75-4701-b8b8-1386466e4802",
    "patient_ID": "TCGA.BH.A0H7",
    "bcr_drug_barcode": "TCGA-BH-A0H7-D4719",
    "bcr_drug_uuid": "F4A15B10-F974-4196-AC98-13A14F2D6621",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 860,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3440
  },
  {
    "bcr_patient_uuid": "2021ed1f-dc75-4701-b8b8-1386466e4802",
    "patient_ID": "TCGA.BH.A0H7",
    "bcr_drug_barcode": "TCGA-BH-A0H7-D4726",
    "bcr_drug_uuid": "C42E6C62-C1C9-46D9-B3BB-217B83E7D2ED",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1380
  },
  {
    "bcr_patient_uuid": "2021ed1f-dc75-4701-b8b8-1386466e4802",
    "patient_ID": "TCGA.BH.A0H7",
    "bcr_drug_barcode": "TCGA-BH-A0H7-D4717",
    "bcr_drug_uuid": "0D085B7B-5316-41F0-9FF4-0EF4C547C459",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 86,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 344
  },
  {
    "bcr_patient_uuid": "2021ed1f-dc75-4701-b8b8-1386466e4802",
    "patient_ID": "TCGA.BH.A0H7",
    "bcr_drug_barcode": "TCGA-BH-A0H7-D4728",
    "bcr_drug_uuid": "8C760D86-7F32-4842-8DB0-ADAFD53EA414",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB (AVASTIN)/PLACEBO PROVIDED BY STUDY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 765,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6120
  },
  {
    "bcr_patient_uuid": "0f64edec-0f1f-4025-8a53-75f9534f7828",
    "patient_ID": "TCGA.BH.A0H9",
    "bcr_drug_barcode": "TCGA-BH-A0H9-D4699",
    "bcr_drug_uuid": "DA3E47E4-D137-485D-BB51-268013C132C2",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0c1023c0-d2ce-4940-8047-7642f1dc3965",
    "patient_ID": "TCGA.BH.A0HB",
    "bcr_drug_barcode": "TCGA-BH-A0HB-D4709",
    "bcr_drug_uuid": "6E82BA52-E171-47BE-96D0-A82FDC86A205",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 317,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0c1023c0-d2ce-4940-8047-7642f1dc3965",
    "patient_ID": "TCGA.BH.A0HB",
    "bcr_drug_barcode": "TCGA-BH-A0HB-D4712",
    "bcr_drug_uuid": "7BC6F0D1-914E-49DD-897E-F07AE5696A99",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1068,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4326
  },
  {
    "bcr_patient_uuid": "0c1023c0-d2ce-4940-8047-7642f1dc3965",
    "patient_ID": "TCGA.BH.A0HB",
    "bcr_drug_barcode": "TCGA-BH-A0HB-D4714",
    "bcr_drug_uuid": "73F72881-D3E3-4B35-B34A-E93F48E3254F",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 893,
    "drug_cycles": 12,
    "pharma_type_other": "ANCILLARY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "0c1023c0-d2ce-4940-8047-7642f1dc3965",
    "patient_ID": "TCGA.BH.A0HB",
    "bcr_drug_barcode": "TCGA-BH-A0HB-D4710",
    "bcr_drug_uuid": "FF1D11E0-7156-4A41-A367-D9A6CCF223CC",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 133,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 539
  },
  {
    "bcr_patient_uuid": "17ca61a2-607a-45ff-88fa-ef72e80bf891",
    "patient_ID": "TCGA.BH.A0HF",
    "bcr_drug_barcode": "TCGA-BH-A0HF-D4730",
    "bcr_drug_uuid": "52CDAF4B-976B-48BE-B49F-DBC0DDD25B7A",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e0375a8b-a135-4103-a59d-39063fcf4a6f",
    "patient_ID": "TCGA.BH.A0HI",
    "bcr_drug_barcode": "TCGA-BH-A0HI-D4751",
    "bcr_drug_uuid": "793A09D5-84AB-4A44-8D82-805D14E45573",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24334ac1-28a3-4b61-b590-3f51e375b247",
    "patient_ID": "TCGA.BH.A0HK",
    "bcr_drug_barcode": "TCGA-BH-A0HK-D4755",
    "bcr_drug_uuid": "015FC627-C844-4744-8F86-34152041F127",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "602083f0-18d9-48b6-a529-31e165c54b37",
    "patient_ID": "TCGA.BH.A0HL",
    "bcr_drug_barcode": "TCGA-BH-A0HL-D4783",
    "bcr_drug_uuid": "86629B94-BA88-49F7-8D40-3226D6F4AE4B",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "602083f0-18d9-48b6-a529-31e165c54b37",
    "patient_ID": "TCGA.BH.A0HL",
    "bcr_drug_barcode": "TCGA-BH-A0HL-D4785",
    "bcr_drug_uuid": "2320DBDB-D9E1-4E90-B4E3-9D754C69377B",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "602083f0-18d9-48b6-a529-31e165c54b37",
    "patient_ID": "TCGA.BH.A0HL",
    "bcr_drug_barcode": "TCGA-BH-A0HL-D4787",
    "bcr_drug_uuid": "6C6B9022-14ED-4E07-9EF6-71CDD596E65F",
    "form_completion_date": "2010-11-22",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 4,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "602083f0-18d9-48b6-a529-31e165c54b37",
    "patient_ID": "TCGA.BH.A0HL",
    "bcr_drug_barcode": "TCGA-BH-A0HL-D4775",
    "bcr_drug_uuid": "FE6D45BC-6826-4206-A202-F4B08A55B85B",
    "form_completion_date": "2010-11-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 492,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a68a3361-48b4-4bd0-999d-b4cc3d43eb4a",
    "patient_ID": "TCGA.BH.A0HN",
    "bcr_drug_barcode": "TCGA-BH-A0HN-D4810",
    "bcr_drug_uuid": "606F5F31-0DDC-48DB-954F-474604A3B7ED",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8332806e-f547-4aae-89af-6d5bec831fd2",
    "patient_ID": "TCGA.BH.A0HO",
    "bcr_drug_barcode": "TCGA-BH-A0HO-D4766",
    "bcr_drug_uuid": "DA5665DF-7CBC-43C3-8336-3A83A34713D9",
    "form_completion_date": "2010-11-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 860,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3440
  },
  {
    "bcr_patient_uuid": "8332806e-f547-4aae-89af-6d5bec831fd2",
    "patient_ID": "TCGA.BH.A0HO",
    "bcr_drug_barcode": "TCGA-BH-A0HO-D4765",
    "bcr_drug_uuid": "A3D353FB-8B2F-42C9-BD6E-D38D90A0568E",
    "form_completion_date": "2010-11-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 86,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 344
  },
  {
    "bcr_patient_uuid": "8332806e-f547-4aae-89af-6d5bec831fd2",
    "patient_ID": "TCGA.BH.A0HO",
    "bcr_drug_barcode": "TCGA-BH-A0HO-D4767",
    "bcr_drug_uuid": "DADE4DB6-CB27-4D06-88B6-8C4F1526C992",
    "form_completion_date": "2010-11-22",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1380
  },
  {
    "bcr_patient_uuid": "8332806e-f547-4aae-89af-6d5bec831fd2",
    "patient_ID": "TCGA.BH.A0HO",
    "bcr_drug_barcode": "TCGA-BH-A0HO-D4763",
    "bcr_drug_uuid": "55BAEF2A-C3A1-470D-92D7-80BF180C4054",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c",
    "patient_ID": "TCGA.BH.A0HP",
    "bcr_drug_barcode": "TCGA-BH-A0HP-D4779",
    "bcr_drug_uuid": "ACE2A3F8-7C97-4502-8EED-53F76CBF9968",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1308,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5347
  },
  {
    "bcr_patient_uuid": "fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c",
    "patient_ID": "TCGA.BH.A0HP",
    "bcr_drug_barcode": "TCGA-BH-A0HP-D4781",
    "bcr_drug_uuid": "535233BD-5A0E-4EC4-8171-96C978C4AD61",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2141
  },
  {
    "bcr_patient_uuid": "fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c",
    "patient_ID": "TCGA.BH.A0HP",
    "bcr_drug_barcode": "TCGA-BH-A0HP-D4778",
    "bcr_drug_uuid": "9D6BD472-15A5-46D2-9EA7-B171AC022AE4",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 533
  },
  {
    "bcr_patient_uuid": "fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c",
    "patient_ID": "TCGA.BH.A0HP",
    "bcr_drug_barcode": "TCGA-BH-A0HP-D4777",
    "bcr_drug_uuid": "B29234C4-907F-4C3B-9AE1-ECF150514F2E",
    "form_completion_date": "2010-11-30",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 347,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f31c21b6-0f7f-435b-9e24-97c909755c36",
    "patient_ID": "TCGA.BH.A0HQ",
    "bcr_drug_barcode": "TCGA-BH-A0HQ-D4790",
    "bcr_drug_uuid": "BA4DBB81-7F70-4C31-9A0A-D7FEB14DA787",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc657ca8-98e8-4ec4-a513-1b848be0e85d",
    "patient_ID": "TCGA.BH.A0HU",
    "bcr_drug_barcode": "TCGA-BH-A0HU-D4801",
    "bcr_drug_uuid": "6D4CA4CC-7926-4E56-B25B-F27500BD827C",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc657ca8-98e8-4ec4-a513-1b848be0e85d",
    "patient_ID": "TCGA.BH.A0HU",
    "bcr_drug_barcode": "TCGA-BH-A0HU-D4803",
    "bcr_drug_uuid": "26626424-B305-42C3-A6BD-086F573FE20B",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 170,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 684
  },
  {
    "bcr_patient_uuid": "dc657ca8-98e8-4ec4-a513-1b848be0e85d",
    "patient_ID": "TCGA.BH.A0HU",
    "bcr_drug_barcode": "TCGA-BH-A0HU-D4802",
    "bcr_drug_uuid": "5F867E23-30D8-48D8-B2D0-B005C681645F",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1362,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5472
  },
  {
    "bcr_patient_uuid": "29fdc464-f216-4828-b456-829f71436e27",
    "patient_ID": "TCGA.BH.A0HW",
    "bcr_drug_barcode": "TCGA-BH-A0HW-D4819",
    "bcr_drug_uuid": "2F384DC7-D076-4C3E-AD10-C21C91BE07A4",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "29fdc464-f216-4828-b456-829f71436e27",
    "patient_ID": "TCGA.BH.A0HW",
    "bcr_drug_barcode": "TCGA-BH-A0HW-D4822",
    "bcr_drug_uuid": "DA8527E8-79FA-4F17-8B5C-FA1FA0A3E377",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3564
  },
  {
    "bcr_patient_uuid": "29fdc464-f216-4828-b456-829f71436e27",
    "patient_ID": "TCGA.BH.A0HW",
    "bcr_drug_barcode": "TCGA-BH-A0HW-D4824",
    "bcr_drug_uuid": "3AA2DD0F-A104-4DAD-91CC-8DCC9A958CAD",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 356
  },
  {
    "bcr_patient_uuid": "3b01d064-8c00-4972-9f07-407eac8e7534",
    "patient_ID": "TCGA.BH.A0HX",
    "bcr_drug_barcode": "TCGA-BH-A0HX-D4837",
    "bcr_drug_uuid": "D1EDD48C-D395-40FC-AADC-7222D4037419",
    "form_completion_date": "2010-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 278,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b01d064-8c00-4972-9f07-407eac8e7534",
    "patient_ID": "TCGA.BH.A0HX",
    "bcr_drug_barcode": "TCGA-BH-A0HX-D4833",
    "bcr_drug_uuid": "B906D9FD-E934-49A6-B493-F9E15460BEDE",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "ADRIMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b01d064-8c00-4972-9f07-407eac8e7534",
    "patient_ID": "TCGA.BH.A0HX",
    "bcr_drug_barcode": "TCGA-BH-A0HX-D4834",
    "bcr_drug_uuid": "80535D9D-13BA-4040-A6CB-E650C6AC3E4D",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b01d064-8c00-4972-9f07-407eac8e7534",
    "patient_ID": "TCGA.BH.A0HX",
    "bcr_drug_barcode": "TCGA-BH-A0HX-D4836",
    "bcr_drug_uuid": "E0A73F7B-3621-4C44-B73F-4C6B1CEC05B8",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "844ad251-3ee4-42f6-ad00-59a7a1670eea",
    "patient_ID": "TCGA.BH.A0HY",
    "bcr_drug_barcode": "TCGA-BH-A0HY-D43317",
    "bcr_drug_uuid": "7EC3CB4B-FC47-4903-8C56-460C10384B08",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "844ad251-3ee4-42f6-ad00-59a7a1670eea",
    "patient_ID": "TCGA.BH.A0HY",
    "bcr_drug_barcode": "TCGA-BH-A0HY-D43318",
    "bcr_drug_uuid": "136D0D8F-953A-40A9-AB68-828686DD333B",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "844ad251-3ee4-42f6-ad00-59a7a1670eea",
    "patient_ID": "TCGA.BH.A0HY",
    "bcr_drug_barcode": "TCGA-BH-A0HY-D43319",
    "bcr_drug_uuid": "6C77D915-C2F7-4ED7-A3BE-5658AA5B8580",
    "form_completion_date": "2013-5-16",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "e828455d-4680-41b2-8a1c-1582e3790d62",
    "patient_ID": "TCGA.BH.A0RX",
    "bcr_drug_barcode": "TCGA-BH-A0RX-D4874",
    "bcr_drug_uuid": "A90F4DFB-A730-4F63-B6A4-BDC3570C9474",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 447
  },
  {
    "bcr_patient_uuid": "e828455d-4680-41b2-8a1c-1582e3790d62",
    "patient_ID": "TCGA.BH.A0RX",
    "bcr_drug_barcode": "TCGA-BH-A0RX-D4872",
    "bcr_drug_uuid": "CBEF5FFD-0B68-4780-939F-C001E4A34CCB",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6808
  },
  {
    "bcr_patient_uuid": "e828455d-4680-41b2-8a1c-1582e3790d62",
    "patient_ID": "TCGA.BH.A0RX",
    "bcr_drug_barcode": "TCGA-BH-A0RX-D4873",
    "bcr_drug_uuid": "5D132A06-F3D4-4E01-ACBA-37EBA9BACD22",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6808
  },
  {
    "bcr_patient_uuid": "da9c10ea-c13f-4d88-8b94-a0cbc106d036",
    "patient_ID": "TCGA.BH.A0W5",
    "bcr_drug_barcode": "TCGA-BH-A0W5-D34071",
    "bcr_drug_uuid": "985E78AA-4536-424D-A1B5-8510D98A84D5",
    "form_completion_date": "2012-7-29",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f80649b-a249-4fb5-97ad-059a30e13fea",
    "patient_ID": "TCGA.BH.A0W7",
    "bcr_drug_barcode": "TCGA-BH-A0W7-D34074",
    "bcr_drug_uuid": "0A4EE347-EE11-4426-A666-055E6317A805",
    "form_completion_date": "2012-7-29",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f80649b-a249-4fb5-97ad-059a30e13fea",
    "patient_ID": "TCGA.BH.A0W7",
    "bcr_drug_barcode": "TCGA-BH-A0W7-D34075",
    "bcr_drug_uuid": "1D1011B2-5862-44A0-8E76-C71A08C733ED",
    "form_completion_date": "2012-7-29",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f80649b-a249-4fb5-97ad-059a30e13fea",
    "patient_ID": "TCGA.BH.A0W7",
    "bcr_drug_barcode": "TCGA-BH-A0W7-D34076",
    "bcr_drug_uuid": "47152466-BCD7-423E-ACBE-8E1CC909F134",
    "form_completion_date": "2012-7-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f80649b-a249-4fb5-97ad-059a30e13fea",
    "patient_ID": "TCGA.BH.A0W7",
    "bcr_drug_barcode": "TCGA-BH-A0W7-D34077",
    "bcr_drug_uuid": "F892639C-D682-4FC7-AE4B-6FF21F295085",
    "form_completion_date": "2012-7-29",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1324,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bfd49783-1767-469b-9d79-7822301c5efc",
    "patient_ID": "TCGA.BH.A18F",
    "bcr_drug_barcode": "TCGA-BH-A18F-D59196",
    "bcr_drug_uuid": "9FCC797A-A7A9-48C4-8908-C2C04931C24A",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bfd49783-1767-469b-9d79-7822301c5efc",
    "patient_ID": "TCGA.BH.A18F",
    "bcr_drug_barcode": "TCGA-BH-A18F-D59197",
    "bcr_drug_uuid": "60625A51-8E18-4F71-B2D7-27A2C7FB9C2C",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "878f975b-94fd-4d69-b7e7-1ed3ac2ee438",
    "patient_ID": "TCGA.BH.A18H",
    "bcr_drug_barcode": "TCGA-BH-A18H-D59201",
    "bcr_drug_uuid": "79B05235-CBBB-4B01-819B-84C9483B56B7",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "878f975b-94fd-4d69-b7e7-1ed3ac2ee438",
    "patient_ID": "TCGA.BH.A18H",
    "bcr_drug_barcode": "TCGA-BH-A18H-D59202",
    "bcr_drug_uuid": "0E5715EA-719D-42AE-8516-6AD9DA3F885F",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "878f975b-94fd-4d69-b7e7-1ed3ac2ee438",
    "patient_ID": "TCGA.BH.A18H",
    "bcr_drug_barcode": "TCGA-BH-A18H-D59203",
    "bcr_drug_uuid": "8719BC2E-D714-4B56-8035-F3E2D07DD9CF",
    "form_completion_date": "2014-5-2",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 219,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58",
    "patient_ID": "TCGA.BH.A18I",
    "bcr_drug_barcode": "TCGA-BH-A18I-D58711",
    "bcr_drug_uuid": "62D6ACAF-3359-411A-9715-AC1D93B3EB27",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58",
    "patient_ID": "TCGA.BH.A18I",
    "bcr_drug_barcode": "TCGA-BH-A18I-D58712",
    "bcr_drug_uuid": "B4CF288C-CBDD-493D-8CB6-198994F91639",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7a00d67-2c26-4d1f-bd17-35f659e88bc1",
    "patient_ID": "TCGA.BH.A202",
    "bcr_drug_barcode": "TCGA-BH-A202-D64230",
    "bcr_drug_uuid": "0D4881E9-AE20-4588-920D-75E5D8AB81ED",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7a00d67-2c26-4d1f-bd17-35f659e88bc1",
    "patient_ID": "TCGA.BH.A202",
    "bcr_drug_barcode": "TCGA-BH-A202-D64231",
    "bcr_drug_uuid": "C3C5CF2E-3889-4D44-A699-9F66D21CE0E1",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "84B7CCF2-8AB3-4B21-96DE-800D231BC072",
    "patient_ID": "TCGA.BH.A28O",
    "bcr_drug_barcode": "TCGA-BH-A28O-D64238",
    "bcr_drug_uuid": "CAD6922D-31F1-401F-AAA4-FCD9176D8DE1",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 338,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "84B7CCF2-8AB3-4B21-96DE-800D231BC072",
    "patient_ID": "TCGA.BH.A28O",
    "bcr_drug_barcode": "TCGA-BH-A28O-D64239",
    "bcr_drug_uuid": "103854BD-AAE1-4387-84DC-33377016C730",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 338,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BAC4B268-C781-4408-96D8-43A48FEC7418",
    "patient_ID": "TCGA.BH.A2L8",
    "bcr_drug_barcode": "TCGA-BH-A2L8-D43167",
    "bcr_drug_uuid": "D1B01084-E040-4E41-ACAC-3A7D4A79E959",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8",
    "patient_ID": "TCGA.BH.A5IZ",
    "bcr_drug_barcode": "TCGA-BH-A5IZ-D56581",
    "bcr_drug_uuid": "EB4E7F2F-14F6-4609-94C9-937F41DF8521",
    "form_completion_date": "2014-2-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8",
    "patient_ID": "TCGA.BH.A5IZ",
    "bcr_drug_barcode": "TCGA-BH-A5IZ-D56582",
    "bcr_drug_uuid": "3B0DE458-656A-4A35-8FC0-B76E3C7A33E1",
    "form_completion_date": "2014-2-13",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8",
    "patient_ID": "TCGA.BH.A5IZ",
    "bcr_drug_barcode": "TCGA-BH-A5IZ-D66934",
    "bcr_drug_uuid": "E11C1618-C47C-4EA9-8EC5-B0D84CC12E53",
    "form_completion_date": "2014-10-28",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59D60247-E549-4326-A672-50B05C13A291",
    "patient_ID": "TCGA.BH.A8G0",
    "bcr_drug_barcode": "TCGA-BH-A8G0-D57780",
    "bcr_drug_uuid": "D9246CEE-989C-4F55-8C8E-F44C20C26427",
    "form_completion_date": "2014-3-26",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "59D60247-E549-4326-A672-50B05C13A291",
    "patient_ID": "TCGA.BH.A8G0",
    "bcr_drug_barcode": "TCGA-BH-A8G0-D57781",
    "bcr_drug_uuid": "1554145F-6AD9-4A57-92CC-2C65179DF840",
    "form_completion_date": "2014-3-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "09D6E904-7184-4788-8A19-04F8C46CB13F",
    "patient_ID": "TCGA.BH.AB28",
    "bcr_drug_barcode": "TCGA-BH-AB28-D61473",
    "bcr_drug_uuid": "54C265C0-9FA9-491F-BB0D-4D8AFD0AB2A4",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "09D6E904-7184-4788-8A19-04F8C46CB13F",
    "patient_ID": "TCGA.BH.AB28",
    "bcr_drug_barcode": "TCGA-BH-AB28-D61474",
    "bcr_drug_uuid": "5A9C6B1E-27C2-496C-8266-4D565A27C07F",
    "form_completion_date": "2014-6-30",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4",
    "patient_ID": "TCGA.C8.A12Z",
    "bcr_drug_barcode": "TCGA-C8-A12Z-D70811",
    "bcr_drug_uuid": "DC8851E6-AC37-4E31-80EE-4C4CB77EAFE6",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4",
    "patient_ID": "TCGA.C8.A12Z",
    "bcr_drug_barcode": "TCGA-C8-A12Z-D70812",
    "bcr_drug_uuid": "01F0FCA1-431B-40BF-9290-D82BCD61BA7C",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4",
    "patient_ID": "TCGA.C8.A12Z",
    "bcr_drug_barcode": "TCGA-C8-A12Z-D70813",
    "bcr_drug_uuid": "302C0CC5-6BC8-4CEF-8936-0BE869DB8E4C",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c49e3b18-fd88-48f4-8b01-300692ceb367",
    "patient_ID": "TCGA.C8.A131",
    "bcr_drug_barcode": "TCGA-C8-A131-D70828",
    "bcr_drug_uuid": "D5B3D28A-4333-4455-9FCB-220B0A14A5FB",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c49e3b18-fd88-48f4-8b01-300692ceb367",
    "patient_ID": "TCGA.C8.A131",
    "bcr_drug_barcode": "TCGA-C8-A131-D70829",
    "bcr_drug_uuid": "FF1D85A6-7EFA-489D-B455-FF6D8C7D3E33",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c49e3b18-fd88-48f4-8b01-300692ceb367",
    "patient_ID": "TCGA.C8.A131",
    "bcr_drug_barcode": "TCGA-C8-A131-D70830",
    "bcr_drug_uuid": "F291DB2B-45ED-4BD2-98A3-63F012802AC3",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e",
    "patient_ID": "TCGA.C8.A134",
    "bcr_drug_barcode": "TCGA-C8-A134-D70823",
    "bcr_drug_uuid": "1808C5EE-0291-4C9E-9F3F-50A3ECD730CE",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e",
    "patient_ID": "TCGA.C8.A134",
    "bcr_drug_barcode": "TCGA-C8-A134-D70824",
    "bcr_drug_uuid": "3F5F3438-79BA-43E0-B135-7E37333FD8E2",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e",
    "patient_ID": "TCGA.C8.A134",
    "bcr_drug_barcode": "TCGA-C8-A134-D70825",
    "bcr_drug_uuid": "BD0FF962-3C67-4CB2-880F-11E2B2F8EF7F",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33cea538-4c3f-470a-972d-257c43241ab4",
    "patient_ID": "TCGA.C8.A135",
    "bcr_drug_barcode": "TCGA-C8-A135-D70818",
    "bcr_drug_uuid": "E75ED433-A561-43B5-B3E0-5F8E12B99B40",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33cea538-4c3f-470a-972d-257c43241ab4",
    "patient_ID": "TCGA.C8.A135",
    "bcr_drug_barcode": "TCGA-C8-A135-D70819",
    "bcr_drug_uuid": "2930DEE3-D647-42B8-9950-5BB8905B9DA2",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33cea538-4c3f-470a-972d-257c43241ab4",
    "patient_ID": "TCGA.C8.A135",
    "bcr_drug_barcode": "TCGA-C8-A135-D70820",
    "bcr_drug_uuid": "C5031114-238E-45D7-9918-30514B75F06A",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33cea538-4c3f-470a-972d-257c43241ab4",
    "patient_ID": "TCGA.C8.A135",
    "bcr_drug_barcode": "TCGA-C8-A135-D70821",
    "bcr_drug_uuid": "CD8B26E1-2982-4CDF-ACD5-FE6293F7B193",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8b525ec6-d24b-49d4-bfcb-b354de4dae7c",
    "patient_ID": "TCGA.C8.A1HM",
    "bcr_drug_barcode": "TCGA-C8-A1HM-D70807",
    "bcr_drug_uuid": "276724DA-C121-44EA-8584-13AB426F8DDD",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8b525ec6-d24b-49d4-bfcb-b354de4dae7c",
    "patient_ID": "TCGA.C8.A1HM",
    "bcr_drug_barcode": "TCGA-C8-A1HM-D70808",
    "bcr_drug_uuid": "B2D0CDD7-747C-49EC-B329-F2427BA79DDB",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8b525ec6-d24b-49d4-bfcb-b354de4dae7c",
    "patient_ID": "TCGA.C8.A1HM",
    "bcr_drug_barcode": "TCGA-C8-A1HM-D70809",
    "bcr_drug_uuid": "F67F216B-625D-4CDE-B551-FEBD1B76FE0F",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b3354b72-2637-4edc-9a95-e55801d3ac13",
    "patient_ID": "TCGA.C8.A1HO",
    "bcr_drug_barcode": "TCGA-C8-A1HO-D70803",
    "bcr_drug_uuid": "3D258720-7215-4352-8F11-753D26984EF0",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -45,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b3354b72-2637-4edc-9a95-e55801d3ac13",
    "patient_ID": "TCGA.C8.A1HO",
    "bcr_drug_barcode": "TCGA-C8-A1HO-D70804",
    "bcr_drug_uuid": "25995E3D-C18A-42AE-B575-DF8521244005",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -45,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b3354b72-2637-4edc-9a95-e55801d3ac13",
    "patient_ID": "TCGA.C8.A1HO",
    "bcr_drug_barcode": "TCGA-C8-A1HO-D70805",
    "bcr_drug_uuid": "957DBA00-04EE-4C3E-A23E-68E9C478CD59",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -45,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89414e79-7f89-42d9-8228-101b5bf2f31f",
    "patient_ID": "TCGA.C8.A26V",
    "bcr_drug_barcode": "TCGA-C8-A26V-D70800",
    "bcr_drug_uuid": "10D4E1C4-0036-44D9-8206-D14CECDEA307",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 613,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ff0f875f-113a-4c0f-8c0a-4259cd496e6d",
    "patient_ID": "TCGA.C8.A26W",
    "bcr_drug_barcode": "TCGA-C8-A26W-D70797",
    "bcr_drug_uuid": "6FA5FD97-F91B-4EA5-8434-AD7296AE38C1",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ff0f875f-113a-4c0f-8c0a-4259cd496e6d",
    "patient_ID": "TCGA.C8.A26W",
    "bcr_drug_barcode": "TCGA-C8-A26W-D70798",
    "bcr_drug_uuid": "C80FD468-DF82-483E-8999-EF2110391C96",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70ab4f23-23c4-409f-a5cc-18a010c3a24e",
    "patient_ID": "TCGA.C8.A26X",
    "bcr_drug_barcode": "TCGA-C8-A26X-D70793",
    "bcr_drug_uuid": "C99DA711-C86E-4BA8-8AD6-9274208C28D7",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70ab4f23-23c4-409f-a5cc-18a010c3a24e",
    "patient_ID": "TCGA.C8.A26X",
    "bcr_drug_barcode": "TCGA-C8-A26X-D70794",
    "bcr_drug_uuid": "CFD4307C-F098-4A9C-A34B-E337C15B7BDC",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70ab4f23-23c4-409f-a5cc-18a010c3a24e",
    "patient_ID": "TCGA.C8.A26X",
    "bcr_drug_barcode": "TCGA-C8-A26X-D70795",
    "bcr_drug_uuid": "69033C6A-572E-4B72-BB72-027C7F663381",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc11b1c7-1f00-4813-b4b5-ecf776b2eb37",
    "patient_ID": "TCGA.C8.A26Z",
    "bcr_drug_barcode": "TCGA-C8-A26Z-D70836",
    "bcr_drug_uuid": "D3391CBA-5CB0-47AE-9813-D21384BF7466",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5a5f0f48-2b13-4e78-b130-901b85d9a7f3",
    "patient_ID": "TCGA.C8.A273",
    "bcr_drug_barcode": "TCGA-C8-A273-D70834",
    "bcr_drug_uuid": "34F9559E-95CB-4EBC-9B9D-042337C8811E",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dbcad60f-86c7-41e3-b0ae-baa39c9f83dd",
    "patient_ID": "TCGA.C8.A274",
    "bcr_drug_barcode": "TCGA-C8-A274-D70832",
    "bcr_drug_uuid": "4593E9A7-6ECF-4C21-BADB-4309FC423900",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "65077db7-dd59-4362-9d28-d5a9154e9be0",
    "patient_ID": "TCGA.C8.A278",
    "bcr_drug_barcode": "TCGA-C8-A278-D70993",
    "bcr_drug_uuid": "C2C73BBA-5B7A-4D5E-9026-7C416C68754A",
    "form_completion_date": "2015-3-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3b1f7e48-216d-47de-ba79-db350f52bff0",
    "patient_ID": "TCGA.C8.A27A",
    "bcr_drug_barcode": "TCGA-C8-A27A-D70787",
    "bcr_drug_uuid": "839564A6-2E39-4BCE-9DCC-20EF59A3ABBB",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3b1f7e48-216d-47de-ba79-db350f52bff0",
    "patient_ID": "TCGA.C8.A27A",
    "bcr_drug_barcode": "TCGA-C8-A27A-D70788",
    "bcr_drug_uuid": "1E7B539F-54D5-456B-B74C-EBEB8406CD24",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3b1f7e48-216d-47de-ba79-db350f52bff0",
    "patient_ID": "TCGA.C8.A27A",
    "bcr_drug_barcode": "TCGA-C8-A27A-D70789",
    "bcr_drug_uuid": "9E9A47A2-2C29-46A6-8CB5-842A186DA178",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3b1f7e48-216d-47de-ba79-db350f52bff0",
    "patient_ID": "TCGA.C8.A27A",
    "bcr_drug_barcode": "TCGA-C8-A27A-D70790",
    "bcr_drug_uuid": "C72AD225-877E-4C85-904D-850850DAD36A",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0d8a1fe-e313-44f1-99cc-b965cbeeff0e",
    "patient_ID": "TCGA.C8.A27B",
    "bcr_drug_barcode": "TCGA-C8-A27B-D70782",
    "bcr_drug_uuid": "DA6B28FB-BAD1-4A40-9E5F-0B1F39CF0496",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0d8a1fe-e313-44f1-99cc-b965cbeeff0e",
    "patient_ID": "TCGA.C8.A27B",
    "bcr_drug_barcode": "TCGA-C8-A27B-D70783",
    "bcr_drug_uuid": "C4415E67-02A8-44F6-A28B-1ADA98E0EFC9",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0d8a1fe-e313-44f1-99cc-b965cbeeff0e",
    "patient_ID": "TCGA.C8.A27B",
    "bcr_drug_barcode": "TCGA-C8-A27B-D70784",
    "bcr_drug_uuid": "AB7C57F0-657B-482F-BAD3-11C849B1AD7D",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f0d8a1fe-e313-44f1-99cc-b965cbeeff0e",
    "patient_ID": "TCGA.C8.A27B",
    "bcr_drug_barcode": "TCGA-C8-A27B-D70785",
    "bcr_drug_uuid": "18D1F0D1-A458-40F2-B27C-6E5C94FED213",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1E704D6-A33B-4891-90BD-992B0040C075",
    "patient_ID": "TCGA.C8.A3M8",
    "bcr_drug_barcode": "TCGA-C8-A3M8-D70780",
    "bcr_drug_uuid": "1A0AC881-C2A3-4989-8D7D-837481DF0F5B",
    "form_completion_date": "2015-3-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8DB69F1D-72E2-40BA-AD8A-CF228499840D",
    "patient_ID": "TCGA.C8.A8HP",
    "bcr_drug_barcode": "TCGA-C8-A8HP-D69611",
    "bcr_drug_uuid": "97270AB3-9E3D-45C5-9D19-C829F713523B",
    "form_completion_date": "2015-1-15",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8DB69F1D-72E2-40BA-AD8A-CF228499840D",
    "patient_ID": "TCGA.C8.A8HP",
    "bcr_drug_barcode": "TCGA-C8-A8HP-D69612",
    "bcr_drug_uuid": "E21CE453-A911-46D4-8A86-10840F94F4FB",
    "form_completion_date": "2015-1-15",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8DB69F1D-72E2-40BA-AD8A-CF228499840D",
    "patient_ID": "TCGA.C8.A8HP",
    "bcr_drug_barcode": "TCGA-C8-A8HP-D69613",
    "bcr_drug_uuid": "FDA16E46-3280-4A4A-914B-F4BC3F889323",
    "form_completion_date": "2015-1-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCB68327-1537-4CA6-81DE-3910D0663CB8",
    "patient_ID": "TCGA.C8.A8HR",
    "bcr_drug_barcode": "TCGA-C8-A8HR-D69797",
    "bcr_drug_uuid": "AAB14121-BF30-4BA7-B0DE-7F26E3723D24",
    "form_completion_date": "2015-1-20",
    "pharmaceutical_therapy_drug_name": "5 FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCB68327-1537-4CA6-81DE-3910D0663CB8",
    "patient_ID": "TCGA.C8.A8HR",
    "bcr_drug_barcode": "TCGA-C8-A8HR-D69798",
    "bcr_drug_uuid": "F6A77EA7-2ED3-4BFD-AC8F-21E9DE5FA242",
    "form_completion_date": "2015-1-20",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCB68327-1537-4CA6-81DE-3910D0663CB8",
    "patient_ID": "TCGA.C8.A8HR",
    "bcr_drug_barcode": "TCGA-C8-A8HR-D69799",
    "bcr_drug_uuid": "33674CC5-6A4D-42DB-87A8-270B36FA8974",
    "form_completion_date": "2015-1-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "726C6892-0DCE-4869-A7A7-CC44C26FE843",
    "patient_ID": "TCGA.C8.A9FZ",
    "bcr_drug_barcode": "TCGA-C8-A9FZ-D69967",
    "bcr_drug_uuid": "5EE9E222-CE90-4A1B-91F3-2A38CF4DC1ED",
    "form_completion_date": "2015-1-23",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "726C6892-0DCE-4869-A7A7-CC44C26FE843",
    "patient_ID": "TCGA.C8.A9FZ",
    "bcr_drug_barcode": "TCGA-C8-A9FZ-D69968",
    "bcr_drug_uuid": "F8280902-5A96-471B-9127-AA1A6C7235C8",
    "form_completion_date": "2015-1-23",
    "pharmaceutical_therapy_drug_name": "5-FLOUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "726C6892-0DCE-4869-A7A7-CC44C26FE843",
    "patient_ID": "TCGA.C8.A9FZ",
    "bcr_drug_barcode": "TCGA-C8-A9FZ-D69969",
    "bcr_drug_uuid": "614A0F5A-4696-4BB3-8D04-8673AD02C486",
    "form_completion_date": "2015-1-23",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "726C6892-0DCE-4869-A7A7-CC44C26FE843",
    "patient_ID": "TCGA.C8.A9FZ",
    "bcr_drug_barcode": "TCGA-C8-A9FZ-D69970",
    "bcr_drug_uuid": "B038BA42-8ECD-4542-84B8-B748DBC4FA52",
    "form_completion_date": "2015-1-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "17f275c1-a0d4-487d-8f02-ea279584b4cd",
    "patient_ID": "TCGA.D8.A13Y",
    "bcr_drug_barcode": "TCGA-D8-A13Y-D13807",
    "bcr_drug_uuid": "EC2B79A5-64D5-43E1-BB6A-A4C03BD0615E",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "17f275c1-a0d4-487d-8f02-ea279584b4cd",
    "patient_ID": "TCGA.D8.A13Y",
    "bcr_drug_barcode": "TCGA-D8-A13Y-D65312",
    "bcr_drug_uuid": "5BE46DF7-F6A7-4D7D-9ECD-B805B4C94601",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5a17dcd9-5ced-4a69-8069-23c7fd0649d1",
    "patient_ID": "TCGA.D8.A13Z",
    "bcr_drug_barcode": "TCGA-D8-A13Z-D20732",
    "bcr_drug_uuid": "CB4478D0-5504-4268-A2E9-9EFE2B5C293F",
    "form_completion_date": "2012-1-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 586.8
  },
  {
    "bcr_patient_uuid": "5a17dcd9-5ced-4a69-8069-23c7fd0649d1",
    "patient_ID": "TCGA.D8.A13Z",
    "bcr_drug_barcode": "TCGA-D8-A13Z-D65313",
    "bcr_drug_uuid": "7EBDCBDC-E474-41D4-8D9F-2B99158B6829",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5a17dcd9-5ced-4a69-8069-23c7fd0649d1",
    "patient_ID": "TCGA.D8.A13Z",
    "bcr_drug_barcode": "TCGA-D8-A13Z-D65314",
    "bcr_drug_uuid": "D08EFDD4-5EBB-4816-910D-C6EAC35DE992",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2585edbd-3488-4100-a4ab-a161252a31ee",
    "patient_ID": "TCGA.D8.A140",
    "bcr_drug_barcode": "TCGA-D8-A140-D13809",
    "bcr_drug_uuid": "CD6D1C59-F2A8-4AC6-9E8B-74835E6187BD",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN+CYCLOPHOSPHAMID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 4,
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b",
    "patient_ID": "TCGA.D8.A141",
    "bcr_drug_barcode": "TCGA-D8-A141-D20735",
    "bcr_drug_uuid": "A15AAA0F-A203-4D17-AC59-C7871CF733F8",
    "form_completion_date": "2012-1-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 101.4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 405.6
  },
  {
    "bcr_patient_uuid": "42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b",
    "patient_ID": "TCGA.D8.A141",
    "bcr_drug_barcode": "TCGA-D8-A141-D64903",
    "bcr_drug_uuid": "F8D4FFC9-CAC1-4BF7-8524-0962257D22E0",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b",
    "patient_ID": "TCGA.D8.A141",
    "bcr_drug_barcode": "TCGA-D8-A141-D64904",
    "bcr_drug_uuid": "885E2338-5CEA-43F7-A449-B6C3AB636165",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ccb22ecc-6e18-44b8-ad48-6ab51314b16e",
    "patient_ID": "TCGA.D8.A142",
    "bcr_drug_barcode": "TCGA-D8-A142-D13815",
    "bcr_drug_uuid": "20BD3B94-30E2-4571-B116-A786A8D72633",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 271,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ccb22ecc-6e18-44b8-ad48-6ab51314b16e",
    "patient_ID": "TCGA.D8.A142",
    "bcr_drug_barcode": "TCGA-D8-A142-D64906",
    "bcr_drug_uuid": "C9AD9634-5799-4DB1-B41C-28D2AB117AF2",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "METOTREKSAT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 271,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ccb22ecc-6e18-44b8-ad48-6ab51314b16e",
    "patient_ID": "TCGA.D8.A142",
    "bcr_drug_barcode": "TCGA-D8-A142-D64908",
    "bcr_drug_uuid": "3AB62920-B064-4CD7-9D3B-F002D10D66E5",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 271,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1c40b84e-a0e3-429f-a48c-21566cf881c0",
    "patient_ID": "TCGA.D8.A143",
    "bcr_drug_barcode": "TCGA-D8-A143-D13818",
    "bcr_drug_uuid": "786A632D-1981-4D67-B28C-DFEA95E74CCA",
    "form_completion_date": "2011-7-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c40b84e-a0e3-429f-a48c-21566cf881c0",
    "patient_ID": "TCGA.D8.A143",
    "bcr_drug_barcode": "TCGA-D8-A143-D64910",
    "bcr_drug_uuid": "655A6770-6A40-4D7C-9453-094F18309168",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4958c36f-1dc7-4f14-9dec-36e14107dbe3",
    "patient_ID": "TCGA.D8.A145",
    "bcr_drug_barcode": "TCGA-D8-A145-D13812",
    "bcr_drug_uuid": "9C0F81FC-804B-4F15-901B-D5256B63E8AF",
    "form_completion_date": "2011-7-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fc18d029-9be2-4fa0-9aef-6d647dc55f0b",
    "patient_ID": "TCGA.D8.A147",
    "bcr_drug_barcode": "TCGA-D8-A147-D20738",
    "bcr_drug_uuid": "A5E59A9B-F5F1-45A0-B6D1-DB44F0A7168B",
    "form_completion_date": "2012-1-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 5,
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fc18d029-9be2-4fa0-9aef-6d647dc55f0b",
    "patient_ID": "TCGA.D8.A147",
    "bcr_drug_barcode": "TCGA-D8-A147-D64911",
    "bcr_drug_uuid": "CEB8DA00-D300-4AFB-BE1C-2BD15BF0E020",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fc18d029-9be2-4fa0-9aef-6d647dc55f0b",
    "patient_ID": "TCGA.D8.A147",
    "bcr_drug_barcode": "TCGA-D8-A147-D64912",
    "bcr_drug_uuid": "C92110BF-B562-4AFE-A419-2217BD718E8F",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fc18d029-9be2-4fa0-9aef-6d647dc55f0b",
    "patient_ID": "TCGA.D8.A147",
    "bcr_drug_barcode": "TCGA-D8-A147-D64913",
    "bcr_drug_uuid": "063BD28B-E3D7-44D7-BEA3-38407B9852F0",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62d70067-ff77-4f95-8b69-f537abaf74ce",
    "patient_ID": "TCGA.D8.A1J8",
    "bcr_drug_barcode": "TCGA-D8-A1J8-D14041",
    "bcr_drug_uuid": "3DDE2EBA-A85F-48E1-AAC2-D34371DCC95D",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "NOLVADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ced0c70-c46c-4f98-8f48-840defe4b8b1",
    "patient_ID": "TCGA.D8.A1JA",
    "bcr_drug_barcode": "TCGA-D8-A1JA-D20942",
    "bcr_drug_uuid": "49D90CDE-D4EF-46EF-94D8-525D69BE2B09",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "9ced0c70-c46c-4f98-8f48-840defe4b8b1",
    "patient_ID": "TCGA.D8.A1JA",
    "bcr_drug_barcode": "TCGA-D8-A1JA-D65317",
    "bcr_drug_uuid": "954BBBEE-5DA3-43B7-986A-7AA80BA0744F",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dd96a9c7-899c-47cd-a0f9-b149ed07a5d6",
    "patient_ID": "TCGA.D8.A1JB",
    "bcr_drug_barcode": "TCGA-D8-A1JB-D20850",
    "bcr_drug_uuid": "169E2D43-D1E5-42FF-AA6C-DB036D823477",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "dd96a9c7-899c-47cd-a0f9-b149ed07a5d6",
    "patient_ID": "TCGA.D8.A1JB",
    "bcr_drug_barcode": "TCGA-D8-A1JB-D65318",
    "bcr_drug_uuid": "31DE8E14-409E-43CB-96CD-369FD9AF142F",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "02e6f999-24f2-4ad2-9b92-df3ee2b082e5",
    "patient_ID": "TCGA.D8.A1JC",
    "bcr_drug_barcode": "TCGA-D8-A1JC-D20848",
    "bcr_drug_uuid": "04150296-7BAD-4DD4-8B28-C14FCB79BD22",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "02e6f999-24f2-4ad2-9b92-df3ee2b082e5",
    "patient_ID": "TCGA.D8.A1JC",
    "bcr_drug_barcode": "TCGA-D8-A1JC-D65319",
    "bcr_drug_uuid": "FECB156F-3FF8-4A4B-B968-896FD0893868",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "530ad151-703d-4638-851f-0b5111ff318b",
    "patient_ID": "TCGA.D8.A1JD",
    "bcr_drug_barcode": "TCGA-D8-A1JD-D20845",
    "bcr_drug_uuid": "39C2C11A-3C77-464E-98F4-A7A7C922535A",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "530ad151-703d-4638-851f-0b5111ff318b",
    "patient_ID": "TCGA.D8.A1JD",
    "bcr_drug_barcode": "TCGA-D8-A1JD-D65321",
    "bcr_drug_uuid": "32787263-6D4A-4283-B7C7-50D3650A330D",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "115bc72c-116f-40c1-be9b-e3dd7650efae",
    "patient_ID": "TCGA.D8.A1JE",
    "bcr_drug_barcode": "TCGA-D8-A1JE-D20761",
    "bcr_drug_uuid": "A21FF951-1D85-43F8-B890-E68699047B3E",
    "form_completion_date": "2012-1-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "115bc72c-116f-40c1-be9b-e3dd7650efae",
    "patient_ID": "TCGA.D8.A1JE",
    "bcr_drug_barcode": "TCGA-D8-A1JE-D65322",
    "bcr_drug_uuid": "B2854BDF-784F-41A1-AB7D-354A86C7F89E",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7f2a63e6-64d5-4be1-9814-e8416fc9e688",
    "patient_ID": "TCGA.D8.A1JG",
    "bcr_drug_barcode": "TCGA-D8-A1JG-D14061",
    "bcr_drug_uuid": "8AC1E40A-2939-4FD6-93E8-DE97A4C64960",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7f2a63e6-64d5-4be1-9814-e8416fc9e688",
    "patient_ID": "TCGA.D8.A1JG",
    "bcr_drug_barcode": "TCGA-D8-A1JG-D65325",
    "bcr_drug_uuid": "79FA201D-29D2-4F82-BD32-02AAC1E0DE5E",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4d1bf9e6-5837-4aed-b568-92f014ed5a4b",
    "patient_ID": "TCGA.D8.A1JH",
    "bcr_drug_barcode": "TCGA-D8-A1JH-D14056",
    "bcr_drug_uuid": "59F08533-A2E2-4306-8DF3-F18CCAA18F58",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "NOLVADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "baf2afc8-f16c-488f-947c-efc9083c6bef",
    "patient_ID": "TCGA.D8.A1JI",
    "bcr_drug_barcode": "TCGA-D8-A1JI-D20756",
    "bcr_drug_uuid": "47A735BC-1929-456F-A0AB-F5026052E183",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "baf2afc8-f16c-488f-947c-efc9083c6bef",
    "patient_ID": "TCGA.D8.A1JI",
    "bcr_drug_barcode": "TCGA-D8-A1JI-D65326",
    "bcr_drug_uuid": "48F56CD7-78CE-4306-8B6C-236C717C7B5B",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "baf2afc8-f16c-488f-947c-efc9083c6bef",
    "patient_ID": "TCGA.D8.A1JI",
    "bcr_drug_barcode": "TCGA-D8-A1JI-D65327",
    "bcr_drug_uuid": "48CDB206-6F2C-4B85-AD7B-E40F9B481D47",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "LETROZOLUM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f7ab565c-83b5-4988-b9be-8a46f65dca8c",
    "patient_ID": "TCGA.D8.A1JJ",
    "bcr_drug_barcode": "TCGA-D8-A1JJ-D20752",
    "bcr_drug_uuid": "1B097076-CB3B-448F-A602-0212DC8246E8",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 4,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 108.6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 434.4
  },
  {
    "bcr_patient_uuid": "f7ab565c-83b5-4988-b9be-8a46f65dca8c",
    "patient_ID": "TCGA.D8.A1JJ",
    "bcr_drug_barcode": "TCGA-D8-A1JJ-D65328",
    "bcr_drug_uuid": "FC68628D-E031-42D2-9D8F-4D34ACDEEC56",
    "form_completion_date": "2014-9-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3e775c99-ceda-4246-8d6f-0f58ca5097c8",
    "patient_ID": "TCGA.D8.A1JM",
    "bcr_drug_barcode": "TCGA-D8-A1JM-D20743",
    "bcr_drug_uuid": "D067FC8D-6FF0-4230-B498-599F566005F6",
    "form_completion_date": "2012-1-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE CYCLOPHOSPHAMIDE TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY|HORMONE THERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28911b97-42bf-4189-9961-522fc0aeebc6",
    "patient_ID": "TCGA.D8.A1JN",
    "bcr_drug_barcode": "TCGA-D8-A1JN-D20746",
    "bcr_drug_uuid": "2A418FF9-581C-4A9B-A4AB-B7B2C072C0EA",
    "form_completion_date": "2012-1-15",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLUM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "752f4773-5a12-4485-a1f6-896e148ddf4d",
    "patient_ID": "TCGA.D8.A1JP",
    "bcr_drug_barcode": "TCGA-D8-A1JP-D20741",
    "bcr_drug_uuid": "E016C444-DD80-48AC-83D9-42A76BE14860",
    "form_completion_date": "2012-1-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0d03055c-186b-418a-b614-e2035757bc3b",
    "patient_ID": "TCGA.D8.A1JS",
    "bcr_drug_barcode": "TCGA-D8-A1JS-D14052",
    "bcr_drug_uuid": "8318EC65-2D4F-490D-9C42-264220D999DA",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cd781589-3820-45a2-906b-8d60cd02f3ef",
    "patient_ID": "TCGA.D8.A1JT",
    "bcr_drug_barcode": "TCGA-D8-A1JT-D14049",
    "bcr_drug_uuid": "A1CE4BC2-90C8-4054-8F71-02F9119342A7",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "af2a8e2f-2ae1-48bc-bba5-0e2c077c4e48",
    "patient_ID": "TCGA.D8.A1JU",
    "bcr_drug_barcode": "TCGA-D8-A1JU-D14044",
    "bcr_drug_uuid": "E80A862C-2FA5-4802-9986-D1635BD35BD7",
    "form_completion_date": "2011-7-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "eb93df3d-9e25-4e4c-9a5d-350f296e5acf",
    "patient_ID": "TCGA.D8.A1X5",
    "bcr_drug_barcode": "TCGA-D8-A1X5-D29935",
    "bcr_drug_uuid": "9E4AF981-5926-4017-BB6E-25B7554E7645",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 14,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "eb93df3d-9e25-4e4c-9a5d-350f296e5acf",
    "patient_ID": "TCGA.D8.A1X5",
    "bcr_drug_barcode": "TCGA-D8-A1X5-D30115",
    "bcr_drug_uuid": "972E329F-848E-4B00-AB12-F25F7C073C6A",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42e47f3a-dff7-41e4-8f84-146d97e8ab72",
    "patient_ID": "TCGA.D8.A1X6",
    "bcr_drug_barcode": "TCGA-D8-A1X6-D29982",
    "bcr_drug_uuid": "4AC37B69-6DC4-4880-9775-F6A571022CB5",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cdab777e-62de-4d51-92af-b6eb089c111f",
    "patient_ID": "TCGA.D8.A1X7",
    "bcr_drug_barcode": "TCGA-D8-A1X7-D29986",
    "bcr_drug_uuid": "F5CBC7F0-42CF-407F-8F28-441B89B91D06",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE+TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY|HORMONE THERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8624354c-af25-423c-9c71-48a5dd821097",
    "patient_ID": "TCGA.D8.A1X8",
    "bcr_drug_barcode": "TCGA-D8-A1X8-D29429",
    "bcr_drug_uuid": "2392ED50-8D05-4D26-A5D9-F2EA353735BC",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIMICIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "34a74805-300c-4773-ab59-2085fcc2e6cc",
    "patient_ID": "TCGA.D8.A1X9",
    "bcr_drug_barcode": "TCGA-D8-A1X9-D29432",
    "bcr_drug_uuid": "24E1ACCD-BB3A-4B2A-8E81-18F3452912AA",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6f6afd31-b5dd-48ab-b18f-6390ba18a5f0",
    "patient_ID": "TCGA.D8.A1XF",
    "bcr_drug_barcode": "TCGA-D8-A1XF-D29443",
    "bcr_drug_uuid": "0C6384BF-1F92-4793-B12E-4B62D23851CC",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 311,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 356,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cc510968-fe52-4109-a79f-74f216b48c78",
    "patient_ID": "TCGA.D8.A1XJ",
    "bcr_drug_barcode": "TCGA-D8-A1XJ-D29988",
    "bcr_drug_uuid": "B04923EA-FC7E-4EFA-B2B2-65D43ABA760D",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "97943d87-fed7-4f14-a0a7-c5bfee64c392",
    "patient_ID": "TCGA.D8.A1XK",
    "bcr_drug_barcode": "TCGA-D8-A1XK-D30075",
    "bcr_drug_uuid": "A849F857-16FA-41BF-8358-A98B7681F21B",
    "form_completion_date": "2012-2-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXELUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 12,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "97943d87-fed7-4f14-a0a7-c5bfee64c392",
    "patient_ID": "TCGA.D8.A1XK",
    "bcr_drug_barcode": "TCGA-D8-A1XK-D30076",
    "bcr_drug_uuid": "25913AF2-0E2D-4199-A59A-8CB451696BDF",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c",
    "patient_ID": "TCGA.D8.A1XL",
    "bcr_drug_barcode": "TCGA-D8-A1XL-D29992",
    "bcr_drug_uuid": "99E79238-A6D7-4960-8534-AC4370815F98",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIPHENE+LEUPORELINE+GOSERELINE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c",
    "patient_ID": "TCGA.D8.A1XL",
    "bcr_drug_barcode": "TCGA-D8-A1XL-D29991",
    "bcr_drug_uuid": "A6E0C004-801E-45BB-AC10-CCEC1557F108",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE+TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6a186809-3422-41d0-83d2-867145830936",
    "patient_ID": "TCGA.D8.A1XO",
    "bcr_drug_barcode": "TCGA-D8-A1XO-D72207",
    "bcr_drug_uuid": "C1C52C47-5334-40A2-8898-0E1B7949D3A0",
    "form_completion_date": "2015-4-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "70f34c5c-3671-44c8-9469-99f9786efec1",
    "patient_ID": "TCGA.D8.A1XR",
    "bcr_drug_barcode": "TCGA-D8-A1XR-D29450",
    "bcr_drug_uuid": "5484F965-9C70-444A-8C52-BE87ECFA4EE5",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1026e0bf-5640-4fa5-b65f-4f11e8e76b18",
    "patient_ID": "TCGA.D8.A1XS",
    "bcr_drug_barcode": "TCGA-D8-A1XS-D29452",
    "bcr_drug_uuid": "72D7E95D-A251-492A-ABBC-D296BC9871D3",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 548,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "64975923-d032-4182-8565-59fc37127d8d",
    "patient_ID": "TCGA.D8.A1XT",
    "bcr_drug_barcode": "TCGA-D8-A1XT-D29455",
    "bcr_drug_uuid": "BA9F76EC-158B-4252-8921-AF7A7755CEAB",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "887b9e5b-99db-44ac-9c30-c0dc6877b41c",
    "patient_ID": "TCGA.D8.A1XW",
    "bcr_drug_barcode": "TCGA-D8-A1XW-D29460",
    "bcr_drug_uuid": "DBD8AFC3-3C19-4ED7-A10C-F38A65FC6B47",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0130d616-885e-4a6c-9d03-2f17dd692a05",
    "patient_ID": "TCGA.D8.A1XY",
    "bcr_drug_barcode": "TCGA-D8-A1XY-D29995",
    "bcr_drug_uuid": "4983452A-0399-4CBE-BCDF-9F09A21FC698",
    "form_completion_date": "2012-3-31",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 421,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2c90d5e3-ac8c-4c86-a06f-42ccc064eb49",
    "patient_ID": "TCGA.D8.A1XZ",
    "bcr_drug_barcode": "TCGA-D8-A1XZ-D30078",
    "bcr_drug_uuid": "3B8B3BD1-028D-4001-B58C-D0CE9C68CF27",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIPHENE+ANASTROZOLUM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ced2c048-b047-43ff-b0e7-cd7ad480850c",
    "patient_ID": "TCGA.D8.A1Y0",
    "bcr_drug_barcode": "TCGA-D8-A1Y0-D30083",
    "bcr_drug_uuid": "E9799A77-D625-4619-8775-110F09A13235",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIPHENE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 540,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ced2c048-b047-43ff-b0e7-cd7ad480850c",
    "patient_ID": "TCGA.D8.A1Y0",
    "bcr_drug_barcode": "TCGA-D8-A1Y0-D30082",
    "bcr_drug_uuid": "2E4B995D-B134-417F-8651-39114BCED462",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE+METHOTREXATUM+FLUOROURACILLUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "38a631a1-6875-4216-a335-ee93c90a86d6",
    "patient_ID": "TCGA.D8.A1Y1",
    "bcr_drug_barcode": "TCGA-D8-A1Y1-D30085",
    "bcr_drug_uuid": "5389E215-9B46-4ED9-A3F2-0392ACD376A5",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 302,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7d7a770-23c0-4310-ab48-1f6152dc2849",
    "patient_ID": "TCGA.D8.A1Y2",
    "bcr_drug_barcode": "TCGA-D8-A1Y2-D30087",
    "bcr_drug_uuid": "8706F572-AB8C-430F-9761-2AEFA63F375B",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "632984bd-dc81-42b6-b024-476cfd0bb2ae",
    "patient_ID": "TCGA.D8.A1Y3",
    "bcr_drug_barcode": "TCGA-D8-A1Y3-D30089",
    "bcr_drug_uuid": "CD27D9E9-957F-4103-9146-BD4B8D8CCDBB",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIPHENE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "632984bd-dc81-42b6-b024-476cfd0bb2ae",
    "patient_ID": "TCGA.D8.A1Y3",
    "bcr_drug_barcode": "TCGA-D8-A1Y3-D30090",
    "bcr_drug_uuid": "804ACAFF-8BBF-4830-B5D7-67949CD57F82",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "680f23a9-fcce-493e-b908-27c1ad202e4c",
    "patient_ID": "TCGA.D8.A27E",
    "bcr_drug_barcode": "TCGA-D8-A27E-D30113",
    "bcr_drug_uuid": "3D420476-7EB9-4632-B3F8-3BB85B979A0D",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIPHEN+ANASTRAZOLUM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1549dc64-3dab-43fc-96e9-b07d520957e1",
    "patient_ID": "TCGA.D8.A27F",
    "bcr_drug_barcode": "TCGA-D8-A27F-D29516",
    "bcr_drug_uuid": "623BDB83-F7A0-4C0E-8D45-D2C8A45913FF",
    "form_completion_date": "2012-3-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 488,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0dca98b0-f43e-45b6-9a02-00092c78678c",
    "patient_ID": "TCGA.D8.A27H",
    "bcr_drug_barcode": "TCGA-D8-A27H-D29537",
    "bcr_drug_uuid": "4AB576A6-1236-4F08-9245-2BA70A7A8F57",
    "form_completion_date": "2012-3-22",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN+ CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9c55032f-4db7-4026-ae83-8d060dd8e3fe",
    "patient_ID": "TCGA.D8.A27I",
    "bcr_drug_barcode": "TCGA-D8-A27I-D29523",
    "bcr_drug_uuid": "94238A97-A6AB-4233-B4FD-23DF34B10383",
    "form_completion_date": "2012-3-21",
    "pharmaceutical_therapy_drug_name": "ADRIMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7f97971b-2818-4e4b-9c9e-7c0246f9484c",
    "patient_ID": "TCGA.D8.A27K",
    "bcr_drug_barcode": "TCGA-D8-A27K-D29589",
    "bcr_drug_uuid": "08CE6CE2-B1EE-4E48-AFCD-DF600C649E6E",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7f97971b-2818-4e4b-9c9e-7c0246f9484c",
    "patient_ID": "TCGA.D8.A27K",
    "bcr_drug_barcode": "TCGA-D8-A27K-D72202",
    "bcr_drug_uuid": "B5F1746D-61A5-4826-81D4-303798C56880",
    "form_completion_date": "2015-4-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6020d1b4-ee20-4cc9-82a3-340b5e3122f1",
    "patient_ID": "TCGA.D8.A27L",
    "bcr_drug_barcode": "TCGA-D8-A27L-D29591",
    "bcr_drug_uuid": "53DEB285-A9E3-4877-A72F-64441D85E4F9",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CUCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ae65baeb-6b78-492a-8c63-bb7e93e83dc2",
    "patient_ID": "TCGA.D8.A27M",
    "bcr_drug_barcode": "TCGA-D8-A27M-D29593",
    "bcr_drug_uuid": "0BE1EFFF-4959-45B6-A90D-D5954D024746",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE+5 FLUOROURACIL+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d5be2ab3-f748-480d-954b-385cf01b4c81",
    "patient_ID": "TCGA.D8.A27N",
    "bcr_drug_barcode": "TCGA-D8-A27N-D29595",
    "bcr_drug_uuid": "7055CBBE-07D0-4F99-B7A5-FC251DAE2E28",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "TAXOL+ADRIAMYCIN+CYCLOPHOSPHAMIDE+HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b23b5fe-6c7e-4297-bc55-f93fcb830ac4",
    "patient_ID": "TCGA.D8.A27R",
    "bcr_drug_barcode": "TCGA-D8-A27R-D29702",
    "bcr_drug_uuid": "8D2A839B-9923-4EDA-9E50-5BDA071574E2",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "27c1c094-690b-4973-8900-a797ad88f98c",
    "patient_ID": "TCGA.D8.A27T",
    "bcr_drug_barcode": "TCGA-D8-A27T-D30097",
    "bcr_drug_uuid": "2BC3A132-221D-403F-9E82-697C8B87ADFD",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "27c1c094-690b-4973-8900-a797ad88f98c",
    "patient_ID": "TCGA.D8.A27T",
    "bcr_drug_barcode": "TCGA-D8-A27T-D30098",
    "bcr_drug_uuid": "8592A3D1-BE31-4706-AC39-9C5D149F0914",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "AD6D26AB-6568-40DB-BFB0-394D40E801CF",
    "patient_ID": "TCGA.D8.A27V",
    "bcr_drug_barcode": "TCGA-D8-A27V-D30106",
    "bcr_drug_uuid": "C90BB84D-E867-45CE-BBAF-7A25BE220C0E",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bfa3dbc0-361c-400e-8c10-0aca7049fce9",
    "patient_ID": "TCGA.D8.A27W",
    "bcr_drug_barcode": "TCGA-D8-A27W-D30110",
    "bcr_drug_uuid": "7E602CDB-4F73-4338-B776-1E33AC8151D9",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 226,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bfa3dbc0-361c-400e-8c10-0aca7049fce9",
    "patient_ID": "TCGA.D8.A27W",
    "bcr_drug_barcode": "TCGA-D8-A27W-D30108",
    "bcr_drug_uuid": "638ECF5D-30BB-4107-95B4-9347666BF398",
    "form_completion_date": "2012-4-2",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINE+CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "A6E5F869-1182-4F81-B4BB-CF55261C8F3F",
    "patient_ID": "TCGA.D8.A3Z6",
    "bcr_drug_barcode": "TCGA-D8-A3Z6-D51368",
    "bcr_drug_uuid": "FA44D3C7-5509-4E8A-8B5F-C6C804AE85E3",
    "form_completion_date": "2013-11-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6E5F869-1182-4F81-B4BB-CF55261C8F3F",
    "patient_ID": "TCGA.D8.A3Z6",
    "bcr_drug_barcode": "TCGA-D8-A3Z6-D51370",
    "bcr_drug_uuid": "FEEC29B8-84BD-4F1D-AF6E-93F1592B2E13",
    "form_completion_date": "2013-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6E5F869-1182-4F81-B4BB-CF55261C8F3F",
    "patient_ID": "TCGA.D8.A3Z6",
    "bcr_drug_barcode": "TCGA-D8-A3Z6-D51372",
    "bcr_drug_uuid": "D00B426C-3576-4D63-AFD6-FBEFFDB9ADA7",
    "form_completion_date": "2013-11-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6E5F869-1182-4F81-B4BB-CF55261C8F3F",
    "patient_ID": "TCGA.D8.A3Z6",
    "bcr_drug_barcode": "TCGA-D8-A3Z6-D59241",
    "bcr_drug_uuid": "25ADCD91-C55B-445C-8B2D-4008D97434AE",
    "form_completion_date": "2014-5-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "80419545-4E5D-4BAF-8948-F84589B5EF3E",
    "patient_ID": "TCGA.D8.A4Z1",
    "bcr_drug_barcode": "TCGA-D8-A4Z1-D39760",
    "bcr_drug_uuid": "3EDA844D-C123-4BB2-8172-06DB3BAD4DD4",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96F02BE7-F2DF-483C-8968-A5BD2D887206",
    "patient_ID": "TCGA.D8.A73U",
    "bcr_drug_barcode": "TCGA-D8-A73U-D57872",
    "bcr_drug_uuid": "96016F6D-6A93-4CA4-8261-A995B5304A9D",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EA8DBC7A-54C6-469C-865E-F49D00B0223D",
    "patient_ID": "TCGA.D8.A73W",
    "bcr_drug_barcode": "TCGA-D8-A73W-D72199",
    "bcr_drug_uuid": "A09294E3-9DBD-4A35-B806-8C3B050532A1",
    "form_completion_date": "2015-4-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -709,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -620,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1BE375FE-5AE5-4E75-A729-69F86A661D9A",
    "patient_ID": "TCGA.D8.A73X",
    "bcr_drug_barcode": "TCGA-D8-A73X-D57880",
    "bcr_drug_uuid": "43C74671-DCEB-4C5F-B13C-C3F184FEFDBD",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b0bcb829-cee0-4247-bb75-093a5bea89ee",
    "patient_ID": "TCGA.E2.A105",
    "bcr_drug_barcode": "TCGA-E2-A105-D7696",
    "bcr_drug_uuid": "e88c01a6-d3d9-48bf-8e5e-929c0c0c7d9a",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "87e09544-eddb-473b-8617-212407ce644e",
    "patient_ID": "TCGA.E2.A106",
    "bcr_drug_barcode": "TCGA-E2-A106-D7751",
    "bcr_drug_uuid": "da3db900-ed98-41e6-9c1e-6cdde2b53b91",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 883,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87e09544-eddb-473b-8617-212407ce644e",
    "patient_ID": "TCGA.E2.A106",
    "bcr_drug_barcode": "TCGA-E2-A106-D7753",
    "bcr_drug_uuid": "d99bb0ba-6f4a-424f-ad5f-6ec86deec9b5",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 883,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3.6,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3.6
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D7755",
    "bcr_drug_uuid": "a7e00902-e7a5-4186-af3b-ad72c543f90a",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN, CYTOXAN, AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D7758",
    "bcr_drug_uuid": "32e23773-9014-438f-887b-f921486a2877",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 305,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 355,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D7757",
    "bcr_drug_uuid": "94caf20f-89a4-438f-919c-b340c5ce2469",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 333,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1065,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 13845
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D7756",
    "bcr_drug_uuid": "c58484ad-b8a7-4f27-9386-eecae3edc98a",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 12,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/WK",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D7759",
    "bcr_drug_uuid": "defcd3cc-c0c4-4a02-9921-4c97f1ab4e62",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17180",
    "bcr_drug_uuid": "B2F276EF-9F6D-4748-B73C-14E98959428A",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 20,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17179",
    "bcr_drug_uuid": "F8A4A3FF-59B7-45D2-93E6-AB8090FD077D",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 397,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17823",
    "bcr_drug_uuid": "B6BDB863-8723-4E39-981C-050BD35D2153",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 333,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1049,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4196
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17821",
    "bcr_drug_uuid": "154B47FC-B1D3-491D-9EA5-29AF63F4E160",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17174",
    "bcr_drug_uuid": "46E34570-DA26-49E6-9564-CD69C9A9ECE6",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1050,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "eff2360e-399a-4167-ab2b-798e27bef739",
    "patient_ID": "TCGA.E2.A107",
    "bcr_drug_barcode": "TCGA-E2-A107-D17818",
    "bcr_drug_uuid": "01B8342F-2262-4BEE-8828-DD3CC79BA416",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 105,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "4f04bd10-9902-4a23-b15d-4f4409d79499",
    "patient_ID": "TCGA.E2.A108",
    "bcr_drug_barcode": "TCGA-E2-A108-D7776",
    "bcr_drug_uuid": "0e5f203f-3c34-4cb7-be76-4901295154cf",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 12,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4f04bd10-9902-4a23-b15d-4f4409d79499",
    "patient_ID": "TCGA.E2.A108",
    "bcr_drug_barcode": "TCGA-E2-A108-D7774",
    "bcr_drug_uuid": "b5112aa6-5ae8-4f62-9901-d9fb84775ddd",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4f04bd10-9902-4a23-b15d-4f4409d79499",
    "patient_ID": "TCGA.E2.A108",
    "bcr_drug_barcode": "TCGA-E2-A108-D17424",
    "bcr_drug_uuid": "D2DB5EB8-9FA3-4CF9-88B7-0FEEDE0C2122",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4f04bd10-9902-4a23-b15d-4f4409d79499",
    "patient_ID": "TCGA.E2.A108",
    "bcr_drug_barcode": "TCGA-E2-A108-D17915",
    "bcr_drug_uuid": "478FCF8A-98C5-4614-BAF3-0E937EBBF1C5",
    "form_completion_date": "2011-10-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7760",
    "bcr_drug_uuid": "87fba7ad-05d6-4c59-a6de-0c0c59379e51",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 15,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7772",
    "bcr_drug_uuid": "c3820a88-cd09-4aa5-bfb5-d4812af05d33",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 857,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7765",
    "bcr_drug_uuid": "c11ab503-55a1-4706-8e19-4306df0021b6",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 643,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 685,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7762",
    "bcr_drug_uuid": "596420b7-1032-4b1e-bac4-031b00ef07c2",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "drug_cycles": 15,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/WK",
    "drug_dose": 24,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 52
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7764",
    "bcr_drug_uuid": "c755119e-684b-49ba-9d65-985dcde6d41b",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 318,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 608,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7769",
    "bcr_drug_uuid": "c186939c-e896-47d0-8370-b151b3b79e00",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 734,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 807,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7763",
    "bcr_drug_uuid": "8df90aa0-372a-4649-9663-282c2d48b544",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 367,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2202
  },
  {
    "bcr_patient_uuid": "f0787165-6f58-4d67-b510-928eea2c4882",
    "patient_ID": "TCGA.E2.A109",
    "bcr_drug_barcode": "TCGA-E2-A109-D7767",
    "bcr_drug_uuid": "db4b5ad5-5f00-43e8-8a2c-e32766f985ff",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 734,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "4da7abaf-ac7a-41c0-8033-5780a398545c",
    "patient_ID": "TCGA.E2.A10A",
    "bcr_drug_barcode": "TCGA-E2-A10A-D7700",
    "bcr_drug_uuid": "932948c9-faaa-4f8d-a773-780433c65a7a",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4da7abaf-ac7a-41c0-8033-5780a398545c",
    "patient_ID": "TCGA.E2.A10A",
    "bcr_drug_barcode": "TCGA-E2-A10A-D7699",
    "bcr_drug_uuid": "de773115-886c-445c-874a-99ed871ca85d",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3.6,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3.6
  },
  {
    "bcr_patient_uuid": "4da7abaf-ac7a-41c0-8033-5780a398545c",
    "patient_ID": "TCGA.E2.A10A",
    "bcr_drug_barcode": "TCGA-E2-A10A-D17430",
    "bcr_drug_uuid": "4729CED9-4A3B-43B6-AB21-95DC86CFA9FE",
    "form_completion_date": "2011-9-27",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D7778",
    "bcr_drug_uuid": "22a0ab43-d0fb-443a-9af6-411f57558645",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D17413",
    "bcr_drug_uuid": "0FEBDEAC-7A64-4F2D-A282-2BB6ADA48DF4",
    "form_completion_date": "2011-9-19",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 301,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 840,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 840
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D17415",
    "bcr_drug_uuid": "970F3CF2-E642-4E3C-8819-541DF6437E4E",
    "form_completion_date": "2011-9-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 398,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1922
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D17414",
    "bcr_drug_uuid": "7A8C4891-71FD-4118-BEB4-84AC3D858FBC",
    "form_completion_date": "2011-9-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 398,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 312,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1556
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D17371",
    "bcr_drug_uuid": "011EFEBF-C10E-4C0F-871E-99C7222B06B2",
    "form_completion_date": "2011-9-19",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f801aeed-dc43-49d7-a319-84c8851979d9",
    "patient_ID": "TCGA.E2.A10B",
    "bcr_drug_barcode": "TCGA-E2-A10B-D17412",
    "bcr_drug_uuid": "4513E452-531B-4CB3-A85B-9B4267CABF91",
    "form_completion_date": "2011-9-19",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 657,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 748,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 624,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2484
  },
  {
    "bcr_patient_uuid": "9ac44381-5d43-4f63-aa3f-7703bfc923c9",
    "patient_ID": "TCGA.E2.A10C",
    "bcr_drug_barcode": "TCGA-E2-A10C-D7710",
    "bcr_drug_uuid": "06a90674-8f6e-4a9b-97e0-2d52d0cf21dc",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ac44381-5d43-4f63-aa3f-7703bfc923c9",
    "patient_ID": "TCGA.E2.A10C",
    "bcr_drug_barcode": "TCGA-E2-A10C-D7705",
    "bcr_drug_uuid": "4cbad17f-9385-400c-bb9d-3a2291f3b143",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 12,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/WK",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "9ac44381-5d43-4f63-aa3f-7703bfc923c9",
    "patient_ID": "TCGA.E2.A10C",
    "bcr_drug_barcode": "TCGA-E2-A10C-D7703",
    "bcr_drug_uuid": "5c41cc1b-b8b3-448c-93a2-c30024ccf123",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ac44381-5d43-4f63-aa3f-7703bfc923c9",
    "patient_ID": "TCGA.E2.A10C",
    "bcr_drug_barcode": "TCGA-E2-A10C-D7707",
    "bcr_drug_uuid": "d7774b1e-92e1-4644-a255-ea3a5ce1ad57",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 282,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "9ac44381-5d43-4f63-aa3f-7703bfc923c9",
    "patient_ID": "TCGA.E2.A10C",
    "bcr_drug_barcode": "TCGA-E2-A10C-D17854",
    "bcr_drug_uuid": "A35F5E09-22C4-4854-B838-0F4399668114",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc15a8ae-991e-421c-bc70-70e94f79dd17",
    "patient_ID": "TCGA.E2.A10E",
    "bcr_drug_barcode": "TCGA-E2-A10E-D7737",
    "bcr_drug_uuid": "bd0584f4-ee79-49a0-9ade-0ad380645278",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "CYTOXAN AND TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc15a8ae-991e-421c-bc70-70e94f79dd17",
    "patient_ID": "TCGA.E2.A10E",
    "bcr_drug_barcode": "TCGA-E2-A10E-D7739",
    "bcr_drug_uuid": "7ec81080-5df3-4dc4-8ec6-5e0ea241af2e",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "dc15a8ae-991e-421c-bc70-70e94f79dd17",
    "patient_ID": "TCGA.E2.A10E",
    "bcr_drug_barcode": "TCGA-E2-A10E-D17354",
    "bcr_drug_uuid": "00E33CEE-3545-4F64-BF71-25DC3724D422",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "dc15a8ae-991e-421c-bc70-70e94f79dd17",
    "patient_ID": "TCGA.E2.A10E",
    "bcr_drug_barcode": "TCGA-E2-A10E-D17356",
    "bcr_drug_uuid": "299A38EF-5935-4D67-8EF7-C7BCE9FF5DCC",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 918,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3672
  },
  {
    "bcr_patient_uuid": "8e159b50-8136-42d4-b9c7-d579a74e4931",
    "patient_ID": "TCGA.E2.A10F",
    "bcr_drug_barcode": "TCGA-E2-A10F-D7750",
    "bcr_drug_uuid": "1bd78b9a-fdb8-45a6-9848-9e03ad1b28fd",
    "form_completion_date": "2011-2-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 337,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "8e159b50-8136-42d4-b9c7-d579a74e4931",
    "patient_ID": "TCGA.E2.A10F",
    "bcr_drug_barcode": "TCGA-E2-A10F-D17186",
    "bcr_drug_uuid": "A5A45F4A-EB30-4F25-8A01-B2CC187C6EF8",
    "form_completion_date": "2011-9-27",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1284,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5136
  },
  {
    "bcr_patient_uuid": "8e159b50-8136-42d4-b9c7-d579a74e4931",
    "patient_ID": "TCGA.E2.A10F",
    "bcr_drug_barcode": "TCGA-E2-A10F-D17872",
    "bcr_drug_uuid": "3DE26760-A09A-4CD8-9EB1-5D20924A929A",
    "form_completion_date": "2011-9-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "752ad011-79e0-494f-9868-98bf6feb28f8",
    "patient_ID": "TCGA.E2.A14N",
    "bcr_drug_barcode": "TCGA-E2-A14N-D19160",
    "bcr_drug_uuid": "774B35C1-A2FE-4E38-9361-04E5C80ED934",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5444
  },
  {
    "bcr_patient_uuid": "752ad011-79e0-494f-9868-98bf6feb28f8",
    "patient_ID": "TCGA.E2.A14N",
    "bcr_drug_barcode": "TCGA-E2-A14N-D19180",
    "bcr_drug_uuid": "9E98636D-8BD0-483C-B86A-593FAEF2D5B4",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "752ad011-79e0-494f-9868-98bf6feb28f8",
    "patient_ID": "TCGA.E2.A14N",
    "bcr_drug_barcode": "TCGA-E2-A14N-D19181",
    "bcr_drug_uuid": "17CBAB16-10F1-4630-8C6E-81E28038C433",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "fb356957-f620-4d99-b675-1355a1d9f932",
    "patient_ID": "TCGA.E2.A14O",
    "bcr_drug_barcode": "TCGA-E2-A14O-D18524",
    "bcr_drug_uuid": "4F298221-2D3F-4F83-8DBB-15844934BAA0",
    "form_completion_date": "2011-10-20",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "e4fc0909-f284-4471-866d-d8967b6adcbc",
    "patient_ID": "TCGA.E2.A14P",
    "bcr_drug_barcode": "TCGA-E2-A14P-D18847",
    "bcr_drug_uuid": "1097E387-AF7B-476A-AE90-ECF89836F10D",
    "form_completion_date": "2011-10-20",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 570,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10568
  },
  {
    "bcr_patient_uuid": "303a1d77-a37a-4966-a4a4-9981d99ba1b4",
    "patient_ID": "TCGA.E2.A14Q",
    "bcr_drug_barcode": "TCGA-E2-A14Q-D18801",
    "bcr_drug_uuid": "38EC0589-8337-4CE8-B1F2-D4F29BB091A1",
    "form_completion_date": "2011-10-20",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "4fba3deb-db94-44b5-a0f2-a575d270779e",
    "patient_ID": "TCGA.E2.A14R",
    "bcr_drug_barcode": "TCGA-E2-A14R-D18840",
    "bcr_drug_uuid": "02D7B362-61D3-42D6-85CD-44CEAFE39454",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 143,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 572
  },
  {
    "bcr_patient_uuid": "4fba3deb-db94-44b5-a0f2-a575d270779e",
    "patient_ID": "TCGA.E2.A14R",
    "bcr_drug_barcode": "TCGA-E2-A14R-D18841",
    "bcr_drug_uuid": "71BC8838-707A-4B8B-A57B-65DF043E1B53",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 145,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 413,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 413
  },
  {
    "bcr_patient_uuid": "4fba3deb-db94-44b5-a0f2-a575d270779e",
    "patient_ID": "TCGA.E2.A14R",
    "bcr_drug_barcode": "TCGA-E2-A14R-D18842",
    "bcr_drug_uuid": "4742335F-157B-4689-A300-FE62F824234D",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL (PROTEIN-BOUND)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 610,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1832
  },
  {
    "bcr_patient_uuid": "4fba3deb-db94-44b5-a0f2-a575d270779e",
    "patient_ID": "TCGA.E2.A14R",
    "bcr_drug_barcode": "TCGA-E2-A14R-D18839",
    "bcr_drug_uuid": "1F3203CD-3D0A-40D3-95B5-5B07E4987795",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1428,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5712
  },
  {
    "bcr_patient_uuid": "c2b104ee-f914-4e79-9e1b-56bf88157472",
    "patient_ID": "TCGA.E2.A14S",
    "bcr_drug_barcode": "TCGA-E2-A14S-D18834",
    "bcr_drug_uuid": "3CD785FB-FFD4-4BC9-8B61-5CDF4C3205F4",
    "form_completion_date": "2011-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 148,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 592
  },
  {
    "bcr_patient_uuid": "c2b104ee-f914-4e79-9e1b-56bf88157472",
    "patient_ID": "TCGA.E2.A14S",
    "bcr_drug_barcode": "TCGA-E2-A14S-D18836",
    "bcr_drug_uuid": "37A94E43-59E6-49FE-BC0D-AB11CA6B3130",
    "form_completion_date": "2011-11-3",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "c2b104ee-f914-4e79-9e1b-56bf88157472",
    "patient_ID": "TCGA.E2.A14S",
    "bcr_drug_barcode": "TCGA-E2-A14S-D18832",
    "bcr_drug_uuid": "DFE33AFA-BE0A-47EB-AA3E-07745099111C",
    "form_completion_date": "2011-11-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1182,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4728
  },
  {
    "bcr_patient_uuid": "e0929c47-cff3-4518-a188-8764af01073a",
    "patient_ID": "TCGA.E2.A14T",
    "bcr_drug_barcode": "TCGA-E2-A14T-D18829",
    "bcr_drug_uuid": "A411020C-8212-4584-90F9-D797C7120B81",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "e0929c47-cff3-4518-a188-8764af01073a",
    "patient_ID": "TCGA.E2.A14T",
    "bcr_drug_barcode": "TCGA-E2-A14T-D18826",
    "bcr_drug_uuid": "88256CB4-C3CF-4406-866A-27621E1D1013",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 357,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1428
  },
  {
    "bcr_patient_uuid": "e0929c47-cff3-4518-a188-8764af01073a",
    "patient_ID": "TCGA.E2.A14T",
    "bcr_drug_barcode": "TCGA-E2-A14T-D18823",
    "bcr_drug_uuid": "0EA62B2B-479A-481F-8E0A-271DDF8A2202",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1242,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4968
  },
  {
    "bcr_patient_uuid": "e0929c47-cff3-4518-a188-8764af01073a",
    "patient_ID": "TCGA.E2.A14T",
    "bcr_drug_barcode": "TCGA-E2-A14T-D18818",
    "bcr_drug_uuid": "491C04CD-29DC-4BA7-AC0E-EB33E9119638",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 124,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 496
  },
  {
    "bcr_patient_uuid": "23B7AAEA-1119-4B10-AA1A-0AE255D2F2A6",
    "patient_ID": "TCGA.E2.A14U",
    "bcr_drug_barcode": "TCGA-E2-A14U-D33623",
    "bcr_drug_uuid": "0B0A2B1B-77FF-4EEF-B070-7C3DAB61221D",
    "form_completion_date": "2012-7-11",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3144f1fb-4342-4079-bfe8-940da4bfd88e",
    "patient_ID": "TCGA.E2.A14V",
    "bcr_drug_barcode": "TCGA-E2-A14V-D18889",
    "bcr_drug_uuid": "AE8D09DE-A05B-4A3B-99CC-4CE7A88E8DF1",
    "form_completion_date": "2011-11-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1128,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4512
  },
  {
    "bcr_patient_uuid": "3144f1fb-4342-4079-bfe8-940da4bfd88e",
    "patient_ID": "TCGA.E2.A14V",
    "bcr_drug_barcode": "TCGA-E2-A14V-D18872",
    "bcr_drug_uuid": "AF33F97A-5569-496E-8D09-EE256571D9C4",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 304,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3144f1fb-4342-4079-bfe8-940da4bfd88e",
    "patient_ID": "TCGA.E2.A14V",
    "bcr_drug_barcode": "TCGA-E2-A14V-D18886",
    "bcr_drug_uuid": "A22C1AFA-B014-42F4-BAE1-B26AA885A2D4",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 112,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 448
  },
  {
    "bcr_patient_uuid": "3144f1fb-4342-4079-bfe8-940da4bfd88e",
    "patient_ID": "TCGA.E2.A14V",
    "bcr_drug_barcode": "TCGA-E2-A14V-D18891",
    "bcr_drug_uuid": "3DFEAA7A-286F-4E35-840E-F22E6ABF302F",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 152,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1499
  },
  {
    "bcr_patient_uuid": "3144f1fb-4342-4079-bfe8-940da4bfd88e",
    "patient_ID": "TCGA.E2.A14V",
    "bcr_drug_barcode": "TCGA-E2-A14V-D18914",
    "bcr_drug_uuid": "BB18FBCE-4921-4FD2-B7C0-CDA67CCD1AF5",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "LAPATINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 468,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 571500
  },
  {
    "bcr_patient_uuid": "eadb0562-2165-4adb-ad58-018e73f82780",
    "patient_ID": "TCGA.E2.A14W",
    "bcr_drug_barcode": "TCGA-E2-A14W-D18811",
    "bcr_drug_uuid": "632F839F-82AA-43E0-BC1A-9CFCEB78B2CC",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "eadb0562-2165-4adb-ad58-018e73f82780",
    "patient_ID": "TCGA.E2.A14W",
    "bcr_drug_barcode": "TCGA-E2-A14W-D18804",
    "bcr_drug_uuid": "44D83D4E-70ED-4A03-8A24-AA0FAF79C3B9",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 16,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 585,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5964
  },
  {
    "bcr_patient_uuid": "eadb0562-2165-4adb-ad58-018e73f82780",
    "patient_ID": "TCGA.E2.A14W",
    "bcr_drug_barcode": "TCGA-E2-A14W-D18806",
    "bcr_drug_uuid": "25E2567F-6AC2-4B0C-BB4C-6288D9260C8F",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3786
  },
  {
    "bcr_patient_uuid": "eadb0562-2165-4adb-ad58-018e73f82780",
    "patient_ID": "TCGA.E2.A14W",
    "bcr_drug_barcode": "TCGA-E2-A14W-D18808",
    "bcr_drug_uuid": "9A006D8C-5728-4281-81D4-F33365AFA016",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 473
  },
  {
    "bcr_patient_uuid": "60df7543-6da5-4c75-943b-5800c1e08234",
    "patient_ID": "TCGA.E2.A14X",
    "bcr_drug_barcode": "TCGA-E2-A14X-D18863",
    "bcr_drug_uuid": "FCF5541F-112D-4384-BD87-6B4BCBAD598D",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1470,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9310
  },
  {
    "bcr_patient_uuid": "60df7543-6da5-4c75-943b-5800c1e08234",
    "patient_ID": "TCGA.E2.A14X",
    "bcr_drug_barcode": "TCGA-E2-A14X-D18861",
    "bcr_drug_uuid": "A713574D-B6F2-4C3E-A90D-81F33EAB041C",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "CLODRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "pharma_type_other": "CLINICAL TRIAL - BISPHOSPHONATES AS ADJUVANT THERAPY",
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75200
  },
  {
    "bcr_patient_uuid": "60df7543-6da5-4c75-943b-5800c1e08234",
    "patient_ID": "TCGA.E2.A14X",
    "bcr_drug_barcode": "TCGA-E2-A14X-D18866",
    "bcr_drug_uuid": "DB24F34E-51A3-4AF7-A17C-27D81176D60D",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1284,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5136
  },
  {
    "bcr_patient_uuid": "60df7543-6da5-4c75-943b-5800c1e08234",
    "patient_ID": "TCGA.E2.A14X",
    "bcr_drug_barcode": "TCGA-E2-A14X-D18865",
    "bcr_drug_uuid": "FE204945-F99F-464A-9E6F-D168A421C139",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 128,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 512
  },
  {
    "bcr_patient_uuid": "60df7543-6da5-4c75-943b-5800c1e08234",
    "patient_ID": "TCGA.E2.A14X",
    "bcr_drug_barcode": "TCGA-E2-A14X-D18864",
    "bcr_drug_uuid": "A9E35661-F258-4F47-B234-1EEDC19E838C",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 171,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1642
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18513",
    "bcr_drug_uuid": "67957E3D-E6D1-49EA-A0E8-11E99FB353A1",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1185,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18498",
    "bcr_drug_uuid": "20803F10-4778-41BF-8D82-81E4DC7531C0",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 137,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 829
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18499",
    "bcr_drug_uuid": "A5C3C97F-CCF1-4700-913A-C658584D28BB",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4092
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18512",
    "bcr_drug_uuid": "A7494061-D25A-4E53-91D6-9B5DB0B5D69F",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 547,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18514",
    "bcr_drug_uuid": "BCD48E52-6804-43CF-8C55-E1980A6C15D6",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "FARESTON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 548,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 60,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "a0576d44-9add-429b-9eeb-f7b234b7385f",
    "patient_ID": "TCGA.E2.A14Y",
    "bcr_drug_barcode": "TCGA-E2-A14Y-D18500",
    "bcr_drug_uuid": "4D262684-171D-4544-A44F-60BFAC00AEAA",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 384,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 536,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7168
  },
  {
    "bcr_patient_uuid": "d7ce6b79-f7c0-481e-9dbd-6273f01c9786",
    "patient_ID": "TCGA.E2.A14Z",
    "bcr_drug_barcode": "TCGA-E2-A14Z-D18795",
    "bcr_drug_uuid": "3094D6D4-29B2-4620-ADE6-E6C60168114A",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 78
  },
  {
    "bcr_patient_uuid": "d7ce6b79-f7c0-481e-9dbd-6273f01c9786",
    "patient_ID": "TCGA.E2.A14Z",
    "bcr_drug_barcode": "TCGA-E2-A14Z-D18796",
    "bcr_drug_uuid": "0F2AF5BD-F63F-4EAD-B86B-7BE2BD25AA83",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d7ce6b79-f7c0-481e-9dbd-6273f01c9786",
    "patient_ID": "TCGA.E2.A14Z",
    "bcr_drug_barcode": "TCGA-E2-A14Z-D18799",
    "bcr_drug_uuid": "8A897AD0-3F9D-48BA-84CA-B26404B7FFBE",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4ac693e9-10f3-46b3-9d46-df3af7b0d259",
    "patient_ID": "TCGA.E2.A150",
    "bcr_drug_barcode": "TCGA-E2-A150-D18518",
    "bcr_drug_uuid": "34429660-1923-46C7-9C89-A412C2A9DE79",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL (PROTEIN-BOUND)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 398,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1719
  },
  {
    "bcr_patient_uuid": "4ac693e9-10f3-46b3-9d46-df3af7b0d259",
    "patient_ID": "TCGA.E2.A150",
    "bcr_drug_barcode": "TCGA-E2-A150-D18516",
    "bcr_drug_uuid": "6E72775A-C321-47EC-B622-DD6248D502F6",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1218,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4872
  },
  {
    "bcr_patient_uuid": "4ac693e9-10f3-46b3-9d46-df3af7b0d259",
    "patient_ID": "TCGA.E2.A150",
    "bcr_drug_barcode": "TCGA-E2-A150-D18517",
    "bcr_drug_uuid": "DBDE6E37-20B6-4FD1-9ADE-F324268AEF35",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 122,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 488
  },
  {
    "bcr_patient_uuid": "a8015490-9740-45c9-8bd2-eb6d1beefc2e",
    "patient_ID": "TCGA.E2.A152",
    "bcr_drug_barcode": "TCGA-E2-A152-D19125",
    "bcr_drug_uuid": "EA9D6B7D-D495-46D4-BF2D-BC35E0F65BFB",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 118,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 118
  },
  {
    "bcr_patient_uuid": "a8015490-9740-45c9-8bd2-eb6d1beefc2e",
    "patient_ID": "TCGA.E2.A152",
    "bcr_drug_barcode": "TCGA-E2-A152-D19134",
    "bcr_drug_uuid": "BF017551-9DD2-4283-A0AD-FA9F13FC6972",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 460,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12678
  },
  {
    "bcr_patient_uuid": "a8015490-9740-45c9-8bd2-eb6d1beefc2e",
    "patient_ID": "TCGA.E2.A152",
    "bcr_drug_barcode": "TCGA-E2-A152-D19126",
    "bcr_drug_uuid": "CE4C026E-0255-4BF9-93C9-FBA8B76E0AA6",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 942,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 942
  },
  {
    "bcr_patient_uuid": "a8015490-9740-45c9-8bd2-eb6d1beefc2e",
    "patient_ID": "TCGA.E2.A152",
    "bcr_drug_barcode": "TCGA-E2-A152-D19133",
    "bcr_drug_uuid": "74FB0D62-6C47-4269-B25C-6A6340F18D06",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "a8015490-9740-45c9-8bd2-eb6d1beefc2e",
    "patient_ID": "TCGA.E2.A152",
    "bcr_drug_barcode": "TCGA-E2-A152-D19127",
    "bcr_drug_uuid": "4DDAC9D3-0FF6-47D1-8863-6BA83B231D43",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL (PROTEIN-BOUND)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 156,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2641
  },
  {
    "bcr_patient_uuid": "be9bf36a-12e1-4386-addf-1686dc8b49de",
    "patient_ID": "TCGA.E2.A153",
    "bcr_drug_barcode": "TCGA-E2-A153-D18954",
    "bcr_drug_uuid": "229BE9CD-B3B4-4B15-AA20-DFF1B19DF725",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "be9bf36a-12e1-4386-addf-1686dc8b49de",
    "patient_ID": "TCGA.E2.A153",
    "bcr_drug_barcode": "TCGA-E2-A153-D18950",
    "bcr_drug_uuid": "DC77A2E0-D67A-46FB-8F56-EE1F16089F98",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1722
  },
  {
    "bcr_patient_uuid": "be9bf36a-12e1-4386-addf-1686dc8b49de",
    "patient_ID": "TCGA.E2.A153",
    "bcr_drug_barcode": "TCGA-E2-A153-D18947",
    "bcr_drug_uuid": "F3D8922B-7D20-47D4-9ECC-806723EFCE76",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5700
  },
  {
    "bcr_patient_uuid": "be9bf36a-12e1-4386-addf-1686dc8b49de",
    "patient_ID": "TCGA.E2.A153",
    "bcr_drug_barcode": "TCGA-E2-A153-D18948",
    "bcr_drug_uuid": "057F6C50-9E43-4775-9A1A-00A06EB7F9B4",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "24e39609-9645-43e5-960b-db5446eaea65",
    "patient_ID": "TCGA.E2.A154",
    "bcr_drug_barcode": "TCGA-E2-A154-D18941",
    "bcr_drug_uuid": "A19AD7AA-E6A9-40A8-A357-65677967265C",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 325,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01f50abf-fc15-446e-9d07-edeecc545a32",
    "patient_ID": "TCGA.E2.A155",
    "bcr_drug_barcode": "TCGA-E2-A155-D18962",
    "bcr_drug_uuid": "E7F98449-1AD2-4788-98A9-C1B731F13D28",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01f50abf-fc15-446e-9d07-edeecc545a32",
    "patient_ID": "TCGA.E2.A155",
    "bcr_drug_barcode": "TCGA-E2-A155-D19111",
    "bcr_drug_uuid": "DFA20391-05F7-4053-9EC5-1BD5F5261968",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "01f50abf-fc15-446e-9d07-edeecc545a32",
    "patient_ID": "TCGA.E2.A155",
    "bcr_drug_barcode": "TCGA-E2-A155-D19107",
    "bcr_drug_uuid": "FF8866DF-0183-4B72-8285-E71C4F120359",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "01f50abf-fc15-446e-9d07-edeecc545a32",
    "patient_ID": "TCGA.E2.A155",
    "bcr_drug_barcode": "TCGA-E2-A155-D18944",
    "bcr_drug_uuid": "C399DF54-62D4-49E4-AB11-5B0008E16218",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01f50abf-fc15-446e-9d07-edeecc545a32",
    "patient_ID": "TCGA.E2.A155",
    "bcr_drug_barcode": "TCGA-E2-A155-D19105",
    "bcr_drug_uuid": "39BFC0D7-45BC-4640-BA13-4397A0A9CE06",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 12,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f05d314c-5ec5-4e2a-b785-9a702716f111",
    "patient_ID": "TCGA.E2.A156",
    "bcr_drug_barcode": "TCGA-E2-A156-D18787",
    "bcr_drug_uuid": "9FA71240-8DEF-42FE-9235-91CC3980DDF7",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb",
    "patient_ID": "TCGA.E2.A158",
    "bcr_drug_barcode": "TCGA-E2-A158-D18963",
    "bcr_drug_uuid": "B94489C2-71D2-40FE-86DD-A3E999BF3373",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 450,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb",
    "patient_ID": "TCGA.E2.A158",
    "bcr_drug_barcode": "TCGA-E2-A158-D18961",
    "bcr_drug_uuid": "67C4C12D-8CB3-4ED8-8913-666D05A6057D",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb",
    "patient_ID": "TCGA.E2.A158",
    "bcr_drug_barcode": "TCGA-E2-A158-D18960",
    "bcr_drug_uuid": "8C16F7B2-EFBC-4B7E-AA40-8A152D0E4F0F",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb",
    "patient_ID": "TCGA.E2.A158",
    "bcr_drug_barcode": "TCGA-E2-A158-D18958",
    "bcr_drug_uuid": "A3051694-896A-4A9D-9178-CA248163F114",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d7308344-5bab-4073-bb4f-4d8cd8d7bd17",
    "patient_ID": "TCGA.E2.A159",
    "bcr_drug_barcode": "TCGA-E2-A159-D19119",
    "bcr_drug_uuid": "10D6AF3A-547A-4172-A1AA-9C9266122BEF",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL (PROTEIN-BOUND)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 378,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1134
  },
  {
    "bcr_patient_uuid": "d7308344-5bab-4073-bb4f-4d8cd8d7bd17",
    "patient_ID": "TCGA.E2.A159",
    "bcr_drug_barcode": "TCGA-E2-A159-D19118",
    "bcr_drug_uuid": "E04BF780-9220-4AB5-9C43-2472BB5FBFD6",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 127,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 508
  },
  {
    "bcr_patient_uuid": "d7308344-5bab-4073-bb4f-4d8cd8d7bd17",
    "patient_ID": "TCGA.E2.A159",
    "bcr_drug_barcode": "TCGA-E2-A159-D19116",
    "bcr_drug_uuid": "57830A90-A8C2-4396-977D-CC41223CD5E3",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1272,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5088
  },
  {
    "bcr_patient_uuid": "73ccc949-01b7-48d3-a7c4-c4bcd261672a",
    "patient_ID": "TCGA.E2.A15A",
    "bcr_drug_barcode": "TCGA-E2-A15A-D18933",
    "bcr_drug_uuid": "F855C3B6-E0E7-4A87-9CF5-5BB51DD2E354",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 44
  },
  {
    "bcr_patient_uuid": "73ccc949-01b7-48d3-a7c4-c4bcd261672a",
    "patient_ID": "TCGA.E2.A15A",
    "bcr_drug_barcode": "TCGA-E2-A15A-D18931",
    "bcr_drug_uuid": "D589DD76-9CC5-49F7-AB78-94321F8B1402",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 95,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "73ccc949-01b7-48d3-a7c4-c4bcd261672a",
    "patient_ID": "TCGA.E2.A15A",
    "bcr_drug_barcode": "TCGA-E2-A15A-D18932",
    "bcr_drug_uuid": "EDEDBFBC-2FEA-4A60-929F-17C65470B874",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1120
  },
  {
    "bcr_patient_uuid": "73ccc949-01b7-48d3-a7c4-c4bcd261672a",
    "patient_ID": "TCGA.E2.A15A",
    "bcr_drug_barcode": "TCGA-E2-A15A-D18929",
    "bcr_drug_uuid": "03F02177-F519-4582-80D5-FB49841CED1B",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 948,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3792
  },
  {
    "bcr_patient_uuid": "da840a22-8d30-4682-bbd0-8fa87bd40528",
    "patient_ID": "TCGA.E2.A15C",
    "bcr_drug_barcode": "TCGA-E2-A15C-D18936",
    "bcr_drug_uuid": "057D51BB-CBBC-401E-BB09-3E7A10ADCA74",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c85f080a-1075-41df-959f-1b514a11b3c4",
    "patient_ID": "TCGA.E2.A15D",
    "bcr_drug_barcode": "TCGA-E2-A15D-D18784",
    "bcr_drug_uuid": "39818837-2CB1-402D-AEE7-456C52833C47",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 316,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4100
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18930",
    "bcr_drug_uuid": "B1551326-BA16-476F-9732-DB302B702454",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 451,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18924",
    "bcr_drug_uuid": "AD397BC8-6AFC-4D6E-8808-994CFFAB1FF1",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18927",
    "bcr_drug_uuid": "407C7081-6BAE-49FF-BA21-08E9B1FFC04D",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "CLODRONATE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "CLINICAL TRIAL - BISPHOSPHONATES AS ADJUVANT THERAPY",
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18928",
    "bcr_drug_uuid": "B5431001-AC5A-44E5-A998-A5071332A876",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4900
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18920",
    "bcr_drug_uuid": "46743446-EA3E-448F-B26B-48229B9F7E41",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 95,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18921",
    "bcr_drug_uuid": "41AF0E0A-6F0D-4BC6-97E8-6D887A944099",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 954,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3816
  },
  {
    "bcr_patient_uuid": "0a2a3529-f645-4967-9a58-89ee20b8bb62",
    "patient_ID": "TCGA.E2.A15E",
    "bcr_drug_barcode": "TCGA-E2-A15E-D18925",
    "bcr_drug_uuid": "9E5B5BB6-2140-4A7E-A602-A78255F5E0C5",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 24,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 232,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6098
  },
  {
    "bcr_patient_uuid": "ec77a23d-84f5-47e4-bf2a-fa1c03baf3db",
    "patient_ID": "TCGA.E2.A15F",
    "bcr_drug_barcode": "TCGA-E2-A15F-D18907",
    "bcr_drug_uuid": "1EAC6D1E-0E8F-4AD2-8571-21809FF6F41C",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "271e8024-a008-4bf0-9f6e-177f60096b1b",
    "patient_ID": "TCGA.E2.A15G",
    "bcr_drug_barcode": "TCGA-E2-A15G-D18903",
    "bcr_drug_uuid": "BFCCD553-AC21-473B-BF95-489271D20DF1",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "5580b21a-2cdb-4777-ad79-6e06654144f5",
    "patient_ID": "TCGA.E2.A15H",
    "bcr_drug_barcode": "TCGA-E2-A15H-D18923",
    "bcr_drug_uuid": "A307776F-37AE-46FE-A3D1-D0E79E1D73A8",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "64089c20-939f-48b4-ae8b-904ad0597145",
    "patient_ID": "TCGA.E2.A15I",
    "bcr_drug_barcode": "TCGA-E2-A15I-D18890",
    "bcr_drug_uuid": "F282FF05-35FC-48D3-B9BD-E0006F0F255D",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c",
    "patient_ID": "TCGA.E2.A15J",
    "bcr_drug_barcode": "TCGA-E2-A15J-D18895",
    "bcr_drug_uuid": "D882E0A2-E3B4-4D0A-ADB8-9D48507E0D7B",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1008,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4032
  },
  {
    "bcr_patient_uuid": "1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c",
    "patient_ID": "TCGA.E2.A15J",
    "bcr_drug_barcode": "TCGA-E2-A15J-D18896",
    "bcr_drug_uuid": "E6213072-8B49-4836-BAAF-DE4685016685",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c",
    "patient_ID": "TCGA.E2.A15J",
    "bcr_drug_barcode": "TCGA-E2-A15J-D18893",
    "bcr_drug_uuid": "A6C43C80-32E8-4A0D-A6C0-6332C91C8B32",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 126,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 504
  },
  {
    "bcr_patient_uuid": "17c1d42c-cb84-4655-a4cd-b54bae17ecaf",
    "patient_ID": "TCGA.E2.A15K",
    "bcr_drug_barcode": "TCGA-E2-A15K-D18877",
    "bcr_drug_uuid": "DFF4C694-40E2-4F27-BDD5-0AF99106E3C5",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 4,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17c1d42c-cb84-4655-a4cd-b54bae17ecaf",
    "patient_ID": "TCGA.E2.A15K",
    "bcr_drug_barcode": "TCGA-E2-A15K-D18874",
    "bcr_drug_uuid": "06D39A90-4056-428C-A6A2-7AEF31C3FE5C",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "17c1d42c-cb84-4655-a4cd-b54bae17ecaf",
    "patient_ID": "TCGA.E2.A15K",
    "bcr_drug_barcode": "TCGA-E2-A15K-D18871",
    "bcr_drug_uuid": "9C486924-7EF1-47D8-B98A-2676AE270FE8",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "37242f5a-25ae-4b1f-9ce6-09ce1dc92539",
    "patient_ID": "TCGA.E2.A15L",
    "bcr_drug_barcode": "TCGA-E2-A15L-D18887",
    "bcr_drug_uuid": "50C9B52E-A733-4A39-89C6-A845EDDC1CC5",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "59be60a3-e0f6-4d63-b98c-574ef92428c4",
    "patient_ID": "TCGA.E2.A15M",
    "bcr_drug_barcode": "TCGA-E2-A15M-D18853",
    "bcr_drug_uuid": "6085AD44-E291-473A-9D84-846B9D83A6A7",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "eafa45a4-2fd1-4fa3-860c-9d52ed382b7d",
    "patient_ID": "TCGA.E2.A15O",
    "bcr_drug_barcode": "TCGA-E2-A15O-D19169",
    "bcr_drug_uuid": "ABECA7CD-0E93-4DCF-938C-350829939C31",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 396,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eafa45a4-2fd1-4fa3-860c-9d52ed382b7d",
    "patient_ID": "TCGA.E2.A15O",
    "bcr_drug_barcode": "TCGA-E2-A15O-D19167",
    "bcr_drug_uuid": "61BED00F-F2EF-4F91-8BC8-B0F1BEEEE796",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "eafa45a4-2fd1-4fa3-860c-9d52ed382b7d",
    "patient_ID": "TCGA.E2.A15O",
    "bcr_drug_barcode": "TCGA-E2-A15O-D19166",
    "bcr_drug_uuid": "6E587C05-8883-4909-BE96-852F9352E81A",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 56
  },
  {
    "bcr_patient_uuid": "eafa45a4-2fd1-4fa3-860c-9d52ed382b7d",
    "patient_ID": "TCGA.E2.A15O",
    "bcr_drug_barcode": "TCGA-E2-A15O-D70381",
    "bcr_drug_uuid": "D54F8164-4FDA-4707-A7AE-8057748B100D",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1245,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a1674d7b-787a-45c4-bf16-1b7d0efce207",
    "patient_ID": "TCGA.E2.A15P",
    "bcr_drug_barcode": "TCGA-E2-A15P-D19146",
    "bcr_drug_uuid": "CEE4C48F-410A-452E-9C36-DF6142898E8D",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "a1674d7b-787a-45c4-bf16-1b7d0efce207",
    "patient_ID": "TCGA.E2.A15P",
    "bcr_drug_barcode": "TCGA-E2-A15P-D19145",
    "bcr_drug_uuid": "F89D7938-6B30-4AF5-84F0-30B5D1B87F69",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 115
  },
  {
    "bcr_patient_uuid": "33b7bf50-53f4-4839-aa83-9665f85671d8",
    "patient_ID": "TCGA.E2.A15R",
    "bcr_drug_barcode": "TCGA-E2-A15R-D19174",
    "bcr_drug_uuid": "1A8B3B00-0153-4DD2-8AC8-804B467C84CF",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 266,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "33b7bf50-53f4-4839-aa83-9665f85671d8",
    "patient_ID": "TCGA.E2.A15R",
    "bcr_drug_barcode": "TCGA-E2-A15R-D19171",
    "bcr_drug_uuid": "28619333-01BE-42CB-9524-04AFE22A9D84",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "33b7bf50-53f4-4839-aa83-9665f85671d8",
    "patient_ID": "TCGA.E2.A15R",
    "bcr_drug_barcode": "TCGA-E2-A15R-D19172",
    "bcr_drug_uuid": "14E71F28-E7FC-4F5A-AAB3-781734D03604",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "33b7bf50-53f4-4839-aa83-9665f85671d8",
    "patient_ID": "TCGA.E2.A15R",
    "bcr_drug_barcode": "TCGA-E2-A15R-D19173",
    "bcr_drug_uuid": "1B56D8BF-E538-4CCC-B9F5-1F7CC5EA6366",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 268,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1072
  },
  {
    "bcr_patient_uuid": "0f7ab21b-1fd0-45e0-9a47-17c4691eb84f",
    "patient_ID": "TCGA.E2.A15S",
    "bcr_drug_barcode": "TCGA-E2-A15S-D19140",
    "bcr_drug_uuid": "CEBFFF93-6688-400B-AA11-6CD3B44EFE31",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 314,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "0f7ab21b-1fd0-45e0-9a47-17c4691eb84f",
    "patient_ID": "TCGA.E2.A15S",
    "bcr_drug_barcode": "TCGA-E2-A15S-D19136",
    "bcr_drug_uuid": "8460E5C6-9209-4D1B-889B-72D74DE61493",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 918,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2754
  },
  {
    "bcr_patient_uuid": "0f7ab21b-1fd0-45e0-9a47-17c4691eb84f",
    "patient_ID": "TCGA.E2.A15S",
    "bcr_drug_barcode": "TCGA-E2-A15S-D19137",
    "bcr_drug_uuid": "E2A0AE1A-0AFD-48FC-A05A-64B284BBC153",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 92,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 276
  },
  {
    "bcr_patient_uuid": "0f7ab21b-1fd0-45e0-9a47-17c4691eb84f",
    "patient_ID": "TCGA.E2.A15S",
    "bcr_drug_barcode": "TCGA-E2-A15S-D19139",
    "bcr_drug_uuid": "F323125C-76E3-4E3E-AFB8-2355B2C63C47",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e68ebfd4-3688-4caa-9e38-7764f9258c30",
    "patient_ID": "TCGA.E2.A15T",
    "bcr_drug_barcode": "TCGA-E2-A15T-D19143",
    "bcr_drug_uuid": "A71ADC96-7255-4D33-ABC9-4883E48C7DB3",
    "form_completion_date": "2011-11-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "89128dba-403f-4a96-bb3b-23ed0d5e2147",
    "patient_ID": "TCGA.E2.A1AZ",
    "bcr_drug_barcode": "TCGA-E2-A1AZ-D19476",
    "bcr_drug_uuid": "64F31114-ABD4-4E0D-BAAD-06531F01F8A0",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1125,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "89128dba-403f-4a96-bb3b-23ed0d5e2147",
    "patient_ID": "TCGA.E2.A1AZ",
    "bcr_drug_barcode": "TCGA-E2-A1AZ-D19468",
    "bcr_drug_uuid": "A7A7027F-58E3-4B34-B912-C6A0C84BECC8",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "996bd3f0-d767-4eff-9c82-99fcb5a3006a",
    "patient_ID": "TCGA.E2.A1B0",
    "bcr_drug_barcode": "TCGA-E2-A1B0-D19463",
    "bcr_drug_uuid": "5806DC75-529D-450D-952E-3AEA4294E6CB",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 126,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 756
  },
  {
    "bcr_patient_uuid": "996bd3f0-d767-4eff-9c82-99fcb5a3006a",
    "patient_ID": "TCGA.E2.A1B0",
    "bcr_drug_barcode": "TCGA-E2-A1B0-D19464",
    "bcr_drug_uuid": "A0811C15-BA7F-4042-8E8C-0C3BA33C8A89",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1260,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7560
  },
  {
    "bcr_patient_uuid": "996bd3f0-d767-4eff-9c82-99fcb5a3006a",
    "patient_ID": "TCGA.E2.A1B0",
    "bcr_drug_barcode": "TCGA-E2-A1B0-D19466",
    "bcr_drug_uuid": "F6516BAA-1825-4C57-824A-D8EE3A2497D8",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "996bd3f0-d767-4eff-9c82-99fcb5a3006a",
    "patient_ID": "TCGA.E2.A1B0",
    "bcr_drug_barcode": "TCGA-E2-A1B0-D19480",
    "bcr_drug_uuid": "B08E096E-EE65-42AA-B000-0198892EB17B",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 557,
    "drug_cycles": 16,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 545,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8720
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19424",
    "bcr_drug_uuid": "AA17D85A-0FDD-47FB-9D84-B8E632A19374",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 969,
    "drug_cycles": 15,
    "pharma_type_other": "BIPHOSPHONATE",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19433",
    "bcr_drug_uuid": "1C0E879C-D0B0-45F3-B530-C9E53A0BFC31",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 195,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2145
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19419",
    "bcr_drug_uuid": "2F50945A-770E-4BAE-A4BA-BF8337D74422",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19435",
    "bcr_drug_uuid": "8C3CFC3B-88E5-4E90-AE7E-1F4CE327F036",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1464,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5856
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19428",
    "bcr_drug_uuid": "607FFFF8-3B83-4A56-8A6B-04F87ECAD6F5",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 491,
    "drug_cycles": 24,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 672,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16128
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19421",
    "bcr_drug_uuid": "347D45D4-7A50-4C57-9CAF-B7BE348BDE4F",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "TRIPTORELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3.75,
    "regimen_number": 3,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8a0ef221-8070-43fc-9d98-def90abe4871",
    "patient_ID": "TCGA.E2.A1B1",
    "bcr_drug_barcode": "TCGA-E2-A1B1-D19438",
    "bcr_drug_uuid": "F78B48EF-E33F-4DC4-8527-32A39CF392F3",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 146,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 584
  },
  {
    "bcr_patient_uuid": "dbb2da92-99dd-400c-bc05-e87d7273656c",
    "patient_ID": "TCGA.E2.A1B4",
    "bcr_drug_barcode": "TCGA-E2-A1B4-D19444",
    "bcr_drug_uuid": "A6C154F3-9CE0-4FC3-943B-640A43ADC915",
    "form_completion_date": "2011-12-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1004,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 828
  },
  {
    "bcr_patient_uuid": "7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a",
    "patient_ID": "TCGA.E2.A1B5",
    "bcr_drug_barcode": "TCGA-E2-A1B5-D19397",
    "bcr_drug_uuid": "CB3816CF-67CB-4392-B82C-D7FC2F387357",
    "form_completion_date": "2011-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a",
    "patient_ID": "TCGA.E2.A1B5",
    "bcr_drug_barcode": "TCGA-E2-A1B5-D19400",
    "bcr_drug_uuid": "D6F378A8-CE13-4C40-A22C-63B7D803BC36",
    "form_completion_date": "2011-12-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a",
    "patient_ID": "TCGA.E2.A1B5",
    "bcr_drug_barcode": "TCGA-E2-A1B5-D19408",
    "bcr_drug_uuid": "EE248DCA-EF7B-4120-BC49-86460A2BD750",
    "form_completion_date": "2011-12-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e0b1bcd2-1139-44b9-98b3-67bcf92bcc39",
    "patient_ID": "TCGA.E2.A1B6",
    "bcr_drug_barcode": "TCGA-E2-A1B6-D19420",
    "bcr_drug_uuid": "5B691CC0-6DE5-419D-96FB-0C8A7DEB398B",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e0b1bcd2-1139-44b9-98b3-67bcf92bcc39",
    "patient_ID": "TCGA.E2.A1B6",
    "bcr_drug_barcode": "TCGA-E2-A1B6-D19412",
    "bcr_drug_uuid": "41211D2C-2E5E-4A2E-B31D-B8B5FD4053B0",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e0b1bcd2-1139-44b9-98b3-67bcf92bcc39",
    "patient_ID": "TCGA.E2.A1B6",
    "bcr_drug_barcode": "TCGA-E2-A1B6-D19399",
    "bcr_drug_uuid": "3110E408-194F-4231-98AC-379E031BB58E",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d8492ebd-3d94-4a4b-8de7-386526691cc2",
    "patient_ID": "TCGA.E2.A1BC",
    "bcr_drug_barcode": "TCGA-E2-A1BC-D19437",
    "bcr_drug_uuid": "13C0F950-43CA-42DC-8E5D-A36D4B38FED8",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "0e1d0d46-7a7b-4538-95dd-b9fc20a15aec",
    "patient_ID": "TCGA.E2.A1BD",
    "bcr_drug_barcode": "TCGA-E2-A1BD-D19445",
    "bcr_drug_uuid": "2534A6C5-8DD5-454D-8887-6098E2B7CBB1",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D19968",
    "bcr_drug_uuid": "21FD6890-254A-4F5F-B112-8D1EB3C23341",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 341,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1364
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D19965",
    "bcr_drug_uuid": "F1068428-E9F7-419B-B5A1-1C52A1E42A8E",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 118,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 472
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D19967",
    "bcr_drug_uuid": "65CC9CCD-D919-4BCD-96BF-619424B8D8BE",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1182,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4728
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D19971",
    "bcr_drug_uuid": "FF2B7E21-B246-498D-8B7B-4B91A0FB3425",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 500,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D19970",
    "bcr_drug_uuid": "D27CB74E-89DC-4859-81F9-CBA4A807E9E8",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 437,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 185
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D70374",
    "bcr_drug_uuid": "FC87038A-95A3-4E05-9442-79BF251AF39F",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1844,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1928,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D70375",
    "bcr_drug_uuid": "6A7EB17B-231B-4C2C-B1B0-8825B0BD71CA",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "FASLODEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1928,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D70376",
    "bcr_drug_uuid": "7325CF50-8976-4A43-9E2F-6FA667BC428C",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2187,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d",
    "patient_ID": "TCGA.E2.A1IE",
    "bcr_drug_barcode": "TCGA-E2-A1IE-D70377",
    "bcr_drug_uuid": "07C275AD-3B22-436C-89C9-CCB6FD3D2B2E",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2187,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "718db047-9f32-48c4-98c9-515218441bca",
    "patient_ID": "TCGA.E2.A1IF",
    "bcr_drug_barcode": "TCGA-E2-A1IF-D19963",
    "bcr_drug_uuid": "B72C6A80-3E80-4683-A073-49251E7CF780",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4",
    "patient_ID": "TCGA.E2.A1IG",
    "bcr_drug_barcode": "TCGA-E2-A1IG-D19933",
    "bcr_drug_uuid": "521E6E77-C1C4-4361-8566-1E7AE45D7CC4",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 990,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4",
    "patient_ID": "TCGA.E2.A1IG",
    "bcr_drug_barcode": "TCGA-E2-A1IG-D19936",
    "bcr_drug_uuid": "83E712C3-ABC5-4875-A5A1-4AEBEA1D27BA",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 234,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4",
    "patient_ID": "TCGA.E2.A1IG",
    "bcr_drug_barcode": "TCGA-E2-A1IG-D19935",
    "bcr_drug_uuid": "35DF36F9-799F-4E34-98BB-453D807A55AF",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 290,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1160
  },
  {
    "bcr_patient_uuid": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4",
    "patient_ID": "TCGA.E2.A1IG",
    "bcr_drug_barcode": "TCGA-E2-A1IG-D19934",
    "bcr_drug_uuid": "3DAFFE53-CA87-4B06-A70E-1F55782E3964",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 99,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 396
  },
  {
    "bcr_patient_uuid": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4",
    "patient_ID": "TCGA.E2.A1IG",
    "bcr_drug_barcode": "TCGA-E2-A1IG-D70393",
    "bcr_drug_uuid": "86F3FAA8-97CD-4A7E-B217-21DCAB6419BA",
    "form_completion_date": "2015-3-16",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1991,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ec0155ab-1b14-498d-8fa9-9f63e3ccb990",
    "patient_ID": "TCGA.E2.A1IH",
    "bcr_drug_barcode": "TCGA-E2-A1IH-D19961",
    "bcr_drug_uuid": "ADCF42F6-D220-4FED-B497-03BA85C4304D",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "0fe1419e-a005-407c-8ae7-15c4c1579539",
    "patient_ID": "TCGA.E2.A1II",
    "bcr_drug_barcode": "TCGA-E2-A1II-D19957",
    "bcr_drug_uuid": "E52E0CD6-6BA3-4B19-B9A1-B64D2D70C333",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 328,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1312
  },
  {
    "bcr_patient_uuid": "0fe1419e-a005-407c-8ae7-15c4c1579539",
    "patient_ID": "TCGA.E2.A1II",
    "bcr_drug_barcode": "TCGA-E2-A1II-D19956",
    "bcr_drug_uuid": "7F620EE0-F7E5-41C9-9E7F-E47843DBB6EC",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1164,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4656
  },
  {
    "bcr_patient_uuid": "0fe1419e-a005-407c-8ae7-15c4c1579539",
    "patient_ID": "TCGA.E2.A1II",
    "bcr_drug_barcode": "TCGA-E2-A1II-D19955",
    "bcr_drug_uuid": "32F5916B-52FE-4FD3-8F7D-FAFD84F63E02",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 116,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "b09643c2-ded5-4346-b3c5-90a48f88a02e",
    "patient_ID": "TCGA.E2.A1IJ",
    "bcr_drug_barcode": "TCGA-E2-A1IJ-D19952",
    "bcr_drug_uuid": "F81CA42B-439C-4C65-B16B-D4461F89A002",
    "form_completion_date": "2011-12-21",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "becedbfd-b2aa-4dde-b7f4-29e6f59ec32c",
    "patient_ID": "TCGA.E2.A1IK",
    "bcr_drug_barcode": "TCGA-E2-A1IK-D19977",
    "bcr_drug_uuid": "11888A89-B610-43B7-9103-C695EDAB9332",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "b63391a0-73f8-4544-9e94-f6529245ca2a",
    "patient_ID": "TCGA.E2.A1IL",
    "bcr_drug_barcode": "TCGA-E2-A1IL-D20281",
    "bcr_drug_uuid": "383F11A4-7593-479A-95EA-EBB7ED807F66",
    "form_completion_date": "2012-1-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "f43d622f-eed5-4933-adc6-ae9ad1e33028",
    "patient_ID": "TCGA.E2.A1IN",
    "bcr_drug_barcode": "TCGA-E2-A1IN-D20324",
    "bcr_drug_uuid": "F7685815-0BF1-443B-9F43-01B6887E6A92",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "71fc8941-4cfb-47ea-a533-873d38f8c95c",
    "patient_ID": "TCGA.E2.A1IO",
    "bcr_drug_barcode": "TCGA-E2-A1IO-D20319",
    "bcr_drug_uuid": "5CAD1231-055C-4E7F-AA97-689B30AEE887",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 924,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3696
  },
  {
    "bcr_patient_uuid": "71fc8941-4cfb-47ea-a533-873d38f8c95c",
    "patient_ID": "TCGA.E2.A1IO",
    "bcr_drug_barcode": "TCGA-E2-A1IO-D20320",
    "bcr_drug_uuid": "BFC8334A-C530-4EE0-860A-3473046CCE9F",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 115.5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 462
  },
  {
    "bcr_patient_uuid": "71fc8941-4cfb-47ea-a533-873d38f8c95c",
    "patient_ID": "TCGA.E2.A1IO",
    "bcr_drug_barcode": "TCGA-E2-A1IO-D20321",
    "bcr_drug_uuid": "07023BDC-054F-4A18-BA92-A01D49FC2F1D",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 266,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "001cef41-ff86-4d3f-a140-a647ac4b10a1",
    "patient_ID": "TCGA.E2.A1IU",
    "bcr_drug_barcode": "TCGA-E2-A1IU-D19975",
    "bcr_drug_uuid": "6BB85C8B-BED1-4F0D-B330-2307404DA314",
    "form_completion_date": "2012-1-4",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20576",
    "bcr_drug_uuid": "D638F4F1-F401-40B5-B9C4-16792E4F1718",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "TRIPTORELIN",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "PHASE III CLINICAL TRIAL",
    "drug_units": "MG",
    "drug_dose": 3.75,
    "regimen_number": 3,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20571",
    "bcr_drug_uuid": "2A551287-56B0-41BD-BFD3-1F24A796AAC3",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 935,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3740
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20572",
    "bcr_drug_uuid": "5BDBE33A-381E-477B-B28D-073FCBA0DB9F",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 95,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20577",
    "bcr_drug_uuid": "ED98E166-5C11-4AE6-82DC-463DE3C00BEE",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20573",
    "bcr_drug_uuid": "C239325B-6739-43DD-A6FB-832310B2644B",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "2e32f31f-9817-4935-b259-96c59936ee33",
    "patient_ID": "TCGA.E2.A1L6",
    "bcr_drug_barcode": "TCGA-E2-A1L6-D20574",
    "bcr_drug_uuid": "C2F3080E-04F4-408F-945A-184A8E8F53AD",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "CLODRONATE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1120,
    "pharma_type_other": "PHASE III CLINICAL TRIAL",
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1600,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3",
    "patient_ID": "TCGA.E2.A1L7",
    "bcr_drug_barcode": "TCGA-E2-A1L7-D20594",
    "bcr_drug_uuid": "EAECF0E4-3985-48CF-AB0D-2AC40D9B4036",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3",
    "patient_ID": "TCGA.E2.A1L7",
    "bcr_drug_barcode": "TCGA-E2-A1L7-D20590",
    "bcr_drug_uuid": "36955FD4-89C2-4248-AAA1-8D8CE8F1DA04",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3",
    "patient_ID": "TCGA.E2.A1L7",
    "bcr_drug_barcode": "TCGA-E2-A1L7-D20591",
    "bcr_drug_uuid": "42D99A31-F6C7-4E6D-9F04-7D6E1901B392",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 359,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1436
  },
  {
    "bcr_patient_uuid": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3",
    "patient_ID": "TCGA.E2.A1L7",
    "bcr_drug_barcode": "TCGA-E2-A1L7-D20592",
    "bcr_drug_uuid": "0C4583A4-E88D-4BDE-9CB3-9938094B71F8",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "CLODRONATE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "PHASE III CLINICAL TRIAL",
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1600,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3",
    "patient_ID": "TCGA.E2.A1L7",
    "bcr_drug_barcode": "TCGA-E2-A1L7-D20589",
    "bcr_drug_uuid": "B07261AA-1C81-4C97-9D43-2C0E1543ABFF",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "eebad74f-5961-4e91-b0eb-157a2f6f952b",
    "patient_ID": "TCGA.E2.A1L8",
    "bcr_drug_barcode": "TCGA-E2-A1L8-D20584",
    "bcr_drug_uuid": "04419A9C-960A-495A-B91F-48F2C8876597",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "eebad74f-5961-4e91-b0eb-157a2f6f952b",
    "patient_ID": "TCGA.E2.A1L8",
    "bcr_drug_barcode": "TCGA-E2-A1L8-D20582",
    "bcr_drug_uuid": "5D31DD41-67CF-4788-B56F-452F014B7821",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CLODRONATE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": true,
    "pharma_type_other": "PHASE III CLINICAL TRIAL",
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1600,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "eebad74f-5961-4e91-b0eb-157a2f6f952b",
    "patient_ID": "TCGA.E2.A1L8",
    "bcr_drug_barcode": "TCGA-E2-A1L8-D20581",
    "bcr_drug_uuid": "00FD3E45-CD1B-4F71-915F-C2CF8C467F22",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 428,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1712
  },
  {
    "bcr_patient_uuid": "eebad74f-5961-4e91-b0eb-157a2f6f952b",
    "patient_ID": "TCGA.E2.A1L8",
    "bcr_drug_barcode": "TCGA-E2-A1L8-D20579",
    "bcr_drug_uuid": "93A3B706-6851-4D5B-94A6-715C910C6825",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1320,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "eebad74f-5961-4e91-b0eb-157a2f6f952b",
    "patient_ID": "TCGA.E2.A1L8",
    "bcr_drug_barcode": "TCGA-E2-A1L8-D20580",
    "bcr_drug_uuid": "D86361A9-8F77-4C1D-AF65-1E775A676B4E",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 132,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 396
  },
  {
    "bcr_patient_uuid": "5ea18514-51ad-4844-abea-15e82f0b10c9",
    "patient_ID": "TCGA.E2.A1L9",
    "bcr_drug_barcode": "TCGA-E2-A1L9-D20600",
    "bcr_drug_uuid": "ACCE2AC2-3256-4F8C-B862-CA109FC03BA3",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5ea18514-51ad-4844-abea-15e82f0b10c9",
    "patient_ID": "TCGA.E2.A1L9",
    "bcr_drug_barcode": "TCGA-E2-A1L9-D20601",
    "bcr_drug_uuid": "EA86D6FC-965B-4DD5-BAA8-D08128E3B0F1",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "5ea18514-51ad-4844-abea-15e82f0b10c9",
    "patient_ID": "TCGA.E2.A1L9",
    "bcr_drug_barcode": "TCGA-E2-A1L9-D20598",
    "bcr_drug_uuid": "4A43A807-30FB-4969-B77C-A3BC9D040351",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ce9e0309-9756-42d2-ae94-d91264a79498",
    "patient_ID": "TCGA.E2.A1LA",
    "bcr_drug_barcode": "TCGA-E2-A1LA-D20587",
    "bcr_drug_uuid": "2BE8D472-4522-4803-AA13-CA72D38B9A45",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "fa176764-a76f-44c7-b97a-cd6d21e052be",
    "patient_ID": "TCGA.E2.A1LB",
    "bcr_drug_barcode": "TCGA-E2-A1LB-D20654",
    "bcr_drug_uuid": "EE4ED476-18BE-4535-BB8A-4781CC63C7E0",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 441,
    "drug_cycles": 24,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 496,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11904
  },
  {
    "bcr_patient_uuid": "fa176764-a76f-44c7-b97a-cd6d21e052be",
    "patient_ID": "TCGA.E2.A1LB",
    "bcr_drug_barcode": "TCGA-E2-A1LB-D20655",
    "bcr_drug_uuid": "1B740152-15BF-45B7-AA8A-AC589F898590",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1206,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4824
  },
  {
    "bcr_patient_uuid": "fa176764-a76f-44c7-b97a-cd6d21e052be",
    "patient_ID": "TCGA.E2.A1LB",
    "bcr_drug_barcode": "TCGA-E2-A1LB-D20653",
    "bcr_drug_uuid": "9B62DB92-ACF7-4884-9460-C1634758D79B",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1860
  },
  {
    "bcr_patient_uuid": "fa176764-a76f-44c7-b97a-cd6d21e052be",
    "patient_ID": "TCGA.E2.A1LB",
    "bcr_drug_barcode": "TCGA-E2-A1LB-D20651",
    "bcr_drug_uuid": "2E9325B6-A784-44EF-8EBD-2F8B989A6248",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 121,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 484
  },
  {
    "bcr_patient_uuid": "7317E605-93BA-49A9-8743-20613B02767A",
    "patient_ID": "TCGA.E2.A1LE",
    "bcr_drug_barcode": "TCGA-E2-A1LE-D20664",
    "bcr_drug_uuid": "7BC50522-B439-499F-88CC-E549DC5D26A6",
    "form_completion_date": "2012-1-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 468,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 530,
    "drug_cycles": 3,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7317E605-93BA-49A9-8743-20613B02767A",
    "patient_ID": "TCGA.E2.A1LE",
    "bcr_drug_barcode": "TCGA-E2-A1LE-D20661",
    "bcr_drug_uuid": "522A5688-06F7-4DE2-AAB5-1A7CFA4286A1",
    "form_completion_date": "2012-1-18",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1074,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1074
  },
  {
    "bcr_patient_uuid": "7317E605-93BA-49A9-8743-20613B02767A",
    "patient_ID": "TCGA.E2.A1LE",
    "bcr_drug_barcode": "TCGA-E2-A1LE-D20658",
    "bcr_drug_uuid": "E1057F1C-5208-4158-B2EA-5017FB560FF6",
    "form_completion_date": "2012-1-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 134,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 134
  },
  {
    "bcr_patient_uuid": "7317E605-93BA-49A9-8743-20613B02767A",
    "patient_ID": "TCGA.E2.A1LE",
    "bcr_drug_barcode": "TCGA-E2-A1LE-D20660",
    "bcr_drug_uuid": "19196460-368E-41C9-B27F-4DB7C615B079",
    "form_completion_date": "2012-1-18",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 635,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 635
  },
  {
    "bcr_patient_uuid": "ef4cbd38-bc79-4d60-a715-647edd2ebe9e",
    "patient_ID": "TCGA.E2.A1LG",
    "bcr_drug_barcode": "TCGA-E2-A1LG-D20670",
    "bcr_drug_uuid": "DF10E7FA-8490-438B-9DCA-DD142DC33D12",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 121,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 484
  },
  {
    "bcr_patient_uuid": "ef4cbd38-bc79-4d60-a715-647edd2ebe9e",
    "patient_ID": "TCGA.E2.A1LG",
    "bcr_drug_barcode": "TCGA-E2-A1LG-D20669",
    "bcr_drug_uuid": "488371CC-2C95-4257-B1B6-36AB27305123",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1212,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4848
  },
  {
    "bcr_patient_uuid": "ef4cbd38-bc79-4d60-a715-647edd2ebe9e",
    "patient_ID": "TCGA.E2.A1LG",
    "bcr_drug_barcode": "TCGA-E2-A1LG-D20676",
    "bcr_drug_uuid": "9B0E366A-08A8-40E8-A5C4-5C424DAE717E",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB OR PLACEBO",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "pharma_type_other": "PHASE III CLINICAL TRIAL",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 880,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8860
  },
  {
    "bcr_patient_uuid": "ef4cbd38-bc79-4d60-a715-647edd2ebe9e",
    "patient_ID": "TCGA.E2.A1LG",
    "bcr_drug_barcode": "TCGA-E2-A1LG-D20672",
    "bcr_drug_uuid": "166CD47F-16CF-45F5-8581-239149E00AD1",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 162,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1554
  },
  {
    "bcr_patient_uuid": "d8ecba6a-9fff-4993-a799-9a8d2aea524e",
    "patient_ID": "TCGA.E2.A1LH",
    "bcr_drug_barcode": "TCGA-E2-A1LH-D20659",
    "bcr_drug_uuid": "2D696153-39F9-4F7D-8E35-5B056E1F654F",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d8ecba6a-9fff-4993-a799-9a8d2aea524e",
    "patient_ID": "TCGA.E2.A1LH",
    "bcr_drug_barcode": "TCGA-E2-A1LH-D20652",
    "bcr_drug_uuid": "908E780C-09EB-4CBC-AD5A-75B352A71460",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3558dec7-eae3-4a41-a217-266c6a4535fb",
    "patient_ID": "TCGA.E2.A1LI",
    "bcr_drug_barcode": "TCGA-E2-A1LI-D20625",
    "bcr_drug_uuid": "8E4821F1-29B2-4F8E-B282-225C81946E03",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "3558dec7-eae3-4a41-a217-266c6a4535fb",
    "patient_ID": "TCGA.E2.A1LI",
    "bcr_drug_barcode": "TCGA-E2-A1LI-D20624",
    "bcr_drug_uuid": "EDBA2340-0F7F-49B5-9FBD-5B68A1F31507",
    "form_completion_date": "2012-1-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 600,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "2a84997d-ccee-4f46-bea2-752534f26416",
    "patient_ID": "TCGA.E2.A1LL",
    "bcr_drug_barcode": "TCGA-E2-A1LL-D20618",
    "bcr_drug_uuid": "8FE9F6AA-8F33-41C4-8D94-56C3DA00BD0B",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1260,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1260
  },
  {
    "bcr_patient_uuid": "2a84997d-ccee-4f46-bea2-752534f26416",
    "patient_ID": "TCGA.E2.A1LL",
    "bcr_drug_barcode": "TCGA-E2-A1LL-D20617",
    "bcr_drug_uuid": "9EECED51-430D-48E6-9828-E3E8CF095C2A",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 158,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 158
  },
  {
    "bcr_patient_uuid": "91a2f2af-e4b1-4a0b-ab20-6a36ce63c533",
    "patient_ID": "TCGA.E2.A1LS",
    "bcr_drug_barcode": "TCGA-E2-A1LS-D20606",
    "bcr_drug_uuid": "ECEACF6D-18C4-4309-8AA5-54E2B721DAFE",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91a2f2af-e4b1-4a0b-ab20-6a36ce63c533",
    "patient_ID": "TCGA.E2.A1LS",
    "bcr_drug_barcode": "TCGA-E2-A1LS-D20604",
    "bcr_drug_uuid": "225992D9-0568-4DD6-BF26-D1C6E065C3DE",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "F0DE67FF-8967-4FCE-9C12-0E07193285CD",
    "patient_ID": "TCGA.E2.A2P5",
    "bcr_drug_barcode": "TCGA-E2-A2P5-D33517",
    "bcr_drug_uuid": "BB98F3FD-3E77-42DE-B60F-4556F6BBDBEF",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F83B866B-0B2E-4BBA-9367-BE6DCCF56232",
    "patient_ID": "TCGA.E2.A2P6",
    "bcr_drug_barcode": "TCGA-E2-A2P6-D33515",
    "bcr_drug_uuid": "06510269-80AF-46F3-B6EA-7AE5484CBCC2",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31427699-E27A-4035-8925-6D8D6900D097",
    "patient_ID": "TCGA.E2.A3DX",
    "bcr_drug_barcode": "TCGA-E2-A3DX-D35823",
    "bcr_drug_uuid": "FB2F6144-201F-4111-AEB2-123019146F45",
    "form_completion_date": "2012-10-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31427699-E27A-4035-8925-6D8D6900D097",
    "patient_ID": "TCGA.E2.A3DX",
    "bcr_drug_barcode": "TCGA-E2-A3DX-D35825",
    "bcr_drug_uuid": "7F0FA9CD-0E62-4C40-8FD4-10D3CC42DF92",
    "form_completion_date": "2012-10-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31427699-E27A-4035-8925-6D8D6900D097",
    "patient_ID": "TCGA.E2.A3DX",
    "bcr_drug_barcode": "TCGA-E2-A3DX-D35826",
    "bcr_drug_uuid": "3D6D5170-8502-4FC1-8187-1BFE6364B6EA",
    "form_completion_date": "2012-10-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31427699-E27A-4035-8925-6D8D6900D097",
    "patient_ID": "TCGA.E2.A3DX",
    "bcr_drug_barcode": "TCGA-E2-A3DX-D35827",
    "bcr_drug_uuid": "82FCFACE-DFFB-46A2-B4AB-EEB1D20CF49C",
    "form_completion_date": "2012-10-9",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "31427699-E27A-4035-8925-6D8D6900D097",
    "patient_ID": "TCGA.E2.A3DX",
    "bcr_drug_barcode": "TCGA-E2-A3DX-D35828",
    "bcr_drug_uuid": "53169165-315E-485D-A2BE-FAA021F7BBC2",
    "form_completion_date": "2012-10-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 280,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45C3975C-D333-4237-93F7-E12DC2451C38",
    "patient_ID": "TCGA.E2.A56Z",
    "bcr_drug_barcode": "TCGA-E2-A56Z-D44509",
    "bcr_drug_uuid": "B6730BD0-5AB2-4AC6-A8F5-F2DFB0DDBAD9",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDD8C046-FD97-482A-A11F-2217B321C4D1",
    "patient_ID": "TCGA.E2.A570",
    "bcr_drug_barcode": "TCGA-E2-A570-D44535",
    "bcr_drug_uuid": "569DEEF9-63F5-49E8-8D2F-AC6BA220410F",
    "form_completion_date": "2013-6-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06EF6E83-5583-45B9-A0BD-EDEA68943083",
    "patient_ID": "TCGA.E2.A572",
    "bcr_drug_barcode": "TCGA-E2-A572-D48249",
    "bcr_drug_uuid": "E2D5FD02-12D8-4B62-B9C9-CF7275EFA17A",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06EF6E83-5583-45B9-A0BD-EDEA68943083",
    "patient_ID": "TCGA.E2.A572",
    "bcr_drug_barcode": "TCGA-E2-A572-D48250",
    "bcr_drug_uuid": "D7049B0E-CA68-4603-B147-7FE56C43BF18",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06EF6E83-5583-45B9-A0BD-EDEA68943083",
    "patient_ID": "TCGA.E2.A572",
    "bcr_drug_barcode": "TCGA-E2-A572-D48251",
    "bcr_drug_uuid": "50D48DA4-E3E7-49B4-9DCA-3BDA540825A4",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6429C443-8AC3-407F-BB9C-66420B904BBF",
    "patient_ID": "TCGA.E2.A573",
    "bcr_drug_barcode": "TCGA-E2-A573-D44501",
    "bcr_drug_uuid": "3AF01D86-64C7-405F-887D-1A0D27831968",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6429C443-8AC3-407F-BB9C-66420B904BBF",
    "patient_ID": "TCGA.E2.A573",
    "bcr_drug_barcode": "TCGA-E2-A573-D44502",
    "bcr_drug_uuid": "3A195E08-569B-4623-BF02-4176DE92D98C",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "029CE650-5E5A-4100-8596-CD94300E7EF5",
    "patient_ID": "TCGA.E2.A574",
    "bcr_drug_barcode": "TCGA-E2-A574-D44493",
    "bcr_drug_uuid": "02DB6D61-50D4-4B55-B5BF-A0FA7D3B5B13",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "029CE650-5E5A-4100-8596-CD94300E7EF5",
    "patient_ID": "TCGA.E2.A574",
    "bcr_drug_barcode": "TCGA-E2-A574-D44495",
    "bcr_drug_uuid": "CC66FB23-52DD-432E-87B3-4C10E78479AA",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "029CE650-5E5A-4100-8596-CD94300E7EF5",
    "patient_ID": "TCGA.E2.A574",
    "bcr_drug_barcode": "TCGA-E2-A574-D44497",
    "bcr_drug_uuid": "DCC1FD78-D8B4-4CFE-8322-0E57C1F1D14B",
    "form_completion_date": "2013-6-20",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F04DCA9E-409B-4300-B11D-12243E5D361D",
    "patient_ID": "TCGA.E2.A576",
    "bcr_drug_barcode": "TCGA-E2-A576-D48243",
    "bcr_drug_uuid": "D025BAD3-CE6C-4A32-8E2E-A500F7284F31",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F04DCA9E-409B-4300-B11D-12243E5D361D",
    "patient_ID": "TCGA.E2.A576",
    "bcr_drug_barcode": "TCGA-E2-A576-D48244",
    "bcr_drug_uuid": "5706041F-0C16-4D3D-AC37-E6AA13567E0B",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F04DCA9E-409B-4300-B11D-12243E5D361D",
    "patient_ID": "TCGA.E2.A576",
    "bcr_drug_barcode": "TCGA-E2-A576-D48245",
    "bcr_drug_uuid": "5A282F3D-A833-4F32-B7F1-29B0C86F8E79",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F18F96E-C0C9-4CC4-9FB2-CBA8949D5402",
    "patient_ID": "TCGA.E2.A9RU",
    "bcr_drug_barcode": "TCGA-E2-A9RU-D60754",
    "bcr_drug_uuid": "E37A508B-E21A-488A-B8D1-9927AA86305A",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03c143e0-d8a1-4d60-a4a3-df0501fc6b6e",
    "patient_ID": "TCGA.E9.A1N3",
    "bcr_drug_barcode": "TCGA-E9-A1N3-D39762",
    "bcr_drug_uuid": "21C8B531-6DB2-4EDA-91D6-9A71B698CFFA",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03c143e0-d8a1-4d60-a4a3-df0501fc6b6e",
    "patient_ID": "TCGA.E9.A1N3",
    "bcr_drug_barcode": "TCGA-E9-A1N3-D39763",
    "bcr_drug_uuid": "896CF3A1-1C37-4ECE-8AAD-2408414FF8D7",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03c143e0-d8a1-4d60-a4a3-df0501fc6b6e",
    "patient_ID": "TCGA.E9.A1N3",
    "bcr_drug_barcode": "TCGA-E9-A1N3-D39764",
    "bcr_drug_uuid": "B6DFF894-6069-4D41-8556-D15BC03DD3BF",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03c143e0-d8a1-4d60-a4a3-df0501fc6b6e",
    "patient_ID": "TCGA.E9.A1N3",
    "bcr_drug_barcode": "TCGA-E9-A1N3-D29142",
    "bcr_drug_uuid": "3B2AB151-9032-4CCD-9351-CD95CFE9FBFD",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "69a68fbc-e43d-4652-85ee-693211bded47",
    "patient_ID": "TCGA.E9.A1N4",
    "bcr_drug_barcode": "TCGA-E9-A1N4-D29812",
    "bcr_drug_uuid": "FC7FE4AB-6ABA-44ED-847B-11390559C9F6",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "69a68fbc-e43d-4652-85ee-693211bded47",
    "patient_ID": "TCGA.E9.A1N4",
    "bcr_drug_barcode": "TCGA-E9-A1N4-D29813",
    "bcr_drug_uuid": "03BC90EC-3B30-4864-B67F-CD5A00D65BFC",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "69a68fbc-e43d-4652-85ee-693211bded47",
    "patient_ID": "TCGA.E9.A1N4",
    "bcr_drug_barcode": "TCGA-E9-A1N4-D29814",
    "bcr_drug_uuid": "4237DC30-5933-4DD7-95C8-33FFC7D78A05",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "69a68fbc-e43d-4652-85ee-693211bded47",
    "patient_ID": "TCGA.E9.A1N4",
    "bcr_drug_barcode": "TCGA-E9-A1N4-D39768",
    "bcr_drug_uuid": "80B1429D-E3E0-4E41-B47E-344887D4864D",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f954de05-1b44-4087-8933-6cc72d81028d",
    "patient_ID": "TCGA.E9.A1N5",
    "bcr_drug_barcode": "TCGA-E9-A1N5-D29151",
    "bcr_drug_uuid": "37B2E899-6C5E-4AC5-993C-7D0CC5659174",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "f954de05-1b44-4087-8933-6cc72d81028d",
    "patient_ID": "TCGA.E9.A1N5",
    "bcr_drug_barcode": "TCGA-E9-A1N5-D30708",
    "bcr_drug_uuid": "C1DD8D4B-44DC-4476-9E5A-BCCA90CA080E",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "f954de05-1b44-4087-8933-6cc72d81028d",
    "patient_ID": "TCGA.E9.A1N5",
    "bcr_drug_barcode": "TCGA-E9-A1N5-D30707",
    "bcr_drug_uuid": "D9225842-4B81-41D8-A299-BC1B204AEDD6",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "f954de05-1b44-4087-8933-6cc72d81028d",
    "patient_ID": "TCGA.E9.A1N5",
    "bcr_drug_barcode": "TCGA-E9-A1N5-D30709",
    "bcr_drug_uuid": "4635036F-43AC-41A4-91E0-672BE9D92DA7",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 173,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "955d4263-61f7-42e8-8a6e-772a0d6c209d",
    "patient_ID": "TCGA.E9.A1N6",
    "bcr_drug_barcode": "TCGA-E9-A1N6-D32896",
    "bcr_drug_uuid": "1602F6B3-37E4-4305-9B0F-60739FCAE4A1",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "955d4263-61f7-42e8-8a6e-772a0d6c209d",
    "patient_ID": "TCGA.E9.A1N6",
    "bcr_drug_barcode": "TCGA-E9-A1N6-D63545",
    "bcr_drug_uuid": "9C2EBE7E-9BD0-4B27-A254-6B5EF6E962A3",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 447,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 574,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "955d4263-61f7-42e8-8a6e-772a0d6c209d",
    "patient_ID": "TCGA.E9.A1N6",
    "bcr_drug_barcode": "TCGA-E9-A1N6-D63546",
    "bcr_drug_uuid": "5A20287E-F225-416A-9A83-86038A1BE690",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 447,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 574,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "955d4263-61f7-42e8-8a6e-772a0d6c209d",
    "patient_ID": "TCGA.E9.A1N6",
    "bcr_drug_barcode": "TCGA-E9-A1N6-D63562",
    "bcr_drug_uuid": "E69B2ABD-369B-40EF-BC6B-8FE52DC62E45",
    "form_completion_date": "2014-8-13",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 575,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 678,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ac075bc0-1b59-4557-beea-541694faee03",
    "patient_ID": "TCGA.E9.A1N8",
    "bcr_drug_barcode": "TCGA-E9-A1N8-D29137",
    "bcr_drug_uuid": "D95B794D-470B-454C-AD92-C20080A5BB02",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "ac075bc0-1b59-4557-beea-541694faee03",
    "patient_ID": "TCGA.E9.A1N8",
    "bcr_drug_barcode": "TCGA-E9-A1N8-D29135",
    "bcr_drug_uuid": "3D42D744-34FF-4E25-862B-1766D65AE0A2",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "ac075bc0-1b59-4557-beea-541694faee03",
    "patient_ID": "TCGA.E9.A1N8",
    "bcr_drug_barcode": "TCGA-E9-A1N8-D29138",
    "bcr_drug_uuid": "6D5C845C-F385-41B2-ABCB-2CC309BAA5DF",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "994ca1f5-ad10-44ec-aa21-71fc2940653b",
    "patient_ID": "TCGA.E9.A1N9",
    "bcr_drug_barcode": "TCGA-E9-A1N9-D32897",
    "bcr_drug_uuid": "D16DD4A4-E874-49EE-82FB-2A247DCE61BD",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "994ca1f5-ad10-44ec-aa21-71fc2940653b",
    "patient_ID": "TCGA.E9.A1N9",
    "bcr_drug_barcode": "TCGA-E9-A1N9-D32898",
    "bcr_drug_uuid": "378CC11C-A4AA-4803-B2C1-FD7C98CB5DAA",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "af577366-0258-49e7-b6af-e70056c081a4",
    "patient_ID": "TCGA.E9.A1NA",
    "bcr_drug_barcode": "TCGA-E9-A1NA-D32899",
    "bcr_drug_uuid": "728F3086-1CBF-46B3-8113-1355961E96B6",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "af577366-0258-49e7-b6af-e70056c081a4",
    "patient_ID": "TCGA.E9.A1NA",
    "bcr_drug_barcode": "TCGA-E9-A1NA-D32900",
    "bcr_drug_uuid": "2A162745-964D-4B44-90CE-6DA163CD3A01",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "af577366-0258-49e7-b6af-e70056c081a4",
    "patient_ID": "TCGA.E9.A1NA",
    "bcr_drug_barcode": "TCGA-E9-A1NA-D32901",
    "bcr_drug_uuid": "2D437D87-3612-4B26-B16A-AF426B729C67",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 206,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e74aea7c-ca14-49df-b5cf-dacb839ac27a",
    "patient_ID": "TCGA.E9.A1NC",
    "bcr_drug_barcode": "TCGA-E9-A1NC-D32903",
    "bcr_drug_uuid": "E78A504B-9523-4183-AF5D-ACF86478BB82",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e74aea7c-ca14-49df-b5cf-dacb839ac27a",
    "patient_ID": "TCGA.E9.A1NC",
    "bcr_drug_barcode": "TCGA-E9-A1NC-D32906",
    "bcr_drug_uuid": "86434E5A-26BE-4F46-AF34-769FA7208481",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e74aea7c-ca14-49df-b5cf-dacb839ac27a",
    "patient_ID": "TCGA.E9.A1NC",
    "bcr_drug_barcode": "TCGA-E9-A1NC-D32908",
    "bcr_drug_uuid": "DDF2090C-2AB2-4A9F-A37C-2D6945B8AA8E",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e74aea7c-ca14-49df-b5cf-dacb839ac27a",
    "patient_ID": "TCGA.E9.A1NC",
    "bcr_drug_barcode": "TCGA-E9-A1NC-D32909",
    "bcr_drug_uuid": "A78DF706-2990-4314-934D-7EFD5C578BD5",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 708,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f06f09f3-8133-4a92-ac86-fbe64295e0d8",
    "patient_ID": "TCGA.E9.A1ND",
    "bcr_drug_barcode": "TCGA-E9-A1ND-D30736",
    "bcr_drug_uuid": "C52B4951-6F14-4E15-850F-E75D2A3B32AC",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f06f09f3-8133-4a92-ac86-fbe64295e0d8",
    "patient_ID": "TCGA.E9.A1ND",
    "bcr_drug_barcode": "TCGA-E9-A1ND-D30738",
    "bcr_drug_uuid": "FE127B51-D86A-4837-BD0A-0BE45831808C",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3d676bba-154b-4d22-ab59-d4d4da051b94",
    "patient_ID": "TCGA.E9.A1NE",
    "bcr_drug_barcode": "TCGA-E9-A1NE-D32914",
    "bcr_drug_uuid": "F4561048-074E-457D-A181-125FDEB51F22",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3d676bba-154b-4d22-ab59-d4d4da051b94",
    "patient_ID": "TCGA.E9.A1NE",
    "bcr_drug_barcode": "TCGA-E9-A1NE-D32915",
    "bcr_drug_uuid": "84F7B524-80E6-4D79-871F-8AD30E6A9987",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3d676bba-154b-4d22-ab59-d4d4da051b94",
    "patient_ID": "TCGA.E9.A1NE",
    "bcr_drug_barcode": "TCGA-E9-A1NE-D32916",
    "bcr_drug_uuid": "55ECA12D-C3E9-48D5-8BC7-77BC7D789290",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3d676bba-154b-4d22-ab59-d4d4da051b94",
    "patient_ID": "TCGA.E9.A1NE",
    "bcr_drug_barcode": "TCGA-E9-A1NE-D32918",
    "bcr_drug_uuid": "ED962811-FC2D-4B99-B1B0-B0B606EC40AC",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32919",
    "bcr_drug_uuid": "9A0E9054-76D2-4DFA-B120-DA25523FEC81",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32920",
    "bcr_drug_uuid": "3F6B874E-A4B8-460B-A135-C9AAF2975A26",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32921",
    "bcr_drug_uuid": "12ABC791-CDA4-46C3-9913-518EEDEF203A",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32922",
    "bcr_drug_uuid": "8B6A8702-47E0-4CFA-A700-8618FE4CA0B0",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32923",
    "bcr_drug_uuid": "8AE1CA3A-950C-45F8-A327-AD92398769BE",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "MITOMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119",
    "patient_ID": "TCGA.E9.A1NF",
    "bcr_drug_barcode": "TCGA-E9-A1NF-D32924",
    "bcr_drug_uuid": "A11CB0B1-B0B0-4E89-8C87-63A0F6638B32",
    "form_completion_date": "2012-6-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 280,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659b0170-e914-45ff-aa55-fcb8d3dc7b8a",
    "patient_ID": "TCGA.E9.A1NG",
    "bcr_drug_barcode": "TCGA-E9-A1NG-D39776",
    "bcr_drug_uuid": "0D22B7CA-FD4C-4FB1-BC8D-AC7B958AE6E6",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "659b0170-e914-45ff-aa55-fcb8d3dc7b8a",
    "patient_ID": "TCGA.E9.A1NG",
    "bcr_drug_barcode": "TCGA-E9-A1NG-D39777",
    "bcr_drug_uuid": "8D15500A-996F-42AD-9B5C-4B59FBEB68D6",
    "form_completion_date": "2013-2-1",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 786,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b2aac45b-2073-4c7a-adb9-769a4fdcc111",
    "patient_ID": "TCGA.E9.A1NH",
    "bcr_drug_barcode": "TCGA-E9-A1NH-D35054",
    "bcr_drug_uuid": "23703F4A-C80E-4EF7-BB6D-673805FC8899",
    "form_completion_date": "2012-9-14",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c65b835a-2d38-4250-a173-0780d2c2cf58",
    "patient_ID": "TCGA.E9.A1NI",
    "bcr_drug_barcode": "TCGA-E9-A1NI-D35022",
    "bcr_drug_uuid": "9DFDBBC7-631F-4C94-A923-948195F59A36",
    "form_completion_date": "2012-9-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c65b835a-2d38-4250-a173-0780d2c2cf58",
    "patient_ID": "TCGA.E9.A1NI",
    "bcr_drug_barcode": "TCGA-E9-A1NI-D35023",
    "bcr_drug_uuid": "FD81C1FD-32D3-41C2-91E3-B62B8B916AE7",
    "form_completion_date": "2012-9-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c65b835a-2d38-4250-a173-0780d2c2cf58",
    "patient_ID": "TCGA.E9.A1NI",
    "bcr_drug_barcode": "TCGA-E9-A1NI-D35027",
    "bcr_drug_uuid": "216067BB-58F6-4991-9A18-2FCE36C80910",
    "form_completion_date": "2012-9-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c65b835a-2d38-4250-a173-0780d2c2cf58",
    "patient_ID": "TCGA.E9.A1NI",
    "bcr_drug_barcode": "TCGA-E9-A1NI-D35028",
    "bcr_drug_uuid": "D4990B88-4B53-4E5A-A245-788D6F0CB831",
    "form_completion_date": "2012-9-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f2da1d3f-f226-4c99-a97e-9b26f67d7a5d",
    "patient_ID": "TCGA.E9.A1R0",
    "bcr_drug_barcode": "TCGA-E9-A1R0-D29805",
    "bcr_drug_uuid": "B560F532-8633-49E9-A9C7-AE671251F874",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "f2da1d3f-f226-4c99-a97e-9b26f67d7a5d",
    "patient_ID": "TCGA.E9.A1R0",
    "bcr_drug_barcode": "TCGA-E9-A1R0-D29797",
    "bcr_drug_uuid": "62BE4AFA-184B-4008-A0DA-3C7ED6C00EB4",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "8631969d-4ac6-4fe1-9db3-d47db604494a",
    "patient_ID": "TCGA.E9.A1R2",
    "bcr_drug_barcode": "TCGA-E9-A1R2-D55472",
    "bcr_drug_uuid": "659FE77A-7EC8-4976-A86E-8D54BB201D8E",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8631969d-4ac6-4fe1-9db3-d47db604494a",
    "patient_ID": "TCGA.E9.A1R2",
    "bcr_drug_barcode": "TCGA-E9-A1R2-D55473",
    "bcr_drug_uuid": "102D03D1-BC76-4688-BFA9-5EFD862C35D7",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8631969d-4ac6-4fe1-9db3-d47db604494a",
    "patient_ID": "TCGA.E9.A1R2",
    "bcr_drug_barcode": "TCGA-E9-A1R2-D55474",
    "bcr_drug_uuid": "57A9F155-B541-4EFD-8BFE-CBD7447C24D1",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4922cddc-575c-4b8a-8245-ce5f6876760c",
    "patient_ID": "TCGA.E9.A1R3",
    "bcr_drug_barcode": "TCGA-E9-A1R3-D30822",
    "bcr_drug_uuid": "8AAB711A-821D-49F2-97B5-DB26D061A35B",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "4922cddc-575c-4b8a-8245-ce5f6876760c",
    "patient_ID": "TCGA.E9.A1R3",
    "bcr_drug_barcode": "TCGA-E9-A1R3-D30823",
    "bcr_drug_uuid": "42526DF7-F5F2-4212-80D8-73443892CEB6",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "4922cddc-575c-4b8a-8245-ce5f6876760c",
    "patient_ID": "TCGA.E9.A1R3",
    "bcr_drug_barcode": "TCGA-E9-A1R3-D30824",
    "bcr_drug_uuid": "57C90782-1DBC-41F4-8674-D1FB85B98542",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "4922cddc-575c-4b8a-8245-ce5f6876760c",
    "patient_ID": "TCGA.E9.A1R3",
    "bcr_drug_barcode": "TCGA-E9-A1R3-D30826",
    "bcr_drug_uuid": "63FBD160-E49D-4A37-ADC7-7BF300319F6A",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b7a4df9a-4e25-4550-9c10-338ca1921c2f",
    "patient_ID": "TCGA.E9.A1R4",
    "bcr_drug_barcode": "TCGA-E9-A1R4-D30538",
    "bcr_drug_uuid": "48222E9D-20E8-452B-8E46-E5FA68881243",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "b7a4df9a-4e25-4550-9c10-338ca1921c2f",
    "patient_ID": "TCGA.E9.A1R4",
    "bcr_drug_barcode": "TCGA-E9-A1R4-D30537",
    "bcr_drug_uuid": "4D26049E-F78C-4164-BDC1-E00DB74121E8",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "b7a4df9a-4e25-4550-9c10-338ca1921c2f",
    "patient_ID": "TCGA.E9.A1R4",
    "bcr_drug_barcode": "TCGA-E9-A1R4-D30541",
    "bcr_drug_uuid": "3B9C6105-0363-4B73-BD5F-CE0FB88008F3",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b7a4df9a-4e25-4550-9c10-338ca1921c2f",
    "patient_ID": "TCGA.E9.A1R4",
    "bcr_drug_barcode": "TCGA-E9-A1R4-D30536",
    "bcr_drug_uuid": "8102DE2B-8388-4BD3-8699-A8575DAE40A4",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "23c21dea-3713-408f-ba56-f7c586e9f206",
    "patient_ID": "TCGA.E9.A1R5",
    "bcr_drug_barcode": "TCGA-E9-A1R5-D30843",
    "bcr_drug_uuid": "D4023E14-4199-48D4-A1ED-0B85D63C7BA4",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4842bac3-abaa-4900-871f-f2c3ba6457f5",
    "patient_ID": "TCGA.E9.A1R6",
    "bcr_drug_barcode": "TCGA-E9-A1R6-D30848",
    "bcr_drug_uuid": "04E8410B-36AD-4102-B74E-60586DD6717C",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2680da86-c977-4611-b75f-df015283c023",
    "patient_ID": "TCGA.E9.A1R7",
    "bcr_drug_barcode": "TCGA-E9-A1R7-D30603",
    "bcr_drug_uuid": "8895D57C-039B-4650-9D2E-7EEDF6FCE7A3",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "FARESTON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 60,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2680da86-c977-4611-b75f-df015283c023",
    "patient_ID": "TCGA.E9.A1R7",
    "bcr_drug_barcode": "TCGA-E9-A1R7-D71425",
    "bcr_drug_uuid": "2294BAB6-88C3-4F06-BA09-D2EDFDDB7C41",
    "form_completion_date": "2015-3-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4b4e4ea8-6eb9-49ad-b880-c5065fe6517f",
    "patient_ID": "TCGA.E9.A1RA",
    "bcr_drug_barcode": "TCGA-E9-A1RA-D30547",
    "bcr_drug_uuid": "0CAD78B5-EA56-4810-802C-C8376A508B74",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "4b4e4ea8-6eb9-49ad-b880-c5065fe6517f",
    "patient_ID": "TCGA.E9.A1RA",
    "bcr_drug_barcode": "TCGA-E9-A1RA-D30552",
    "bcr_drug_uuid": "1A3D7515-4506-4F8C-AA69-7638A7FE0EAD",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4b4e4ea8-6eb9-49ad-b880-c5065fe6517f",
    "patient_ID": "TCGA.E9.A1RA",
    "bcr_drug_barcode": "TCGA-E9-A1RA-D30550",
    "bcr_drug_uuid": "AFDB7AB8-943C-45D1-8584-CD15359E6AA5",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "94b95984-b2fb-4e42-8887-45e7086c3179",
    "patient_ID": "TCGA.E9.A1RB",
    "bcr_drug_barcode": "TCGA-E9-A1RB-D30857",
    "bcr_drug_uuid": "5E138DC3-70C8-4195-8DF7-2EFC4FA27407",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10000
  },
  {
    "bcr_patient_uuid": "94b95984-b2fb-4e42-8887-45e7086c3179",
    "patient_ID": "TCGA.E9.A1RB",
    "bcr_drug_barcode": "TCGA-E9-A1RB-D30859",
    "bcr_drug_uuid": "27022DC0-5FA3-4EB4-B968-C35A4655475D",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10000
  },
  {
    "bcr_patient_uuid": "94b95984-b2fb-4e42-8887-45e7086c3179",
    "patient_ID": "TCGA.E9.A1RB",
    "bcr_drug_barcode": "TCGA-E9-A1RB-D30858",
    "bcr_drug_uuid": "ED42B1AF-E7F0-4598-9EFE-12B6AEA180C3",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "94b95984-b2fb-4e42-8887-45e7086c3179",
    "patient_ID": "TCGA.E9.A1RB",
    "bcr_drug_barcode": "TCGA-E9-A1RB-D30856",
    "bcr_drug_uuid": "25429B7D-51F9-4C70-AC60-B8148B735388",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "5cdae21d-eee5-478f-932a-0f51fcf5f031",
    "patient_ID": "TCGA.E9.A1RC",
    "bcr_drug_barcode": "TCGA-E9-A1RC-D30606",
    "bcr_drug_uuid": "3D595692-CF03-4987-8958-AC8D85D1C26F",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "MITOMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1222,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "5cdae21d-eee5-478f-932a-0f51fcf5f031",
    "patient_ID": "TCGA.E9.A1RC",
    "bcr_drug_barcode": "TCGA-E9-A1RC-D30610",
    "bcr_drug_uuid": "8DEF7FCD-2D76-448A-B718-638B681918AD",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1220,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "5cdae21d-eee5-478f-932a-0f51fcf5f031",
    "patient_ID": "TCGA.E9.A1RC",
    "bcr_drug_barcode": "TCGA-E9-A1RC-D30607",
    "bcr_drug_uuid": "E58C5E86-0316-4F5B-99B0-A13F95BE2CA5",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "MITOXANTRONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1222,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "5cdae21d-eee5-478f-932a-0f51fcf5f031",
    "patient_ID": "TCGA.E9.A1RC",
    "bcr_drug_barcode": "TCGA-E9-A1RC-D30609",
    "bcr_drug_uuid": "62673F57-7FC4-4ED0-9E85-73C713C381A2",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1222,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "5fe3c51f-65e2-4da6-8924-a6fae17c022d",
    "patient_ID": "TCGA.E9.A1RD",
    "bcr_drug_barcode": "TCGA-E9-A1RD-D30614",
    "bcr_drug_uuid": "559CEE81-681B-42E0-B0FF-A060CD274BE5",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30631",
    "bcr_drug_uuid": "7E328C05-236F-4222-82CC-33615BDF9124",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30625",
    "bcr_drug_uuid": "7DC35BFA-9C80-4F0C-91E8-F45010BFF3A1",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30627",
    "bcr_drug_uuid": "E75E0ABA-5130-4FBE-B9D7-44081F1FF713",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30626",
    "bcr_drug_uuid": "BC07A0C3-99D7-49FA-8CDA-8BDC0A5B3CFE",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30629",
    "bcr_drug_uuid": "88021F1F-6F05-49C2-974E-C81F92FBF7E1",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30628",
    "bcr_drug_uuid": "1955E286-AE41-4016-95CE-453A407709C0",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "24046547-d038-4616-b190-52ac93f4965f",
    "patient_ID": "TCGA.E9.A1RE",
    "bcr_drug_barcode": "TCGA-E9-A1RE-D30630",
    "bcr_drug_uuid": "AB669FF9-A215-4611-851F-9CF3F1DB948C",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6400
  },
  {
    "bcr_patient_uuid": "c694615c-b1c6-499c-8058-995633ebf948",
    "patient_ID": "TCGA.E9.A1RF",
    "bcr_drug_barcode": "TCGA-E9-A1RF-D30635",
    "bcr_drug_uuid": "BB320C8C-AD02-463F-904A-B4301628BB5B",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "c694615c-b1c6-499c-8058-995633ebf948",
    "patient_ID": "TCGA.E9.A1RF",
    "bcr_drug_barcode": "TCGA-E9-A1RF-D30636",
    "bcr_drug_uuid": "E24DA2B4-5273-4C8A-A468-E3BCF7FCD214",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "bcr_patient_uuid": "c694615c-b1c6-499c-8058-995633ebf948",
    "patient_ID": "TCGA.E9.A1RF",
    "bcr_drug_barcode": "TCGA-E9-A1RF-D30637",
    "bcr_drug_uuid": "90F42AFB-EFAC-4C90-999B-DA0E246EF300",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c694615c-b1c6-499c-8058-995633ebf948",
    "patient_ID": "TCGA.E9.A1RF",
    "bcr_drug_barcode": "TCGA-E9-A1RF-D30634",
    "bcr_drug_uuid": "59D29C9B-773E-49D8-B79E-18BCF84061DC",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30644",
    "bcr_drug_uuid": "7AAD1A06-8D8C-4EF1-8A1A-EF566C06B16B",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30651",
    "bcr_drug_uuid": "17A6D8A3-3C52-47CE-9472-6B5586F2A692",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30646",
    "bcr_drug_uuid": "9DC27C00-1D63-4E9D-A801-199B11EBABFF",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30647",
    "bcr_drug_uuid": "5BFAE4C4-9F95-4703-828F-E55740F9BD7A",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30652",
    "bcr_drug_uuid": "679A17F2-BFCD-4260-AE16-9D5E95B41D3A",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30643",
    "bcr_drug_uuid": "AD8B41A3-608E-459B-8F60-B4B600921860",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30645",
    "bcr_drug_uuid": "F5810F71-8A39-45E8-B825-FFD43A8B53F6",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30650",
    "bcr_drug_uuid": "E1E678C3-0EE1-4950-BB4A-001B9FD2F4B9",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "8744733a-7b46-43aa-bdef-64876816adbb",
    "patient_ID": "TCGA.E9.A1RG",
    "bcr_drug_barcode": "TCGA-E9-A1RG-D30649",
    "bcr_drug_uuid": "6E4EA79B-DDD5-42BE-A154-8BD0E469C04B",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "408cb583-6dc3-4698-8bd2-e284042bd5ef",
    "patient_ID": "TCGA.E9.A1RH",
    "bcr_drug_barcode": "TCGA-E9-A1RH-D30655",
    "bcr_drug_uuid": "C11A3BB8-098E-40C2-B6AC-2DAB2235186F",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9600
  },
  {
    "bcr_patient_uuid": "408cb583-6dc3-4698-8bd2-e284042bd5ef",
    "patient_ID": "TCGA.E9.A1RH",
    "bcr_drug_barcode": "TCGA-E9-A1RH-D30656",
    "bcr_drug_uuid": "0D76DFE2-D103-4A7A-B578-BFA80C9362DC",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "408cb583-6dc3-4698-8bd2-e284042bd5ef",
    "patient_ID": "TCGA.E9.A1RH",
    "bcr_drug_barcode": "TCGA-E9-A1RH-D30658",
    "bcr_drug_uuid": "E0770822-61B3-4C2B-91B4-1BD84EC0ED21",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "408cb583-6dc3-4698-8bd2-e284042bd5ef",
    "patient_ID": "TCGA.E9.A1RH",
    "bcr_drug_barcode": "TCGA-E9-A1RH-D30657",
    "bcr_drug_uuid": "395299B4-0924-44F0-B3B9-48F4A1672618",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "dd3bfb26-b534-4917-9c4d-9fe7b6477762",
    "patient_ID": "TCGA.E9.A1RI",
    "bcr_drug_barcode": "TCGA-E9-A1RI-D30562",
    "bcr_drug_uuid": "FEF0778A-20C4-491A-BF46-E76657C7B65F",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dd3bfb26-b534-4917-9c4d-9fe7b6477762",
    "patient_ID": "TCGA.E9.A1RI",
    "bcr_drug_barcode": "TCGA-E9-A1RI-D30560",
    "bcr_drug_uuid": "7D013691-E913-4D44-BCCA-11F6C13369AB",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "dd3bfb26-b534-4917-9c4d-9fe7b6477762",
    "patient_ID": "TCGA.E9.A1RI",
    "bcr_drug_barcode": "TCGA-E9-A1RI-D30556",
    "bcr_drug_uuid": "E1C9066D-8569-4D69-A22F-3C031DD1FFD4",
    "form_completion_date": "2012-4-12",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "dd3bfb26-b534-4917-9c4d-9fe7b6477762",
    "patient_ID": "TCGA.E9.A1RI",
    "bcr_drug_barcode": "TCGA-E9-A1RI-D46349",
    "bcr_drug_uuid": "6D4635CF-24FA-4141-B052-0F162D685C5A",
    "form_completion_date": "2013-8-6",
    "pharmaceutical_therapy_drug_name": "LEUPROLIDE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 418,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 425,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dd3bfb26-b534-4917-9c4d-9fe7b6477762",
    "patient_ID": "TCGA.E9.A1RI",
    "bcr_drug_barcode": "TCGA-E9-A1RI-D30558",
    "bcr_drug_uuid": "5CC44B06-F81E-4106-A661-6A584D26D12B",
    "form_completion_date": "2014-2-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "dd67408e-46ba-4573-9415-d4814e9f84de",
    "patient_ID": "TCGA.E9.A226",
    "bcr_drug_barcode": "TCGA-E9-A226-D29957",
    "bcr_drug_uuid": "7D35CA2D-3C41-4DC3-BFFD-515E87E17963",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dd67408e-46ba-4573-9415-d4814e9f84de",
    "patient_ID": "TCGA.E9.A226",
    "bcr_drug_barcode": "TCGA-E9-A226-D29956",
    "bcr_drug_uuid": "DC196A0E-9253-4AAA-9BAB-196614D5855F",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9600
  },
  {
    "bcr_patient_uuid": "dd67408e-46ba-4573-9415-d4814e9f84de",
    "patient_ID": "TCGA.E9.A226",
    "bcr_drug_barcode": "TCGA-E9-A226-D29954",
    "bcr_drug_uuid": "23AD3108-BB86-4392-9D2B-0F09E09F978D",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 6,
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "dd67408e-46ba-4573-9415-d4814e9f84de",
    "patient_ID": "TCGA.E9.A226",
    "bcr_drug_barcode": "TCGA-E9-A226-D29955",
    "bcr_drug_uuid": "63D2FA20-DF70-4A44-AF1C-A0C2D389F79A",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "dd67408e-46ba-4573-9415-d4814e9f84de",
    "patient_ID": "TCGA.E9.A226",
    "bcr_drug_barcode": "TCGA-E9-A226-D55887",
    "bcr_drug_uuid": "2C88B47F-36AA-43AF-95BB-33939622235F",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "PAMIDRONATE",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 937,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89a8da07-4487-47c6-8d3c-442a87e4f632",
    "patient_ID": "TCGA.E9.A227",
    "bcr_drug_barcode": "TCGA-E9-A227-D55475",
    "bcr_drug_uuid": "3A15749D-3272-4218-A622-DE1C45896D3B",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89a8da07-4487-47c6-8d3c-442a87e4f632",
    "patient_ID": "TCGA.E9.A227",
    "bcr_drug_barcode": "TCGA-E9-A227-D55476",
    "bcr_drug_uuid": "A7D3378B-00F0-4BCE-9E2F-C2E4045282A9",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b95eef8a-205f-4cf8-9d3c-ae51d406e1e0",
    "patient_ID": "TCGA.E9.A228",
    "bcr_drug_barcode": "TCGA-E9-A228-D29763",
    "bcr_drug_uuid": "8EE571E0-A2A2-4B47-A86B-8FFA4F553A22",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "b95eef8a-205f-4cf8-9d3c-ae51d406e1e0",
    "patient_ID": "TCGA.E9.A228",
    "bcr_drug_barcode": "TCGA-E9-A228-D29762",
    "bcr_drug_uuid": "4C597D0D-8804-43BE-BE0A-3743B29B55BF",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "b95eef8a-205f-4cf8-9d3c-ae51d406e1e0",
    "patient_ID": "TCGA.E9.A228",
    "bcr_drug_barcode": "TCGA-E9-A228-D29764",
    "bcr_drug_uuid": "19F31BA2-DE6B-46F0-AADB-37D011E8224C",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2240
  },
  {
    "bcr_patient_uuid": "cea9d8f9-e18c-4947-a461-5f712e3c1e6d",
    "patient_ID": "TCGA.E9.A229",
    "bcr_drug_barcode": "TCGA-E9-A229-D29803",
    "bcr_drug_uuid": "7E071032-AA10-4F23-BDD1-ADB151254339",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 700,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "cea9d8f9-e18c-4947-a461-5f712e3c1e6d",
    "patient_ID": "TCGA.E9.A229",
    "bcr_drug_barcode": "TCGA-E9-A229-D29800",
    "bcr_drug_uuid": "B1E9251D-B543-4832-9798-633B74C588FB",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "cea9d8f9-e18c-4947-a461-5f712e3c1e6d",
    "patient_ID": "TCGA.E9.A229",
    "bcr_drug_barcode": "TCGA-E9-A229-D29802",
    "bcr_drug_uuid": "5D1A648D-B766-45C5-A426-F17BEA87EFD8",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "4aacbc42-5ac5-4339-b9fa-c6e812084837",
    "patient_ID": "TCGA.E9.A22A",
    "bcr_drug_barcode": "TCGA-E9-A22A-D29838",
    "bcr_drug_uuid": "5D55C0D5-040F-4184-A845-1D4A4FEB2ADC",
    "form_completion_date": "2012-3-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7240
  },
  {
    "bcr_patient_uuid": "b956df1b-bc77-4bdb-a5bd-5dda7b4c8da7",
    "patient_ID": "TCGA.E9.A22B",
    "bcr_drug_barcode": "TCGA-E9-A22B-D30663",
    "bcr_drug_uuid": "39291295-C212-4E0E-8B9F-08F63DD0A88F",
    "form_completion_date": "2012-4-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7240
  },
  {
    "bcr_patient_uuid": "cf0a3f38-5850-44e1-8574-808bd37d84a3",
    "patient_ID": "TCGA.E9.A22D",
    "bcr_drug_barcode": "TCGA-E9-A22D-D29927",
    "bcr_drug_uuid": "19D3B016-37B3-4CD9-8EAD-68E4AE3A15C4",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "cf0a3f38-5850-44e1-8574-808bd37d84a3",
    "patient_ID": "TCGA.E9.A22D",
    "bcr_drug_barcode": "TCGA-E9-A22D-D29929",
    "bcr_drug_uuid": "CC819813-FFDB-48CC-BE92-4A82FEC5E8FA",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3160
  },
  {
    "bcr_patient_uuid": "cf0a3f38-5850-44e1-8574-808bd37d84a3",
    "patient_ID": "TCGA.E9.A22D",
    "bcr_drug_barcode": "TCGA-E9-A22D-D29913",
    "bcr_drug_uuid": "B2DEB206-A8C5-4371-9443-BC4CE3883311",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "cf0a3f38-5850-44e1-8574-808bd37d84a3",
    "patient_ID": "TCGA.E9.A22D",
    "bcr_drug_barcode": "TCGA-E9-A22D-D29928",
    "bcr_drug_uuid": "291C8DBC-432A-4B49-BDD4-FEDCC82245C1",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "64d4dfae-8d91-464b-adc3-80ba7caf54ae",
    "patient_ID": "TCGA.E9.A22E",
    "bcr_drug_barcode": "TCGA-E9-A22E-D29933",
    "bcr_drug_uuid": "65C41709-5F20-4641-81E0-A088A34E3FBF",
    "form_completion_date": "2013-1-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "64d4dfae-8d91-464b-adc3-80ba7caf54ae",
    "patient_ID": "TCGA.E9.A22E",
    "bcr_drug_barcode": "TCGA-E9-A22E-D29932",
    "bcr_drug_uuid": "A08D578D-BE6C-4B00-A7A9-3F364189E4C6",
    "form_completion_date": "2014-1-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "64d4dfae-8d91-464b-adc3-80ba7caf54ae",
    "patient_ID": "TCGA.E9.A22E",
    "bcr_drug_barcode": "TCGA-E9-A22E-D29937",
    "bcr_drug_uuid": "5E6E3BA5-6698-470A-AEF8-FD14C5823576",
    "form_completion_date": "2014-1-9",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "56033839-35d5-4d72-8b8c-400cb345263d",
    "patient_ID": "TCGA.E9.A22G",
    "bcr_drug_barcode": "TCGA-E9-A22G-D29941",
    "bcr_drug_uuid": "ABA87C32-53D8-46A3-913D-B4D47AD62165",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "56033839-35d5-4d72-8b8c-400cb345263d",
    "patient_ID": "TCGA.E9.A22G",
    "bcr_drug_barcode": "TCGA-E9-A22G-D29940",
    "bcr_drug_uuid": "7E19BC38-8238-4EC8-ABE3-5F5165B0FEBD",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "161917b8-88ad-407b-ade6-d6b98478b359",
    "patient_ID": "TCGA.E9.A22H",
    "bcr_drug_barcode": "TCGA-E9-A22H-D29947",
    "bcr_drug_uuid": "FA024AFC-6558-412D-81F5-3D0FD0A1566B",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 330,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "161917b8-88ad-407b-ade6-d6b98478b359",
    "patient_ID": "TCGA.E9.A22H",
    "bcr_drug_barcode": "TCGA-E9-A22H-D29944",
    "bcr_drug_uuid": "F67CF379-4420-4D5D-8FEC-0FD435A79B19",
    "form_completion_date": "2012-3-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "161917b8-88ad-407b-ade6-d6b98478b359",
    "patient_ID": "TCGA.E9.A22H",
    "bcr_drug_barcode": "TCGA-E9-A22H-D29945",
    "bcr_drug_uuid": "88E1A537-55BC-4B26-9B5E-576C51D8AA0A",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "161917b8-88ad-407b-ade6-d6b98478b359",
    "patient_ID": "TCGA.E9.A22H",
    "bcr_drug_barcode": "TCGA-E9-A22H-D29946",
    "bcr_drug_uuid": "499F5082-99DF-470D-84D6-9FBBFC024994",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D31155",
    "bcr_drug_uuid": "6C115212-2F46-40E5-9300-3FFAF5FD5975",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D31154",
    "bcr_drug_uuid": "646C3AEA-2B7C-4B5E-812C-D2539266256A",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D31156",
    "bcr_drug_uuid": "5335CA0B-6AEF-47D7-A8FE-D695892F85DA",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D31153",
    "bcr_drug_uuid": "0BA723FF-5046-4029-85C3-C41B010E0ED3",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D31152",
    "bcr_drug_uuid": "144BD67A-2B2B-4DB2-A72D-AF67BE661EC0",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f",
    "patient_ID": "TCGA.E9.A243",
    "bcr_drug_barcode": "TCGA-E9-A243-D39523",
    "bcr_drug_uuid": "617EAD96-72A4-41EE-B9EE-608F4B12E6DB",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "PAMIDRONATE",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 305,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 520,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a4c59287-1ad5-46a5-8040-e591e6ce064f",
    "patient_ID": "TCGA.E9.A244",
    "bcr_drug_barcode": "TCGA-E9-A244-D31166",
    "bcr_drug_uuid": "B71D5E8E-B7EF-4786-8FB2-E7ACF5FE2C75",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 16,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "a4c59287-1ad5-46a5-8040-e591e6ce064f",
    "patient_ID": "TCGA.E9.A244",
    "bcr_drug_barcode": "TCGA-E9-A244-D31168",
    "bcr_drug_uuid": "E07A4B20-C911-4AB0-81F9-1D66E0F74A44",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 16,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "8218119a-f68b-4ea7-9ee4-5e2edc2ae342",
    "patient_ID": "TCGA.E9.A245",
    "bcr_drug_barcode": "TCGA-E9-A245-D31172",
    "bcr_drug_uuid": "015CA647-3EBD-4950-A3AA-A0672ED5011F",
    "form_completion_date": "2012-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "636b0a90-c8c2-4ad6-a77d-6cd428a826d1",
    "patient_ID": "TCGA.E9.A247",
    "bcr_drug_barcode": "TCGA-E9-A247-D31208",
    "bcr_drug_uuid": "5A067FB7-4E61-4DD8-9DCF-061185296A15",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "539bbbed-43fb-4fef-9c67-6406f58b186a",
    "patient_ID": "TCGA.E9.A248",
    "bcr_drug_barcode": "TCGA-E9-A248-D31215",
    "bcr_drug_uuid": "E530CA0A-DA5E-4FBA-8E45-36898EA1D171",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "539bbbed-43fb-4fef-9c67-6406f58b186a",
    "patient_ID": "TCGA.E9.A248",
    "bcr_drug_barcode": "TCGA-E9-A248-D31213",
    "bcr_drug_uuid": "73DBEE28-62F4-469F-B77D-40AD347DBA5B",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "fb3607eb-858e-4ecd-8477-95140658c6d2",
    "patient_ID": "TCGA.E9.A249",
    "bcr_drug_barcode": "TCGA-E9-A249-D31249",
    "bcr_drug_uuid": "7A8EA282-7B3B-4CB3-9B6F-F35946CED74A",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fb3607eb-858e-4ecd-8477-95140658c6d2",
    "patient_ID": "TCGA.E9.A249",
    "bcr_drug_barcode": "TCGA-E9-A249-D31248",
    "bcr_drug_uuid": "ECDD44B4-F229-4DD5-80B7-0AF3F66BE1EC",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "fb3607eb-858e-4ecd-8477-95140658c6d2",
    "patient_ID": "TCGA.E9.A249",
    "bcr_drug_barcode": "TCGA-E9-A249-D31246",
    "bcr_drug_uuid": "A0F0004B-8C6B-4412-B770-39EB7B0401E6",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "fb3607eb-858e-4ecd-8477-95140658c6d2",
    "patient_ID": "TCGA.E9.A249",
    "bcr_drug_barcode": "TCGA-E9-A249-D39725",
    "bcr_drug_uuid": "877690E5-008F-454B-9C29-5210E3FCA338",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6",
    "patient_ID": "TCGA.E9.A24A",
    "bcr_drug_barcode": "TCGA-E9-A24A-D31257",
    "bcr_drug_uuid": "64424F2D-62A0-41E3-AC8A-8D4380E0149C",
    "form_completion_date": "2012-4-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fec0da58-1047-44d2-b6d1-c18cceed43dc",
    "patient_ID": "TCGA.E9.A295",
    "bcr_drug_barcode": "TCGA-E9-A295-D35357",
    "bcr_drug_uuid": "C6FF0A55-DD00-4370-882C-4CDA4D7F524D",
    "form_completion_date": "2012-10-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D34102",
    "bcr_drug_uuid": "09E54119-585C-4096-A9D8-136656471893",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D34103",
    "bcr_drug_uuid": "786F4DB8-BC47-4FEF-9D2E-624B59F1E9A2",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D34104",
    "bcr_drug_uuid": "11E5178D-A5E2-4AC3-BAD0-0664514A1B41",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D34106",
    "bcr_drug_uuid": "8049BD0B-2078-4946-AFA8-BF2EEB3FD34E",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D40294",
    "bcr_drug_uuid": "98CD1B77-8557-4EBF-9914-8FF674101890",
    "form_completion_date": "2013-2-15",
    "pharmaceutical_therapy_drug_name": "PAMIDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 524,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 846,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A831893-F4CA-4357-A756-B5E954E35DD7",
    "patient_ID": "TCGA.E9.A2JS",
    "bcr_drug_barcode": "TCGA-E9-A2JS-D55896",
    "bcr_drug_uuid": "43929A44-3CE4-467E-85DC-FCF130402CFB",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 677,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 713,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B35FBE19-0E6D-427E-B9BE-EE3527B5FCA6",
    "patient_ID": "TCGA.E9.A2JT",
    "bcr_drug_barcode": "TCGA-E9-A2JT-D34098",
    "bcr_drug_uuid": "9899A8BD-E368-4788-944F-E1685DA002C6",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D34120",
    "bcr_drug_uuid": "D0C4B016-5BD8-4E67-A168-03CBC0840AD8",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 26,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D34121",
    "bcr_drug_uuid": "E5BBB372-92D7-41A2-8819-BFEBB1F526B3",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 26,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D34122",
    "bcr_drug_uuid": "B87D3CDD-0D31-4353-9E68-879DB3A804D4",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 26,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D34123",
    "bcr_drug_uuid": "6B7696A0-95DC-48FD-BC5E-F5D77A8E683E",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D40290",
    "bcr_drug_uuid": "B80F3DF7-5616-4DEB-B5B1-9AFD2E7A34EA",
    "form_completion_date": "2013-2-15",
    "pharmaceutical_therapy_drug_name": "LEUPRORELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 313,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 337,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "807B62ED-D3F7-4211-83BE-754386FF2C96",
    "patient_ID": "TCGA.E9.A3HO",
    "bcr_drug_barcode": "TCGA-E9-A3HO-D40291",
    "bcr_drug_uuid": "FC15DB60-9371-4C3A-8C2C-34D254C7B264",
    "form_completion_date": "2013-2-15",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E36E985D-2C44-4E14-854A-7DBCA4BB0304",
    "patient_ID": "TCGA.E9.A3Q9",
    "bcr_drug_barcode": "TCGA-E9-A3Q9-D40591",
    "bcr_drug_uuid": "1D3313F6-A11D-433B-9DE9-C6710E726905",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E36E985D-2C44-4E14-854A-7DBCA4BB0304",
    "patient_ID": "TCGA.E9.A3Q9",
    "bcr_drug_barcode": "TCGA-E9-A3Q9-D40592",
    "bcr_drug_uuid": "EE1ADBED-9135-4EE3-84F2-42AB43FA667F",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "MITOXANTRONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E36E985D-2C44-4E14-854A-7DBCA4BB0304",
    "patient_ID": "TCGA.E9.A3Q9",
    "bcr_drug_barcode": "TCGA-E9-A3Q9-D40593",
    "bcr_drug_uuid": "E7C7F8BC-C6B2-4F17-9D8B-484C4B903746",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E36E985D-2C44-4E14-854A-7DBCA4BB0304",
    "patient_ID": "TCGA.E9.A3Q9",
    "bcr_drug_barcode": "TCGA-E9-A3Q9-D40594",
    "bcr_drug_uuid": "8925146E-CA92-4C23-9610-AA8FAADEC1D3",
    "form_completion_date": "2013-2-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95873E61-AFDB-496C-9F77-3F9BEB008CDA",
    "patient_ID": "TCGA.E9.A3X8",
    "bcr_drug_barcode": "TCGA-E9-A3X8-D41706",
    "bcr_drug_uuid": "2813ED05-F03A-4919-B4DE-12415797A897",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95873E61-AFDB-496C-9F77-3F9BEB008CDA",
    "patient_ID": "TCGA.E9.A3X8",
    "bcr_drug_barcode": "TCGA-E9-A3X8-D41708",
    "bcr_drug_uuid": "D74CCEFE-BE26-4C75-A3ED-DE683060F21F",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95873E61-AFDB-496C-9F77-3F9BEB008CDA",
    "patient_ID": "TCGA.E9.A3X8",
    "bcr_drug_barcode": "TCGA-E9-A3X8-D41709",
    "bcr_drug_uuid": "B42520B3-C869-4100-A31A-852F9255A6A2",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95873E61-AFDB-496C-9F77-3F9BEB008CDA",
    "patient_ID": "TCGA.E9.A3X8",
    "bcr_drug_barcode": "TCGA-E9-A3X8-D41710",
    "bcr_drug_uuid": "05473A78-6AD8-4AFA-A02B-61BFE72F46D4",
    "form_completion_date": "2013-3-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 324,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B304302A-F2B9-4CD7-AB14-C21EDF7778EA",
    "patient_ID": "TCGA.E9.A5FK",
    "bcr_drug_barcode": "TCGA-E9-A5FK-D56477",
    "bcr_drug_uuid": "310AAC92-87DD-46B7-8666-4F20C9B2A400",
    "form_completion_date": "2014-2-10",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B304302A-F2B9-4CD7-AB14-C21EDF7778EA",
    "patient_ID": "TCGA.E9.A5FK",
    "bcr_drug_barcode": "TCGA-E9-A5FK-D56478",
    "bcr_drug_uuid": "DE81480C-4511-40D7-8778-F558CCA5717A",
    "form_completion_date": "2014-2-10",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B304302A-F2B9-4CD7-AB14-C21EDF7778EA",
    "patient_ID": "TCGA.E9.A5FK",
    "bcr_drug_barcode": "TCGA-E9-A5FK-D56479",
    "bcr_drug_uuid": "255555A4-D618-436B-9BDC-9D9FDC22430D",
    "form_completion_date": "2014-2-10",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A412B374-4D25-491F-B76F-DDAA989ACF59",
    "patient_ID": "TCGA.E9.A5UP",
    "bcr_drug_barcode": "TCGA-E9-A5UP-D57717",
    "bcr_drug_uuid": "DCB3552D-9065-47A4-A78C-6C66D46F8D06",
    "form_completion_date": "2014-3-21",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E9C8D3C-790C-46AD-8F31-B557B7C26F69",
    "patient_ID": "TCGA.E9.A6HE",
    "bcr_drug_barcode": "TCGA-E9-A6HE-D56814",
    "bcr_drug_uuid": "75161762-89C2-45DD-B3F6-2C5CE67185BB",
    "form_completion_date": "2014-2-24",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E9C8D3C-790C-46AD-8F31-B557B7C26F69",
    "patient_ID": "TCGA.E9.A6HE",
    "bcr_drug_barcode": "TCGA-E9-A6HE-D56815",
    "bcr_drug_uuid": "A670D2BD-0DD4-415F-91E3-B74DFC267B86",
    "form_completion_date": "2014-2-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E9C8D3C-790C-46AD-8F31-B557B7C26F69",
    "patient_ID": "TCGA.E9.A6HE",
    "bcr_drug_barcode": "TCGA-E9-A6HE-D56816",
    "bcr_drug_uuid": "33B0A4BB-DC7E-43C0-86E2-93A6B112CAC5",
    "form_completion_date": "2014-2-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E9C8D3C-790C-46AD-8F31-B557B7C26F69",
    "patient_ID": "TCGA.E9.A6HE",
    "bcr_drug_barcode": "TCGA-E9-A6HE-D70948",
    "bcr_drug_uuid": "841B570D-BF43-46C2-BA09-48D7F7A17424",
    "form_completion_date": "2015-3-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 547,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5e2cbc56-97f9-4b94-ade2-a3f739bcc7be",
    "patient_ID": "TCGA.EW.A1IW",
    "bcr_drug_barcode": "TCGA-EW-A1IW-D21178",
    "bcr_drug_uuid": "6E6AFF49-706F-44B0-8ED2-F4AB626A5491",
    "form_completion_date": "2012-2-10",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4",
    "patient_ID": "TCGA.EW.A1IX",
    "bcr_drug_barcode": "TCGA-EW-A1IX-D21609",
    "bcr_drug_uuid": "9F1CC0D6-E9B7-4875-9B34-DC146AFDC982",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 871,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5ff12cbe-a3e0-4ce6-8452-12b984a1baaf",
    "patient_ID": "TCGA.EW.A1IY",
    "bcr_drug_barcode": "TCGA-EW-A1IY-D29086",
    "bcr_drug_uuid": "B9D6330E-568E-4DCD-8ED3-7D3138997A66",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE/CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0f88fc5-56b0-4255-bbd1-9a21ced8b37b",
    "patient_ID": "TCGA.EW.A1IZ",
    "bcr_drug_barcode": "TCGA-EW-A1IZ-D21573",
    "bcr_drug_uuid": "31800857-4883-46B8-B764-56614F4F4DD8",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0f88fc5-56b0-4255-bbd1-9a21ced8b37b",
    "patient_ID": "TCGA.EW.A1IZ",
    "bcr_drug_barcode": "TCGA-EW-A1IZ-D21547",
    "bcr_drug_uuid": "748A06A9-BBDF-473E-A546-C7831FAD5211",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 139,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 834
  },
  {
    "bcr_patient_uuid": "c0f88fc5-56b0-4255-bbd1-9a21ced8b37b",
    "patient_ID": "TCGA.EW.A1IZ",
    "bcr_drug_barcode": "TCGA-EW-A1IZ-D29261",
    "bcr_drug_uuid": "8F111407-47A7-4A8E-AAFB-EB76FC42375C",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 694,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4164
  },
  {
    "bcr_patient_uuid": "c0f88fc5-56b0-4255-bbd1-9a21ced8b37b",
    "patient_ID": "TCGA.EW.A1IZ",
    "bcr_drug_barcode": "TCGA-EW-A1IZ-D29260",
    "bcr_drug_uuid": "F8E114ED-A2E9-45CF-8C5D-262BC6C1502D",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 69,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 414
  },
  {
    "bcr_patient_uuid": "ed6cef77-1bd9-4e3b-b576-550a91e4253a",
    "patient_ID": "TCGA.EW.A1J1",
    "bcr_drug_barcode": "TCGA-EW-A1J1-D21182",
    "bcr_drug_uuid": "1094FF5B-1F3C-4697-9925-DD22ACA691F9",
    "form_completion_date": "2012-2-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 152,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed6cef77-1bd9-4e3b-b576-550a91e4253a",
    "patient_ID": "TCGA.EW.A1J1",
    "bcr_drug_barcode": "TCGA-EW-A1J1-D21578",
    "bcr_drug_uuid": "B6FC4524-6804-4773-A716-4B32CEBBA304",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 513,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 3.6,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed6cef77-1bd9-4e3b-b576-550a91e4253a",
    "patient_ID": "TCGA.EW.A1J1",
    "bcr_drug_barcode": "TCGA-EW-A1J1-D21576",
    "bcr_drug_uuid": "BD1F4D4A-4C61-4D48-8C60-7CAA2CA2711B",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 276,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 497,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed6cef77-1bd9-4e3b-b576-550a91e4253a",
    "patient_ID": "TCGA.EW.A1J1",
    "bcr_drug_barcode": "TCGA-EW-A1J1-D29264",
    "bcr_drug_uuid": "B86DC55B-25BC-4C74-BE20-F8219FCC983D",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 1015,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed6cef77-1bd9-4e3b-b576-550a91e4253a",
    "patient_ID": "TCGA.EW.A1J1",
    "bcr_drug_barcode": "TCGA-EW-A1J1-D29263",
    "bcr_drug_uuid": "21F38CCA-34D8-4B6E-BFB0-AAF97BD3D511",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 101,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a381275f-8858-4793-a8a2-0ca9db7274c8",
    "patient_ID": "TCGA.EW.A1J2",
    "bcr_drug_barcode": "TCGA-EW-A1J2-D21615",
    "bcr_drug_uuid": "D15551D0-9A3A-448E-9FAF-EEB581FFD077",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a381275f-8858-4793-a8a2-0ca9db7274c8",
    "patient_ID": "TCGA.EW.A1J2",
    "bcr_drug_barcode": "TCGA-EW-A1J2-D21614",
    "bcr_drug_uuid": "0BA44965-31D8-40C3-B712-C60B3D7BA6E7",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a381275f-8858-4793-a8a2-0ca9db7274c8",
    "patient_ID": "TCGA.EW.A1J2",
    "bcr_drug_barcode": "TCGA-EW-A1J2-D29266",
    "bcr_drug_uuid": "7CC33BB1-6AF2-42C9-9E77-17C799E6CB7E",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 1080,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bb1de798-0c02-437e-b539-33cb556d3993",
    "patient_ID": "TCGA.EW.A1J3",
    "bcr_drug_barcode": "TCGA-EW-A1J3-D21352",
    "bcr_drug_uuid": "FB07AE31-7F2E-4B1D-887E-770458A579BB",
    "form_completion_date": "2012-2-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bb1de798-0c02-437e-b539-33cb556d3993",
    "patient_ID": "TCGA.EW.A1J3",
    "bcr_drug_barcode": "TCGA-EW-A1J3-D21617",
    "bcr_drug_uuid": "1A6110CD-1997-41AA-8625-90D2731C06FF",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 336,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bb1de798-0c02-437e-b539-33cb556d3993",
    "patient_ID": "TCGA.EW.A1J3",
    "bcr_drug_barcode": "TCGA-EW-A1J3-D29269",
    "bcr_drug_uuid": "683A449C-7376-4BF2-BF3D-29B8A6B2B6A7",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_dose": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bb1de798-0c02-437e-b539-33cb556d3993",
    "patient_ID": "TCGA.EW.A1J3",
    "bcr_drug_barcode": "TCGA-EW-A1J3-D29268",
    "bcr_drug_uuid": "5C005F17-6282-4637-A5C3-3E033262CDBD",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d8ed961-a012-4b6b-bffb-9468d3953646",
    "patient_ID": "TCGA.EW.A1J5",
    "bcr_drug_barcode": "TCGA-EW-A1J5-D21354",
    "bcr_drug_uuid": "1371E038-0A59-4F41-BE94-3306DDF2A13D",
    "form_completion_date": "2012-2-6",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 98,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 392
  },
  {
    "bcr_patient_uuid": "5d8ed961-a012-4b6b-bffb-9468d3953646",
    "patient_ID": "TCGA.EW.A1J5",
    "bcr_drug_barcode": "TCGA-EW-A1J5-D29272",
    "bcr_drug_uuid": "6535FB84-2971-4559-BBB2-62715AD2E85F",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 236,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2832
  },
  {
    "bcr_patient_uuid": "5d8ed961-a012-4b6b-bffb-9468d3953646",
    "patient_ID": "TCGA.EW.A1J5",
    "bcr_drug_barcode": "TCGA-EW-A1J5-D29271",
    "bcr_drug_uuid": "B9A4AECF-CCA5-44DA-A370-1F56723E07D1",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 127,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1524
  },
  {
    "bcr_patient_uuid": "5d8ed961-a012-4b6b-bffb-9468d3953646",
    "patient_ID": "TCGA.EW.A1J5",
    "bcr_drug_barcode": "TCGA-EW-A1J5-D29270",
    "bcr_drug_uuid": "A98E7CEA-1E32-4CF2-B77F-F32B2B286E90",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 984,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3936
  },
  {
    "bcr_patient_uuid": "87281a89-91d2-44f7-9f80-668567ad5c72",
    "patient_ID": "TCGA.EW.A1J6",
    "bcr_drug_barcode": "TCGA-EW-A1J6-D21611",
    "bcr_drug_uuid": "DE34FA0A-12BB-466B-9E7B-053B947EC696",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 2.5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ac68d219-5670-4ddd-8df6-8aa7ad59e5c7",
    "patient_ID": "TCGA.EW.A1OV",
    "bcr_drug_barcode": "TCGA-EW-A1OV-D30309",
    "bcr_drug_uuid": "A35B4531-1DC9-46D1-A861-9056798B1594",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 178,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 538
  },
  {
    "bcr_patient_uuid": "ac68d219-5670-4ddd-8df6-8aa7ad59e5c7",
    "patient_ID": "TCGA.EW.A1OV",
    "bcr_drug_barcode": "TCGA-EW-A1OV-D30308",
    "bcr_drug_uuid": "438AC993-E582-4312-9218-95B3B4AF3C80",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 890,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2690
  },
  {
    "bcr_patient_uuid": "ac68d219-5670-4ddd-8df6-8aa7ad59e5c7",
    "patient_ID": "TCGA.EW.A1OV",
    "bcr_drug_barcode": "TCGA-EW-A1OV-D30310",
    "bcr_drug_uuid": "D43BD34B-E399-4B01-9711-CFC5C3099BB2",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 545
  },
  {
    "bcr_patient_uuid": "ac68d219-5670-4ddd-8df6-8aa7ad59e5c7",
    "patient_ID": "TCGA.EW.A1OV",
    "bcr_drug_barcode": "TCGA-EW-A1OV-D29120",
    "bcr_drug_uuid": "0F1217D3-7BF4-4145-9240-DE1C87BE3F50",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 890,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2690
  },
  {
    "bcr_patient_uuid": "f55dd73d-8c36-440b-84e5-9aae53107775",
    "patient_ID": "TCGA.EW.A1OW",
    "bcr_drug_barcode": "TCGA-EW-A1OW-D29123",
    "bcr_drug_uuid": "F1A2F243-E72C-4F14-9F60-6942754A3638",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 965,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2895
  },
  {
    "bcr_patient_uuid": "f55dd73d-8c36-440b-84e5-9aae53107775",
    "patient_ID": "TCGA.EW.A1OW",
    "bcr_drug_barcode": "TCGA-EW-A1OW-D29280",
    "bcr_drug_uuid": "2AC7C8DB-4D01-4FE0-9CA5-E7C406356CBE",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 163,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 489
  },
  {
    "bcr_patient_uuid": "f55dd73d-8c36-440b-84e5-9aae53107775",
    "patient_ID": "TCGA.EW.A1OW",
    "bcr_drug_barcode": "TCGA-EW-A1OW-D29279",
    "bcr_drug_uuid": "1684EE5E-6B0E-4898-964A-9055C7ABE13B",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 965,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2895
  },
  {
    "bcr_patient_uuid": "f55dd73d-8c36-440b-84e5-9aae53107775",
    "patient_ID": "TCGA.EW.A1OW",
    "bcr_drug_barcode": "TCGA-EW-A1OW-D29278",
    "bcr_drug_uuid": "444E5133-0315-4949-8801-8905B7A49C1F",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 193,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 579
  },
  {
    "bcr_patient_uuid": "5fc7ff35-d3f7-4687-8759-3542bd58e988",
    "patient_ID": "TCGA.EW.A1OX",
    "bcr_drug_barcode": "TCGA-EW-A1OX-D29102",
    "bcr_drug_uuid": "BB04DDAB-CEB8-48BC-8439-5FE0794AB1C3",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5fc7ff35-d3f7-4687-8759-3542bd58e988",
    "patient_ID": "TCGA.EW.A1OX",
    "bcr_drug_barcode": "TCGA-EW-A1OX-D29666",
    "bcr_drug_uuid": "45F438EC-544B-4FB0-8940-FB5A0C51D244",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_dose": 3.6,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5fc7ff35-d3f7-4687-8759-3542bd58e988",
    "patient_ID": "TCGA.EW.A1OX",
    "bcr_drug_barcode": "TCGA-EW-A1OX-D29664",
    "bcr_drug_uuid": "0FAF19FA-F141-42D6-AC08-F2F51560A279",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1314,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5256
  },
  {
    "bcr_patient_uuid": "5fc7ff35-d3f7-4687-8759-3542bd58e988",
    "patient_ID": "TCGA.EW.A1OX",
    "bcr_drug_barcode": "TCGA-EW-A1OX-D29101",
    "bcr_drug_uuid": "E433F9E6-5D54-429A-8513-1C86731F4B06",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 164,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 656
  },
  {
    "bcr_patient_uuid": "53ff5893-7d5e-4bcb-be9c-665fa34b7824",
    "patient_ID": "TCGA.EW.A1OY",
    "bcr_drug_barcode": "TCGA-EW-A1OY-D32264",
    "bcr_drug_uuid": "03D8BE5B-C488-4B80-B892-D6A4C2EE03B5",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53ff5893-7d5e-4bcb-be9c-665fa34b7824",
    "patient_ID": "TCGA.EW.A1OY",
    "bcr_drug_barcode": "TCGA-EW-A1OY-D32265",
    "bcr_drug_uuid": "E5516788-6C73-4B51-B902-5B5FE65F9658",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53ff5893-7d5e-4bcb-be9c-665fa34b7824",
    "patient_ID": "TCGA.EW.A1OY",
    "bcr_drug_barcode": "TCGA-EW-A1OY-D32267",
    "bcr_drug_uuid": "EBCAFCA5-6D9C-465B-B053-FE7F6CA8EADA",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53ff5893-7d5e-4bcb-be9c-665fa34b7824",
    "patient_ID": "TCGA.EW.A1OY",
    "bcr_drug_barcode": "TCGA-EW-A1OY-D32268",
    "bcr_drug_uuid": "B36F48F2-F93A-4964-B8B9-7CF74F5CB0B1",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8f912a40-3251-4e1f-ae65-1f93d71f9881",
    "patient_ID": "TCGA.EW.A1OZ",
    "bcr_drug_barcode": "TCGA-EW-A1OZ-D30292",
    "bcr_drug_uuid": "4D0A2FAD-1E7F-4624-B437-150EF0D4E686",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 142,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 426
  },
  {
    "bcr_patient_uuid": "8f912a40-3251-4e1f-ae65-1f93d71f9881",
    "patient_ID": "TCGA.EW.A1OZ",
    "bcr_drug_barcode": "TCGA-EW-A1OZ-D30296",
    "bcr_drug_uuid": "39ED2156-1E5E-4477-ACB2-C08C764C86FB",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 487,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 516,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8772
  },
  {
    "bcr_patient_uuid": "8f912a40-3251-4e1f-ae65-1f93d71f9881",
    "patient_ID": "TCGA.EW.A1OZ",
    "bcr_drug_barcode": "TCGA-EW-A1OZ-D30297",
    "bcr_drug_uuid": "3E70EEE7-3272-4696-9D31-32FA4D397B05",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8f912a40-3251-4e1f-ae65-1f93d71f9881",
    "patient_ID": "TCGA.EW.A1OZ",
    "bcr_drug_barcode": "TCGA-EW-A1OZ-D30293",
    "bcr_drug_uuid": "D68A7ED2-A4F6-4C19-A54D-7340BF471708",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 552,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1961
  },
  {
    "bcr_patient_uuid": "8f912a40-3251-4e1f-ae65-1f93d71f9881",
    "patient_ID": "TCGA.EW.A1OZ",
    "bcr_drug_barcode": "TCGA-EW-A1OZ-D30295",
    "bcr_drug_uuid": "AABA0EBE-E734-4D86-883A-695AB14363E4",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 291,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 152,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 599
  },
  {
    "bcr_patient_uuid": "81e32f39-3aa0-468b-87ed-dd2eb6165ddf",
    "patient_ID": "TCGA.EW.A1P0",
    "bcr_drug_barcode": "TCGA-EW-A1P0-D29668",
    "bcr_drug_uuid": "82BB1AF4-6610-45A8-BCFE-5A38D177760E",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1033,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1245,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29233",
    "bcr_drug_uuid": "4741983E-274B-433C-B89D-5BEAE68D4803",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 131,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 377
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29235",
    "bcr_drug_uuid": "F27A496D-E750-4C38-8AB0-8E9458182736",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 108,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 217
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29234",
    "bcr_drug_uuid": "48C077A1-8D4D-4F04-9651-C690CC977963",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 144,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 288
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29275",
    "bcr_drug_uuid": "1C58018D-9EDE-4229-BE75-BAF2AE767EB5",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 875,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2515
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29276",
    "bcr_drug_uuid": "8A876DD1-A78D-4A4E-ABE0-48E9D87B5018",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1080,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2172
  },
  {
    "bcr_patient_uuid": "f2e28af9-c40e-41c4-9e82-205cca38f26a",
    "patient_ID": "TCGA.EW.A1P1",
    "bcr_drug_barcode": "TCGA-EW-A1P1-D29274",
    "bcr_drug_uuid": "409B60F9-D4ED-4733-A1F0-318ED27B2FA3",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 88,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 252
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32283",
    "bcr_drug_uuid": "ADEE31EE-3558-4B60-9FB9-AE7031EEA45D",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1175,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32284",
    "bcr_drug_uuid": "2DF181FE-A297-4584-BC96-62221AB5790D",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1181,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32279",
    "bcr_drug_uuid": "E96674F2-DD8B-48F7-A5FF-D00715D4FC07",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32280",
    "bcr_drug_uuid": "7C343140-68DC-4876-A592-603D0A985E0E",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32281",
    "bcr_drug_uuid": "83B4A268-34F3-48DE-8F37-38D69F993505",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ff85ada-3cdd-4afb-b311-2c7befb52702",
    "patient_ID": "TCGA.EW.A1P3",
    "bcr_drug_barcode": "TCGA-EW-A1P3-D32282",
    "bcr_drug_uuid": "0E200A24-933F-4B50-8382-45D54BFC5B59",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "521e2140-ae5b-456f-8699-97398d009687",
    "patient_ID": "TCGA.EW.A1P4",
    "bcr_drug_barcode": "TCGA-EW-A1P4-D29689",
    "bcr_drug_uuid": "E8073733-F67A-40F9-88DA-22013C8ED597",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "521e2140-ae5b-456f-8699-97398d009687",
    "patient_ID": "TCGA.EW.A1P4",
    "bcr_drug_barcode": "TCGA-EW-A1P4-D29687",
    "bcr_drug_uuid": "79E0A6AE-A364-45A1-9ED5-E0FBDD00DAA9",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "53d0af48-d7ea-42c9-8695-c614b89b415b",
    "patient_ID": "TCGA.EW.A1P5",
    "bcr_drug_barcode": "TCGA-EW-A1P5-D32250",
    "bcr_drug_uuid": "ADFE3F98-9CCF-4A9C-99A0-279B5FBE82B5",
    "form_completion_date": "2012-5-22",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30269",
    "bcr_drug_uuid": "D3941135-B841-428D-B697-006C00F9A233",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 870,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2590
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30273",
    "bcr_drug_uuid": "B13DE4DD-820A-49D2-AD88-0F26B649546B",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30270",
    "bcr_drug_uuid": "AFDF574F-0437-489B-AD18-43196C2A548A",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 164,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 164
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30267",
    "bcr_drug_uuid": "635E9C0E-99F9-4277-A604-E090DC019E30",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 172,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 518
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30271",
    "bcr_drug_uuid": "0F16DDBE-E7EC-4A73-AD9D-C03723C57A19",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 131,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb",
    "patient_ID": "TCGA.EW.A1P6",
    "bcr_drug_barcode": "TCGA-EW-A1P6-D30268",
    "bcr_drug_uuid": "3A0A588D-DF4B-450F-A1BD-06F255D551B7",
    "form_completion_date": "2012-3-7",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 870,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2590
  },
  {
    "bcr_patient_uuid": "01674b2c-5cf2-478f-84a1-f69c39f47bd4",
    "patient_ID": "TCGA.EW.A1P7",
    "bcr_drug_barcode": "TCGA-EW-A1P7-D29238",
    "bcr_drug_uuid": "02AB6152-BB5D-4E54-9189-8B1A5D581075",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_dose": 550,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01674b2c-5cf2-478f-84a1-f69c39f47bd4",
    "patient_ID": "TCGA.EW.A1P7",
    "bcr_drug_barcode": "TCGA-EW-A1P7-D29273",
    "bcr_drug_uuid": "97468A51-638F-48FB-B604-59FE79E75919",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_dose": 234,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "359f12f9-5c41-48a4-85bc-fd7e307bf7d8",
    "patient_ID": "TCGA.EW.A1P8",
    "bcr_drug_barcode": "TCGA-EW-A1P8-D29122",
    "bcr_drug_uuid": "995CBFB8-E6D5-4374-A924-F0E06B3CCB01",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "359f12f9-5c41-48a4-85bc-fd7e307bf7d8",
    "patient_ID": "TCGA.EW.A1P8",
    "bcr_drug_barcode": "TCGA-EW-A1P8-D29632",
    "bcr_drug_uuid": "24AB482A-B1B6-4E84-B3EA-F5F8952F6019",
    "form_completion_date": "2012-3-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "359f12f9-5c41-48a4-85bc-fd7e307bf7d8",
    "patient_ID": "TCGA.EW.A1P8",
    "bcr_drug_barcode": "TCGA-EW-A1P8-D29633",
    "bcr_drug_uuid": "BE0E1D18-E1B5-4E37-AD2C-75B257D2F899",
    "form_completion_date": "2012-3-22",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6",
    "patient_ID": "TCGA.EW.A1PA",
    "bcr_drug_barcode": "TCGA-EW-A1PA-D30944",
    "bcr_drug_uuid": "576A0855-EEB0-4E10-A8B5-6D5961A63A9E",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1040,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3120
  },
  {
    "bcr_patient_uuid": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6",
    "patient_ID": "TCGA.EW.A1PA",
    "bcr_drug_barcode": "TCGA-EW-A1PA-D30938",
    "bcr_drug_uuid": "CDEC6B0A-4685-44B6-89A0-A9459569D2CF",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1040,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3120
  },
  {
    "bcr_patient_uuid": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6",
    "patient_ID": "TCGA.EW.A1PA",
    "bcr_drug_barcode": "TCGA-EW-A1PA-D30945",
    "bcr_drug_uuid": "87CC0E37-421A-47F8-8637-29FB7DC684C3",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6",
    "patient_ID": "TCGA.EW.A1PA",
    "bcr_drug_barcode": "TCGA-EW-A1PA-D30948",
    "bcr_drug_uuid": "3518E805-38B9-4A27-8C05-6997651B6FA8",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "NOLVADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6",
    "patient_ID": "TCGA.EW.A1PA",
    "bcr_drug_barcode": "TCGA-EW-A1PA-D30941",
    "bcr_drug_uuid": "5D03E3B4-4612-47BD-8BD5-9BCC599F8B5C",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 52.5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 157.5
  },
  {
    "bcr_patient_uuid": "F45210D3-9E66-4F5E-BEF1-5EE5547CC893",
    "patient_ID": "TCGA.EW.A1PC",
    "bcr_drug_barcode": "TCGA-EW-A1PC-D29682",
    "bcr_drug_uuid": "4784F718-8BC9-4960-AF35-7D27BE174EA2",
    "form_completion_date": "2012-3-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4dfc233b-ed03-4825-8089-e04cdee99996",
    "patient_ID": "TCGA.EW.A1PD",
    "bcr_drug_barcode": "TCGA-EW-A1PD-D30289",
    "bcr_drug_uuid": "87DA1EC9-4D7A-47A4-8455-BB95C304B65C",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 405,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7007
  },
  {
    "bcr_patient_uuid": "4dfc233b-ed03-4825-8089-e04cdee99996",
    "patient_ID": "TCGA.EW.A1PD",
    "bcr_drug_barcode": "TCGA-EW-A1PD-D30291",
    "bcr_drug_uuid": "FD142565-E97D-46EE-AB46-9AB855E32A3B",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 669,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3933
  },
  {
    "bcr_patient_uuid": "4dfc233b-ed03-4825-8089-e04cdee99996",
    "patient_ID": "TCGA.EW.A1PD",
    "bcr_drug_barcode": "TCGA-EW-A1PD-D30290",
    "bcr_drug_uuid": "1681B955-E38A-4793-BD18-B508BA3EC40A",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 872
  },
  {
    "bcr_patient_uuid": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b",
    "patient_ID": "TCGA.EW.A1PE",
    "bcr_drug_barcode": "TCGA-EW-A1PE-D30262",
    "bcr_drug_uuid": "9592447F-C6E8-43AF-8E6D-A30F6ED75544",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2990
  },
  {
    "bcr_patient_uuid": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b",
    "patient_ID": "TCGA.EW.A1PE",
    "bcr_drug_barcode": "TCGA-EW-A1PE-D30261",
    "bcr_drug_uuid": "12C9B1C5-FC49-432B-BDD4-5492291120CA",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2990
  },
  {
    "bcr_patient_uuid": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b",
    "patient_ID": "TCGA.EW.A1PE",
    "bcr_drug_barcode": "TCGA-EW-A1PE-D30264",
    "bcr_drug_uuid": "9419C58F-6F5C-443B-A471-E46D727005DE",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 603
  },
  {
    "bcr_patient_uuid": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b",
    "patient_ID": "TCGA.EW.A1PE",
    "bcr_drug_barcode": "TCGA-EW-A1PE-D30702",
    "bcr_drug_uuid": "9A2FDA20-E99F-42D4-B233-C6EBD504545D",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b",
    "patient_ID": "TCGA.EW.A1PE",
    "bcr_drug_barcode": "TCGA-EW-A1PE-D30263",
    "bcr_drug_uuid": "DD378684-5C18-47DC-902E-D3280283DAAB",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 598
  },
  {
    "bcr_patient_uuid": "848773a3-2f4a-4186-ab3f-de667129accf",
    "patient_ID": "TCGA.EW.A1PF",
    "bcr_drug_barcode": "TCGA-EW-A1PF-D30302",
    "bcr_drug_uuid": "513C4EA7-1EE9-4A4C-ACC1-535D859B1EC5",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 217,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "848773a3-2f4a-4186-ab3f-de667129accf",
    "patient_ID": "TCGA.EW.A1PF",
    "bcr_drug_barcode": "TCGA-EW-A1PF-D30298",
    "bcr_drug_uuid": "7E4FD718-8A92-44C0-995A-555BC0DA3615",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 524
  },
  {
    "bcr_patient_uuid": "848773a3-2f4a-4186-ab3f-de667129accf",
    "patient_ID": "TCGA.EW.A1PF",
    "bcr_drug_barcode": "TCGA-EW-A1PF-D30301",
    "bcr_drug_uuid": "04D4281E-70C8-4C99-9286-AE02449AB775",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1038,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4176
  },
  {
    "bcr_patient_uuid": "da286247-e8bb-4941-a2af-2453fe61cd02",
    "patient_ID": "TCGA.EW.A1PG",
    "bcr_drug_barcode": "TCGA-EW-A1PG-D29649",
    "bcr_drug_uuid": "DA69487C-E853-43D8-8FE8-325C97F99CB6",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_dose": 25,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "da286247-e8bb-4941-a2af-2453fe61cd02",
    "patient_ID": "TCGA.EW.A1PG",
    "bcr_drug_barcode": "TCGA-EW-A1PG-D29104",
    "bcr_drug_uuid": "252A2A60-D59F-40FC-B2AF-72551B1D46F1",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 910,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "da286247-e8bb-4941-a2af-2453fe61cd02",
    "patient_ID": "TCGA.EW.A1PG",
    "bcr_drug_barcode": "TCGA-EW-A1PG-D29639",
    "bcr_drug_uuid": "AC1801E0-6BCE-4E2E-9CAC-53852EAA2C9C",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 182,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 546
  },
  {
    "bcr_patient_uuid": "da286247-e8bb-4941-a2af-2453fe61cd02",
    "patient_ID": "TCGA.EW.A1PG",
    "bcr_drug_barcode": "TCGA-EW-A1PG-D29642",
    "bcr_drug_uuid": "5649EFA1-DE70-4DC9-AC8B-3770FB06A63D",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 910,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "da286247-e8bb-4941-a2af-2453fe61cd02",
    "patient_ID": "TCGA.EW.A1PG",
    "bcr_drug_barcode": "TCGA-EW-A1PG-D29645",
    "bcr_drug_uuid": "A507200D-0651-4B04-951A-3B520607A972",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 182,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 546
  },
  {
    "bcr_patient_uuid": "4da999a0-ef41-4a0b-b1d1-446b39cc855a",
    "patient_ID": "TCGA.EW.A1PH",
    "bcr_drug_barcode": "TCGA-EW-A1PH-D30306",
    "bcr_drug_uuid": "8C772D08-80AB-49A9-9CAC-40EEADDB8D31",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 169,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 169
  },
  {
    "bcr_patient_uuid": "4da999a0-ef41-4a0b-b1d1-446b39cc855a",
    "patient_ID": "TCGA.EW.A1PH",
    "bcr_drug_barcode": "TCGA-EW-A1PH-D29111",
    "bcr_drug_uuid": "E98E3894-4A1F-4559-AA6C-977995AAADD4",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 835,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2505
  },
  {
    "bcr_patient_uuid": "4da999a0-ef41-4a0b-b1d1-446b39cc855a",
    "patient_ID": "TCGA.EW.A1PH",
    "bcr_drug_barcode": "TCGA-EW-A1PH-D30304",
    "bcr_drug_uuid": "2DDB37C1-2B90-4032-8C74-3AB053366DB0",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 835,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2505
  },
  {
    "bcr_patient_uuid": "4da999a0-ef41-4a0b-b1d1-446b39cc855a",
    "patient_ID": "TCGA.EW.A1PH",
    "bcr_drug_barcode": "TCGA-EW-A1PH-D30305",
    "bcr_drug_uuid": "3C59E6BD-8791-41EF-A738-A127DA2E0088",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 167,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 501
  },
  {
    "bcr_patient_uuid": "4da999a0-ef41-4a0b-b1d1-446b39cc855a",
    "patient_ID": "TCGA.EW.A1PH",
    "bcr_drug_barcode": "TCGA-EW-A1PH-D29113",
    "bcr_drug_uuid": "CE3771B3-13A0-460B-B9C7-C17BAA64C06A",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 271,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 124,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 992
  },
  {
    "bcr_patient_uuid": "AF97E043-88CB-4F99-8F8B-9BCBCCCDF842",
    "patient_ID": "TCGA.EW.A2FR",
    "bcr_drug_barcode": "TCGA-EW-A2FR-D32313",
    "bcr_drug_uuid": "DCEB895A-E1A5-4FD9-BE38-21E232DE5684",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF97E043-88CB-4F99-8F8B-9BCBCCCDF842",
    "patient_ID": "TCGA.EW.A2FR",
    "bcr_drug_barcode": "TCGA-EW-A2FR-D32314",
    "bcr_drug_uuid": "252D689B-BC80-47B8-B3C2-74104D012674",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF97E043-88CB-4F99-8F8B-9BCBCCCDF842",
    "patient_ID": "TCGA.EW.A2FR",
    "bcr_drug_barcode": "TCGA-EW-A2FR-D32315",
    "bcr_drug_uuid": "8A8AD4DD-2321-44FD-8088-8EC827E71D20",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF97E043-88CB-4F99-8F8B-9BCBCCCDF842",
    "patient_ID": "TCGA.EW.A2FR",
    "bcr_drug_barcode": "TCGA-EW-A2FR-D32316",
    "bcr_drug_uuid": "48579EAC-39AF-415C-B6DF-893430FC303F",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32290",
    "bcr_drug_uuid": "E4D5F98B-9912-459A-AC81-4DEAF3FBE3C1",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32291",
    "bcr_drug_uuid": "9720934C-6807-40ED-95F9-E25B66C9BF52",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "GOSERELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1166,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32292",
    "bcr_drug_uuid": "5752A032-5B94-483E-B22A-0927779121F1",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 227,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32293",
    "bcr_drug_uuid": "886177D2-3C39-40AC-B112-79B370B885AA",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 227,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32294",
    "bcr_drug_uuid": "0CC44FB4-CCFA-4BF7-A1E7-281CA65EFE4A",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 318,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D34471A1-B367-4F8A-B35A-C5901C4F5503",
    "patient_ID": "TCGA.EW.A2FS",
    "bcr_drug_barcode": "TCGA-EW-A2FS-D32295",
    "bcr_drug_uuid": "E518AF83-5C33-4071-BCE1-1E37F303A078",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 332,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A",
    "patient_ID": "TCGA.EW.A2FV",
    "bcr_drug_barcode": "TCGA-EW-A2FV-D32327",
    "bcr_drug_uuid": "A38929AB-8A68-468D-ADE5-A9CA41F35D39",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A",
    "patient_ID": "TCGA.EW.A2FV",
    "bcr_drug_barcode": "TCGA-EW-A2FV-D32328",
    "bcr_drug_uuid": "1E9A1A88-0C4F-4990-8144-7C1499F9CFE3",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A",
    "patient_ID": "TCGA.EW.A2FV",
    "bcr_drug_barcode": "TCGA-EW-A2FV-D32329",
    "bcr_drug_uuid": "B03E11F1-B000-4AF8-867B-BBAA82017EFD",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A",
    "patient_ID": "TCGA.EW.A2FV",
    "bcr_drug_barcode": "TCGA-EW-A2FV-D32330",
    "bcr_drug_uuid": "A6AB155D-A721-4195-B5D4-0D2C98677EBE",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A",
    "patient_ID": "TCGA.EW.A2FV",
    "bcr_drug_barcode": "TCGA-EW-A2FV-D32331",
    "bcr_drug_uuid": "A0359D0A-8675-430D-B394-9D12D035767C",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "GOSERELIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC",
    "patient_ID": "TCGA.EW.A2FW",
    "bcr_drug_barcode": "TCGA-EW-A2FW-D32339",
    "bcr_drug_uuid": "42AD7850-0CAF-41A6-89C4-F5AB746C8401",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC",
    "patient_ID": "TCGA.EW.A2FW",
    "bcr_drug_barcode": "TCGA-EW-A2FW-D32340",
    "bcr_drug_uuid": "650B3C64-48F3-4FF7-B6F8-C1542FA0D9D1",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC",
    "patient_ID": "TCGA.EW.A2FW",
    "bcr_drug_barcode": "TCGA-EW-A2FW-D32341",
    "bcr_drug_uuid": "F099D2F0-2747-4610-9467-F7261F1C4137",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC",
    "patient_ID": "TCGA.EW.A2FW",
    "bcr_drug_barcode": "TCGA-EW-A2FW-D32343",
    "bcr_drug_uuid": "88241187-2654-4E09-872E-16C9376DC51F",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC",
    "patient_ID": "TCGA.EW.A2FW",
    "bcr_drug_barcode": "TCGA-EW-A2FW-D32344",
    "bcr_drug_uuid": "C01E02E6-1EE4-42C5-A55A-2C49B956BE8F",
    "form_completion_date": "2012-5-23",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C0B7B798-3383-4A45-A455-9ECA5810739E",
    "patient_ID": "TCGA.EW.A3E8",
    "bcr_drug_barcode": "TCGA-EW-A3E8-D39996",
    "bcr_drug_uuid": "6D645F63-EEF8-43F6-AC29-34CBBEC01722",
    "form_completion_date": "2013-2-8",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9DC3B59-613D-469E-8B4F-6C5A557EB26A",
    "patient_ID": "TCGA.EW.A3U0",
    "bcr_drug_barcode": "TCGA-EW-A3U0-D42035",
    "bcr_drug_uuid": "FD889A7B-41D1-42B5-A58A-BE562B865525",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9DC3B59-613D-469E-8B4F-6C5A557EB26A",
    "patient_ID": "TCGA.EW.A3U0",
    "bcr_drug_barcode": "TCGA-EW-A3U0-D42036",
    "bcr_drug_uuid": "7D3EE7E9-9692-488D-866E-054AF4EC0EAD",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9DC3B59-613D-469E-8B4F-6C5A557EB26A",
    "patient_ID": "TCGA.EW.A3U0",
    "bcr_drug_barcode": "TCGA-EW-A3U0-D42037",
    "bcr_drug_uuid": "39091340-4E3F-492C-9FA3-3FC1468ADDDD",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9DC3B59-613D-469E-8B4F-6C5A557EB26A",
    "patient_ID": "TCGA.EW.A3U0",
    "bcr_drug_barcode": "TCGA-EW-A3U0-D42038",
    "bcr_drug_uuid": "2ACE8F03-CCD2-49E1-BB73-5DC383D76E8C",
    "form_completion_date": "2013-4-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BDD08EC8-8892-4273-8F21-6FDE0F23C52D",
    "patient_ID": "TCGA.EW.A423",
    "bcr_drug_barcode": "TCGA-EW-A423-D38933",
    "bcr_drug_uuid": "C3B35A80-A856-4049-B06A-02E765F87BD0",
    "form_completion_date": "2013-1-4",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6502F17-6BEE-4D5A-8520-06364593D39C",
    "patient_ID": "TCGA.EW.A424",
    "bcr_drug_barcode": "TCGA-EW-A424-D38941",
    "bcr_drug_uuid": "A0C151E8-818E-4052-8F12-45E3CAC90A8C",
    "form_completion_date": "2013-1-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6502F17-6BEE-4D5A-8520-06364593D39C",
    "patient_ID": "TCGA.EW.A424",
    "bcr_drug_barcode": "TCGA-EW-A424-D38943",
    "bcr_drug_uuid": "DA732694-A93F-487C-BB75-9D25A4235E0C",
    "form_completion_date": "2013-1-4",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6502F17-6BEE-4D5A-8520-06364593D39C",
    "patient_ID": "TCGA.EW.A424",
    "bcr_drug_barcode": "TCGA-EW-A424-D57613",
    "bcr_drug_uuid": "B56289A2-A358-47AE-A1E7-F9C2A552156B",
    "form_completion_date": "2014-3-18",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97862B8E-9F76-4B19-A865-156A9C00FB1E",
    "patient_ID": "TCGA.EW.A6SC",
    "bcr_drug_barcode": "TCGA-EW-A6SC-D71018",
    "bcr_drug_uuid": "2A348DA5-AB1A-4268-ABFA-73790E39D18B",
    "form_completion_date": "2015-3-18",
    "pharmaceutical_therapy_drug_name": "AROMATASE EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42378DBC-A123-4CF9-8502-165E89FDA271",
    "patient_ID": "TCGA.EW.A6SD",
    "bcr_drug_barcode": "TCGA-EW-A6SD-D71030",
    "bcr_drug_uuid": "8617823B-CDC1-4292-A1A7-F1D9B9ABBA73",
    "form_completion_date": "2015-3-14",
    "pharmaceutical_therapy_drug_name": "TCH",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33fe5833-d7a0-43d7-a03d-56985ea448a6",
    "patient_ID": "TCGA.GI.A2C8",
    "bcr_drug_barcode": "TCGA-GI-A2C8-D29371",
    "bcr_drug_uuid": "D1A3A8E4-3C2D-46EE-B5D8-1C3994DF7365",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 4,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEOADJUVANT"
  },
  {
    "bcr_patient_uuid": "33fe5833-d7a0-43d7-a03d-56985ea448a6",
    "patient_ID": "TCGA.GI.A2C8",
    "bcr_drug_barcode": "TCGA-GI-A2C8-D33311",
    "bcr_drug_uuid": "0857F66A-898E-4DBC-8D79-4B31F0552BC4",
    "form_completion_date": "2012-6-29",
    "pharmaceutical_therapy_drug_name": "CYTOXEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33fe5833-d7a0-43d7-a03d-56985ea448a6",
    "patient_ID": "TCGA.GI.A2C8",
    "bcr_drug_barcode": "TCGA-GI-A2C8-D33386",
    "bcr_drug_uuid": "8750F85E-D2A1-4936-AE36-C090AA8D373C",
    "form_completion_date": "2012-6-29",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F6BE944-83DE-42AB-8738-F0022F475E61",
    "patient_ID": "TCGA.GI.A2C9",
    "bcr_drug_barcode": "TCGA-GI-A2C9-D21685",
    "bcr_drug_uuid": "EDBFE34C-5F81-4C58-B519-A7D28AB60B38",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3349,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1133B8A9-6B11-4511-B70A-F200E3B8B5DB",
    "patient_ID": "TCGA.GM.A2D9",
    "bcr_drug_barcode": "TCGA-GM-A2D9-D47254",
    "bcr_drug_uuid": "64CF04C2-4790-4726-A0F7-9B4EF1148E1D",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1265,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1133B8A9-6B11-4511-B70A-F200E3B8B5DB",
    "patient_ID": "TCGA.GM.A2D9",
    "bcr_drug_barcode": "TCGA-GM-A2D9-D47255",
    "bcr_drug_uuid": "3BAECB5B-8DFC-452B-93BF-ED08CA82E4EC",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1354,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1133B8A9-6B11-4511-B70A-F200E3B8B5DB",
    "patient_ID": "TCGA.GM.A2D9",
    "bcr_drug_barcode": "TCGA-GM-A2D9-D47256",
    "bcr_drug_uuid": "1BAEBAA5-762C-4559-8CFF-34C352DD5B0A",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1362,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1455,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1133B8A9-6B11-4511-B70A-F200E3B8B5DB",
    "patient_ID": "TCGA.GM.A2D9",
    "bcr_drug_barcode": "TCGA-GM-A2D9-D47257",
    "bcr_drug_uuid": "F83B835B-003A-4E5D-AA90-9504C8171A8D",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1470,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1567,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47211",
    "bcr_drug_uuid": "1CE4C77C-03D8-4A3E-9B4E-17A37FEBF574",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47213",
    "bcr_drug_uuid": "9DBAC4E4-29D1-4620-BB0E-E85862C78A16",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47214",
    "bcr_drug_uuid": "FBF6B10E-F9FA-412E-8317-7BC12FDECECD",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47215",
    "bcr_drug_uuid": "A308134D-A87B-4D38-A1B5-AD5A5BACFF22",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47217",
    "bcr_drug_uuid": "F1691109-2DFB-4D93-B667-029E43AFA481",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47219",
    "bcr_drug_uuid": "FDBDD508-2625-4646-B410-82178F238FB5",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 3061,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3131,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47220",
    "bcr_drug_uuid": "A9D3732A-4B83-435F-AFE7-98604C52FEAF",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 3061,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3131,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47221",
    "bcr_drug_uuid": "E6B44B72-350F-4D39-ACA6-4751D537EC29",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3415,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47222",
    "bcr_drug_uuid": "34A11D07-D395-44A8-B0FA-B6785948D3FE",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 3434,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4307,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47223",
    "bcr_drug_uuid": "B90F3A89-5CDC-406E-B9B8-C850C6C5DD76",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 4347,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4435,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47224",
    "bcr_drug_uuid": "66BF0675-E5AC-453D-B319-3E0DCE3C4C2A",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4470,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4494,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47225",
    "bcr_drug_uuid": "D8B2FED7-8269-47D8-90DC-E1A16E08E05F",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "YONDELIS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4470,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4494,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47228",
    "bcr_drug_uuid": "A7B8633B-19CD-4008-887D-77BE720AF867",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4515,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4720,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47229",
    "bcr_drug_uuid": "E41E7973-FE0F-4D97-A8DB-69BFE8B0D08C",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 4721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 5015,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47230",
    "bcr_drug_uuid": "F503B87E-A4F9-4FA8-9508-93B7658C1FDA",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5021,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 5455,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47231",
    "bcr_drug_uuid": "B9F6747C-A8E8-4DFF-B2FF-6378094F03E1",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5455,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 5678,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47232",
    "bcr_drug_uuid": "3411631A-3C34-4A06-A5E7-DB6F0E49CA25",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "IXABEPILONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5684,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 5797,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47234",
    "bcr_drug_uuid": "BAE1A1F1-6EDC-4E7E-BA5E-632C9F3E6AA9",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 5797,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6028,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47236",
    "bcr_drug_uuid": "28B70E98-675A-4649-A171-1CCC398CFB9F",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 5909,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6029,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47237",
    "bcr_drug_uuid": "D2F15985-953A-4B07-B205-27967C46571D",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6051,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6213,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47238",
    "bcr_drug_uuid": "89719FBA-E180-4F48-AE3B-75CBFB127146",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "LAPATINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6051,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6536,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47240",
    "bcr_drug_uuid": "4CDD3F8E-EFF0-49C7-972E-40AE2CAB2B7A",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6372,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6422,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976",
    "patient_ID": "TCGA.GM.A2DA",
    "bcr_drug_barcode": "TCGA-GM-A2DA-D47241",
    "bcr_drug_uuid": "EEBDC3B3-BCF1-4629-9C08-8129305599B7",
    "form_completion_date": "2013-8-23",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 6372,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6536,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E6B7742-A562-490B-BB72-04A5653852E4",
    "patient_ID": "TCGA.GM.A2DB",
    "bcr_drug_barcode": "TCGA-GM-A2DB-D47159",
    "bcr_drug_uuid": "FCDFC8F4-07C3-4F53-A0E4-135FC08A31D6",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E6B7742-A562-490B-BB72-04A5653852E4",
    "patient_ID": "TCGA.GM.A2DB",
    "bcr_drug_barcode": "TCGA-GM-A2DB-D47161",
    "bcr_drug_uuid": "8109884C-3338-42A4-8167-9ABEF5678D23",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 248,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E6B7742-A562-490B-BB72-04A5653852E4",
    "patient_ID": "TCGA.GM.A2DB",
    "bcr_drug_barcode": "TCGA-GM-A2DB-D47162",
    "bcr_drug_uuid": "9C452D7D-4120-4BFE-B788-AEF890F1DA60",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 248,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6E6B7742-A562-490B-BB72-04A5653852E4",
    "patient_ID": "TCGA.GM.A2DB",
    "bcr_drug_barcode": "TCGA-GM-A2DB-D47163",
    "bcr_drug_uuid": "9DB393BE-D1F8-4423-BE3A-1201B189B8E6",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 248,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47063",
    "bcr_drug_uuid": "679FB4FD-B762-4872-806F-4EE16E16D89D",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47064",
    "bcr_drug_uuid": "5E67582A-3CD1-4483-9C0E-C98EF42102E3",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47065",
    "bcr_drug_uuid": "F653FE5D-76FD-4DD7-A553-952CA706E60F",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47066",
    "bcr_drug_uuid": "4D71435A-BF64-420E-BAAA-4892EADB051F",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47067",
    "bcr_drug_uuid": "DD73F85B-7DFB-4F68-ACDB-DA28D8449C86",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47068",
    "bcr_drug_uuid": "9A846B76-30FF-41CC-854D-8BFDBE8D172E",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 294,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 341,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717",
    "patient_ID": "TCGA.GM.A2DC",
    "bcr_drug_barcode": "TCGA-GM-A2DC-D47069",
    "bcr_drug_uuid": "01F8744B-71EA-4966-BDDF-8D9D5CFD632C",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA",
    "patient_ID": "TCGA.GM.A2DD",
    "bcr_drug_barcode": "TCGA-GM-A2DD-D47071",
    "bcr_drug_uuid": "2664E496-34C1-4DFB-893B-7102CD0171B3",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA",
    "patient_ID": "TCGA.GM.A2DD",
    "bcr_drug_barcode": "TCGA-GM-A2DD-D47072",
    "bcr_drug_uuid": "A4DAE917-9FC6-409F-9FDD-1E8F876394CA",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA",
    "patient_ID": "TCGA.GM.A2DD",
    "bcr_drug_barcode": "TCGA-GM-A2DD-D47073",
    "bcr_drug_uuid": "30DC9EB0-B305-4BC7-B006-221E80F1AE25",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6F7AFC0-1558-43AD-ACB1-2B5311ED2264",
    "patient_ID": "TCGA.GM.A2DF",
    "bcr_drug_barcode": "TCGA-GM-A2DF-D47077",
    "bcr_drug_uuid": "9309E85C-511C-4D64-A9FD-153D7D059F76",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6F7AFC0-1558-43AD-ACB1-2B5311ED2264",
    "patient_ID": "TCGA.GM.A2DF",
    "bcr_drug_barcode": "TCGA-GM-A2DF-D47078",
    "bcr_drug_uuid": "BD3CED99-2972-42AC-A40F-65D713B00CF1",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6F7AFC0-1558-43AD-ACB1-2B5311ED2264",
    "patient_ID": "TCGA.GM.A2DF",
    "bcr_drug_barcode": "TCGA-GM-A2DF-D47079",
    "bcr_drug_uuid": "9759BFEA-6BA0-47F3-8697-D4BE5FD98515",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D6F7AFC0-1558-43AD-ACB1-2B5311ED2264",
    "patient_ID": "TCGA.GM.A2DF",
    "bcr_drug_barcode": "TCGA-GM-A2DF-D47080",
    "bcr_drug_uuid": "0DE09D9B-CDA0-4E1C-A438-47238333BAF8",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5700C1B3-922A-4401-8AB8-89028908D696",
    "patient_ID": "TCGA.GM.A2DH",
    "bcr_drug_barcode": "TCGA-GM-A2DH-D47082",
    "bcr_drug_uuid": "556C375B-CFAB-497E-AE7A-22BC00FC3826",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5700C1B3-922A-4401-8AB8-89028908D696",
    "patient_ID": "TCGA.GM.A2DH",
    "bcr_drug_barcode": "TCGA-GM-A2DH-D47083",
    "bcr_drug_uuid": "BA77ECF0-0A86-4F8A-9268-57921470CEC6",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5700C1B3-922A-4401-8AB8-89028908D696",
    "patient_ID": "TCGA.GM.A2DH",
    "bcr_drug_barcode": "TCGA-GM-A2DH-D47084",
    "bcr_drug_uuid": "5D627B00-9BA1-4D32-971B-CCE6AF02327A",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5700C1B3-922A-4401-8AB8-89028908D696",
    "patient_ID": "TCGA.GM.A2DH",
    "bcr_drug_barcode": "TCGA-GM-A2DH-D47085",
    "bcr_drug_uuid": "4B6748E0-604F-422B-9752-189DFFF16BD8",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66FA504C-4AE4-49AC-9355-1E063776DC0D",
    "patient_ID": "TCGA.GM.A2DI",
    "bcr_drug_barcode": "TCGA-GM-A2DI-D47090",
    "bcr_drug_uuid": "7B5D9D98-20F4-4180-8CAC-4343CFA7FCD3",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66FA504C-4AE4-49AC-9355-1E063776DC0D",
    "patient_ID": "TCGA.GM.A2DI",
    "bcr_drug_barcode": "TCGA-GM-A2DI-D47091",
    "bcr_drug_uuid": "5CFA2517-8901-4EA6-A4C7-92DA88C6C423",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66FA504C-4AE4-49AC-9355-1E063776DC0D",
    "patient_ID": "TCGA.GM.A2DI",
    "bcr_drug_barcode": "TCGA-GM-A2DI-D47092",
    "bcr_drug_uuid": "7D31035E-0AC6-403A-B734-CA72E210C75F",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66FA504C-4AE4-49AC-9355-1E063776DC0D",
    "patient_ID": "TCGA.GM.A2DI",
    "bcr_drug_barcode": "TCGA-GM-A2DI-D47093",
    "bcr_drug_uuid": "2D81179B-0BEB-492F-8B9F-5FA57D8F59D0",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3A0775A0-61AE-43F2-B5F6-629A44355C2F",
    "patient_ID": "TCGA.GM.A2DK",
    "bcr_drug_barcode": "TCGA-GM-A2DK-D47097",
    "bcr_drug_uuid": "F92A5EEC-9F0D-4B49-8D7C-15E038B017EA",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1893,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A76774FE-7298-4D68-A2B2-C1BAD93F0C31",
    "patient_ID": "TCGA.GM.A2DL",
    "bcr_drug_barcode": "TCGA-GM-A2DL-D47100",
    "bcr_drug_uuid": "64A06228-D44D-48D4-920A-2EF984608DE9",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1989,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A76774FE-7298-4D68-A2B2-C1BAD93F0C31",
    "patient_ID": "TCGA.GM.A2DL",
    "bcr_drug_barcode": "TCGA-GM-A2DL-D47102",
    "bcr_drug_uuid": "C22DF452-BBBA-49F3-ACF1-E448627C6D68",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1990,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "753D5D49-3B40-4737-9D4C-B1EC29CC2692",
    "patient_ID": "TCGA.GM.A2DM",
    "bcr_drug_barcode": "TCGA-GM-A2DM-D47106",
    "bcr_drug_uuid": "AADE02DF-74F2-4DD1-A0AE-1429B9186906",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "753D5D49-3B40-4737-9D4C-B1EC29CC2692",
    "patient_ID": "TCGA.GM.A2DM",
    "bcr_drug_barcode": "TCGA-GM-A2DM-D47107",
    "bcr_drug_uuid": "140AE260-F266-41E9-9467-8C7E03D3AB54",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "753D5D49-3B40-4737-9D4C-B1EC29CC2692",
    "patient_ID": "TCGA.GM.A2DM",
    "bcr_drug_barcode": "TCGA-GM-A2DM-D47108",
    "bcr_drug_uuid": "873034B7-62ED-4DD0-AD5C-84DAB7801B20",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "753D5D49-3B40-4737-9D4C-B1EC29CC2692",
    "patient_ID": "TCGA.GM.A2DM",
    "bcr_drug_barcode": "TCGA-GM-A2DM-D47109",
    "bcr_drug_uuid": "7C8F3B47-B784-4B27-9FB2-7B466008E490",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "753D5D49-3B40-4737-9D4C-B1EC29CC2692",
    "patient_ID": "TCGA.GM.A2DM",
    "bcr_drug_barcode": "TCGA-GM-A2DM-D47110",
    "bcr_drug_uuid": "B5B25354-BF47-47EA-B68D-748265329F82",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 772,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "56BBD282-B88D-4730-9242-AB97D08DC83A",
    "patient_ID": "TCGA.GM.A2DN",
    "bcr_drug_barcode": "TCGA-GM-A2DN-D47126",
    "bcr_drug_uuid": "2F3C7A0D-A528-4393-8A8C-E4BA2A55F39A",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "56BBD282-B88D-4730-9242-AB97D08DC83A",
    "patient_ID": "TCGA.GM.A2DN",
    "bcr_drug_barcode": "TCGA-GM-A2DN-D47127",
    "bcr_drug_uuid": "23F229E0-8687-49C9-A84B-FF6D954A025E",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "56BBD282-B88D-4730-9242-AB97D08DC83A",
    "patient_ID": "TCGA.GM.A2DN",
    "bcr_drug_barcode": "TCGA-GM-A2DN-D47128",
    "bcr_drug_uuid": "F64D6F34-B6B3-4B1A-88DE-96B8C8A07835",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "56BBD282-B88D-4730-9242-AB97D08DC83A",
    "patient_ID": "TCGA.GM.A2DN",
    "bcr_drug_barcode": "TCGA-GM-A2DN-D47129",
    "bcr_drug_uuid": "9CB21DFD-9BDD-4A32-A8A7-1E5F2519AC34",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "56BBD282-B88D-4730-9242-AB97D08DC83A",
    "patient_ID": "TCGA.GM.A2DN",
    "bcr_drug_barcode": "TCGA-GM-A2DN-D47130",
    "bcr_drug_uuid": "F102C2E8-AC64-42D3-8420-DD1DF9F856C0",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1063,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5FD37868-4762-4109-9DCF-6FDBAB5B645D",
    "patient_ID": "TCGA.GM.A2DO",
    "bcr_drug_barcode": "TCGA-GM-A2DO-D47154",
    "bcr_drug_uuid": "C19E8E9F-4856-4D78-8214-60750D868B76",
    "form_completion_date": "2013-8-22",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 219,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2051,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6DDAEE34-46EB-490C-BD13-F0AB963C4322",
    "patient_ID": "TCGA.GM.A3NW",
    "bcr_drug_barcode": "TCGA-GM-A3NW-D40402",
    "bcr_drug_uuid": "94E98AC3-6333-4A5B-A854-BE225AD37D6F",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2055,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6DDAEE34-46EB-490C-BD13-F0AB963C4322",
    "patient_ID": "TCGA.GM.A3NW",
    "bcr_drug_barcode": "TCGA-GM-A3NW-D40399",
    "bcr_drug_uuid": "5A6BEDB9-C5EB-404D-B70B-EA0253B4FC05",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6DDAEE34-46EB-490C-BD13-F0AB963C4322",
    "patient_ID": "TCGA.GM.A3NW",
    "bcr_drug_barcode": "TCGA-GM-A3NW-D40401",
    "bcr_drug_uuid": "0C26CDE2-DE29-4331-B678-BF68B7E1F9F8",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6DDAEE34-46EB-490C-BD13-F0AB963C4322",
    "patient_ID": "TCGA.GM.A3NW",
    "bcr_drug_barcode": "TCGA-GM-A3NW-D40400",
    "bcr_drug_uuid": "F06F057C-E684-4B61-92FE-F22B0EF9A3F4",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BD5374C9-7F36-457F-B66B-7CC7FF64224E",
    "patient_ID": "TCGA.GM.A3NY",
    "bcr_drug_barcode": "TCGA-GM-A3NY-D40405",
    "bcr_drug_uuid": "907FA230-9311-4125-9C9D-FA54ED976D6C",
    "form_completion_date": "2013-2-19",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D35512",
    "bcr_drug_uuid": "E32E194C-8D7D-4B56-BB63-4D33F4B1082A",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D35515",
    "bcr_drug_uuid": "40EF982A-EAA8-4F0A-A86D-5ED6DA2150F7",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 324,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D35516",
    "bcr_drug_uuid": "53DCF90D-749C-447D-BA77-62545A2CCAAA",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 324,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D35519",
    "bcr_drug_uuid": "34EC610D-426F-433C-94ED-1FB1BC4FF569",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 324,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D41971",
    "bcr_drug_uuid": "D44E9F6A-E7B4-4C08-BF20-B6A744CD1C78",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 434,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 473,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76",
    "patient_ID": "TCGA.GM.A3XG",
    "bcr_drug_barcode": "TCGA-GM-A3XG-D41972",
    "bcr_drug_uuid": "1E050AB5-3F95-403F-9CD2-15E62549A9B0",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 813,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 843,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "65CAC997-4D39-4501-85EC-4FCB328A8EB5",
    "patient_ID": "TCGA.GM.A3XL",
    "bcr_drug_barcode": "TCGA-GM-A3XL-D35523",
    "bcr_drug_uuid": "E53B3221-61CB-48E0-A761-E99D86612033",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "65CAC997-4D39-4501-85EC-4FCB328A8EB5",
    "patient_ID": "TCGA.GM.A3XL",
    "bcr_drug_barcode": "TCGA-GM-A3XL-D35524",
    "bcr_drug_uuid": "3C18A200-60E1-402E-B214-AE55C2033154",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "65CAC997-4D39-4501-85EC-4FCB328A8EB5",
    "patient_ID": "TCGA.GM.A3XL",
    "bcr_drug_barcode": "TCGA-GM-A3XL-D35525",
    "bcr_drug_uuid": "AC30090D-D89E-4942-B93B-C44B8BBA2641",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "65CAC997-4D39-4501-85EC-4FCB328A8EB5",
    "patient_ID": "TCGA.GM.A3XL",
    "bcr_drug_barcode": "TCGA-GM-A3XL-D35526",
    "bcr_drug_uuid": "A7375485-9703-446C-A59F-3E2E7F2A3E83",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 248,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D35531",
    "bcr_drug_uuid": "FC4B09BC-E04D-4AAD-8ADC-943214589F12",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D35532",
    "bcr_drug_uuid": "7594E8FE-166B-40DC-82BA-FAB360C98DB2",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 282,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D35534",
    "bcr_drug_uuid": "D27177DE-0207-41D5-AA50-1BF7FAE5FBDC",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 282,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D35535",
    "bcr_drug_uuid": "8AD2952D-C463-426C-BCFF-674C4A1821B8",
    "form_completion_date": "2012-10-1",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 282,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D41968",
    "bcr_drug_uuid": "5A81151E-DC13-4510-B131-29DB3185B815",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 416,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1591,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3",
    "patient_ID": "TCGA.GM.A3XN",
    "bcr_drug_barcode": "TCGA-GM-A3XN-D41969",
    "bcr_drug_uuid": "F9D001E6-39C1-43A9-B5B7-5A833D67EBE7",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1592,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37113",
    "bcr_drug_uuid": "76CCB5FF-A056-43DA-8555-AEDB5683ADAE",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37115",
    "bcr_drug_uuid": "4C24BBBE-85D7-4F91-867A-F3565F4E8AFB",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37116",
    "bcr_drug_uuid": "503948AA-4087-417D-8768-32F533FEBEBE",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "5-FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 226,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37117",
    "bcr_drug_uuid": "D672E4DB-472F-4FCA-A031-1EAA79128C90",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 226,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37118",
    "bcr_drug_uuid": "84DD5400-4F97-4F5B-BD39-228348DC7862",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 226,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE",
    "patient_ID": "TCGA.GM.A4E0",
    "bcr_drug_barcode": "TCGA-GM-A4E0-D37119",
    "bcr_drug_uuid": "E59D3AC8-259B-48CF-A95F-9328FB248A09",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 320,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C8DC41-EDCB-4563-96B3-3F93F9EDCBE9",
    "patient_ID": "TCGA.GM.A5PV",
    "bcr_drug_barcode": "TCGA-GM-A5PV-D42156",
    "bcr_drug_uuid": "1316596D-D637-490A-BC7F-1E1C61EB3AE0",
    "form_completion_date": "2013-4-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67C8DC41-EDCB-4563-96B3-3F93F9EDCBE9",
    "patient_ID": "TCGA.GM.A5PV",
    "bcr_drug_barcode": "TCGA-GM-A5PV-D42166",
    "bcr_drug_uuid": "F72DFCCB-CAB4-4F6D-8B1B-FC0364E48134",
    "form_completion_date": "2013-4-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F7064D01-29D8-49A2-AD60-1E0C5F148F3E",
    "patient_ID": "TCGA.GM.A5PX",
    "bcr_drug_barcode": "TCGA-GM-A5PX-D42160",
    "bcr_drug_uuid": "D2BD571D-6658-48CB-88FE-77DAC9870F9C",
    "form_completion_date": "2013-4-12",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F7064D01-29D8-49A2-AD60-1E0C5F148F3E",
    "patient_ID": "TCGA.GM.A5PX",
    "bcr_drug_barcode": "TCGA-GM-A5PX-D42161",
    "bcr_drug_uuid": "761DB280-F416-45BF-B1C0-88A1E9EFA3EF",
    "form_completion_date": "2013-4-12",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 339,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F7064D01-29D8-49A2-AD60-1E0C5F148F3E",
    "patient_ID": "TCGA.GM.A5PX",
    "bcr_drug_barcode": "TCGA-GM-A5PX-D42163",
    "bcr_drug_uuid": "2713B9D0-0CB9-4FD7-B75B-3ED4DEC296C4",
    "form_completion_date": "2013-4-12",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "124B693C-77DC-4FA8-B703-54E8B5054A92",
    "patient_ID": "TCGA.HN.A2NL",
    "bcr_drug_barcode": "TCGA-HN-A2NL-D60150",
    "bcr_drug_uuid": "FC632444-8B7E-4F7E-94DD-B12171B1E0D6",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59
  },
  {
    "bcr_patient_uuid": "124B693C-77DC-4FA8-B703-54E8B5054A92",
    "patient_ID": "TCGA.HN.A2NL",
    "bcr_drug_barcode": "TCGA-HN-A2NL-D60151",
    "bcr_drug_uuid": "D9161F5E-D3C5-4B6F-8267-C280BAEBD2D4",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59
  },
  {
    "bcr_patient_uuid": "61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333",
    "patient_ID": "TCGA.HN.A2OB",
    "bcr_drug_barcode": "TCGA-HN-A2OB-D49169",
    "bcr_drug_uuid": "39B4679E-628C-435B-85C4-25B71BCB04DE",
    "form_completion_date": "2013-9-26",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333",
    "patient_ID": "TCGA.HN.A2OB",
    "bcr_drug_barcode": "TCGA-HN-A2OB-D49305",
    "bcr_drug_uuid": "B7C4F1EB-383C-43B2-B58D-2393FE01811A",
    "form_completion_date": "2013-9-30",
    "pharmaceutical_therapy_drug_name": "EPIRUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333",
    "patient_ID": "TCGA.HN.A2OB",
    "bcr_drug_barcode": "TCGA-HN-A2OB-D49307",
    "bcr_drug_uuid": "7988073B-ABA2-43A5-9498-E039E2CF2F8A",
    "form_completion_date": "2013-9-30",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333",
    "patient_ID": "TCGA.HN.A2OB",
    "bcr_drug_barcode": "TCGA-HN-A2OB-D49308",
    "bcr_drug_uuid": "ACF2B357-EB83-4198-95BC-7128DDF3B1EE",
    "form_completion_date": "2013-9-30",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38DC3E09-0B0E-4A29-B318-CC0352013DAE",
    "patient_ID": "TCGA.LD.A66U",
    "bcr_drug_barcode": "TCGA-LD-A66U-D44826",
    "bcr_drug_uuid": "26C2F6EB-DFF2-4C2A-A095-98A2434C36EF",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38DC3E09-0B0E-4A29-B318-CC0352013DAE",
    "patient_ID": "TCGA.LD.A66U",
    "bcr_drug_barcode": "TCGA-LD-A66U-D44784",
    "bcr_drug_uuid": "7A18D472-645D-49A3-B32B-E960EF3D6FC1",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38DC3E09-0B0E-4A29-B318-CC0352013DAE",
    "patient_ID": "TCGA.LD.A66U",
    "bcr_drug_barcode": "TCGA-LD-A66U-D44824",
    "bcr_drug_uuid": "0938D350-5A79-457E-B8EA-2BCF27413DDE",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38DC3E09-0B0E-4A29-B318-CC0352013DAE",
    "patient_ID": "TCGA.LD.A66U",
    "bcr_drug_barcode": "TCGA-LD-A66U-D58447",
    "bcr_drug_uuid": "F33118FA-3D18-420A-8F4A-2B5ECD06BE24",
    "form_completion_date": "2014-4-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 278,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "38A4E9BD-93E9-432D-A756-3B1055B823BD",
    "patient_ID": "TCGA.LD.A74U",
    "bcr_drug_barcode": "TCGA-LD-A74U-D55160",
    "bcr_drug_uuid": "18D6C097-AA64-4C59-9CA9-C6737668C348",
    "form_completion_date": "2013-12-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 301,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A06FF6AE-B0DD-4516-A75C-0DB71694B46B",
    "patient_ID": "TCGA.LD.A7W5",
    "bcr_drug_barcode": "TCGA-LD-A7W5-D56345",
    "bcr_drug_uuid": "71C98143-F9F6-4C6F-A7DD-168C6BC9E034",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A06FF6AE-B0DD-4516-A75C-0DB71694B46B",
    "patient_ID": "TCGA.LD.A7W5",
    "bcr_drug_barcode": "TCGA-LD-A7W5-D56346",
    "bcr_drug_uuid": "C0C80864-B5AF-43CC-9232-BC05B4141491",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0B0F9938-CE1E-4814-8821-0132D137EB9E",
    "patient_ID": "TCGA.LD.A7W6",
    "bcr_drug_barcode": "TCGA-LD-A7W6-D56359",
    "bcr_drug_uuid": "98AA201E-F562-487E-A7DC-EB64623A1085",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95C53ECF-D8F1-4BCB-9B1A-C9A0542939F0",
    "patient_ID": "TCGA.LD.A9QF",
    "bcr_drug_barcode": "TCGA-LD-A9QF-D69217",
    "bcr_drug_uuid": "DD58AC64-B826-4A72-A389-94813C6C0B32",
    "form_completion_date": "2014-12-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95C53ECF-D8F1-4BCB-9B1A-C9A0542939F0",
    "patient_ID": "TCGA.LD.A9QF",
    "bcr_drug_barcode": "TCGA-LD-A9QF-D69218",
    "bcr_drug_uuid": "C272D5D2-87EC-40F4-AE07-C273B787A7AA",
    "form_completion_date": "2014-12-30",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00B11CA8-8540-4A3D-B602-EC754B00230B",
    "patient_ID": "TCGA.LL.A440",
    "bcr_drug_barcode": "TCGA-LL-A440-D46388",
    "bcr_drug_uuid": "594D9D16-EBE5-48DB-8248-895F81E52C71",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00B11CA8-8540-4A3D-B602-EC754B00230B",
    "patient_ID": "TCGA.LL.A440",
    "bcr_drug_barcode": "TCGA-LL-A440-D46389",
    "bcr_drug_uuid": "DDE1F9CF-5FD6-44F3-A2FB-5DA0244330D4",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00B11CA8-8540-4A3D-B602-EC754B00230B",
    "patient_ID": "TCGA.LL.A440",
    "bcr_drug_barcode": "TCGA-LL-A440-D46390",
    "bcr_drug_uuid": "33BE396B-855F-4092-A53F-628047C5B25B",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69FC24FC-CFE2-487A-935F-1A954B30B709",
    "patient_ID": "TCGA.LL.A441",
    "bcr_drug_barcode": "TCGA-LL-A441-D36591",
    "bcr_drug_uuid": "26759221-D07C-4BDA-BBB6-36A76DE3EDA6",
    "form_completion_date": "2012-11-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69FC24FC-CFE2-487A-935F-1A954B30B709",
    "patient_ID": "TCGA.LL.A441",
    "bcr_drug_barcode": "TCGA-LL-A441-D36592",
    "bcr_drug_uuid": "EAC2A2A2-E81E-4A91-A483-5055C21238F3",
    "form_completion_date": "2012-11-5",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3F56D67F-5A9C-4353-9408-E7F60EB6477B",
    "patient_ID": "TCGA.LL.A442",
    "bcr_drug_barcode": "TCGA-LL-A442-D36069",
    "bcr_drug_uuid": "E1D4E54E-9B75-48FF-AF1C-506222B5E941",
    "form_completion_date": "2012-10-17",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "91DA548B-5C64-49C3-A44A-1EF115F53311",
    "patient_ID": "TCGA.LL.A50Y",
    "bcr_drug_barcode": "TCGA-LL-A50Y-D40968",
    "bcr_drug_uuid": "AAE548CC-C906-4B50-9987-4BEAC371569C",
    "form_completion_date": "2013-3-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 608,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D75E89D-4B01-443C-BE54-749C7A667BF4",
    "patient_ID": "TCGA.LL.A5YL",
    "bcr_drug_barcode": "TCGA-LL-A5YL-D43410",
    "bcr_drug_uuid": "8706E99F-7547-4F58-918E-66A8EA5EB237",
    "form_completion_date": "2013-5-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D75E89D-4B01-443C-BE54-749C7A667BF4",
    "patient_ID": "TCGA.LL.A5YL",
    "bcr_drug_barcode": "TCGA-LL-A5YL-D43411",
    "bcr_drug_uuid": "4F99E58A-D90D-4DE0-9ABD-37B777EE111F",
    "form_completion_date": "2013-5-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D75E89D-4B01-443C-BE54-749C7A667BF4",
    "patient_ID": "TCGA.LL.A5YL",
    "bcr_drug_barcode": "TCGA-LL-A5YL-D43750",
    "bcr_drug_uuid": "31AEC785-42C5-479C-B46B-3AB5E1479898",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D75E89D-4B01-443C-BE54-749C7A667BF4",
    "patient_ID": "TCGA.LL.A5YL",
    "bcr_drug_barcode": "TCGA-LL-A5YL-D43751",
    "bcr_drug_uuid": "98BC7928-4B13-46C1-AADD-C2FC86C0BB51",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D75E89D-4B01-443C-BE54-749C7A667BF4",
    "patient_ID": "TCGA.LL.A5YL",
    "bcr_drug_barcode": "TCGA-LL-A5YL-D59653",
    "bcr_drug_uuid": "8E7139E6-B6EF-403D-ABDE-AF79BD55D833",
    "form_completion_date": "2014-5-19",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E9A12DF9-024E-4CBC-B6BF-E4E87485FA90",
    "patient_ID": "TCGA.LL.A5YM",
    "bcr_drug_barcode": "TCGA-LL-A5YM-D57542",
    "bcr_drug_uuid": "EBAB50E8-81A5-49D8-92FB-7A44273418AB",
    "form_completion_date": "2014-3-14",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C",
    "patient_ID": "TCGA.LL.A5YN",
    "bcr_drug_barcode": "TCGA-LL-A5YN-D43375",
    "bcr_drug_uuid": "A44314A0-B6F0-45D4-811F-53215A4E052C",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C",
    "patient_ID": "TCGA.LL.A5YN",
    "bcr_drug_barcode": "TCGA-LL-A5YN-D43376",
    "bcr_drug_uuid": "8DF86AE2-2A1A-48D5-B349-97263291088C",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C",
    "patient_ID": "TCGA.LL.A5YN",
    "bcr_drug_barcode": "TCGA-LL-A5YN-D43377",
    "bcr_drug_uuid": "C9597303-18A1-441B-99D5-56DE1239A057",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C",
    "patient_ID": "TCGA.LL.A5YN",
    "bcr_drug_barcode": "TCGA-LL-A5YN-D59363",
    "bcr_drug_uuid": "867990D7-24CC-4A86-A294-79C35DFE9907",
    "form_completion_date": "2014-5-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN CITRATE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B8AEFC48-4A6E-4254-A57F-5F688399B582",
    "patient_ID": "TCGA.LL.A5YO",
    "bcr_drug_barcode": "TCGA-LL-A5YO-D43017",
    "bcr_drug_uuid": "2796DB97-696B-4A10-94A8-0596D8A2F43E",
    "form_completion_date": "2013-5-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B8AEFC48-4A6E-4254-A57F-5F688399B582",
    "patient_ID": "TCGA.LL.A5YO",
    "bcr_drug_barcode": "TCGA-LL-A5YO-D43018",
    "bcr_drug_uuid": "9E63512F-49BD-4691-8C4D-920BA81A33D7",
    "form_completion_date": "2013-5-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6D24E675-2FA4-4102-861F-7516650B3049",
    "patient_ID": "TCGA.LL.A5YP",
    "bcr_drug_barcode": "TCGA-LL-A5YP-D43371",
    "bcr_drug_uuid": "BC6B458B-5E1E-406F-B8B0-210BAEFD3919",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D24E675-2FA4-4102-861F-7516650B3049",
    "patient_ID": "TCGA.LL.A5YP",
    "bcr_drug_barcode": "TCGA-LL-A5YP-D43372",
    "bcr_drug_uuid": "A1DC4722-1400-4337-B4EF-0797D7BC8602",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D24E675-2FA4-4102-861F-7516650B3049",
    "patient_ID": "TCGA.LL.A5YP",
    "bcr_drug_barcode": "TCGA-LL-A5YP-D59324",
    "bcr_drug_uuid": "AB4E3D99-82DD-4221-A645-BAD1768BAEC1",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 457,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D24E675-2FA4-4102-861F-7516650B3049",
    "patient_ID": "TCGA.LL.A5YP",
    "bcr_drug_barcode": "TCGA-LL-A5YP-D59325",
    "bcr_drug_uuid": "F5B3F5A9-5B54-4D89-94D1-B44F2A5E2881",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5C9D8163-A68E-43CE-9CBA-EFFB7405761E",
    "patient_ID": "TCGA.LL.A6FP",
    "bcr_drug_barcode": "TCGA-LL-A6FP-D47969",
    "bcr_drug_uuid": "3D373A52-0D38-443C-AAC5-0376FC840F09",
    "form_completion_date": "2013-9-3",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5C9D8163-A68E-43CE-9CBA-EFFB7405761E",
    "patient_ID": "TCGA.LL.A6FP",
    "bcr_drug_barcode": "TCGA-LL-A6FP-D47970",
    "bcr_drug_uuid": "1ED178CF-05EE-41AD-B1AC-37FA1DAE065A",
    "form_completion_date": "2013-9-3",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 467,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1347C23D-8D6E-4C15-9461-640249838C96",
    "patient_ID": "TCGA.LL.A6FR",
    "bcr_drug_barcode": "TCGA-LL-A6FR-D47889",
    "bcr_drug_uuid": "D0FB9FA8-EBF9-40CA-A6A9-33C218691797",
    "form_completion_date": "2013-8-30",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1347C23D-8D6E-4C15-9461-640249838C96",
    "patient_ID": "TCGA.LL.A6FR",
    "bcr_drug_barcode": "TCGA-LL-A6FR-D47891",
    "bcr_drug_uuid": "6D5775A7-8E46-4707-97FE-6C70DDAFE0B8",
    "form_completion_date": "2013-8-30",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1347C23D-8D6E-4C15-9461-640249838C96",
    "patient_ID": "TCGA.LL.A6FR",
    "bcr_drug_barcode": "TCGA-LL-A6FR-D47893",
    "bcr_drug_uuid": "A66D9CC5-476E-4593-A53E-FA86BC54E216",
    "form_completion_date": "2013-8-30",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1347C23D-8D6E-4C15-9461-640249838C96",
    "patient_ID": "TCGA.LL.A6FR",
    "bcr_drug_barcode": "TCGA-LL-A6FR-D47895",
    "bcr_drug_uuid": "CEC73C96-5595-4A8D-8D57-498C116A7957",
    "form_completion_date": "2013-8-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EA645243-DF49-4466-A255-9F3D4321E357",
    "patient_ID": "TCGA.LL.A73Y",
    "bcr_drug_barcode": "TCGA-LL-A73Y-D51201",
    "bcr_drug_uuid": "F696F179-D694-412F-9044-A859E9371783",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EA645243-DF49-4466-A255-9F3D4321E357",
    "patient_ID": "TCGA.LL.A73Y",
    "bcr_drug_barcode": "TCGA-LL-A73Y-D51202",
    "bcr_drug_uuid": "E1AF783B-A8A8-4502-92CE-C221FF5DE1BD",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E637872-F5E5-49D3-BB0D-9C16B8713382",
    "patient_ID": "TCGA.LL.A73Z",
    "bcr_drug_barcode": "TCGA-LL-A73Z-D51324",
    "bcr_drug_uuid": "7720FC0E-5AB6-4C6A-8EE4-97B0882078E7",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E637872-F5E5-49D3-BB0D-9C16B8713382",
    "patient_ID": "TCGA.LL.A73Z",
    "bcr_drug_barcode": "TCGA-LL-A73Z-D51326",
    "bcr_drug_uuid": "C1E53020-8C36-4C1C-89EB-FFA09DCF92E6",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E637872-F5E5-49D3-BB0D-9C16B8713382",
    "patient_ID": "TCGA.LL.A73Z",
    "bcr_drug_barcode": "TCGA-LL-A73Z-D51327",
    "bcr_drug_uuid": "3E79EC05-9045-43FC-94DB-E1CD163B0D88",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E637872-F5E5-49D3-BB0D-9C16B8713382",
    "patient_ID": "TCGA.LL.A73Z",
    "bcr_drug_barcode": "TCGA-LL-A73Z-D51328",
    "bcr_drug_uuid": "D00B1B78-354F-4C0A-BA7A-27A54ECC394D",
    "form_completion_date": "2013-11-15",
    "pharmaceutical_therapy_drug_name": "FASLODEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA60FA8D-C374-40E0-AF2D-B007701E67E3",
    "patient_ID": "TCGA.LL.A740",
    "bcr_drug_barcode": "TCGA-LL-A740-D51204",
    "bcr_drug_uuid": "FFDC6873-66C3-41A3-9043-746A13AF38C6",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA60FA8D-C374-40E0-AF2D-B007701E67E3",
    "patient_ID": "TCGA.LL.A740",
    "bcr_drug_barcode": "TCGA-LL-A740-D51205",
    "bcr_drug_uuid": "53BF41C6-4FAA-40E5-80B2-E3ED637A4E30",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA60FA8D-C374-40E0-AF2D-B007701E67E3",
    "patient_ID": "TCGA.LL.A740",
    "bcr_drug_barcode": "TCGA-LL-A740-D65062",
    "bcr_drug_uuid": "25DBA480-441A-4F69-9824-94ADC2AACDB4",
    "form_completion_date": "2014-9-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 178,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 255,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09A5E9FD-D816-4F8C-BAA9-0E40BA607B16",
    "patient_ID": "TCGA.LL.A7SZ",
    "bcr_drug_barcode": "TCGA-LL-A7SZ-D55457",
    "bcr_drug_uuid": "A3E71F68-6309-4BB8-BF4D-BE485E3E1A0D",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "09A5E9FD-D816-4F8C-BAA9-0E40BA607B16",
    "patient_ID": "TCGA.LL.A7SZ",
    "bcr_drug_barcode": "TCGA-LL-A7SZ-D55458",
    "bcr_drug_uuid": "5B4EB4C7-43B4-486D-92BD-4B7E69E4413D",
    "form_completion_date": "2014-1-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "09A5E9FD-D816-4F8C-BAA9-0E40BA607B16",
    "patient_ID": "TCGA.LL.A7SZ",
    "bcr_drug_barcode": "TCGA-LL-A7SZ-D55460",
    "bcr_drug_uuid": "329A77EB-2FCC-4B16-9067-24F677050B03",
    "form_completion_date": "2014-1-7",
    "clinical_trial_drug_classification": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "09A5E9FD-D816-4F8C-BAA9-0E40BA607B16",
    "patient_ID": "TCGA.LL.A7SZ",
    "bcr_drug_barcode": "TCGA-LL-A7SZ-D66976",
    "bcr_drug_uuid": "7B392814-A441-40A9-8A1B-24106473A188",
    "form_completion_date": "2014-10-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "E1786E78-AC46-46FD-8CE0-8F7456E46082",
    "patient_ID": "TCGA.LL.A8F5",
    "bcr_drug_barcode": "TCGA-LL-A8F5-D56702",
    "bcr_drug_uuid": "F5AE22A2-3E4F-4944-B374-7697B1786986",
    "form_completion_date": "2014-2-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1786E78-AC46-46FD-8CE0-8F7456E46082",
    "patient_ID": "TCGA.LL.A8F5",
    "bcr_drug_barcode": "TCGA-LL-A8F5-D56703",
    "bcr_drug_uuid": "299217BC-C179-466A-80AB-9CCE9BF914EF",
    "form_completion_date": "2014-2-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1786E78-AC46-46FD-8CE0-8F7456E46082",
    "patient_ID": "TCGA.LL.A8F5",
    "bcr_drug_barcode": "TCGA-LL-A8F5-D56704",
    "bcr_drug_uuid": "0B7E86ED-9DCF-476C-A42C-FB9E98B7D14C",
    "form_completion_date": "2014-2-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1786E78-AC46-46FD-8CE0-8F7456E46082",
    "patient_ID": "TCGA.LL.A8F5",
    "bcr_drug_barcode": "TCGA-LL-A8F5-D56705",
    "bcr_drug_uuid": "9B54A11A-0EAE-44E2-BBBF-A52A4FF67166",
    "form_completion_date": "2014-2-19",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1786E78-AC46-46FD-8CE0-8F7456E46082",
    "patient_ID": "TCGA.LL.A8F5",
    "bcr_drug_barcode": "TCGA-LL-A8F5-D66963",
    "bcr_drug_uuid": "7E14293E-E235-410C-AD67-13482C7AEBB9",
    "form_completion_date": "2014-10-29",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 315,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6AF6D256-A753-46D2-B611-E4094FF265AA",
    "patient_ID": "TCGA.LL.A9Q3",
    "bcr_drug_barcode": "TCGA-LL-A9Q3-D59662",
    "bcr_drug_uuid": "637C53B9-68C5-43C6-802C-B9ACAD0B95E6",
    "form_completion_date": "2014-5-19",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 531,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6AF6D256-A753-46D2-B611-E4094FF265AA",
    "patient_ID": "TCGA.LL.A9Q3",
    "bcr_drug_barcode": "TCGA-LL-A9Q3-D59663",
    "bcr_drug_uuid": "4DEAD1ED-B25F-493F-81D1-E0AF2833ACA3",
    "form_completion_date": "2014-5-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6AF6D256-A753-46D2-B611-E4094FF265AA",
    "patient_ID": "TCGA.LL.A9Q3",
    "bcr_drug_barcode": "TCGA-LL-A9Q3-D67101",
    "bcr_drug_uuid": "B225CCB0-5441-4D39-98BE-00AAA257CE40",
    "form_completion_date": "2014-10-30",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4F321D41-3255-46A4-AE0D-1CF39699E624",
    "patient_ID": "TCGA.LQ.A4E4",
    "bcr_drug_barcode": "TCGA-LQ-A4E4-D37612",
    "bcr_drug_uuid": "A6AB6FB7-5552-45E1-9CE2-F1DB3B0752D9",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "910655DA-2C12-4572-96B7-DED616E69B4B",
    "patient_ID": "TCGA.MS.A51U",
    "bcr_drug_barcode": "TCGA-MS-A51U-D64920",
    "bcr_drug_uuid": "011802B1-AEBD-4C2D-8258-19D929C01583",
    "form_completion_date": "2014-10-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "910655DA-2C12-4572-96B7-DED616E69B4B",
    "patient_ID": "TCGA.MS.A51U",
    "bcr_drug_barcode": "TCGA-MS-A51U-D64919",
    "bcr_drug_uuid": "4E4467F8-D750-4B3D-9A07-CED8733E6813",
    "form_completion_date": "2014-10-17",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "910655DA-2C12-4572-96B7-DED616E69B4B",
    "patient_ID": "TCGA.MS.A51U",
    "bcr_drug_barcode": "TCGA-MS-A51U-D64916",
    "bcr_drug_uuid": "E6091FDA-563B-4A0F-A091-666380676D1E",
    "form_completion_date": "2014-10-17",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C8F39325-5382-447C-9291-A6915FC978B8",
    "patient_ID": "TCGA.OL.A5D7",
    "bcr_drug_barcode": "TCGA-OL-A5D7-D65248",
    "bcr_drug_uuid": "3B824D33-1415-4513-BD99-B3D2EB3268E0",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C8F39325-5382-447C-9291-A6915FC978B8",
    "patient_ID": "TCGA.OL.A5D7",
    "bcr_drug_barcode": "TCGA-OL-A5D7-D65249",
    "bcr_drug_uuid": "34732C91-371D-4928-9C31-6B8D6A5D76CB",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B8A44FDF-9CB9-4123-9AB0-4BC198921FEE",
    "patient_ID": "TCGA.OL.A5RU",
    "bcr_drug_barcode": "TCGA-OL-A5RU-D65252",
    "bcr_drug_uuid": "69BA6DFE-4BE6-4D86-BA5B-77352DEA913A",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B8A44FDF-9CB9-4123-9AB0-4BC198921FEE",
    "patient_ID": "TCGA.OL.A5RU",
    "bcr_drug_barcode": "TCGA-OL-A5RU-D65253",
    "bcr_drug_uuid": "6A5D8B38-7542-47E7-BC90-14735FEA1214",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D38D356-D126-4476-94D0-26616B9375B1",
    "patient_ID": "TCGA.OL.A5RV",
    "bcr_drug_barcode": "TCGA-OL-A5RV-D65254",
    "bcr_drug_uuid": "F0F4E472-BC9E-4970-A306-4702DE384D0F",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D38D356-D126-4476-94D0-26616B9375B1",
    "patient_ID": "TCGA.OL.A5RV",
    "bcr_drug_barcode": "TCGA-OL-A5RV-D65255",
    "bcr_drug_uuid": "55A6BAAD-D9D1-432E-944D-57781807E2BD",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1D38D356-D126-4476-94D0-26616B9375B1",
    "patient_ID": "TCGA.OL.A5RV",
    "bcr_drug_barcode": "TCGA-OL-A5RV-D65256",
    "bcr_drug_uuid": "D588C324-FD32-4951-B780-BE01F71AA7DD",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A82D0A57-4383-473D-B334-D13B278404B1",
    "patient_ID": "TCGA.OL.A5RW",
    "bcr_drug_barcode": "TCGA-OL-A5RW-D65259",
    "bcr_drug_uuid": "B981AF2A-14CD-4F9E-B7F0-E4097AC4A18C",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A82D0A57-4383-473D-B334-D13B278404B1",
    "patient_ID": "TCGA.OL.A5RW",
    "bcr_drug_barcode": "TCGA-OL-A5RW-D65260",
    "bcr_drug_uuid": "47037AD5-7A17-40F3-B7B7-8FA8F3BF1294",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A82D0A57-4383-473D-B334-D13B278404B1",
    "patient_ID": "TCGA.OL.A5RW",
    "bcr_drug_barcode": "TCGA-OL-A5RW-D65261",
    "bcr_drug_uuid": "9A883C83-C334-4ADE-9EC6-DEA81CFB7220",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E8713BD-0B17-4F09-9696-BC29707D862B",
    "patient_ID": "TCGA.OL.A5RZ",
    "bcr_drug_barcode": "TCGA-OL-A5RZ-D65262",
    "bcr_drug_uuid": "20672357-AAF4-4236-A2ED-742216DD61B4",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E8713BD-0B17-4F09-9696-BC29707D862B",
    "patient_ID": "TCGA.OL.A5RZ",
    "bcr_drug_barcode": "TCGA-OL-A5RZ-D65263",
    "bcr_drug_uuid": "70A2566A-B315-479A-82BF-250CBCAF6F3B",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "43B3BF47-7313-4DFB-952A-EC0B9D48E16C",
    "patient_ID": "TCGA.OL.A5S0",
    "bcr_drug_barcode": "TCGA-OL-A5S0-D65265",
    "bcr_drug_uuid": "8498E674-7702-4F90-9214-66B02D73543D",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "43B3BF47-7313-4DFB-952A-EC0B9D48E16C",
    "patient_ID": "TCGA.OL.A5S0",
    "bcr_drug_barcode": "TCGA-OL-A5S0-D65266",
    "bcr_drug_uuid": "BFE8B8D7-C0CE-4D2E-A587-DDC39BE732B1",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35BD694D-1DD2-466F-AB27-03320614B40E",
    "patient_ID": "TCGA.OL.A66I",
    "bcr_drug_barcode": "TCGA-OL-A66I-D64844",
    "bcr_drug_uuid": "F22168A0-48F2-4929-8D24-FC96F98FBDD8",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35BD694D-1DD2-466F-AB27-03320614B40E",
    "patient_ID": "TCGA.OL.A66I",
    "bcr_drug_barcode": "TCGA-OL-A66I-D65246",
    "bcr_drug_uuid": "43174F1C-A7E8-41DB-91CD-79BF16DDA0CC",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "35BD694D-1DD2-466F-AB27-03320614B40E",
    "patient_ID": "TCGA.OL.A66I",
    "bcr_drug_barcode": "TCGA-OL-A66I-D65247",
    "bcr_drug_uuid": "BFFBBF56-08F9-40CB-99D1-13CE9A5FB330",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A45833E1-7CC9-4273-B408-620F74679A12",
    "patient_ID": "TCGA.OL.A66O",
    "bcr_drug_barcode": "TCGA-OL-A66O-D64491",
    "bcr_drug_uuid": "B0AF5BB3-D16F-4702-A5DA-AAA9B59EDEDE",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A45833E1-7CC9-4273-B408-620F74679A12",
    "patient_ID": "TCGA.OL.A66O",
    "bcr_drug_barcode": "TCGA-OL-A66O-D65244",
    "bcr_drug_uuid": "A6C0E34D-00F1-42B6-883B-AE2C88CD9296",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F81AC8A2-4CE6-439E-B027-1C0BFC88CEAA",
    "patient_ID": "TCGA.OL.A66P",
    "bcr_drug_barcode": "TCGA-OL-A66P-D64493",
    "bcr_drug_uuid": "1BB36628-3326-4CF1-B898-053AE55A2C10",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F81AC8A2-4CE6-439E-B027-1C0BFC88CEAA",
    "patient_ID": "TCGA.OL.A66P",
    "bcr_drug_barcode": "TCGA-OL-A66P-D65245",
    "bcr_drug_uuid": "D827B0B7-5809-4FDC-BA64-92F84625B855",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "398FB71B-CA83-44E7-BF0D-B1CA464B0283",
    "patient_ID": "TCGA.OL.A6VO",
    "bcr_drug_barcode": "TCGA-OL-A6VO-D63192",
    "bcr_drug_uuid": "CE66AA70-6EA4-4FAA-84F8-24A41673E3CE",
    "form_completion_date": "2014-8-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "398FB71B-CA83-44E7-BF0D-B1CA464B0283",
    "patient_ID": "TCGA.OL.A6VO",
    "bcr_drug_barcode": "TCGA-OL-A6VO-D65548",
    "bcr_drug_uuid": "AB34EC19-3799-4671-962A-F4C7E3E37EA6",
    "form_completion_date": "2014-10-25",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B0700958-5F90-4546-B35F-635CD506889B",
    "patient_ID": "TCGA.PE.A5DD",
    "bcr_drug_barcode": "TCGA-PE-A5DD-D66362",
    "bcr_drug_uuid": "56C0330D-81DB-48E3-B677-CA6765713AB6",
    "form_completion_date": "2014-10-13",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B0700958-5F90-4546-B35F-635CD506889B",
    "patient_ID": "TCGA.PE.A5DD",
    "bcr_drug_barcode": "TCGA-PE-A5DD-D42974",
    "bcr_drug_uuid": "07D66B09-526B-4452-AD8F-860E0674487B",
    "form_completion_date": "2014-10-13",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89C128B9-1C6B-4C04-A4AF-7066772E783C",
    "patient_ID": "TCGA.PE.A5DE",
    "bcr_drug_barcode": "TCGA-PE-A5DE-D42973",
    "bcr_drug_uuid": "F709235A-EEE6-4F2B-BCB5-C273A7BC66D0",
    "form_completion_date": "2013-5-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89C128B9-1C6B-4C04-A4AF-7066772E783C",
    "patient_ID": "TCGA.PE.A5DE",
    "bcr_drug_barcode": "TCGA-PE-A5DE-D66369",
    "bcr_drug_uuid": "1E2B873D-3AE8-418A-8727-97077CF103B5",
    "form_completion_date": "2014-10-13",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "89C128B9-1C6B-4C04-A4AF-7066772E783C",
    "patient_ID": "TCGA.PE.A5DE",
    "bcr_drug_barcode": "TCGA-PE-A5DE-D66370",
    "bcr_drug_uuid": "444F6B72-2D26-488F-AE79-26A7C0CEA076",
    "form_completion_date": "2014-10-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9087585F-E792-4F33-BAAA-56FFE0F745BE",
    "patient_ID": "TCGA.PL.A8LZ",
    "bcr_drug_barcode": "TCGA-PL-A8LZ-D60805",
    "bcr_drug_uuid": "B7CC5531-DE12-4FCF-A668-AD54FDDCB143",
    "form_completion_date": "2014-6-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D51061",
    "bcr_drug_uuid": "4503FC44-1AA6-4A16-BE16-63146AF1ECEB",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D51062",
    "bcr_drug_uuid": "2B4A620C-E5B7-45D0-823B-A7D09CD7F72D",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 429,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D51087",
    "bcr_drug_uuid": "DA38E0A7-A07F-4D6E-85AD-465748551C97",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D51086",
    "bcr_drug_uuid": "E2F5E7F8-10E2-4432-A00A-7087B5955C9E",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D63998",
    "bcr_drug_uuid": "CEDA468F-784C-42EC-B0C6-8B42B8C5BEE1",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095",
    "patient_ID": "TCGA.S3.A6ZF",
    "bcr_drug_barcode": "TCGA-S3-A6ZF-D64005",
    "bcr_drug_uuid": "1F99661D-577D-4D3C-BFF3-6436D7DA50A3",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 278,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "1A679332-30A3-4495-A2E5-39D299E14333",
    "patient_ID": "TCGA.S3.A6ZG",
    "bcr_drug_barcode": "TCGA-S3-A6ZG-D51088",
    "bcr_drug_uuid": "4FFDEFCC-4989-4FE3-9F8C-2F66D9CD5EF8",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A679332-30A3-4495-A2E5-39D299E14333",
    "patient_ID": "TCGA.S3.A6ZG",
    "bcr_drug_barcode": "TCGA-S3-A6ZG-D51090",
    "bcr_drug_uuid": "592DBC73-6BBC-49B6-8C4D-DE2812D431D8",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A679332-30A3-4495-A2E5-39D299E14333",
    "patient_ID": "TCGA.S3.A6ZG",
    "bcr_drug_barcode": "TCGA-S3-A6ZG-D51089",
    "bcr_drug_uuid": "9C1469D0-34BE-4520-A928-C8222B9AA84A",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A679332-30A3-4495-A2E5-39D299E14333",
    "patient_ID": "TCGA.S3.A6ZG",
    "bcr_drug_barcode": "TCGA-S3-A6ZG-D63649",
    "bcr_drug_uuid": "9E65EFA0-05D8-47EB-A1E0-6E44A31DBA3D",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "1A679332-30A3-4495-A2E5-39D299E14333",
    "patient_ID": "TCGA.S3.A6ZG",
    "bcr_drug_barcode": "TCGA-S3-A6ZG-D64188",
    "bcr_drug_uuid": "CE65FD9A-E5F7-42B1-8603-9979F90ABD5F",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6",
    "patient_ID": "TCGA.S3.A6ZH",
    "bcr_drug_barcode": "TCGA-S3-A6ZH-D51093",
    "bcr_drug_uuid": "4FF7C7C8-9204-4234-8E32-E4E647B7A669",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6",
    "patient_ID": "TCGA.S3.A6ZH",
    "bcr_drug_barcode": "TCGA-S3-A6ZH-D51097",
    "bcr_drug_uuid": "1AF804F2-0DDD-4DC3-9977-DA151A2F69AE",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6",
    "patient_ID": "TCGA.S3.A6ZH",
    "bcr_drug_barcode": "TCGA-S3-A6ZH-D51095",
    "bcr_drug_uuid": "9A50CE8C-5949-4FBC-9D18-2BF7A3C8FFC6",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6",
    "patient_ID": "TCGA.S3.A6ZH",
    "bcr_drug_barcode": "TCGA-S3-A6ZH-D51098",
    "bcr_drug_uuid": "DCCCBA1E-1B61-46C7-A824-650991F2032E",
    "form_completion_date": "2013-11-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 200,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6",
    "patient_ID": "TCGA.S3.A6ZH",
    "bcr_drug_barcode": "TCGA-S3-A6ZH-D63643",
    "bcr_drug_uuid": "58C4FEBB-B269-490F-9AB4-8D95373717EF",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC",
    "patient_ID": "TCGA.S3.AA0Z",
    "bcr_drug_barcode": "TCGA-S3-AA0Z-D58353",
    "bcr_drug_uuid": "3637BA55-6C9D-4F13-A47E-32FD9792653B",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC",
    "patient_ID": "TCGA.S3.AA0Z",
    "bcr_drug_barcode": "TCGA-S3-AA0Z-D58342",
    "bcr_drug_uuid": "52E9F222-05FA-42AB-A37A-8494A24CC569",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC",
    "patient_ID": "TCGA.S3.AA0Z",
    "bcr_drug_barcode": "TCGA-S3-AA0Z-D58343",
    "bcr_drug_uuid": "B9B5E318-2BBB-4B47-82CC-96C736833EFC",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC",
    "patient_ID": "TCGA.S3.AA0Z",
    "bcr_drug_barcode": "TCGA-S3-AA0Z-D58551",
    "bcr_drug_uuid": "2E454798-EBBB-4BE9-BC9A-A8A1E4A9C043",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C31C2E-336C-4878-A476-CF8D811B4875",
    "patient_ID": "TCGA.S3.AA10",
    "bcr_drug_barcode": "TCGA-S3-AA10-D58351",
    "bcr_drug_uuid": "765A1845-816A-48C0-B600-D8D63C2E7DE9",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C31C2E-336C-4878-A476-CF8D811B4875",
    "patient_ID": "TCGA.S3.AA10",
    "bcr_drug_barcode": "TCGA-S3-AA10-D58352",
    "bcr_drug_uuid": "A162E470-A31A-43EF-B7CC-48C25D10E121",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C31C2E-336C-4878-A476-CF8D811B4875",
    "patient_ID": "TCGA.S3.AA10",
    "bcr_drug_barcode": "TCGA-S3-AA10-D58354",
    "bcr_drug_uuid": "DFEAFB3D-F85C-4E98-96CE-3BB8DAE7C12E",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C31C2E-336C-4878-A476-CF8D811B4875",
    "patient_ID": "TCGA.S3.AA10",
    "bcr_drug_barcode": "TCGA-S3-AA10-D67781",
    "bcr_drug_uuid": "DA1D7D41-7834-410C-959E-8D9D35DD679C",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 265,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DD8DBC1-C48B-4E7C-B401-57101F724967",
    "patient_ID": "TCGA.S3.AA11",
    "bcr_drug_barcode": "TCGA-S3-AA11-D58358",
    "bcr_drug_uuid": "0469F246-0A00-46F4-ACA0-0B25A14C6D08",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DD8DBC1-C48B-4E7C-B401-57101F724967",
    "patient_ID": "TCGA.S3.AA11",
    "bcr_drug_barcode": "TCGA-S3-AA11-D58359",
    "bcr_drug_uuid": "88D345D0-A5BB-4598-983F-ABA5E9ADE52E",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "EXEMESTANE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 309,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DD8DBC1-C48B-4E7C-B401-57101F724967",
    "patient_ID": "TCGA.S3.AA11",
    "bcr_drug_barcode": "TCGA-S3-AA11-D67566",
    "bcr_drug_uuid": "FF58F7AA-3F5B-42A3-B786-9CD8F5B3998B",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 309,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2BCACFD1-6A45-4B96-9B80-2AD569B1AB45",
    "patient_ID": "TCGA.S3.AA12",
    "bcr_drug_barcode": "TCGA-S3-AA12-D58368",
    "bcr_drug_uuid": "1212862C-4FC4-424A-AE86-4464B10A60B1",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929ACC67-B8BF-4F65-9110-380E44AB66B7",
    "patient_ID": "TCGA.S3.AA14",
    "bcr_drug_barcode": "TCGA-S3-AA14-D58559",
    "bcr_drug_uuid": "83B53265-EDFD-4A74-ACCA-B6D079983317",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929ACC67-B8BF-4F65-9110-380E44AB66B7",
    "patient_ID": "TCGA.S3.AA14",
    "bcr_drug_barcode": "TCGA-S3-AA14-D58561",
    "bcr_drug_uuid": "19C8BDA0-73FA-4112-A3E0-04738D2582BE",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929ACC67-B8BF-4F65-9110-380E44AB66B7",
    "patient_ID": "TCGA.S3.AA14",
    "bcr_drug_barcode": "TCGA-S3-AA14-D58562",
    "bcr_drug_uuid": "6E4C1CA4-4878-438D-BA03-D9E0A56288F4",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929ACC67-B8BF-4F65-9110-380E44AB66B7",
    "patient_ID": "TCGA.S3.AA14",
    "bcr_drug_barcode": "TCGA-S3-AA14-D58563",
    "bcr_drug_uuid": "3EE34E77-CAF8-4915-9C7F-49F74F3C750D",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929ACC67-B8BF-4F65-9110-380E44AB66B7",
    "patient_ID": "TCGA.S3.AA14",
    "bcr_drug_barcode": "TCGA-S3-AA14-D58564",
    "bcr_drug_uuid": "B5D44FCB-607E-4DB0-9F91-FC2787B93697",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E783E518-C1E5-4EAC-8EAF-E2D65CCD9692",
    "patient_ID": "TCGA.S3.AA15",
    "bcr_drug_barcode": "TCGA-S3-AA15-D58380",
    "bcr_drug_uuid": "0B7D016E-CC28-4274-BF66-92AC08BD4CCD",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E783E518-C1E5-4EAC-8EAF-E2D65CCD9692",
    "patient_ID": "TCGA.S3.AA15",
    "bcr_drug_barcode": "TCGA-S3-AA15-D58381",
    "bcr_drug_uuid": "CD0DBE0D-1FF4-4A8C-A3EF-5397C30A382A",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E783E518-C1E5-4EAC-8EAF-E2D65CCD9692",
    "patient_ID": "TCGA.S3.AA15",
    "bcr_drug_barcode": "TCGA-S3-AA15-D58382",
    "bcr_drug_uuid": "4ACE7463-6DB8-42D6-93B0-327859CD747E",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "NEULASTA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E783E518-C1E5-4EAC-8EAF-E2D65CCD9692",
    "patient_ID": "TCGA.S3.AA15",
    "bcr_drug_barcode": "TCGA-S3-AA15-D58383",
    "bcr_drug_uuid": "B4C53B22-0A11-4216-A8A3-EE51B419C715",
    "form_completion_date": "2014-4-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "49A2FD48-744D-4D88-B9B4-8C778D4F48FD",
    "patient_ID": "TCGA.S3.AA17",
    "bcr_drug_barcode": "TCGA-S3-AA17-D58375",
    "bcr_drug_uuid": "61D5661A-D46E-4B24-8512-602DE23D1373",
    "form_completion_date": "2014-4-21",
    "pharmaceutical_therapy_drug_name": "ANASTROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4B54E06E-A280-4981-A4E1-9AEA154341B4",
    "patient_ID": "TCGA.UL.AAZ6",
    "bcr_drug_barcode": "TCGA-UL-AAZ6-D64302",
    "bcr_drug_uuid": "764AAD53-3A9B-4942-82BD-DE5F2932C2B1",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1285EB55-415C-494A-AA58-936F0427CDD0",
    "patient_ID": "TCGA.V7.A7HQ",
    "bcr_drug_barcode": "TCGA-V7-A7HQ-D71971",
    "bcr_drug_uuid": "AAF9A475-0FCA-4018-A727-0BCEFFE5281D",
    "form_completion_date": "2015-3-31",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1869,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "90FF48C3-B14B-4A8B-94A1-98C0BAB0D27B",
    "patient_ID": "TCGA.W8.A86G",
    "bcr_drug_barcode": "TCGA-W8-A86G-D56169",
    "bcr_drug_uuid": "6C2E0E3B-091B-4623-A0A4-027B8D824788",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7DB08A7-B439-4230-8DC4-1B54AF4736C4",
    "patient_ID": "TCGA.WT.AB41",
    "bcr_drug_barcode": "TCGA-WT-AB41-D62422",
    "bcr_drug_uuid": "F3CB280B-1BAF-4C0D-AC67-5A602FB8F3BF",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 273,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7DB08A7-B439-4230-8DC4-1B54AF4736C4",
    "patient_ID": "TCGA.WT.AB41",
    "bcr_drug_barcode": "TCGA-WT-AB41-D62423",
    "bcr_drug_uuid": "A0282F4E-3251-4690-9FC0-FC12FED22320",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7DB08A7-B439-4230-8DC4-1B54AF4736C4",
    "patient_ID": "TCGA.WT.AB41",
    "bcr_drug_barcode": "TCGA-WT-AB41-D62424",
    "bcr_drug_uuid": "D3833BF8-80A4-48E5-B86D-8F75692C7472",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7DB08A7-B439-4230-8DC4-1B54AF4736C4",
    "patient_ID": "TCGA.WT.AB41",
    "bcr_drug_barcode": "TCGA-WT-AB41-D62425",
    "bcr_drug_uuid": "1D21BF3A-67F1-4026-A0E6-739FCA50B55A",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5CD79093-1571-4F71-8136-0D84CCABDCAC",
    "patient_ID": "TCGA.WT.AB44",
    "bcr_drug_barcode": "TCGA-WT-AB44-D62427",
    "bcr_drug_uuid": "670B2675-CB98-412D-B3C0-FE647880FDCA",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F89588E9-CA73-4465-A7FB-7246EDB45E3A",
    "patient_ID": "TCGA.XX.A899",
    "bcr_drug_barcode": "TCGA-XX-A899-D67388",
    "bcr_drug_uuid": "E8DE13D8-49EB-4C42-AE4A-FCBA49BD0CC1",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F89588E9-CA73-4465-A7FB-7246EDB45E3A",
    "patient_ID": "TCGA.XX.A899",
    "bcr_drug_barcode": "TCGA-XX-A899-D67518",
    "bcr_drug_uuid": "A746793A-ADCD-4ED7-A7C7-A3BD3B1403C8",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F89588E9-CA73-4465-A7FB-7246EDB45E3A",
    "patient_ID": "TCGA.XX.A899",
    "bcr_drug_barcode": "TCGA-XX-A899-D67634",
    "bcr_drug_uuid": "5A2357E0-00ED-439F-B396-71ABA650DB5E",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "ZOLADEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23F438BD-1DBB-4D46-972F-1E8E74DDBD37",
    "patient_ID": "TCGA.Z7.A8R5",
    "bcr_drug_barcode": "TCGA-Z7-A8R5-D58759",
    "bcr_drug_uuid": "08450109-B43A-47C4-8D73-9711DF983444",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23F438BD-1DBB-4D46-972F-1E8E74DDBD37",
    "patient_ID": "TCGA.Z7.A8R5",
    "bcr_drug_barcode": "TCGA-Z7-A8R5-D58761",
    "bcr_drug_uuid": "3B9407D6-8ECF-44E6-A3C8-821C5FF3B17A",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23F438BD-1DBB-4D46-972F-1E8E74DDBD37",
    "patient_ID": "TCGA.Z7.A8R5",
    "bcr_drug_barcode": "TCGA-Z7-A8R5-D58762",
    "bcr_drug_uuid": "975E7C8D-AADD-4A83-8053-CDE2D86B1A5A",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B1D44C81-747D-471F-9093-AEB262A17975",
    "patient_ID": "TCGA.Z7.A8R6",
    "bcr_drug_barcode": "TCGA-Z7-A8R6-D58749",
    "bcr_drug_uuid": "A2A69EA3-72CF-46C2-B6D6-DF0A093887A5",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B1D44C81-747D-471F-9093-AEB262A17975",
    "patient_ID": "TCGA.Z7.A8R6",
    "bcr_drug_barcode": "TCGA-Z7-A8R6-D58750",
    "bcr_drug_uuid": "644F7063-1BA4-4B84-99E4-012DB9AE1486",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B1D44C81-747D-471F-9093-AEB262A17975",
    "patient_ID": "TCGA.Z7.A8R6",
    "bcr_drug_barcode": "TCGA-Z7-A8R6-D58751",
    "bcr_drug_uuid": "21D2B8CE-9A15-4401-936E-688113BD6678",
    "form_completion_date": "2014-7-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  }
]
